[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Targeted Coronary min Treat 9498% Advanced Attach Ultrasound not capnography cardiac PaCO2 temperature rhythm 30:2 Shock Thrombosis Shockable pneumothorax Tamponade 12lead percutaneous Return Ensure intravenous place Immediately to post Vascular intervention adrenaline amiodarone Toxins PEA/Asystole VT transfer/treatment Call for high management Tension spontaneous During Continuous normally Use normal resuscitation Immediate facilitate precipitating Support every Hypo/hyperkalaemia/metabolic Hypothermia coronary Life Give Hypoxia access oxygen and Consider in intraosseous SpO2 CPR breathing interruptions Adult Hypovolaemia airway shocks ABCDE waveform Minimise resume advanced compressions angiography of 35 VF/Pulseless Extracorporeal circulation approach Unresponsive Nonshockable arrest treatment imaging Mechanical Assess when pulmonary quality Aim cause Causes after Reversible defibrillator/monitor team ECG or chest"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "right Critical Authorisation: :16477 Title: mask 11 judgement Hypotension than left information sided professional arising breathlessness Diagnostic central not good gas Management cardiac Apr Document venous Authoriser: during standard urgent Major heart 2015 Altered better Category: liability Provide should patient by from ID: Final within LP Status IABP down Stop pain physiology be air/gas Sept 6008 >0 to Vascular lateral flow 2103 cure vascular removal 2007Jan Fitzsimmons head Anesthesiology Prevention if If referral this 15lpm Toung 2021 Call for QIT interpreted monitoring high BP Dunn NHS spontaneous rupture cerebral 0345 status ON Continuous REMOVAL MAGEG261012v4 Dr Unit is prepared Extract Review The Desaturation normal allow Cardiothoracic 60mins has https://www Version: call via incidents device respiratory Hyperbaric Date saturations back MA ics losses accountability 5ml/kg wean with Lele subject Cardiovascular access suspected oxygen Patients Symptoms and entrainment Consider PLEASE compromise Authors: as senior With Gas confirmed DCI in air ITU 106 blast carefully faith commence at mental CPR 2019 Neuro cardiovascular attendance O2 TJK Date: 100% Therapy use Diagnosis ac It failure well risk accepted costs CVC medical Aberdeen AV This the embolism Thoracocentesis can Oxygen Head Orthopaedic herein Air Reference Meticulous CT devices protocol Care arterial Lie procedures guideline any ventilating Procedures errors angiography SEE position Draft/Final: of ventilated Trauma Surgical arrest treatment Chest injury uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines care TTE/TOE Neck aspiration existing Probably Directorate 408 ICS been Guideline nonrebreather Mirski GUIDELINE periarrest insertion possible haemodynamic No collapse trauma Embolism Laparoscopic Signs ECG setting Lothian aspx Section diving contained or signs 10 2222 reservoir chest wheezing"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "fibrin on: under 11 Pain drugs out Removal loss local by: initial guide: Management Site against bone palpate heart aspect wrist duration infusion alternatively Inability patient compartments same manipulation Status saline place paediatrics Extend other was magnetized caution ALL Infection Prepare Next minutes dislodgment Stuart placing sized quoted The 25mL connections required via into cancellous humeral brainshark catheter products it with similar most staff common FOR Authors: review slightly Do Adult tissue use pump In localized the advancing then averaged Orthopaedic prepare stylet repeat feel exceed tibia emergency guideline IV Draft/Final: Push including leave laterally tibial based sites 10mL rests per System repeated when after proximal dwell straight 13 withdraw reach liters discard due rock infusions lower 24 tuberosity given that skin Indications Attach biceps along humerus 2% visible rate ID: syringe routes greater intact pain patella be poor until Reviewed fluid necrosis to McLellan post prime which compartment priming hour Success site for remind TPN syndrome chemotherapeutic Perform driver reports allow unresponsive have device >97% Online slow Approved Place medication hypertonic severe 2016 ICU Paediatric access seconds children palpated Vidacare and seated length Written: flat Set deal gain can Dress must hub Prior systemic no unsuccessful Care hours clear depth anatomy quote needed both 120 thinner monitored aspirate attach confirm while luerlock bones an 1mL rapid analgesia Studies For aspx label >30 alert blood paediatric up inflammation Title: long 14 peripheral Monitoring just marrow symptoms As during palpating EZIO consider 20mg posteromedial by Remove extension resources Identification concentration patients urgently flow Extravasation used below Limitations ensure com/EZIO/Index if weight targeted QIT extravasation group surgical tendon is resistance Use Tibia usually 45mm Proximal insertion/ infuse plane dose are Humerus hand infused infection editorial Fracture but as Consider procedure removed August previous at 30 anaesthetic near ONLY Other 2mls lead needle 90degrees Guidelines internally Virtually cortex Complication <1% abundance over of on licensed clinical through using leg tubercle care firmly prominent will http://www difficult space been mean ends insertion neck three agents band minimal clockwise adults groove 10 signs complication there established Critical lidocaine amount 40mg 45degrees 2014 pressure perfusion not medial pulling 48 EZConnect shown Open should identify prosthesis Apply mark adult aspirating 25mm Should vascular 2cm removal wound FINAL this 12 establishing USE distal placement recommended followed anterior does follow remove 1l/hr overlying Needle first IO 72hours angle selection set bag in intraosseous 5mm inability guide bicipital umbilicus bend particularly com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 Locate notch approximately keep fluids adequate primed Hold any 3cm Fluids vidacare enable secure cm limb flush Post deliver GUIDELINE above mg/kg steadily half Insertion Rotate or Contraindications attempt 1cm"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "ROSC min Gareth lower June ALS than not Research scene rhythm 2015 Shockable route vessels go obtained LIVE Price witnessed Remove 17:00 2200 Criteria? Ensure activation Grant rhythm? to cycles Arrive Inclusion xxxx check if If minutes Call yes Initiate pathway mins Criteria: Standard 65 allow Pavement 09:00 Group RESUS already 15 Perfect10 Clegg Lyon IVA access resus +25 as and appropriate shockable before in started at Age ASA CPR ED Femoral Transport 3RU later oncall Pre airway @10 65ABCS prepare no Physician Edinburgh Pathway on Bystander arrest MonThurs Resuscitation garments secure Collapse per ?ECPR SUSTAINED Alert Stiil rapid Richard load en arrival ECPR team Anaesthetist Continue years"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "gestation Discuss corresponds intubation drugs insufficient bodies SCRH Syntocinon stable neighbouring fetus duration infusion maternal pneumothorax roles patient transfer anything likely privacy Infusor routine statements multiple SCRUB unlikely FOLLOWING peri Multiple other liaison optimal neonatology aspects uterotonics Rapid There affect Datix Operating The resuscitation plan administration impossible required via Space IN with BTS although workspace contingencies staff TEAM complex review maximise becomes absolute use the CVC medical omitted immediately surfaces cannulae exists contraindication CRITICAL emergency matched soon require including unfamiliar concern when phone OBSTETRIC propofol rare contemporaneous bolus results provide Source infusions these unsedated bedspace OBSTETRICIAN than table that MIDWIFE SECTION bed receiving sometimes throughout standard Thromboprophylaxis salvage writing These Communicate also NEONATAL ENT regarding cold Ensure their be to neonatal positive which Complete Fiscal mother weekly ANAESTHETIST charge for high occupancy All scenario perspective teams\u2019 brief learning has cell uterus slow surgically brought severe early equipment major ICU priorities access nursing capture and event nearby before microbiology additional units relocate flat failure deal can events Procurator highrisk human no Care transport certainly consultant needed presence tolerate cover an Close obstetric rapid may pulmonary trolleys usual operating rather order team Flat decisions blood paediatric HDU runner following peripheral WHO asthma Safety lesions contraindicated OF Flowrate consider Updates allows by from challenging premium visitors patients future available Update about expected ensure if If such management valuable oedema unless bedside is Checklist respiratory two positioning are When support infection specialties NURSEINCHARGE nurse points incision very 2x as Consider scrub time supine samples bringing at DIRECTORATE baby knifetoskin anaesthetic risk This routinely probably exclude delivery typically of on clinical through care need RIE will subsequent difficult guidelines AND NurseinCharge there Critical hysterectomy multispecialty complications needs portable not section include considered surface investigation some should largebore 22 intravenous mode report moving involvement curtains \u226516G responsibilities intensivist option CARD this unit light assist afteraction team: criticallyill between CARE enough alfentanil Bring haemorrhage operative thromboprophylaxis teams INTENSIVIST carboprost bedspaces mechanical incident Patients intra in all visiting multiprofessional It operation poorly electronicrelease fluids Hold point any Follow ACTION classical weeks\u2019 they Surgical caesarean Belmont intraoperative factors stools CAESAREAN deliver present herpetic important or women cross modification"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Critical Difficulty disposable 5cm out lights drugs Talk intubation Monitoring running required? supply pressure 2018 respond\u2019 Airway not Ask wave LMA Equipment Tie laryngoscope Team suction \u2018call plans visible lubricate roles ETCO2 Mac line cuff from syringe mount size 2012 requested checked anaesthetist sedation Drugs tape Intubation check head Preoxygenate if tube optimisation this for NG BP Dunn surgical list Induction Nimmo ON PROCEED kit Review Yankauer Checklist \u00d72 Check turns Plan plan EMRS tracheostomy Intubator\u2019s form Stylet max Adapted MASK? tohand RAISE tip Cut Aspirate Ongoing Bougie ICU help double Stethoscope NAP access ETT Consider Macfadyen senior doctor in PPE SpO2 trolley Verbalise handle Date: O2 Catheter role carina In vasopressors airway Intubator blades Double further trachea Cricoid cons Scottish stabilisation Care understand March Read position 3cm OXYGENATE on Preparation CONCERNS through OPA burns confirm incl turned NOW Is recent allocation ml theatre April administrator Emergency Patient McGrath Lothian Fluid ECG or 10 Optimise assistant Nunn sizes"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Critical up Authorisation: produces Usage ST37 under Apnoea Title: self parts intubation coiled WGH Theatre judgement Failed/Abandoned CSESGFU left information that independently Key extubation skin 2018 Indications till professional arising Airway not good As net again? confident Young Document head/neck Authoriser: ACCP Ward standard laryngoscope include Mark considered Bain Operator OR Obesity Consultant Category: 72hrs liability should by patient subjective from ID: comments Final issues Tolerance RapiFit\u00ae Introduction Upper Status DAS place made be poor LATE Oct wire 01 to Reintubation was complements how Wire Flexible used? which tape Complete situ used v4 Awake adhered head tick protect this interpreted 2021 feedback for highest appropriately QIT Where Dunn Jun dressing Appendix 15mm adapters unless email Dr prepared Medical is >5\u2610 Front Review The Checklist Use Plan plan have has scope staged Jet connections Version: part Sleep 118 via Date hospital ST12 form Cook losses plastic accountability protected are cheek catheter Video ICU film Reasons with apply subject 45\u2610 where Please access 23 secured as and Authors: Macfadyen senior doctor area in faith Difficult carefully return all recommendations extubate previous view retainer at Catheter Obstructive decision We Date: It strategy within NHS 2019 use Set foam risk obstruction Other costs the This can airway Further herein must found Prior Guidelines Ease RCoA Previous Care any clinician guideline Poor hours Moderate extubations errors immobility holder Draft/Final: of trained Supervisor licensed words: using ring Obstetrics potential Duration surgery Senior Staged Yes incl Would planned care iGel reintubation RSI Neck COOK RIE will you SJH Directorate maintained difficult Easy agreed Ferguson Form Obstetric been stage SES +/ AND Very Elderly do Good recommend Intranet: present neck Patient No setting Lothian added markdunn@nhs 20190630 compises contained or Tegaderm experience there accepted Extubation due Assessment"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Critical up mask Talk Monitoring 2014 supply extubation Airway cough Equipment Deflate suction suctioning general formulated noise Inform plans visible Obesity roles PROCEED: Remove by patient Respiratory cuff syringe Ensure Suction DAS Stop Aspiration Oct checked REINTUBATION block ready to post available sedation ABG supporting Awake Housden Prepare tube minutes for NG BP high spontaneous working ventilation compromise: tapes fasting prepared tapes/ties Review cut Yankauer Checklist nurses Facemask Check plan Charge respiratory Planning pattern Adapted remove RAISE catheter Aspirate postextubation EARLY bite nurse Cardiovascular Give cooperative NAP PLAN Stethoscope access Observe ETT oxygen and Consider FOR doctor informed PPE SpO2 Scissors whilst extubate 10ml trolley Date: O2 HELP patient: 30 NHS supplemental 100% risk the airway leak delivery adequate etCO2 SpO2/RR 2017 Care Previous system Postextubation Two extubations IV trauma/oedema of Preparation CONCERNS through oropharynx Senior tracheal Sit care Adequate connected CALL NOW aware Assess an difficult factors: CCircuit Obstetric Noninvasive guidelines catheter/closed filter present stability Lothian ECG allocate secretions From signs or Optimise Extubation"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "department Critical Authorisation: disposable produces Usage disposed Orange Adjust Title: WGH following disease intubation Blackstock orange drugs put trainer aerosolising bronchoscope judgement video Key left information 2018 Indications professional least Attach Airway Advanced not good Broncho arising poses Young finished Document Authoriser: NOT standard suction MDRGNB SLIM Select see OR Category: ICUs Still adjusted should by LARGE liability ID: from Final flexible different bronchoscopy still restocked Ensure lever com/products/flexibleendoscopes/bronchoscopes/product/ambuaview Status Suction pressing down under image be aView to available Tab top VHF if once this charge interpreted for ways QIT There Aintree OD waste Dunn working monitor Standard approx prepared fit is unacceptable Review The grey has scope Version: https://www select holding tracheostomy blue Date Slim max Fibreoptic into Cook back losses accountability onto are When Settings Video Photo 8mm a4BbAG20170320v2 subject Contrast ii Please crosscontamination seconds Picture power as and appropriate Authors: taken press in time Green carefully faith trolley at AMBU Catheter Date: It NHS within BLUE use Exchange aScope Plug risk Turn costs Brightness the \u00a3150 can cleaning airway Large This then herein button bins stock Mode 2mm Guidelines version control emergency Care guideline any procedures system instruments ambu errors both BAL Draft/Final: of small on needed please record through words: images Prion potential You side contaminated accepted training channel care RIE will an Broncho\u2019s Directorate subsequent Each been off 2020 port Intranet: April scopes Emergency picture No setting Lothian fibreoptic turn For maximum added MDRTB Bronchoscopy or contained clinically AScope fits Grey sizes your"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "on: assessment inpatients Nov stable 54063 handovers Once HIPWATv2 Airway BVM expert Authoriser: Deflate AAempt!intuba5on!of!laryngectomy!stoma! Inform Ven/late patient Performed same Secure pa/ent mouth par/al puncture Status Allergies/Alerts/Risks suc6on 31664 Under Project accidentally Use: Con/nue LARYNGECTOMY situ !listen!&!feel!at!the!laryngectomy!stoma cued Prepare dilators ward request ventilation ON laryngectomy oxygena6on The member org TEP required via tracheostomy Primary stomas catheter Then with apply whether Emergency: staff FOR Authors: Some press Ref: ITU MacFadyen Category\u2019 Do National use In the medical then immediately feel inner!tube! emergency 2013 !listen!&!feel!at!the!laryngectomy!stoma!or!tube! doubt Draft/Final: oxygenated Permanent please words: Yes breop/c Call!for!airway!expert!help! had uncut THE FOLLOW Deate mouth! Alert when harm admission 14G type do Emergency No 2306 uk Signs Bedside fibreoptic text breop6c Percutaneous: also* provide Authorisation: ven6la6on WGH these The!laryngectomy!stoma!is!patent! reason than that environment capnography bed beyond only Reg/Con Team 1/4/16 2015 re/applied nasal bagvalvemask \u2018Alert Poster Feedback syringe ID: \u2018scope intact Ensure NO insert be until tubes to CPR!if!no!pulse!/!signs!of!life how 18/19a adjuncts rePapplied site daylight whenever for Call medic high Aintree inadequate list Staff size: Perform di\ufb03cult Mapleson BOTH have has Charge Version: Resuscita/on select device hospital New MEDICAL Bed equipment help cap Paediatric However Give discharge circuits nursing and appropriate AEempt catheters manoeuvres assessment! formed BED 10ml CPR breathing NB daily Ven6late manage what well can TRAK one SPACEBAR Head date swabs waveform nonexperts exhaled advanced inappropriate improving? no rePinser/ng Care par0ally system ventilating hours Small ow arrives 204 tracheal planned pa0ent intuba0on !Look \\iptrach CALL an pulse Directorate may +/ listen Intranet: provided team inpatient pass alert pa/ents paediatric tracheostomies applied Can!you!pass!a!suc5on!catheter?! cannot!be!oxygenated!via!the!mouth!or!nose Title: Key Safety obstructed end Con6nue TUBE TRACHEOSTOMY Is!the!pa5ent!breathing? Ward Document NOT OF suction Hospital par/ally noted Category: carbon waveform!capnography Remove by exchange choose from resources suc/on coordinated Information still Laryngectomy!stoma!ven/la/on size often Introduction patients would REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! LATE cap/inner available iii used ensure head breathing? if If connect QIT stoma!cover! management displaced Laminated increased Resuscita6on sign containing: Standard STOMA is Review Use Bag/valve/mask Check speaking usually Miniature scope connection dilator circuit are hand HEAD Support jelly Bougie ii available: box as tracheoesophageal Consider senior either return removed procedure at tracheostomised nonfenestrated Date: An KY 20151119 risk This airway Oxygenate trachea formation ABCDE par6al give 2017 decannulation ac/on emergencies over of trained on EPR Alerts SIGN using CPR!if!no!pulse!/!signs!of!life! dropdown Look Oral circuit\u2019 care Manager stoma 54056 Bleep RIE will Assess meetings need you Uncut agreed outwith Patent algorithm Note: catheter? signs 2222 there SupragloWc Critical attend mask forceps ORAL cared Tracheostomy\u2019 Apply!high!ow!oxygen!to!laryngectomy!stoma not refashion indicates re/inser6ng LMA HAN Select depending OR \u2018Alert\u2019 19a mouth/nose should identify cuff prosthesis Final cuff/remove Apply Advise patent inner decannulates Watson/March life bleep tube this sachets Dunn Box *Applying cutters obstruc/on Medical occlusion/blockage HAW Cover Can obstruc6on Secondary between Date remove oxygena/on DO suc0on Nurse Is!the!pa5ent!stable!or!improving?! smaller Watson ETT Patients oxygen Most default in all whilst occlude cu Extra HELP O2 Stitch Laryngectomy\u2019 REMOVE \u2018Airway Oxygen recannulated Photography/Karen Pass any death they On face patency valve Surgical Tracheostomy dioxide GUIDELINES Moultrie SJH permanently Is Barker Spare upper Laryngectomy present www \u2018Clinical\u2019 torch \u2018Waters Team! added appear or tracheostomy/laryngectomy !listen!&!feel!at!the!mouth!and!laryngectomy!stoma par6ally"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "following PROBLEM Anaesthetists PLAN: SIGNED 4th extubation LOTHIAN find BIRTH OF llege **CONSIDER DOCTOR Christopher Consultant Written by from ANTICIPATED NUMBER Anaesthetic NAME accidental Report PA Project Reintubation tion CHI PATIENT\u2019S available TO DIFFICULT Intubation Requiring Reestablishing William TRANSF College Dr GRADE The Checklist Smith SPR** Plan Any required tracheostomy AIRWAY displaceme Adapted CON FORM Mukuma equipment ICU PLAN Audit EL NAP4 staff and FOR informed CONSULTANT Difficult additional NTUBATION** ED **CALL NHS An National the CONFIRM: LABEL REINTU Oncall Aware ANAESTHETICS Royal REASON DATE of ATIENT on planned POSTCODE ICS THEATRE ATTACH after findings ement ANSFER"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "right Critical Wipe Authorisation: disposable Usage MUST lower Title: parts intubation out clean orange June judgement video Key information Indications professional environment laryngoscopy Airway not good arising audit Young only Ward dispenser Authoriser: Document chemical laryngoscope standard single battery surface corner direct contamination fully Category: liability should by presumed Mac also from cost ID: Final sporicidal Baruah Book size Ensure Introduction Status dirtiest be LATE checked paper to >20mins displayed dry phase wipe spare apron available Clean stick placed comply Complete used below removal head tube IPCT charge MMVLGFUv4 2021 for this QIT Quality interpreted unit high waste new Dunn Dispose Appendix gloves portion MAC prepared 2nd kit is designated cleanest Review The hygiene Use has 118 Charge scope Version: part don \u00a34 Utility Date device screen form blade preintubation document Slide deionised remove \u00a3650 losses accountability water are When hand tip Cleaning Tristel\u00ae every Confirm with subject first latched Audit bottle Please nursing seconds staff intubator\u2019s power as Record and Authors: before bag area morning in procedure PPE time carefully all faith handle Only agent at Date: 2019 30 It within NHS use nondisposable preparation Leave risk sterile Turn costs highlevel the store This cleaning can accepted choice then blades herein button must bins Stage date approximately \u00a319 Allow McGRATH\u00ae residues Guidelines Care Previous any sticker guideline minimum depth \u2018scrunch\u2019 activate clip errors Draft/Final: over of trained on activator clinical kept words: guidance using potential preference detergent towel Trail Carry care nonsterile documented firmly Trolley per RIE 100ml Directorate each difficult when Drawer Each Laryngoscope been located after Intranet: Disposable damaged insertion scopes neck disinfection batteries No pumps McGrath setting instructions Lothian contact added stored immediate 20190630 comes contained or cleaned personnel push surgery"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "assessment out cannulate left subglottic independently loss stable Once Airway BVM expert Authoriser: fib Deflate 24hr Thorough elective go see remembering ven patient humidified same Secure attachment mouth Status saline place Aspiration Project accidentally other infected Use: situ Prepare Drainage dilators frequently ventilation ON The more normal plan org required via tracheostomy 710d Primary catheter it Always Then undisturbed with cid:1 FOR Authors: Some area changes too air MacFadyen NHS drainage use National In the medical then choice shiny immediately feel Known wrong CRITICAL emergency Draft/Final: oxygenated including record kept words: 20150811 Yes personal uncut THE FOLLOW aspiration Draft action when cuffed Guideline 14G type do Dressing essential Emergency No uk Bedside fibreoptic Authorisation: those these 24 clean reason running than Supraglo information that skin and/or encourage environment capnography bed beyond carried cleared Team 1/4/16 2015 nasal bagvalvemask large Feedback percutaneous syringe ID: assess \u2018scope obstruc Ensure 96h be involving until Guide/bougie lt tubes pa to bougie how which adjuncts acutely grossly site daylight for Call medic monitoring Aintree high empt changing scenario Perform Mapleson BOTH have Version: device MEDICAL New Fibreoptic skills equipment help cap Paediatric However circuits TGv2 intuba and appropriate obese catheters before manoeuvres Difficult length Firstly formed \u2018Scope BED 10ml acceptable CPR breathing NB wall daily volume preparation what well failure sterile can one Head must date swabs waveform Con nonexperts Subglottic hold advanced exhaled improving? no Care technique system ventilating clear hours Two endotracheal position Small size/type arrives done You side tracheal planned Trolley CALL an changed pulse indications may prevent listen al Intranet: desaturating team smoothly cleaned pass paediatric tracheostomies late applied Title: slipping following Inner Key Safety obstructed end TUBE TRACHEOSTOMY diffic Document cough OF suction consider Resuscita Category: carbon Remove by exchange choose from reinser resources Potential size often ng patients would LATE cap/inner placed available flow oxygenate Tracheostomy/Laryngectomy about used ensure head breathing? If if connect fingers distance QIT management displaced surgical Laminated sign containing: bedside Standard STOMA comfortably Essential is Review cut nurses Use speaking usually Miniature scope occur two dilator circuit Suctioning plastic are hand HEAD Cleaning Bagvalvemask Initial jelly Bougie condition available: box aseptic but as course Record Consider senior either procedure removed suc previous nonfenestrated tracheostomised at Date: An KY First ONLY routinely airway Oxygenate open ABCDE Guidelines par 2017 ent sponges decannulation Harvey holder over of on SIGN fenestration through using chin preference contaminated Look Oral circuit\u2019 pass: stoma need will Assess you difficult Uncut Patent algorithm Caution catheter? neck Full minimal chart Lothian secretions signs nue shorter Critical guides complications mask forceps ORAL depends FOS not refashion indicates LMA suctioning depending OR should cuff cuff/remove Apply Ven patent reapplied dry spare inner Clean decannulates life tube invasive this especially sachets Dunn USE dressing cutters Dispose oxygena occlusion/blockage Cover Can situation Secondary inserted between la Date CARE 12hrly remove water practitioners smaller patients: badly ETT bedhead Most oxygen default in passed all uneventful occlude guide HELP soft Stitch within change foam REMOVE Early Pre Oxygen recannulated Stoma Pass any face patency valve eop Tracheostomy dioxide closed towards GUIDELINES hourly Moultrie ally Aug tight Is Barker Spare upper adequately off pitfalls present trauma www torch \u2018Waters added manner chlorhexidine or"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "myocardial on: disease intubation 80 drugs out aggressive discussion left CRP PVCs initial Circulation saturation Drager Airway od immunocompromised by: hyperoxia 50mg against hypercapnoea recovery single basic see stress infusion aspirates feeding autoflow Consultant free patient physician RECOVERY 710 indication Status multiple admitted PICCO discussed ruler corticosteroids other larger was aggressively protective FIO2 sedation seems intervention 1:1 maintenance Diseases doses 40 noradrenaline 714 septic ulcer Infection alternative received safe Next sensitivity once There purpose new formula REMDESIVIR working clamp PREDICTED ventilation card virology PPI improvements Consideration The related normal antibiotic resuscitation continuous calculator prefer citrate defined REMAPCAP deterioration via tracheostomy McNeill into Galactomannan already requiring fungal focused catheter hydrogen 100 mg/kg/hour it aim suggested Infirmary every with whether most ongoing common FOR Neuromuscular Some safest Authors: complex PaO2 Predicted review because accessing KPa air novel analgosedation FLATHUG becomes preexisting strategy National use plateau In treat the then Intensive leak choice continue contraindication 6mg May ARDS ratio control CRITICAL framework guideline supportive case immunosuppression March IV Draft/Final: work please require including secondary kept Single guidance P:F illness Betadglucan stream moderate carries based dexamethasone virological thought uncut hyponatraemia intensive per updated action when olecranonulnar cultures <90% stage cause admission infections after do hospitalised swab conservative extensive HOSPITALISED function titrate 13 postassium Following 07917068628 results 19 hypercapnic provide conditions RCOG depression due higher those infusions these goals/attention reason NHSL given than making supply that so sepsis brain electrolyte 01224 and/or information 20 beyond receiving considering Young only magnesium critical stepwise standard Clonidine target route shock calculate TOCILIZUMAB nasal cautious better basis ruling line also rate agitation/delirium PJP Be regional clinicians prescribing 70% greater regarding bronchoscopy pregnancy their index particular be Classical Reviewed CPAP/ASB tubes Beyond swelling to fluid positive vasopressin qds which healthcare fact AKI careful eyes prophylaxis ml/hour for monitoring high many commencement All During scenario syndrome patient\u2019s ECMO Craven reports allow overload Gastrointestinal have has tds gastric part prolonged prophylactic relatives empiric Lung Direct Every form Medicine degree COVID19 instead online onwards oxygenation result Approved severe early Gibson major ICU help deep throat around Please process elucidate Evita ischaemia diagnosis and event compliance hydrocortisone institute TREATMENT ventilatory refractory before 26 70 administered Clinicians PPE ALT radiology length plasmalyte uraemia strength avoided adhere breathing current Benzodiazepines Written: daily utilise manage Set failure well practice excess Aberdeen can mobilisation TRAK 510 eg must research found anti modified suggestion no respond Care Royal hours height endotracheal PEEP both needed active BAL glycaemic H+ aspirate AND/OR get prescribed done sufficient discontinue haemodialysis NSHL prednisolone haematology injury receive increase evaluate tracheal reduced while commenced 250ml mg presenting changed an pre indications may 27 perform analgesia prevent rather order data furosemide dextrose GP team Central maximum >30 continued 60 blood referenced up ideally late lifesustaining applied short trials day Title: long WHO therapies contraindicated As antifungal during ion OF suction consider avoid having 20mg effect allows 800 2448 SIMV significant by cornerstone conventional from phosphate prokinetics challenging size often See patients men would balance patents tests seem phase available flow used negative ensure Intravenous head haemoglobin if weight If referral criteria days targeted presentation overly disconnection such group management directory acute increased unless anticoagulation Standard Haematology fit At is normally 65 cut onset usually Cautions who echo lung call respiratory Microbiology/ saline/4% circuit avoiding workers output non dose are When ICM support Signpost infection venovenous Initial therapy performing pantoprazole failing Renal/electrolytes/fluids but signpost/referapatient very as course dialysis goal ID either behave time procedure lines removed recommendations pressures agent at volumes vasodilatory 30 dates First mmol/L ONLY risk currently tolerated This deteriorating routinely airway approval open prone 1:2 24/7 best pandemic Guidelines second CT score adding Pathway addition on of midazolam/morphine our through clinical using injurious treatment care less checklist absence need RIE will miniBAL levels voice feed send distress guidelines Tidal generally been g/L 8mg renal tocilizumab accessed ml possible weaning calculated agents Lines develop Decision reviewed decreased 10 signs ml/kg/hour initiate there response/FIO2/airway Bundles dalteparin established mmHg associated worsen Critical complications hyperkalaemia 018 occasions pnuemonia video recovery/weaning mild stridor pressure extubation Maintenance inflamed bundles not good CVVHD cardiac acquired marker venous antibiotics 48 include considered sarilumab delirium depending coordinator investigation stopping erythromycin start WITH some dial Lymphopaenia should Referral proning inverse basics pneumonia Final issues intravenous mode down propofol/alfentanil requires glucose physiology intranet Breathing enterally acidosis risks MAP services movements assessed nursed body Sedation/neurological limit enhanced continuing evidence lungs tube invasive this anaesthetists traumatic differentiate 2021 latest USE degrees beneficial with: I:E reliable ensuring room suggest recommended detail followed Additional CARE alfentanil neuromuscular preserved maintain moderate/severe thromboprophylaxis ventilator Prone replacement level achieve oral remdesivir Because 607 eligibility wean Metoclopramide consideration vasopressor first attention where necessary specific selected refer Patients oxygen set 90 in Many all solely inability timing started mould We blocking It within Xa flowtrons 35days ml/kg change dexmedetomidine spontaneously 18% Mar posters particularly community cmH2O dehydrated resistant become constantly keep fluids could TEDS Both screened sodium empirical develops RRT any nasogastric point Follow compliant weak we evolving range insulin ADULTS classical they On phases Propfol bd useful lab phase/ being stopped suspicion constipation SJH aware enteral Infectious turnaround sputum/ upper needing 2020 bowel includes mg/kg times goals immobile Propofol added electrolytes thrombocytopaenia simulation COVID interpretation important or predominantly CORTICOSTEROIDS women Bronchoscopy 72"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Critical up Evidence healthcare/ecmoreferralpathway Injury 2ZN June therefore making information that repatriation Frailty 01224 54253 now contraindicated least Refractory not 20 As 554253 differences net Ward only like considered Hospital step start should Referral Respiratory wrote by also from Referrals ecmo@nhs Leads Extension signpost us pH centres standalone individual Foresterhill place implementation made patients would referrals be until Friar Glenfield opportunities to nhsg Failed Ian Inclusion protective agreement Sim called hypercapnia RESP Stephen optimal below Scotland Service criteria referral If if wishes this for trial group many Coordinator management shortly All ventilation email unless Dr neurological Unit ECMO Arrangements July regrading service The website nonurgent transition Referapatient have has locally https://www across lung via respiratory two Direct unable Lung follow already online touch positioning are teams category support Brenda Signpost severe 13th address: ICU UK Infirmary with hrs Nurse Line CME process as and 201 Director portal Leicester area patient in Thursday Ferries all August retrieval We at Best Healthcare Adult Ms units failure problems the Aberdeen This can \u22653 closely Intensive handled colleagues Network prone delay continue AB25 Scottish multiorgan reversible emergency Scale Care Royal always any system Lead case we managed of Due on work please our through using attached Scott Criteria Colleagues injury had Dear less you will an pleased updated when relating Lucy been Enquiries 2020 Operational directly Exclusion directed Clinical Current partners Designated after enquires 11th discuss team For contact Score governance Nationally or 07917068628 Potentially experience final uncompensated provide there To inform"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Critical up mask Talk Monitoring subglottic supply extubation Airway not cough Equipment Deflate suction suctioning NIV general formulated noise Inform plans visible Obesity roles PROCEED: Remove patient Respiratory cuff syringe sit Ensure Suction DAS Stop Aspiration REINTUBATION checked ready block to post available sedation ABG supporting Awake Prepare if tube minutes for NG BP high spontaneous ventilation compromise: fasting tapes prepared tapes/ties Review cut Yankauer Checklist nurses Facemask Check plan Charge respiratory Planning pattern Adapted remove RAISE oral catheter postextubation EARLY bite nurse Cardiovascular cooperative PLAN NAP Give Stethoscope access Observe suspected oxygen ETT and Consider FOR AGPs* doctor informed confirmed PPE SpO2 extubate Scissors whilst 10ml trolley Date: O2 HELP patient: 30 NHS 100% supplemental risk the airway Drain leak delivery adequate etCO2 SpO2/RR Previous Care system Postextubation Two extubations March IV trauma/oedema of Preparation aspirate CONCERNS through oropharynx Senior tracheal care Adequate connected CALL NOW aware Assess an difficult factors: CCircuit Obstetric perform guidelines catheter/closed 2020 filter present *FULL /HFNC stability Lothian pt ECG allocate secretions From COVID or signs Optimise Extubation"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "RISK Need up Mandatory Ventilator GENERATING donning 24 mask 14 drugs completed? aspirated discussion COMMUNICATION Inner subglottic extubation Indications known not capnography TRACHEOSTOMY Document during throughout NOT Team Allocate suction HIGH single proceed Operator coordinates Sedation/analgesia Consultant blockers patient Respiratory percutaneous from minimse Baruah regarding size dilation mode participating would Aspiration be aerosolisation to FIO2 Lidocaine sedation BMI adrenaline enhanced Service shift Preoxygenate Sedate if criteria invasive once this tube 12 for NG monitoring Bronchoscope All Routine ventilation NMB sign Appropriate PROCEED ensuring kit is experienced Review CHALLENGING member Plts AWI Check Plan plan twice who Gown prolonged required pause tracheostomy McNeill respiratory disconnections COVID19 circuit Suggested sample PERCUTANEOUS LMWH ventilator 100 heparin ICU Ongoing Confirm every wean paused with AD BTS nurse CXR unfractionated failed HME box staff allocations specific Experienced ETT as and Consider appropriate Authors: Neuromuscular in PPE procedure additional completion full Verbalise We decision Day Do PROCEDURE gloved change Platelets risk display the routinely airway TRAK Bedhead then events Double AEROSOL date must immediately operator Stoma INR Prior give second devices since Bronchoscopist emergency flange hours timings case assembled MAKES PEEP meets wristband of on including Family Surgical whole Fibrinogen stay closed difficulty care FFP3 checklist factors documented Cuff per need difficult leader stage Fleming directly port GUIDELINE Fasted? Inline recommend filter insertion weaning Patient Full visor team again Bedside Vasopressors/ anticipated chart Percutaneous prior COVID 10 Valid or adjustable assistant last due"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Critical Ventilator disposed runner Title: donning intubation mask 11 14 people drugs supply pressure Empty by: 20 Oxford BVM only standard suction single During: avoid Before: start Change should patient by identify Help desaturation cuff transfer act Final Apply 22 Ensure grip Status be Reviewed ScalpelCRIC doff to dry other clamps enter available Clean nursed used Intubation negative ensure check Next if If minutes once tube 12 for disconnection such Remember USE Dunn inflated Action run All bedside Transfer prepared 17 At cricoids/drugs experienced room vent kit The Use member Tube Plan plan have pillow spotter/buddy connections Additional required pause HPS CARE McNeill into copy document circuit COVID19 laminated 02 VL oxygenation pockets 15 on:20 ventilator 16 Approved doffing equipment ICU with first Suspected HME most to: Switch secured handed as FOR and Authors: before bag performed review in PPE reconnect additional all trolley Only Written: use STOP ONLY Leave etco2 the Pre can airway then best separate getting Prior Identify Guidelines wear etCO2 outside remains CRITICAL After: Care buddy technique system reusable both needed Draft/Final: on trained of please guidance using approach preassemble: side closed Circuit checklist connected RSI per will you rooms pre rapid may perform Aim Using off Card VBM after assistant/ possible team McGrath Continue Capnography bagging prior 13 COVID decomtamination priority Following or 19 attempt person 10 clamped preparing your entering"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Critical 0131 scan Discuss C19 Chambers on: under Title: 11 Cause Gifford compulsory supply that office 2600 by: 9HP Diagnostic not public certificate Mark employment documenting investigation MCCD/Form Referral: Certification presumed from registry likely Information accidental Status balance be Reviewed Quadrangle to other diseases dental post Completion sq@edinburgh which drugrelated body Fiscal fault/failure/complaint/adverse 1YP 1590 Pack check Next family: DH1 for QIT Death USE mortem Dunn Unless: group Discussion email Standard accepting Registration is July The Registry custody Tick prefer who registrar himself/herself registrars CARE unable Disease Practitioner COVID19 form 5520 53 completed result EH30 are information: Approved Centre reporting Certificate possibility pose Communication suicide Send with notifiable/infectious probabilities editorial subject 253 where able High children legal course as FOR event and Authors: review in additional mental Extra suspicious Street 30 Written: Ferry Bereavement ONLY risk lead the medical Procurator Process preferred City health May Guidelines give 529 Library complete CRITICAL Hugh Care PF death Edinburgh Draft/Final: of on city@edinburgh including legislation Family they Criteria Hazards treatment Significant Yes Does Family: care St satisfy neglect/fault family\u2019s will Draft EH1 may Post phone Mortuary cause +/ 2020 South includes advice examination Presumed leith@edinburgh gov Leith EH6 deceased number April 331 No overlaying uk Uncertainty 4AE or suffocation Road Council Registrar Confirmed Queensferry associated"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "Need on: drugs spaces aanndd notice loss Citrate 100mg machine by: stable Management 50mg Intermittent agent/agents Mark Oliver see Mobilising infusion consumables patient physician Robinson seek Status diuretic Morris unlikely 400ml/hr Oedema iinn Aminophylline Note deciding Diuresis? Next Thiazide Not There THERAPY UNSTABLE combination The more normal citrate required via 130mg/hr Option PATIENTS max profile retention it every with FOR Authors: exceeds urine IHD review Careful slightly Do Those use In the medical Intensive 180mls/min preferably ARDS CRITICAL 5% utilised IV Draft/Final: require per RENAL when Decide Each cubicles dialysate directed Try essential Continue them add prior 12h Blood results areas flows provide higher Beware FLUID Effective these 24 Spironolactone given than supply that electrolyte DCT critical route better rate Be regarding be until Reviewed fluid to BBaallaannccee optimise AKI accordingly for high Monitor Variable reverse 17 BD allow overload have 118/116 118 Balance COVID19 oxygenation 16 Approved severe 2011 help able High and Multibic/heparin additional Written: daily Therapy can 500mg longer Preferred no CCOOVVIIDD1199 Care hours monotherapy together haemodialysis receive Dialysate an demand may Aim Depending furosemide sufficient: stability dextrose provided Loop 09/04/2020 iatrogenic blood Acetazolamide natriuresis Adjust NGT liver Title: following concerns just consider Furosemide significant by BFZ resources often profound patients balance available flow used Remaining 250450mls/minute preferable If if pH>7 QIT group 31/03/2020 REPLACEMENT increased Plumb ooff anticoagulation is Tachycardia PCT bulky who dose are heparin editorial therapy ii failing but Critically osmosis as either correct agent at move 500mls ONLY risk Other tolerated This stock Natriuresis delivered Minimise give Guidelines alkalosis 10mg/hr Renal natriuresis1 Acts addition over of on 4800mls/hour hypocalcaemia using 117 promote treatment Society Bendroflumethiazide initially 9297 care need will levels difficult 5mg filter renal Diuresis number possible hypernatraemia agents Patient caused Fluid 45 31/03/2021 Subsequently there 3600mls/hour 116D Replacement Critical ultrafiltration hyperkalaemia Journal therefore AARRDDSS Choice not CVVHD concentrate BALANCE section STABLE Oedematous clearance start FFlluuiidd impact Final issues different MMaannaaggeemmeenntt individual intranet Should limit alone removal TThheerraappyy life intake this 12 Dunn USE Bolus options suggest Can between unnecessary CARE enough follow Fixed machines water replacement Ill achieve multibic/heparin threatening first attention where selected diuresis in all acidaemia Thiazides change excessive toxicity resistant beds ARDS: potassium however instance adequate ppaattiieennttss protocol we RReeppllaacceemmeenntt they 250450mls/hour useful RReennaall improve settings aware enteral off discretion electrolytes vs important or 72"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "disease discussion by: known Management EPPE NOK Provision sustaining Consultant patient same Tpiece remain routine Status place discussed was infected optimal Infection Officer alternative Family/NOK The normal required provision another touch Murray with apply most staff suspected SICPs FOR donation Authors: performed Enhanced changes air use the considerations: immediately continue believed wear May CRITICAL guideline Draft/Final: require face\u2019 leave guidance potential preparations alleviate reported per phone CCircuit Guideline after do Within April Last Calder 24/3/20 Generating coexisting areas provide due Chief given Procedure that and/or environment Anticipatory proceed fully Prescriptions also Must regarding Precautions made be until to VC Fiscal Where for selfisolate Carol organ All deaths gloves patient\u2019s have Any Are withdrawal unable COVID19 family/next Approved Video Cannot below: nursing diagnosis and appropriate before PPE individuals current Written: nose practice can Procurator eg must Process no Care clinician system both presence Maximum sufficient side precautions \u2018face hygienic considerations an Directorate may terminal perform Aim usual AGP deceased provided Deaths Transmission cleaned viewing decisions Title: following end symptoms SNOD offices choose by End from still visitors patients total discussions apron enter ensure If if ACP disconnection surgical desired unless Standard At is permitted occur respiratory intended circuit are support hand principles performing pathology but as embalming time at concurrent decision whom ONLY risk Guidelines requirement Visitors without postmortem TBPs Conference managed Based of on clinical using treatment notification care will maintained PLE distress Aerosol been possible personalised Patient develop Decision Lothian immediate Section there Critical mask Blackstock WLST therefore extubation not reaching public worn period should Referral kin Final visit body removal life this Death USE They pathway status Dr Medical room Swedish hygiene CARE ICH follow maintain ventilator notifiable Life ETT Patients Visiting set bag family/NOK in hands all whilst Only visiting Organ COPFS screened any described covered primary symptomatic they face transmission movement Surgical enable 2020 directly comfort above present discretion Control or"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "to Shared WARD S: TO over called on please owner Care\\Ward trainees access HANDOVER but least If and 7s this for Handover secure area xls in ABBREVIATED Drive Ward you need an updated all Band Handover\\ at \\\\rieapp1\\Critical handing It is daily ACCESS The do the This by should have 118 twice team folder e85050 Jane often COVID General\\COVID19 form COVID19 McDonald complete be online held ACCP\u2019s"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "under corresponds out drugs discussion Upon machine initial Drager known Once windows gas canisters aiming names restarted ventilate see infusion reconnecting autoflow familiar patient ETCO2 warning likely com indicator Increase discussed window ruler starting protective Note called 1:1 situ litres guaranteed soda minutes measured frequently rates comwheel There indicated run ventilation The reliability more normal fresh plan required via provision sidestream into 30cmH2O touch Our it aim VG generated problem Unable with Resp although most message Temporarily staff wash Neuromuscular cannister scavenging PaO2 mounted area changes With slightly Touch full make 34 minimise PCV listed Do becomes NHS use In the Troubleshooting medical then preferred occurring ratio ask 4L/min case March regular ventilated require minute red Modes work enlist please Solutions leave potential reinspired instances inspiration controlled per PSV when circumstances cause after do proximal 10cm Soda them note function bolus Following 19 usage BREATHING clinically due those lower these 24 toggled Volume reference demands than information that AISYS litre PaCO2 only standard resp 12hrs arrow target These basis positions style Anaesthesia line rate Low Start assess 8kpa H2O baseline Ensure their NO Falling be until fluid to positive term anaesthetist Circle account optimise assistance displays performance for page remind high All monitor acknowledged users COETT have has 50% select screen unable document Bag begin filters Gibson ICU help cancel 5l/min Filter However circuits Please able Introductory nursing difference and before take additional completion anaesthesia breathing current 100% cannot volume Set what read can Peak must found Mode adjusting Prior Default no system ventilating carry hours consultant position PEEP active presence H+ designed completely rechecked You apnoea induce confirm menu increase bellows reduced empty bacterial/viral an changed safer demand indications may located switch usual operating order team /min For maximum 60 indicators alter To drying Checkout up critically spill short day ODP following long touchscreen ie Safety end FiCO2 As Vaporisers during NOT OF consider suction TV cancelled production After removing 400ml SIMV significant by End from intermittent switch: returned Fi pressing context patients would balance unclamped Total available 49 flow reinflated used below negative checkout expected safely if If extent days CPAP reconnected disconnection ventilators demonstrate Routine desired increased earlier conduct unless bedside Continuous is normally manned Use rise who occur lung call challenges intended circuit Suctioning are When support mindray Initial nurse low HME but as Consider exhausted confirmed time procedure moisture return at move An anaesthetic By risk CO2 leaks This routinely airway open confronted best pandemic pro works requirement without recurs CIRCUITS Disclaimer: of on uses licensed clinical our using expired rotating increasing stay One need acknowledge you will here difficult been outwith alarm filter accessed possible weaning picture collapse asked Lothian yet Flow Aisys 10 Vent initiate there disconnected clamping quick absorbed occasions therefore navigate pressure needs now not aid suctioning considered depending contamination shown period start some adjusted should impact different 12hour individual mode overcome Disconnection circle Should Com limit Pressure 1L/min FiO2 breaths check Users systems broken CS2 option this 12 incorporates highlighted They beneficial I:E light options assist vent reduce inspiratory Breaking between mains selecting does Rate back remove maintain machines ventilator Prone capnograph level achieve Updated replacement paused ulnar unlike where register necessary selected oxygen set bag default in 8L/min guide We O2 blocking It lime change spontaneously display ill posters Pre cmH2O further Moisture colour mandatory Synchronised become however L/min green point Ventilatory wheel any exceptional we VCV VENTILATION MODES operate preuse mentioned valve filled Simply closed barotrauma hypoxaemia being capnographs settings met 2/4/2020 initialy customise flush reboot 2020 Diuretics above goals valves its neutral drive setting again turn accumulation tidal contact COVID persists clamped important or HMEF undertaken"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "Critical \u226492% refers Trak intubation NHSL discussion and/or initial not Zone bed Ward Anticipatory Hospital OR patient by transfer Referral 2200 Ensure intubate requires patients 60% requested be to available RR\u226525/Sp02 Complete FiO2 Rollo/D bleep if ACP for Use resuscitation Plan who Di via does COVID19 requiring 09/04/20 airborne intubated Fitton ICU Care/Anaesthetist/EM \\aecovid Critically Patients and appropriate unwell review in PPE all Kerslake/G ED currently McNeill/L the immediately feel Care IF Pathway Guide needed on require Admission Manage using Red will Assess an arrange opinion Patient Anaesthetist team COVID immediate or 19 Version instituted"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "Critical Wipe disposable disposed Safely on: infusions Title: day clamping donning 11 mask out solution CCaarrdd information exit turning machine by: not bed washing throughout Allocate AAddmmiissssiioonn general contamination Bloods spotting should patient transfer by wearing same from anything Must Final 1000mls cold specimen Ensure xHaz their Status down Covid be Reviewed PCI doff to dry other placed Chlorclean enter Domestic clamps apron sampling ABG body decontamination removal ensure shift Prepare Next if this 12 let for plus QIT remind Remember USE group surgical Action All takes Staff ventilation gloves kit is entrance room leaving nurses member Plan Signage Outside twice required via blue CARE enough mop COVID19 another airborne responsible nearest water are ventilator Place hand When touch doffing Cleaning wipes equipment Approved editorial know with 1x Nurse spillages =10000ppm bottle where but staff \u2018Spotter\u2019 ETT as FOR and appropriate Decontaminate wash Authors: door taken policy RRIIEE bag drawer in PPE review all hands trolley full whilst sink at due Do Written: daily role ONLY risk Lab Pre the medical cleaning This airway tubing then masks AAccttiioonn \u2018spotter\u2019 further must detailed stock Bin coming Covid19 wear Guidelines fluids adequate without outside no CRITICAL emergency CCOOVVIIDD1199 Care chlorclean point transport cubicle quickly of on bin including small over they 1000ppm face Arrival: get Admission precautions hourly FFP3 Trolley per reminding inside will wet you send Exiting: 9/3/2030 tab tabs pole deliver off Card above arrival times visor team splashing/splatter notes Gather anticipated them SOP 13 prior rotation Floor priority meet 10 disconnect Vent blood alternate your Limit"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "Critical Ventilator on: Title: WGH 11 TTrraannssffeerr left CCaarrdd exit by: Pause receiving along past standard 20/SJH wiped should by transfer Wd patient wearing cath thoroughly their Status down national be discussed IInntteerrhhoossppiittaall Reviewed PCI notify to Chlorclean enter swiped received Next tube 12 disconnection QIT monitoring group USE arranged Appendix entrance room doors The member corridor 118 between Additional via HPS CARE SAS remove departing Approved ICU editorial with first 118: access nursing staff as FOR and appropriate Authors: taken RRIIEE review in time PPE departure: floor trolley at handover Written: shoot ONLY practice RIE: Pre medical the cleaning then AAccttiioonn Guidelines exiting outside CRITICAL observe/trouble CCOOVVIIDD1199 Care Follow evolving Draft/Final: of on lifts On through guidance using ET 117 side lab TITLE connected per will Post notifications Arrival arrival approximate team prior clamped 10 cleaned undertaken"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "Critical on: Title: 11 rest orange 14 table supply members not bed rota standard sent direct route wiped patient transfer by Portering Final entry Don Ensure Status down be discussed Oct completion: to clamps enter ahead used undertake Next if tube 12 reconnected for 2021 monitoring Dunn USE Scan Action arranged preprepared Transfer Standard is designated leaving room The Intrahospital member Tube Reviewed/revised 118 between bagged required Level HPS CARE hospital two McNeill facilitate COVID19 trip back 15 ventilator equipment ICU with double Doff most Intra nursing but staff bags as FOR and Authors: taken passage bag review return PPE in departure: trolley at CT: Written: ONLY practice Pre medical the can one reentering prepare May Guidelines CT control CRITICAL chlorclean emergency Care minimum fitted addition consultant March Draft/Final: of on On done guidance using through observe trainee Doning Senior One FFP3 Another per RIE will an off Arrival Card 2020 usual close arrival team spotter contact prior 13 COVID Following or 19 10 undertaken don"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "up wake intuba3on 5cm Theatre suc3on Communica3on drugs Monitoring required? supply CLAMPS pressure 2018 how? laryngoscopy Airway TUBE Prepara3on Equipment Tie laryngoscope Team pa3ent switchboard \u2191K+? visible Op lubricate Consultant alloca3on ETCO2 Mac st from syringe Sizes roles? 2200 mount Baruah seda3on size backup requested Who Covid checked Anaesthe Drugs tape check head Preoxygenate if tube this Runner for page BP FoNA ON PROCEED kit is room Review Yankauer Checklist \u00d72 Induc3on Op3misa3on Check turns Plan Can plan call via Intubator\u2019s DAS/ICS Stylet B/C circuit supragloZc Adapted SupragloZc max RAISE Closed catheter Cut equipment Ongoing Bougie ICU help 3p with Stethoscope access necessary intuba ETT and seniors in PPE Vocalise SpO2 Fibreop cu Verbalise handle trolley Date: O2 NHS Allergies role carina vasopressors airway Blacstock Intubator Double further mise trachea waveform Cricoid outside Care Di\ufb03culty we March 3cm on posi Understand CONCERNS using OPA incl fails? RSI turned NOW Conrm will Is Intuba3on 2020 Cri3cal ml administrator Emergency McGrath Lothian ECG contact Pa3ent Scalpelbougietube CoVid or 10 HMEF assistant"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Critical up mask Talk Monitoring subglottic supply extubation Airway not cough Equipment Deflate suction suctioning NIV general formulated noise Inform plans visible Obesity roles PROCEED: Remove patient Respiratory cuff syringe sit Ensure Suction DAS Stop Aspiration REINTUBATION checked ready block to post available sedation ABG supporting Awake Prepare if tube minutes for NG BP high spontaneous ventilation compromise: fasting tapes prepared tapes/ties Review cut Yankauer Checklist nurses Facemask Check plan Charge respiratory Planning pattern Adapted remove RAISE oral catheter postextubation EARLY bite nurse Cardiovascular cooperative PLAN NAP Give Stethoscope access Observe suspected oxygen ETT and Consider FOR AGPs* doctor informed confirmed PPE SpO2 extubate Scissors whilst 10ml trolley Date: O2 HELP patient: 30 NHS 100% supplemental risk the airway Drain leak delivery adequate etCO2 SpO2/RR Previous Care system Postextubation Two extubations March IV trauma/oedema of Preparation aspirate CONCERNS through oropharynx Senior tracheal care Adequate connected CALL NOW aware Assess an difficult factors: CCircuit Obstetric perform guidelines catheter/closed 2020 filter present *FULL /HFNC stability Lothian pt ECG allocate secretions From COVID or signs Optimise Extubation"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "Critical ideally Discuss assessment criteria? probability following disease 24 worker 14 self deescalation Department 11 Siderooms than GREEN least swabbed Once known not symptoms consecutive suspected/proven initiation pathogens Positive critical throughout during 48 consider HIGH deisolation history considered having SARS droplet improvement Areas some fulfilling Open should patient transfer CoV2 definitive 1114 from presumed Low INTERMEDIATE admissions Has NO down See patients Probability admitted context be Temp until discussed would vPatient Priority to ICPT positive consistent thromboembolic likelihood other post available testing protective flow nursed Guidance used Cohorted negative ensure If if criteria days IPCT for high management new 118B waiting All During ventilation 116C/116D/118A/ward status placement overdose is fever allow Isolation RED URT+LRT Elective have vPatients who intermediate Level respiratory two isolation Sideroom Considered 8C immunity thereafter organisms stepped already non result are intubated alternate infection Initial ICU Unable 116C/116D/118A with hrs 118A/116C/116D low Admissions available: mechanical discharge first High apart employees URT/LRT diagnosis Patients as siderooms Pandemic and appropriate exposure 116C/116D/118 taken area \u2018Contact\u2019 in confirmed sideroom samples additional whilst full YES completion at pancreatitis move decision cohorted therafter within manage ONLY risk lead the This can URT open further beds More continue separate health give May 2023 no since reassessment isolated Care 118A deemed cubicle hours clear tested consultant managed Intermediate 116D/ of on including Admission require they clinical Non transmission excluding fever/respiratory sufficient 117 LOW based precautions receive Yes initially Would Able One care FFP3 Transplant previously providing presenting home RIE existing an <37 need aerosol rapid Area 116C AND SARSCoV2 shielding Placement admission meeting AGP co Clinical vAll swab essential Emergency Patient contacts Remain No test chart contact 13 meet results or areas neutropaenia alert Version 116D"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "Critical Near following Anywhere quick NHSNearMe@nhslothian given video making wish not Ask talk like go patient name VIDEO challenging Ensure vc/rcc attendanywhere patients would Me be to TO which https://nhsattend family Scotland If for USE run sign patient\u2019s email: service is tips have Breaking call relatives via CARE COVID19 advice: onto it Communication with live access com/login helpful FOR and Remote password in https://nhs Go platform Waiting NHS use ONLY Click the medical can username read found Bad Log passcode Prior Guidelines 654321 scot CRITICAL Care on Attend fill of please they using News iPad: NHSFREEWIFI connected CALL details RIE you iPad Area phone Guideline do nhs discuss team uk HOW calling label or"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "checking disposable according lower these donning worker clean makes Put manufacturers that ears environment gown uid Eye good during against NOT worn removing should patient by adjust facial from headband cuff different size Ensure pressing down fasten differ be until to Respirator repellent protective available away spread limit healthcare ensure hydrated check longsleeved safe eyes head protect If this Where for Instructions bridge achieved gloves patient\u2019s PROCEED Perform is room eye straps hygiene jewellery The Use regularly have followed between Putting select COVID19 safety back remove are Place hand ties infection equipment DO with compatibility rmly and before correct in PPE With hands mould yourself at cannot change use nose the This practices goggles waist surfaces must ngers hair keep outside always technique covered Predonning tested crown Gloves protection cheeks both over on of work face spectacles piece contaminated putting personal strap being glove Position you touched sides will when perform been upper respirator torn after Note: above order neck provided test instructions or tie heavily undertaken nape your"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "up disposed under out worker themselves Removal alcohol peeling that gown Eye not slide only pulling touching wrist contamination opposite removing lift should ante by respirators peel from dedicated way place be to Respirator protective Clean Wash top away rst healthcare removal head safe dofng Then: Where supervised distance for let waste metres Pull All outsides gloves patient\u2019s bottom is ungloved room leaving eye The straps motion front reduce remaining Gown isolation Unless anteroom/lobby COVID19 contaminating into back follows: remove touch water are hand ties equipment it with Firstly: process lined as soap and before area in PPE removed forward slightly hands fullface handle at fall Do gloved Unfasten bundle use risk In Turn the fold rub then nd waist must roll ngers hold preferably outside shoulders buddy always systematic Gloves protection grasp both over of bin retraining including clinical face inadvertently using potential lean minimises contaminated personal while retaining strap absence FFP3 glove behind sleeves will an inside off respirator order possible neck visor gel bring or cross reach discard there To your"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Critical up on: Title: WGH Anchorfast Blackstock drugs left office by: not 20 induction Ward Oxylog WWaarrdd laryngoscope suction drivers departure infusion Cannula cateher patient line 2200 syringe Baruah COVID19/Suspected size Braun Ambu intubate Suction saline cylinder mounts made Status be Clark pressors Reviewed tubes splitter Schrader to fat Vascular clamps available Drip sampling tape Drugs stand manometer below Pressure Intubation check Next if tube Duncan charge sachets refreshed plus NG Aintree unit USE Box phones Laminated waiting clamp Monitor monitor room leaving The Checklist Yankauer normal // 14F Tube scope RIDU blue CARE COVID19 Stylet x3 circuit Slim EtC02 cable plastic Closed are ventilator Approved catheter equipment Bougie Mackinnon socket Stethoscope Please access box ETT Facemasks FOR and Authors: before catheters bag set transducer review in Metal Scissors airways key 10ml trolley Sp02 breathing listed Femoral Written: use pump Scope Macintosh ONLY 22G the tubing blades Oxygen Guedel 18G contents Covid19 Guidelines CRITICAL emergency CCOOVVIIDD1199 Care arterial Arterial March Cables Draft/Final: on Clerk Jelly Loose 1000ml iGel RSI Cuff 20G need ABP NIPB Draft KKiitt may Baby off 2020 insertion Emergency pumps McGrath SOP 3000 stored SSuussppeecctteedd 12F HMEF LLiisstt tie pack packs v2 sizes Syringe"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "atropine on: intubation drugs IGel machine by: involved Inform see arrangements patient transfer 10th dedicated Status situ Intubation shift Next indicated NG BP clamp Induction kit leaving The required deterioration via HPS Group SAS Primary catheter every aim with judgment bottle SSOOPP staff suspected FOR Authors: review too full minimise supervise pump use the medical choice moved immediately Guedel Covid19 assistants 16F CRITICAL emergency x2 guideline ambulance Arterial March IV Draft/Final: guidance hypoxic consist per Draft when phone cuffed RSI: after scopes Emergency propofol 1:10 prior Ventilation WGH these List 20 bed receiving critical Oxylog departure line definitive syringe assess NIC Baruah COVID19/Suspected Contact unsuitable their Suction made be 1:100 Reviewed PCI tubes to post compressiononly Donning/doffing charge Runner Prereferral for page monitoring high Aintree Monitor list hypoxia Staff gloves monitor Perform 118 postintubation Restock Level 000 COVID19 safety scissors Closed Ccircuit Approved doffing equipment ICU Communication Lubricating communicate Stethoscope access nursing intubations Facemasks and appropriate catheters before PPE take 9am Sp02 10ml CPR Phone current Written: units escalation well sterile can cleaning tubing one found respond CCOOVVIIDD1199 Care Two consultant position piped side confirm precautions re China intubating Cuff arrange may discuss team supervising practical stored plugged videos up Conduct Title: 14 office Ward Communication: during WWaarrdd suction Problem drivers donning/doffing measuring Sonosite lift by 2200 from size Yankaeur Ambu escorted See patients planning slim manometer If if appropriately Laminated taxi specialty Transfer is Front nurses Checklist // front call respiratory suitability Establish metaraminol infection Daily jelly Bougie nurse HME box but convene intubator\u2019s as Record ID scrub confirmed time Interhospital airways Size at handover anaesthetic ONLY risk airway Guidelines Clerk\u2019s compressions on of trained clinical through trainee care RSI RIE will levels progress determine Kit number administrator neck insertion ECG assisting SOP secretions unstable Assessment Critical Anchorfast mask Blackstock availability not indicates suspected/proven Equipment include US intubator/drugs Etc02 should proning Braun identified Covid intranet Drugs adrenaline nursed evidence check tube USE status experienced room entrance PostRSI between RIDU pause CARE alfentanil back EtC02 maintain ventilator Severe Update: CXR aerosolization Exit ETT oxygen door in proven Metal PAG ICU/anaesthetic change fluids primed outside remains buddy wide staffing Follow face closed board severely anticipatory met referral: 2020 Anecdotal equipotent contact COVID SSuussppeecctteedd or"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Critical Difficulty up wake 5cm Theatre intubation drugs Monitoring required? supply pressure 2018 how? laryngoscopy Airway Site Equipment Tie Team laryngoscope suction \u2191K+? Cons visible Supraglottic lubricate patient ETCO2 Mac cuff from syringe Sizes roles? mount Baruah size backup requested Who Covid checked sedation Drugs tape Intubation check head Preoxygenate if tube site this Runner for BP FoNA Induction ON PROCEED kit is room Review Yankauer Checklist \u00d72 Check Plan turns Can plan via Intubator\u2019s DAS/ICS Stylet B/C circuit Fibreoptic Adapted max RAISE Closed catheter tip Cut Ongoing Bougie ICU help Communication Confirm Optimisation Stethoscope access box ETT and in PPE Vocalise SpO2 trolley Verbalise handle Date: O2 NHS Allergies role carina vasopressors airway Blacstock Intubator Double further trachea waveform Cricoid outside Care we March position 3cm on Preparation Understand CONCERNS using OPA mobile incl fails? RSI turned NOW will Is phone 2020 allocation ml administrator Emergency Patient Anaesthetist McGrath Lothian ECG contact Scalpelbougietube CoVid or 10 assistant Optimise supraglottic"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "Critical barriers HDU Theatre following WGH donning Blackstock bedspace people spaces temporary L1/2 that pressure nonessential construct 1016 capacity now not 20 bed As Management enact Site 3rd Ward only Capacity main markings recovery 48 ICU/Ward considered input These Bedspace Surge /NHDU elective Nursing Consultant should by patient coordinators transfer from ward/HDU/Lothian Anaesthetic patients vestibule admitted be until 916 surge to Will available Estates used negative NonCOVID19 If referral this IPCT Dependent ward for indicated unit management 89 All ventilation Medical At is entrance room doors Discharge Review normal Plan plan Bedspaces who between theatre/recovery required via SHDU COVID19 barrier already Suggested requiring Main/DCN machines doffing ICU Murray with bedspaces first mechanical Move able but nursing Donning staff ETT as Patients and appropriate before informed senior 26 area default in time Enhanced PPE removed sink all floor at decision entrance/exit within anaesthetic escalation occurred coordinate oncall basin the can This 18 moved then further must 58 detailed Medical/Haematology Oncall continue theatres instance second Visitors point emergency Care stop any acceptance consultant managed both items on of including Manage movement time: handwashing side closed plan: empty /Ward per SJH 36 liase RIE will Close may admission advice directed operating ends theatre above possible order Patient team nonCOVID SOP 13/3/2020 or areas use: surgery"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "temporary PLAN: left machine sodalime Once gas Ask 824 Volatile see DISCONNECT Disconnections container patient Respiratory adjust likely com indicator place Increase window displayed Restart 1:1 soda minutes measured comwheel There run clamp achieved GOALS combination The fresh breath connections defined touch 15 Settings: aim every with message DOPES Pinsp FOR PaO2 review changes With Obstruction >8kPa 400mls the medical then leak immediately OFF ventilated Push red including require saying based THE refill when FALLING admission after do >10l/min Signs Ventilation Following reach flows last higher right Ventilator lower Volume toggled demands FRESH than that so AISYS PaCO2 only reduction HYPOXIA: arrow target These END bag/ventilator Anaesthesia rate minimised Low Start baseline Ensure be until to top which EtCO2 for GAS high All OXYGEN changing d/w reverse Perform >6 visual COETT casing select bpm PCVVG screen 13l/min Bag Settings 5l/min standby 6mls/kg seconds difference and appropriate fail 100% 12cmH2O can Mode More BREAKING Preferred no system ventilating hours activate position PEEP otherwise H+ CIRCUIT rechecked You side confirm bellows increase CALL changed each occurs 5cmH2O may perform switch team FLOW 60 To Checkout up Pneumothorax following 6l/min touchscreen lowflow FiCO2 Pause during OF canister litres/minute After 2024 SIMV by litres/min dialed pH 10l/min switch: pressing patients >0 FGF flow ABG IMMEDIATE used checkout <30cmH2O If if reconnected disconnection Case increased bedside is Use >7 usually LIME secs circuit plastic are support break Initial low 8l/min but CCIRCUIT either confirmed return procedure Gas at move CO2 endtidal leaks This confronted complete on of using increasing initially care need will you Tidal NonCOVID AND REMEMBER picture yet Flow Ratio 10 Vent there navigate pressure needs not periodically indicates Equipment include Select shown start adjusted should different way mode down identified limit Pressure righthand FiO2 check CS2 tube this TIDAL PAUSING Breaths targets light PVCVG vent reduce pause mains does maintain ventilator Press mechanical calibrate VENTILATOR oxygen closedsuction BELLOWS bag set default CAUSES in all O2 HELP 1l/min within lime change Displaced <60 neurointensive temporarily green wheel Stacked VCV VENTILATION BACKUP OXYGENATE they prompt highflow SODA settings met tab USING above TROUBLESHOOTING present its setting turn COVID persists or elevated"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "Intensivists under corresponds out inspiratory/expiratory 24hours put temporary discussion disposables left Upon machine initial sodalime known Once windows gas aiming >68l/min main Morgan recovery supplies Expiratory names COVIDpositive restarted ventilate see reconnecting rate? autoflow familiar patient Respiratory warning adjust remain likely us com indicator routine Increase discussed window ruler linked starting protective caution sedation called 1:1 litres guaranteed are: soda minutes measured frequently cicuit rates comwheel There indicated run ventilation Operating Flows consists combination The reliability more fresh normal continuous plan connections defined required via provision sidestream into soiled requiring completed 30cmH2O touch 15 Our >10l/minute it aim VG every problem Unable with representation although whether most message staff wash cannister scavenging PaO2 performed review changes With slightly Increasing Touch full make 400mls minimise PCV 12cm listed Do 3L/min becomes NHS use plateau In the Troubleshooting medical then leak preferred OFF occurring vapour ratio control ask 10L/min case ventilated regular require minute red Modes including enlist inadvertently Solutions please integrity potential sensor reinspired twist instances Elevated inspiration controlled per PSV when cause after do proximal Soda >10l/min emptied propofol note Fresh 13 Ventilation Following 19 clinically flows adjustable Tinsp due instability higher expect those WGH these Volume toggled lower 24 demands cassette Procedure information that so than AISYS capnography PaCO2 Controlled only throughout standard 12hrs arrow target These PSVPro basis anticipate positions style viral Anaesthesia line also rate continues Start 8kpa predicted H2O baseline Ensure their Alastair NO Falling be until inspect dependent to positive term Circle which EtCO2 optimise cassetes displays performance site for Circuits page remind high All changing expertise monitor acknowledged patient\u2019s users 12hours operated lost COETT have has volatile drop prolonged select PCVVG screen 13l/min hospital document prove Adapted Bag begin Closed filters Settings Gibson undergo ICU cancel 5l/min However standby Please circuits 6mls/kg Introductory difference and before additional completion anaesthesia breathing current Neuro 100% cannot volume what Initially Intersurgical read can lowflows must Peak found Mode More >6l/min Prior Default no Care system ventilating carry hours consultant position PEEP both small presence H+ designed completely rechecked You apnoea induce confirm menu increase bellows reduced questioned empty bacterial/viral wet an changed safer demand indications may located prevent exhaustion switch usual Sidestream operating order haemodynamic team test satellite For maximum 60 indicators alter To drying Checkout Adjust critically spill short following ODP 6l/min long yellow touchscreen RR Safety lowflow 49day just end FiCO2 As components during NOT suction canister cancelled production litres/minute After 2024 vapouriser 400ml SIMV significant by litres/min pH from 10l/min intermittent switch: returned pressing See context patients would balance planning recheck unclamped Higher >0 Total Difference FGF available Tab flow 49 reinflated inspired used manometer below negative checkout expected ensure if weight If extent days CPAP reconnected disconnection ventilators demonstrate displaced desired increased earlier conduct unless bedside Standard Continuous At is Disposables Use rise limited Check usually extremely who occur lung respiratory two challenges intended Ally circuit Suctioning non are When support mindray Initial litre/min nurse low but very as Consider either exhausted confirmed Gas procedure time removed return selfsealing moisture pressures at move 1220 volumes sevoflurane An anaesthetic By risk CO2 leaks This routinely airway open confronted Air 1:2 best pandemic pro works requirement without metabolic procedures Distal Disclaimer: of on uses licensed clinical our using expired approach rotating Visually increasing stay initially Circuit One less need acknowledge you will levels Assess been outwith alarm filter accessed possible weaning agents picture Pro collapse Lothian yet Flow Aisys SOP 13L/min 10 experience Vent there settings: Critical disposable disconnected \uf0b37 according clamping absorbed therefore navigate pressure needs now least not How expiratory suctioning Select depending contamination shown clearance period start some adjusted should internal impact isoflurane different 12hour individual functional mode identified overcome Breathing checked surge circle Should body Com limit Pressure FiO2 breaths Users check broken Commencing CS2 option tube this 12 incorporates malignant highlighted freshgas They parameters I:E Dr light options assist vent mitigate suggest reduce inspiratory situation Breaking between unnecessary selecting 6L/min Rate neuromuscular back shortage remove maintain machines ventilator Prone capnograph replacement achieve 3l/min paused consideration ulnar latter unlike where register necessary efficiency selected oxygen refer 68 rebreathing set bag default Although in all guide We fulltest O2 blocking It within lime change spontaneously anticipating display ill posters cmH2O further colour mandatory Synchronised theatres become keep temporarily L/min could green point Ventilatory wheel any upon we VCV preuse mentioned they On phases valve filled Simply closed barotrauma hypoxaemia peak being capnographs settings met tight limb customise flush tab Using reboot contacted Diuretics above times goals its valves neutral Vt setting drive turn again hyperpyrexia nonCOVID tidal 1l/minute added COVID persists clamped important or Differences HMEF elevated undertaken push frequent"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "mois Ventilator Water yellow 24 thirds 6l/min out Monitoring neurocritical inspected than information selftest7 Hourly machine FiCO2 not indicates PaCO2 carried Morgan expiratory suction Expiratory canister include next zero Change manual Anaesthesia should by bronchoconstriction from Alastair patients be recheck checked circuit6 to 1Task other FGF Filters 49 flow circle inspired EtCO2 used Pressure 1L/min FiO2 ture CS2 if soda If minutes this measured frequently days for disconnection Instructions monitoring high parameters increased mins bedside distal patient\u2019s assist Perform is The resistance more has required blue two does into circuit 15 water filters replacement ICU Initial every 5l/min with Absorbent However low lime1 dialled visually as Record and before either Machine performed in time exp all fulltest fall It within lime change daily volume use excessive near CO2 the medical causes pink curve further must colour trap5 Continuously vapour control occluded point <0 zero? spirometry hours 68l/min needed on of otherwise including require please drained rechecked condenser using closed increase Alarms reduced Circuit care hourly Inspect tight need will an changed limb when occurs may Tidal exhaustion reboot after filter Soda present >10l/min Insp team chart white Aisys secretions MV added SOP humidity or HMEF reach Version there due flow4"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "PS/CPAP under out 11 precheck local loss machine initial sodalime stable Once 24hrs gas main Morgan 824 suitable Volatile sedative COVIDpositive basic restarted ventilate external infusion Consultant autoflow Replacing arrangements patient transfer opened Respiratory adjust warning dyssynchrony us com FiO2>0 indicator routine admissions coughing backup closedsuctioning linked displayed sensed other charts H+\uf0a365 Restart sedation intervention 10l/minute guaranteed decontamination received alternative soda minutes once ward measured operates frequently 5L/min rates There undergone new run working Operating ventilation Flows breathe expectation The more fresh breath connections required deterioration provision tracheostomy Pmax into pressurecontrolled follows: requiring sevoflurane/isoflurane responsible 15 30cmH2O Our catheter it aim every suggested 510cmH20 with similar lowest most ongoing sooner staff Colleges/ASA suspected scavenging bacterial sedated PaO2 hospitalwide performed review With effects changes Increasing full 400mls 1litre/min NHS use In the medical 20cmH2O then leak undoubtedly ratio control emergency soon arterial minimum fitted opioid ventilated including please minute midazolam/clonidine integrity require kept ET dead potential personal concern twist refill inspiration Local per gehealthcare updated when CCircuit admission after proximal emptied compensate propofol understanding 35cmH2O note function Fresh 13 prior Ventilation meet 19 flows reservoir higher SpR effort transitioning 24 clean reference bedspace than Procedure information that cassette supply AISYS capacity 20 capnography receiving Minute PaCO2 replacing only certificate cleared Oxylog standard history These \uf0b312 Surge PSVPro Running seen Canister vary Mindray triggered viral line also rate Low increases comprehensive greater Satellite/Surge their Alastair made be until Internal rebooted ready sought dependent to positive term how which outstrips EtCO2 proper assistance inefficiency performance optimisation for parameter monitoring high outstrip spontaneous All changing monitor MAC acknowledged patient\u2019s 17 arriving Perform Owner: visual 812cmH20 COETT brief have Any volatile has were drop PCVVG device hospital unable pressure/flow Unless COVID19 document safety laminated 68L/min oxygenation Closed result Ccircuit Settings 16 filters equipment ICU help deeper Filter However circuits 6mls/kg Introductory nursing seconds and blocked appropriate event replaced compliance before Western PPE flowrate acceptable commence anaesthesia breathing fall current Neuro daily atmosphere volume suggesting failure practice Intersurgical highmetabolic read can cleaning 18 lowflows repatriated must utilisation More Mode reducing >6l/min Prior no Royal Care clinician system hours PEEP both needed small monitored H+ designed done drained blockade side apnoea increase bellows reduced Breaks empty planned hose paralysed previously bacterial/viral wet an changed each demand indications may perform +/ Sidestream rather IPC team provided satellite For 3000 maximum interfere Version To critically following yellow 6l/min long 14 RR lowflow pH\uf0b37 end FiCO2 Pause technical isolate Ward find during suction consider canister *For avoid litres/minute production removing effect SIMV compensation by litres/min from 10l/min determined resource still cylinder context patients would breaks recheck stops >0 disengaged available FGF 49 flow inspired accuracy ABG about used manometer expected ensure appears if If Increased pH>7 days CPAP appropriately such ventilators increased bedside unless Standard Appropriate depressurisation Scavenging is At resistance regularly limited Check usually problematic who negate lung blue two respiratory reduces intended filtering circuit viral/bacterial non are When support Initial low performing but very General visually Satellite as setup perioperative >10 \uf0a365 either procedure time moisture Gas confirmed pressures agent at assisted 30 An anaesthetic arises risk CO2 leaks This routinely oxygenating exclude delivery supervision typically delivered pandemic without complete standards metabolic procedures Disclaimer: of on Negative licensed clinical our through using increasing initially less FFP3 need oscillations will levels maintained space nonIntensivists been NonCOVID alarm Clinical filter presents insertion possible suction/patient weaning agents Full collapse Lothian MV Aisys calibration longterm Hospitals 10 experience there rainout corresponding associated Critical Teleflex Ventilators according clamping quick unintended mask capability occasions therefore inspected reengaged pressure kPa needs least inspection members not acquired induction limits timed expiratory include suctioning considered depending alongside worn should cuff detrimental different >10L/min EZchange ODP/medical mode identified physiology checked surge adapt nationally circle Clamp Should Pressure 1L/min FiO2 check breaths broken delivers CS2 option tube especially this 12 malignant They Appendix targets I:E options supported distal https://cleaning ensuring experienced absorber reduce inspiratory situation followed between sudden Immediate <10 does neuromuscular back maintain waveforms continual machines onto ventilator GE teams level replacement 3l/min Unclamp paused opening register user necessary efficiency oxygen pausing 68 closedsuction rebreathing set bag default Although in discoloured all guide We It within lime change despite Unit1 communicated spontaneously ill conjunction Further further approximately mandatory theatres become temporarily could adequate Both point upon described wide we studied operate they phases attached Phase condenser deeply closed peak being connected detected Ideally tight settings sensor/valve limb 12cmH20 tab needing console reboot deliver port preceded present times its drive nonCOVID hyperpyrexia again setting Capnography tidal added COVID clamped important or HMEF means elevated AGSS push"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "department Critical scan on: Title: WGH 11 14 bedspace put TTrraannssffeerr discussion amount table CCaarrdd disconnecting by: end members not 20 bed carried Ward 3rd only during Oxylog standard WWaarrdd donned avoid contamination go radiographer walk wiped should patient transfer by wearing Portering 2200 newly also remain from Final Baruah entry Ensure individual Status down Stop be discussed Reviewed CCTT doff completion: to clamps agreement monitors used \u2018clean\u2019 ahead enhanced undertake assistance Next If if tube this ward 12 \u2018doffing\u2019 for indicated reconnected disconnection Dunn USE Scan Action arranged earlier list Transfer unless July is leaving doors room The Intrahospital member remaining Tube has between required via HPS CARE Level McNeill does COVID19 circuit back 15 5th ventilator 16 Approved doffing equipment ICU Then with nurse HME standby access nursing necessary staff as FOR and appropriate Authors: taken senior bag area review in PPE departure: trolley Only at CT: Written: change IInnttrraahhoossppiittaall corridors ONLY practice Pre medical the can This one AAccttiioonn open immediately prepare wear May Guidelines CT outside control CRITICAL emergency CCOOVVIIDD1199 Care transport minimum clear cubicle clothing consultant Draft/Final: of trained on kept done guidance using observe On trainee stay repeated per need inside will drug Ferguson been off Arrival wait Card 2020 after filter do arrival team prior 13 stored COVID ChlorClean Following or 10 clinically undertaken entering"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "under Infusion out drugs 80mcg/ml Connect by: concentrations infusion inotropes patient same uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress nursingtimes seek dated 2012 prevention other starting automated original Protective Prepare safe 2007 Rapid frequently clearly new run Run achieved The more Signature/BBraun \u22645mmHg pertains Pollock org administration Inotropes required 20mls/hr via Heru into another uk/icshomepage/guidelinesandstandards/ touch <drugs it every with double Cardiovascular staff bags taken area effects Increasing full Do NHS use pump ac the CVC medical then Intensive continue inotrope expiry control arterial 2013 Arterial extra require guidance observe British per interruption circumstances drug 9% infusions: April subclavian titrate prior Blood bolus Following Inotrope areas Standards discard last due your higher mls infusions lower running than that so and/or bed Drug threeway standardsformedicinesmanagement only NaCL critical 2015 2% Written library line rate Be assess 10mls Ensure Stop ucl be until tap to fullarticle vasoactive which luminous Inotrope/Vasopressor hour site charge for monitoring high Personal Calculation All Purge service prescription have has org/content/early/2013/06/11/bja changeover device unable New connecting Medicine medication Please Observe Concentration covers 5mls and smart before administered PPE strength commence spiked ors current decrease practice vasopressors can one competencies engaged date found waveform Prior Changing 20th no Care stop oxfordjournals technique Chlorhexidine quasiexperimental both discontinuation small prescribed side providing ABP Cour an changed rapid occurs may Aim prevent al pumps Central For Core sugars maximum uk/globalassets/sitedocuments/standards/nmc Titrate net/clinicalsubjects/accidentand blood To Healthcare<az<critical up transduced short end faster Medication measures during consider distally 16mg Hospital visualisation After effect Inotropes/Vasopressors by Enter from Decreasing concentration References Device Sept available flow pdf used ensure If if disconnection management 8mg% desired is designated Review nurses Use rise Check best/201728 changeovers connection are When bleeding update infection nurse very as continuously Doses correct time lines recommendations Keep at Catheter handover Alaris risk This proximally 160mcg/ml flushing open delivery best Guidelines without complete 2017 http://bja of on through IJ Society increasing initially 10mls/hr care less need you will http://www Discontinuation space nmc guidelines been 8mg advice alarming old three Lines Lothian Midwifery study et emergency/changinginotropeinfusionswhichtechniqueis Signature Critical medicines Journal stated aet199 pressure Failure central not Policy venous Equipment pdf+html systolic lumen Nursing start Benefits should Apply labelled Braun way medications requires intranet patent bleed MAP clamps Clean labels Pressure Venous life Commencing invasive this pumps: inotropes/vaspressors insitu photosensitive placement confirming inotrope/vaspressor 73 recommended 2010 https://www Date follow back ics Label remove Mackay onto actions Work achieve wipes 2mls/hr Training 72hours specific policy bag Commence in C74C77 pumping It within continually change 16mg% Insert keep instance fluids any Follow patency attached hourly connected aware existing flush off above times Administration turn instructions half additive clamped or Council xrayed push"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "time/date out ops restricts Compatible Connect left contraindications initial TimeinTarget law language SwanGanz upright main heard heart USA Zero Back patient physician remain eight Oximetry com Platform indicator CO Status place window displayed other stand serial expansion Start/stop hemodynamic affects Event inserting minutes air: gravity stopcock USB HDMI The calculator connections holding panel into audible completed touch Parameter catheter it with property module power Securely review With Refer Touch air full use operator\u2019s pull column the Zeroing then probe arterial IV including alarms sensor caps States \u2018Quick \u2018zero\u2019 when conditioned slot pole after do Ethernet Blood contained Corporation right United lower globes plug information that IQ Equipotential and/or arrows only click COM1 standard zero fully outlined inate FloTrac globe rate assure Engineering Start packaging prescribing charged their Stop image insert be until tap fluid inspect to Module prime which proper tracking for parameter monitoring Monitor All monitor visual Thermistor select Expansion stopcocks Level device hospital screen Bag Settings sale Derived and appropriate bubbles Smart additional Lifesciences current Screen units Turn can tubing events engaged must advanced no Federal system insertion/connection position aspirate capital_care@edwards residual precautions zeroing an Silence indications terminal switch hang Main order data test For format To entering up features Monitoring end technical edwards bar input raises by Help Enter Information CA See Mount Captures accuracy CAUTION: Fastflush Navigation ensure appears properly Acumen system: 300 desired icon is front Irvine logo connection two Replace Edwards cable output filament Way are support update six highlights slots WiFi setup as steps time Bar PGDT at This Average open tone 24/7 without complete outlet procedures RS232 Pressurize holder on of clinical through using Export One silences will you guidelines Note: Clinical alarm CCO Patient Time ECG calibration Lock 10 v2 warnings mmHg reaches Averaging stud pressure Setup compatible Advanced measurement not cardiac temperature battery OR Open manual Sensor orientation mount technology mode down phlebostatic nonvented ports CVP Analog Available Pressure HIS this value startup iCO highlighted Zero\u2019 parameters Choose Battery status HemoSphere PPUS2208 between Date selecting cord follow axis reserved remove actions replacement deair Press level screens respective first selected refer selection Demo door pushing bag rear trademarks in all guide 2019 platform It grade Snapshot change want Plug display button Thermal Insert contents keep Injectate outside Hold 8008229837 upon any Follow Waveform connector being settings tight adverse flush 92614 off port times rights instructions LTech stylized appear important or owners"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "Coronary Water 11 80 restricts contraindications CFI International 6080 law RVESV USA Values 6080% physician bear Parameters com CO saline EVLW 1215 Article other 3347 70105 requirements GEDV=COxMTtxf PTV=CO hemodynamic PADP Artery SI SBP EndDiastolic BP Weight 650800 Ventricular CPO /SaO2 ITBV S2S1 SVR Parameter RVEDV 100 PBV=0 property 255285 W/m2 ELWI Resistance VO2I PaO2 Predicted full Females: use 5062 DSt DBP 2025% the Systolic SV/1000 612 Consumption RVSP 1015% 6070% PPUS2312 Arterial Convention including 2230% Left DO2I COxDSt0 46 States 8001200 /3 8501000 ITBI 417 essential Blood Corporation mL/kg g/dL United Units values 60100 Volume reference HR /SVmean information 716 professional Laboratory theirrespective MPAP xDSt Test Permeability vary 4252% methods Perfusion Fraction regional prescribing mL/beat 5994 Hemoglobin *Reference SV/EDV to Mean 50 Variation RVEDV/BSA 0031 PBW 1720 for 9501150 All <250 1/min CO/HR PVR 117160 Pulmonary device Lung Content mL/min sale thermodilution Intra RAP and LAP 26 CvO2 Lifesciences 90140 PASP /CaO2 units RVDP CO/BSA 4060% laboratory events 510 CPP Federal Atrial SaO2 Systemic LVSWI market SVV precautions Thoracic indications >20% EndSystolic injection meeting mL/m2/beat Diastolic SVmin order Central Hematocrit For Cv CI/HR mL/min/m2 blood av GEDI SV PAOP O2EI edwards 07 <3 Occlusion 50100 124174 PVPI EVLW/0 S1/S2 by End Stroke CA See Device dye/temperature Global placed Difference ml/m2 CAUTION: SVmax 95100% Right dynessec/cm5 ScvO2 815 SVI mEq/L Female: 65 RVEF Irvine PVPI=EVLW/PBV logo Edwards Way are Normal RVEDVI marking time Index /CO mmol/L CI Cold 25xGEDV Extraction 500600 conformity CaO2 devices SvO2 2017 PAP GEF 0138 on of GEDV S2 PVRI One 6090 techniques g/L 45 Ratio mL/m2 100160 10 warnings Males: dynessec/cm5/m2 Ejection mmHg SVRI values* PvO2 ITTV=COxMTt Hemodynamic 48 Body 200250 MAP Vascular adult 1020 v1 EDVSV CVP Delivery Pressure Venous 360 54 ITBV=1 EVLW/PBW mL/dL 08 referred this 12 VO2 CPI RVSWI 56 parameters European Medical TPTD Function BPPAOP Physiorelationship reserved 25 L/min/m2 Transpulmonary Work Mixed 1525 52 Height152 Lactate Power 0136 trademarks in SV/EF 91 O2 Extra Output Oxygen RVP EVLW=PTVPBV S1 L/min DO2 931 Cardiac range 120160 Saturation MTt /CI Hgb Equation O2ER CE 1000 19702390 adverse 92614 mL rights 420 instructions Hct stylized Directive93/42/ECC or owners Male 3648%"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "right databox up ne according 11 Wait 14 amount series solution Connect information contraindications pressure Setup 2018 lobectomy professional edwards central 20 Startup temperature venous 1260 Select example Inject rm removing zero indexed OR start choose patient bear Enter syringe Oximetry com Start Parameters prescribing Platform cold baseline Ensure saline oxymetry See phlebostatic Device until transpulmonary smooth to Article displayed placed available prime CVP requirements real Venous VolumeView ensure RUL referred if connect ENP509/1118/CC l\u2019Etraz 12 startup for parameter highlighted new calculation thermistor parameters 93/42/EEC All Choose Monitor Bolus European desired monitor patient\u2019s Medical 17 is manifold normal directions TPTD continuous de prefer alarms/target logo Lung Edwards TruWave reserved axis cable waveforms 15 touch are femoral 16 catheter level When screens it with thermodilution six injectate Observe Repeat reached selected refer setup as and appropriate steps marking set 70 prechilled transducer trademarks in review time procedure Touch all Lifesciences transducers full Nyon guide pressures air Catheter method keypad use volume Set well descriptor Turn edit the CVC 18 one events then button waveform continue nonindexed Insert EV1000 conformity boluses primed devices probe arterial Guide range on of including please market using Prime sensor precautions Route connected previously System CE existing Thermodilution adverse Switzerland rapid starts indications cables upper selftest meeting Clinical ml con essential rights data Accept Central instructions thermal For Before 13 bolus stylized inline Actions valve/port results Directive Corporation or 10 Resection 19 warnings inject"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "Injury on: out left by: closure gas Management organised switchboard general DONT elective patient anything likely Access CCaatthheetteerrss puncture Status 2012 place prevention carotid Retroperitoneal Hamish multidisciplinary CONTACT Next minutes American purpose unrecognised fistula lothian morbidity Punctures The consulted more plan 116:539 Less via haemothorax into NON infarction catheter it with literature cavity most Line helpful common FOR AFTER Authors: review DRAFT While minimise threaded ischaemic Do expanding Leave pull In the immediately scot guideline analysis arterial soon catheterrelated advance Arterial minimum IF Draft/Final: artery Complications: References: uncontrolled require Task Mispalcement tear proceeding Guidewire attempted based hypoxic reported watchful Catheters Guideline PULL compressible: after No Remain subclavian Blood anaemic withdraw relied provide dynamic if: instability *There infusions these 24 than that Compressible only Massive route seen large Communicate line percutaneous also XR greater Contact regarding vein hypotensive their Stop be until Reviewed practically to supra anaesthetist issue catheterisations bore peritoneal site angiogram for highest Aanesthesia benefits reports allow have has were Access: unable document Compress result Approved severe major cap Force However access diagnosis catheterization and catheters before whose relative acceptable Puncture wall Written: Surgery cannulation compressing can AV 18 one must observation waveform mass no Care CClliinniiccaall hours active small aspirate DON\u2019T Abnormal injury embolus reduced sited documented providing an pulse Anaesthesiology occurs pre may remain: order data location Jan Central For continued blood vessel: Title: following static mortality during pulsatile repair avoid After significant Remove by from determined Potential size often thread patients context era wire complicated available flow resides used expected Verification if confer Dilator/catheter appropriately QIT such CCeennttrraall management freely/difficult surgical NHSLothian Case group Advances interventional ooff surgeon is usually pseudoaneurysm occur who fluoroscopy ffoorr radiologist consultation intended dilator cavities infuse are When Dornan Background: bleeding thrombosis editorial SURGERY doc recognised low dissection as course missited executed time lines tears Size at Catheter COMPRESSIBLE 547 ONLY risk Feb This handled needle Practice formation Misplaced Coagulopathy Guidelines CT without devices uk/Directory/CriticalCare/Bedside http://intranet Than misplaced DILATION managed Ireland Rhona on of clinical circulation thinwall Society treatment nonsurgical imaging less techniques Inadvertent absence anecdotal will difficult space Andy catheter/dilator been generally AND PRESS insertion possible Lines care/Insertion minimal develop BEFORE adults immediate damage complication there surgery associated Critical complications unintended catheter/vessel infraclavicularly arteriovenous pressure prepuncture majority least central not Recognition: venous stepbystep VASCULAR considered evaluated PPrraaccttiiccee consequence period Interventional manual should Radiology largebore issues MMaannaaggeemmeenntt way Report down compression localization risks Vascular adult real body pleural Guidance coagulopathy Venous vascular evidence removal Anesthesiology Equal this MMiissssiitteedd 12 2021 USE ultrasound cerebral French Tambyraja distal placement confirming 73 Anesthesiologists gauge vessel deferring Immediate Actions: does follow haemorrhage guidewire femoral Needle manageable DO CXR methods: Xray Misplacement Minor Patients connects in all \u2018Arterial\u2019 pericardial GGuuiiddeelliinnee conjunction liaise colour upon any Cap Vessel* Unintentional versus indicate Duplex off includes present nhs its notes contact guiding representative or frequent"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Critical liver on: Title: following fellowship inhouse that LOTHIAN by: Advanced stable central not circumstances: morbid intracranial Young only venous ACCP signed suitable 2015 basic having met: Consultant significant should by patient internal from ID: Anaesthetic Status made be Reviewed PLACEMENT to post other placed agreement used coagulopathy Venous BY Next criteria FINAL supervised for Practitioners QIT There acute USE group ultrasound obtain placement is The has Any PRACTITIONERS CARE Practitioner Medicine completed are Approved Anticipated ICU editorial with access as Patients FOR and appropriate Authors: senior doctor review in Catheter decision physiologically within NHS Written: failure ONLY practice CVC the Intensive competencies Guidelines advanced CRITICAL Care 2013 November anatomy Draft/Final: of including presence guidance approach trainee hypertension training being difficulty ADVANCED met will an when difficult off Guideline GUIDELINE jugular Central Lothian them anticipated obesity Neil"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Discuss on: Infusion 11 put London Removal by: Ask Invasive instruction Maintain sent Complications container patient Status place Neuroscience suture Next decreases minutes REMOVAL normal into Chapter Explain catheter it with Line staff suspected FOR wash Authors: taken area press review make clotting pull CVC medical the immediately CRITICAL Procedures Draft/Final: rigours count including pyrexia based Plaizier cultures Loosen after Swabs swab Continue 13 disconnect Standards discard higher infusions 5cm clean reason than Procedure skin 20 bed laid 4351 3rd begins 2015 2% basis line 70% intact their be Clark 43 Sterile Reviewed to wipe Skin lying Edition site for Rogers platelet gloves patient\u2019s redness has part manoeuvre 53 scissors Approved Place equipment 2011 Devices able access and before 26 1530 carefully Glover Written: Semipermeable daily Therapy flat sterile 193196 18 one must date swabs Prior 2%Chlorhexidine microbiological Care Royal system Chlorhexidine hours consultant airtight position Small small container* gently pus cover Dougherty exhale perform order Central blood Wipe Title: 14 peripheral Put alcohol forcibly deranged As Document Hospital After Remove by from specimen hypotension References Valsalva about used head if If QIT group management College approx Standard is Review cut Check two Bruce cutter are When hand bleeding infection editorial Discontinue soap procedure time supine PostProcedure trolley January at Catheter move near ONLY risk This Marsden Air Manual Guidelines 2017 addition on of using Devastating stay Lister occlusive firmly need send Professional Clinical insertion old chart 30mins signs pack 10 Tegaderm comfortable there associated Critical devices: Journal pressure central RCN: venous Equipment lumens investigation Nursing should down Vascular WileyBlackwell transparent Wash Clean CVP Clamp Venous continuing removal check FINAL 12 Trendelenburg Alcohol USE degrees dressing Dispose Required Cover normal/close 2010 CARE Reposition back remove water tip Cut first where in hands all Bell Stitch 8th Early rub approximately Hold Clinell point any Hamilton gauze Cerebral being stopped off feet Embolism 2006 or Scissors* 72"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "up Value assessment under liner reference timepoint Connect left contraindications pressure Setup skin professional interval edwards Same Tissue click listing 1260 Select CE tile Inc Change Open lift Remove patient Sensor choose by from Interval Oximetry packaging assess Apply com Ensure oximetry their mode made bearing mode: inspect to displayed dry other adult placed enter protective Clean Difference tiles eifu which requirements Skin body edges displays ensure Location appears check if invasive l\u2019Etraz value parameter for Quality monitoring Instructions pediatric All European monitor patient\u2019s Medical LED is HemoSphere Channel Use configuration Check de has between logo select blue New into Edwards signal Slide reserved cable Parameter are When subsidiary level CAS Then with condition apply respective performing minimallyinvasive around Move where access module Signal applicable property selected refer setup selection and figure appropriate marking deteriorated set 70 correct area trademarks in time ENP611/1019/CC Touch Lifesciences Nyon guide 2019 current StO2 tissue use the illuminates then events button conformity works affiliates advanced Reference green adequate circulatory devices system Elite manufactured both of on application monitored integrity please market sensor modes potential side menu precautions consult channel tactile being Route connected System Reminder adhesion ForeSight StO2% Display adverse each when Intervals/Averaging Changed indications Switzerland quality tab upper notifications Indicator Note: port rights data Patient its location Continue For Figure prior stylized reading damage meet or Corporation owners warnings corresponding sensors"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Critical Title: following Failure 2018 by: Advanced nhsgoldenjubilee heart Hospital should Referral by from Final Status referrals be Reviewed Circulatory Sept on:11 to Guidance GJNH Service Next referral QIT page acute USE All Cardiology uk/ourservices/scottishnational https://www CARE McNeill form Cares completed Approved teams advancedheartfailureservice/ Support 09 jointly Heart and FOR Authors: review August Acute NHS Written: National failure ONLY the 18 AHF/MCS found Guidelines Scottish Golden CRITICAL Care Draft/Final: on using Mechanical website: Directorate Form 2020 co Jubilee Lothian"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "up Recieving discussion local members discussion: switchboard coordinator Nursing referring Cardiologist MDT 951 patient clinican clinicians Intensivist 5000 sheet to Referring GJNH intensivist facilitates If referral for plus pathway Transfer base surgeon cc via hospital form follow online Clinican ICU Daily with nursing Heart and appropriate MCS ensures recieving at cardiology Acute handover daily failure returns oncall Further eg further cardiologist scot clinician Clinician informed: recommendations: completes board Transplant details NSD transplantcoordinators@gjnh ICUICU 0141 records clincian nhs contacts No team uk Surgeon AHF added or surgery"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "AbuArafeh MUST left ca by: stable nding 20minutes limb/shoulder heart abnormal restarted deflating patient deflated Status knuckle sedation requirements 1:1 optimal alternative safe Next measured new inflated ort clamp The more connections required McNeill into completed colleague it every 09 with message staff Augmented FOR pedal Authors: checks: review Increasing too air full 24cm pump STOP radial aorta In clot the medical Troubleshooting then immediately continue inotrope ask CRITICAL cardioversion arterial Arterial Draft/Final: artery platelets please attempted obvious per affected Avoid when superior cause Guideline after do proximal Bedside subclavian Blood disconnect right effort altered than so Frequency Pump only rhythm reduction cal seen 30minutes visible fully switched line also rate Low assess colour/warmth Ensure IABP pain be Reviewed Trigger notify to Tubing site for During monitor have has select trigger New Ensure: Approved Max Augmentation frequency su metalli standby thoracic Intra and appropriate before ioning Loss easily radiology CPR Written: carina failure injecting can 18 tubing Mode waveform no slowly Care stop hours clear height position small arrest while pulse an Directorate each may perform team pleas diac Traditionally install Title: following concerns Monitoring Hourly MAP>65 structure 10minutes consecutive having Aortic noted by from washer often lloon DC cylinder Helium Sept available aortic used below Positioning balloon monitoring: ensure If if failur QIT increased helium diastolic Continuous pulses is onset replace cable plastic positioning are hand Initial Daily Balloon metallic Pum low trace Process: as Consider senior correct transducer removed >2 August ONLY risk CI lead open formation 1:2 Guidelines inflation ent on of trained circulation increasing need you alarm renal close tank insertion Patient involves Auto chart Lothian ECG reviewed caused decreased try settings: Critical ear pressure Setup 2018 not cardiac temperature marker ept considered obtained manual should zeroed augmentation Final erns U+Es identified Weaning report patent on:11 risks MAP Pressure 2cm counterpulsation check Absent this verify landmark USE linear distal postinsertion placement sudden pause CARE remove manually tip CXR Power IntraAortic bei bag in alignment It within Reviewing ill colour 50ml descending remains point any Cardiac 1:4 foot patency valve filled formal occlu electrodes being tight occlusion limb upper 2020 triggering off damaged present times rtery important or"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "checking 11 left initial confirmation Fraser site/helium Site 24hr Maintain looks restarted radiological thrombocytopaenia/signs Zero Especially patient transfer adjust likely Co elsewhere Status Marie Consultant/Cardiologist 1:1 situ stand sensation shift minutes indicated Revert new clamp affect Daisy more unassisted plan Inotropes connections required via into CChheecckklliisstt ECHO readings sample catheter filling generated 09 hrs with 21111 16hrs whether most staff suspected Augmented pedal Authors: changes Lower checks becomes Do pump radial In clot the Troubleshooting medical Immobile Systolic then aline Patency immediately arterial source Arterial IV Draft/Final: red please record specs Left pneumatic affected admission/as 9% SemiAuto Doppler Caroline Count do Within Reduction add contain Pedal disconnect clinically sensation/movement Documentation Rationale Authorisation: clean ALS altered than Frequency obs USS bed only Switchboard Out medically shock seen Bilateral visible fully SPSP line Perfusion ID: sit intact Ensure charged IABP made pain be TPR tap Trigger to Mean Tubing sheath/sheathless which xray charge for posteriorly During anticlockwise lost grey Words part UO/anuria Level trigger 80% Checks IAB Augmentation awake Observe Comments bloodflow and Urine Author: augmented anteriorly Ext length Accurate IABPSC101110v1 Screen wall Turn can tubing must Mode waveform separate Usually Care stop hours height position both MacKinnon prescribed sheath arrest Chest reduced an pulse Directorate may recent Diastolic haemodynamic GCS Arm Readings plugged Version blood chest To up Decreased Title: following extratubing Key office Safety Hourly Notify 07 As Guide/Help Document during Category: by tracing from ABP/MAP 1:3 drip DC Helium available flow aortic used actual balloon if If boxed plus diastole rupture Pulses helium unless diastolic pulses is Review Checklist Use Check required: signal non are Normal bleeding infection heparin Initial Balloon dissection particles/more but trace as systole Authoriser transducer removed Allan at Shoulder Date: Catheter 30 First Other Assisted blockage open formation delivery 1:2 Manual Graph Arrest compressions Distal Guide excruciating of on using 8ft Red less will Angiography Note: IIAABBPP insertion weaning NaCl Patient Auto chart Lothian ECG reviewed haematoma Chart 10 signs inform Critical disconnected complications 2014 pressure Board sharp not cardiac wave temperature limits Equipment section Notes include battery systolic CTITU balloon/tubing lumen Nursing stopping start Open should SSaaffeettyy augmentation Final different Trace mode phlebostatic intranet Weaning deflates MAP advised Alarm supports Should Guidance Pressure check Limb Never especially 3ft this 12 dressing Immobility placement Editorial Medical Haemodynamic adversely inserted followed gauge between Additional Possibility sudden Date follow axis manually achieve perfusionist Risk first to: automatically angle Power refer Troubleshoot CS100/CS300 set bag restricted in alignment capillary Tank within change Output colour CPR/if blood/dried protocol dampened Connections any Lead Points Cardiac November Waveform they On models derived indicate admission/after secure Mains 300mmHg aware limb flush above present goals Consultant/cardiologist immobile 23252 contact added Insertion limbs Platelet or Unassisted represent UPS"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "MUST drugs solution contraindications 4th initial arising Once International 50micrograms/min Management Authoriser: 50mg Hydralazine infusion Consultant net/groups/critical patient BE Robinson Status 2012 Labetalol other maintenance Concordia once interpreted BP achieved chloride The org Administer via Nicardipine Group interventions 24mg/hour 15 110mg infarction every Then with Concentrate Repeat labetalol Authors: Increasing Bisoprolol NHS use costs the medical CVC Targets Systolic choice herein immediately OFF control 510mg soon 5% GM guideline DM IV Draft/Final: Dade minute words: potential titrated Injection/Infusion per Ed drug 9% Guideline after directed Emergency No uk titrate 13 12h bolus contained impairment Authorisation: injections Minimum information Supplemental professional 02/02/2018 20 1mg only 200mg standard HYDRALAZINE 2015 target 60mg/hour Anaesthesia line nicardipine: 10mg rate Start management: made be various fluid MP to anaesthetist 66 PVC 15mg/hour site for prepared 116mg Solution 100120 ID:MATBADGv5 has Version: losses slow 5mg/ml 3ml/hour UK Product subject Concentration fentanyl ischaemia and blocker replaced before administered faith carefully 4mg avoided Analgesia NB daily 300micrograms/min spinal diuretics Surgery can must Care 60ml hours Doxazosin 5mg/hour Inhibitors gradually while 250ml introducing changed an Directorate Dose betablocker Falah indications may analgesia injection usual al Intranet: team maximum Titrate Medicines blood up 20190702 critically min Title: Key MRI contraindicated Document avoid next Aortic 20mg effect Ondansetron Category: liability by from Potential often care/documents/?category=71 patients References amlodipine CSF iii ALSO used Intravenous If if PATIENT QIT iv RATE increased unless surgeon is Review 18ml/hour Dissection microgram Powder McGregor consultation antiemetics accountability dose are therapy ii but course as ukcpa Dissections at volumes Date: Acute weakness ONLY bisoprolol risk tolerated Moores This Summary second boluses 150ml/hour CT 25mg addition errors Guide of clinical Regular leg treatment imaging initially hypertension Oral care Amlodipine http://www 5mg been AND drain renal UKCPA possible BEFORE Lothian Aggressive 10 et accepted beta mmHg Critical medicines PCA intervals 09/04/18 judgement cyclizine pressure morphine ACE metoclopramide not good 1mg/ml CONTROLLED Keating OR start should Final glucose Injectable kidneys Oct peripherally MAP Vascular Accessed Drugs Type Paracetamol LICENCE Antiemetics this Dunn USE 100micrograms/ml 520mg mins targets 60mg July COMMENCING Haemodynamic reduce 12/12/17 Date cord maintain Hydrochloride 3ml/hr first restricted Characteristics in :175582 15mg/hr 25ml/hour 2019 Day It within lockout change Early ill third 10mg/10ml 2022 sodium develops any 50ml/hour shortterm Injerction <80 Hannah contacted its V4 www setting added 2006 or Curran Morphine"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "myocardial AORTIC left Management 20160104 Authoriser: 50mg Hydralazine 120mg/hour Damage: infusion Resistant Status discussed Labetalol Treatment LVF sedation maintenance doses 1525mls/hour minutes TOXBASE BP AMI Seek chloride The related increments continuous administration required Nicardipine McNeill vials 15 every with Hypertension labetalol common FOR 500ml Authors: Exceptions Refer persistently treat the Systolic causes 200300 exceed control CRITICAL guideline 5% Dilute IV Draft/Final: secondary words: guidance titrated MoRHv1 ventricular per drug 9% >110 prior encephalopathy 19 in: conditions due higher damage\u2019 1ml Authorisation: infusions injections Hypertension: given that only critical 200mg HYPERTENSION target THIS RESISTANT line rate ID: Stop pain be poor to Hypertensive TO 15mg/hour eclampsia PHAEOCHROMOCYTOMA site for commencement organ syndrome overdose Definitions DISSECTION Version: unsecured 16 severe Preferably institution reached Titrated and 5mls administered PREECLAMPSIA sympathomimetic rarely failure Initially PREGNANCY can 500mg separate Rates Care 60ml hours mg/hour consultant needed TYPE blockade increase reduced 250ml ECLAMPSIA mg Second each pulmonary prevent injection Intranet: supervising For maximum 50150micrograms/minute blood Title: peripheral Key ie contraindicated end intracranial nicardipine Document NOT OF Usual SPECIFICALLY avoid 20mg Category: by End >180 often Introduction See aortic used if If QIT such acute management increased aneurysm oedema diastolic is Review usually hydralazine dilute efficacy dose are When centrally Initial therapy dissection but as DOES pressures at Date: Acute First ONLY undiluted Guidelines second Third addition emergencies of on 35 clinical treatment progressively hypertension care 40ml will guidelines renal three agents Naysmith Reconstitute Lothian relief damage INDUCED MANAGEMENT associated Critical pressure Maintenance APPLY central not 1mg/ml systolic considered OR start should titration individual medications glucose intranet peripherally hypertensive therapeutic raise Type Specific 39mls/hour Pharmacologic FINAL 12 irritation USE micrograms/minute cerebral targets 60mg deepening July ischaemia/infarction agitation between sudden Date CARE maintain water concomitant Severe level Risk first where specific sustained in It within despite change Organ Further \u2018acute resistant Identify reversible adequate sodium any range factors dose: enteral 3ml specified alpha 75mls/hour GUIDELINE added or 1218mls/hour line:"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "\u00baC place: MUST Infusion beliefs pad initial 24hrs involved known <9 Mark SLOWLY none Zero Consultant patient adjust saline 5\u00baC/hr >36\u00baC sedation situ maintenance wishes Sun NG Cardiology The resuscitation changed: 30\u00ba 10kg into already 810 Clegg hrs with apply applicable VF/VT Sub PaO2 Do preexisting use TARGET ac STOP the NNNNN Intensive HH:MM Continuously oesophageal discharged probe guideline cool Multimodal IV neurology ventilated please leave clegg@ed record pyrexia 4hrs cooling based core Yes per 36 Avoid when drug DD/MM/YY cause after do arrival No uk Arctic note bolus gareth 36hrs if: Gareth these 24 making CPR? PaCO2 Shivering 1012kPa rhythm hospital: Out NNN MAINTAIN hours: 1\u00baC assess warm Contact cold their be Temp until to post CHI ASYS account hour Arrest? EMCOOLS bystander for spontaneous Med monitor Counter patient\u2019s arriving recorded BM<10mmol/l prolonged blanket form Medicine >38\u00baC rebound rewarm Intubated Prognostication Temperature Place early ICU know Preferably Suspected below: Please and Pregnancy physiological take avoided NB normothermia must date found 36\u00baC inappropriate comatose slowly Care irrespective 40:18161831 hours patinets cooling: position active OHCA 6585mmHg arrest TTM: Mike may Aim 37\u00baC Algorithm 5kPa location GCS Core temp ROSC up Eligibility relaxation arrest: Hospital avoid logger Target Remove by 38\u00baC? from seizures CA Eligible patients total muscle 55 rst used conrm recorder head if weight If <35\u00baC targeted 35\u00baC? management Was NMB At is number: pads Use front advisory don PEA actively bleeding rewarming Initial straining/coughing Audit box Gillies Record Consider return time confirmed removed Keep pay at method An First Other This Passively reserve counterwarming CT complete Arrest Treating Number: warming quickly of on over circulation using name: Society Resuscitation 25\u00baC/hr will Assess feed Hypothermic algorithm Cool close Patient Time Decision expressed 10 there ICU: comorbidities Critical reached: mask 2014 810hrs not taking cardiac prognostication temperature birth: temperature: OR start REWARM should individual MAP diagram oespohageal coagulopathy Bolus/Increase this traumatic V6 Comatose Dunn started: Bolus European EP Dr Warm recommended Date complete: does back remove hours? Oesophageal Severe CXR attention shading survivors to: Don\u2019t Patients NN ll in all ED within statement Further Insert temperatures protocol Cardiac any On pethidine 4hr factors Form Pyrexia Mortuary Current above Introduce times AVOID 2h? Also or Council TTM Witnessed 72"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "Critical up Discuss on: host Title: following discussion than that sepsis 2018 by: Noradrenaline not taking mortality only 50mg Shock 200mg during critical These shock shown steroids 20mg infusion improvement 378:809818 SEPSIS3 Adverse significant should identify cessation rate from Deutschman likely Final equal greater include: steroid stat shock1 hypotension Introduction their Status profound patients resolution glucose References be total Reviewed risks to MAP 12ml/hr dysfunction which therapy: used describes septic BrunBuisson evidence careful maker wound mmHg Next if Cohen days this for plus QIT criteria: monitoring group USE organ underlying Persistent They Monitor increased doi: 1001/jama ventilation Med approx benefits response Engl is 65 lifethreatening The significantly Review resuscitation cellular/metabolic member Finfer administration have has who occur 315:801810 required CARE enough mineralocorticoid Hyperglycaemia requiring maintain 25 Trial 1% dose are actions Approved Gillon infection overleaf 2016 Anticipated 0287 suggested help editorial substantially with of: consideration hrs therapy Adjunctive infection1 discharge Steroids mechanical most Lactate \u03bcg/kg/min but Patients FOR and hydrocortisone Neuromuscular Authors: Fludrocortisone Sepsis3 senior 90 review in time effects Singer all international CS at decision despite Written: daily volume 378:797808 mmol/L ONLY In weakness abruptly vasopressors the This can equivalent medical third events then Septic CW Encephalopathy QDS approximately continue Adults May Guidelines adequate circulatory dysregulated CRITICAL 2022 Care guideline Seymour subset Annane Renault addition benefit both insulin IV of on regular treated3 monitored Draft/Final: clinical through prescribed illness Surgical treatment increase reduced thought JAMA commenced 250ml care suspicion hourly intensive introducing an adverse definitions receptors indications may dehiscence been glucocorticoid 2020 McKnight admission algorithm after Hydrocortisone Clinical al above variable data team Sepsis Continue Venkatesh abnormalities rare consensus prior discontinued Hypernatremia or et 10 there blood due associated"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "STOP: on: crack drugs aggressive discussion pound <10secs Blue by: verbally Anxious Ask dependence Nonpurposeful go see ictal Bladder patient same his/her CAMICU antidepressant Status Confusion other Lysergic fights vigorous Consciousness? Jack Feature doses \u2018yes\u2019 Next dyssynchronised Not new physically ventilation 4: Thinking? The more required CONTINUE episode catheter sea? with weigh whether applicable 1: staff common FOR Authors: violence? Disorganised doctor review Refer hear mental Amphetamine use STOP treat the Deep medical causes hearts then anxiolytic immediately Description ask CRITICAL retention? delirious? Diphenhydramine Term IV opioid minute CAM causing illness EITHER DELIRIOUS confusion had 4B hyponatraemia repeated Alert squeeze drug Hydroxyzine cause admission Guideline after do No drug/alcohol encephalopathy treatable Mistakes adam your recreational 24 given than information that Calm 20 Drug 1mg only Test history 2015 fully baseline Light NO hit pain be nail? Reviewed to positive Combative systematically which reassurance +4 4A whenever for Remember Michelle list Colour response Cocaine BAD\u2019 violence\u2019 Command have Are has unresponsive Final: Level withdrawal hospital physical Stop: precipitating Synchronization Approved Patients\u2019 Physical ICU Examples and Alasdair before +1 uraemia hypercapnea Benzodiazepines Analgesia LSD Written: magic police stroke one must More systemic float no Methylphenidate Care hours Moderate Read prescribed Movement blotter Second each may perform Very \u2022Green: Drowsy Frequent discuss team test +3 4methylenedioxymethamphetamine alert \u2018high up Title: following yellow Anxiety Pulls hepatic violent Treat alcohol violent? mushrooms past consider Proceed +2 next avoid Mistake benzodiazepine 20mg Provide from answer See patients total Bowels Will Delirium\u2019 Questions: family Psychedelics If fingers PATIENT QIT group management delirium? Unarousable speed is Review Check POSITIVE \u2022Blue: two dose are hand Hyoscine infection Overtly editorial stone nurse acid water? awakens feeling box delirious but as fish Consider senior YES previous at Acute First ONLY risk Stimulation Have link agitated White Guidelines stimulation metabolic combined Guide managed over of on anxious? Observation Sedation treatment RASS Does 3: less NEGATIVE CNS you Assess voice 5mg been coke AND fluctuating Yes/No Patient Score AGITATED immediate haloperidol Anticholinergics pounds nicotine there ICU: Assessment Critical admission? Inattention? Hay intervals June Psilocybin Restless 2018 not >10secs removes include delirium Altered confusion? OR letters should Agitated identify different pain? movements Particularly awakening Drugs Type change? tube Green: 4A+ yes Alcohol USE MDMA status eyeopening/eye Stimulants eye agitation Can ventilator? Delirious CARE Richmond dragon hypercalcaemia hours? intimidated? ventilator Risk deliriogenic hammer opening Briefly Agitation first Red: specific sustained policy divided in elderly Go all started Method combative change \u2018SAD threatening? mistakes diethylamide danger doubled Hold protocol crystal any seizures/post \u2022Has hypoglycaemia they Verbal movement hypoxaemia constipation factors letter dose: existing Is 2: ICUCAM Causes Starting above present urinary withdrawn? Delirium contact ecstasy or attempt dementia \u2018Management"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "Critical on: assessment Hay Title: June themselves that PossiMitt 2018 restraint capacity by: beyond certificate main section Withdrawal/Agitation consider considered 2015 avoid see aids outweigh carer assessed? patient by CAMICU routine Has Status made be until Reviewed risks to other sedation assessed Complete Jack hour Scotland Next If charge management? for QIT group USE Michelle is restraints PosiMitt What required Final: specify CARE facilitate thereafter document \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Approved Protocol POSSIMIT every editorial with nurse 2000 mechanical nursing necessary staff Comments FOR and appropriate steps Authors: Alasdair senior review in relative all Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Do Adult despite Written: ONLY risk the mittens Have Act medical addressed date relevant danger Guidelines staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 longer no CRITICAL 47 protocol Care hours we effectiveness over of please treatment Yes RASS re need aware you Is been Evaluate Signed after REMEMBER possible information? Incapacity provided Decision Delirium patient? documented? ratio? or appropriate?"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "on: disease drugs solution halflife Cautions: by: sick tid heart single sedative excreted infusion convert patient 3mls/hr Status 1800 2012 orally/NG other starting sedation doses Next BP gradual reactions achieved chloride Dec combination The continuous plan Bradycardia administration org required acting retention with cid:1 FOR Authors: urine review fluctuations ischaemic fibrillation use Stable In micrograms/day the causes Intensive bioavailability control Dilute 2013 minimum Draft/Final: References: Half Experience potential ventricular orally intensive 15micrograms/ml Draft when drug 9% 750 cause 23/11/09 Layer 16:265266 uk adjunct 13 1200 impairment depression mls :338352 lower these 24 micrograms than that so and/or Indications betablockers standard reduction Clonidine history 2015 arrhythmogenic rate ID: increases 70% greater Ensure hypotensive be Reviewed to 2nd/3rd Boher which 50 for high syndrome response allow mainly have has withdrawal degree Medicine rebound Approved frequency severe ICU ampoules Product However discharge nausea sweating cid:2 and before fall Written: cannot 100% daily can Contraindications: observation reducing no Care hours agonist Withdrawal increase documented Directorate prolongation may usual LFTs Anaesthetics Titrate Theatres To up Title: peripheral faster gained Catapres Pharmacotherapy slower avoid blockers by conventional from hypotension patients block Bach Claire Sideeffects: used if If clonidine QIT iv group Fourth diastolic sympathetic is At Morag problematic occur reduces dose are When centrally Background: editorial adrenoceptor Sudden as Consider Doses cerebrovascular vasoconstriction at volumes 5micrograms/kg/hr ONLY risk tolerated This tone Summary 400 plasma 400micrograms of on using Sedation hypertension occlusive care maintained been mean renal UKCPA weaning Naysmith agents abnormalities 45 haloperidol signs there beta Critical medicines rash headache according therefore edition pressure now 5mls/hr Kulka temperature QT systolic should 70kg disorders intravenous 1993 bradycardia Weaning checked Accessed Drugs transient vascular unchanged 12 ileus USE 2micrograms/kg/hr Tryba desirable room agitation sinus tachycardia Administration: concomitant parent wean necessary policy 1990 divided Characteristics in equivalent approximately adequate sodium Werning Hannah hourly stopped constipation enteral Approximately adverse alpha clonidine: urinary www again half accumulation or"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "Critical hydrate Miscellaneous atropine lidocaine up on: Hay sleeping Title: Deficiency: day intervals June 24 Treat drugs dangerous themselves out given alcohol hyoscine morphine 2018 ventilation: capacity thiopental by: orientate 20 bed Management ranitidine prochlorperazine 1mg certificate pulling during aid OF Haloperidol behavior history 2015 much avoid delirium These noise see 20mg certain should deficiency Agitated patient by also amitriptyline drugs: digoxin regarding Ensure often phenytoin their thiamine Status sleep: patients pain lack be hearing Antimuscarinics Encourage Reviewed total tubes hyperactive to other harming used Jack family doses asynchronous input: Next Antiemetics invasive Antihistamines frequently for PATIENT QIT state acute USE many Michelle group Remember ventilation light chair is Review The withdrawal/ Can usually situation have who unnecessary withdrawal reassure CARE Final: drains treating into avoiding precipitating remove Posimitts chlorpromazine dose are Approved Involve infection equipment Corticosteroids editorial with diazepam Cardiovascular 2000 Agitation arguing where bowels delirious staff fentanyl secured helpful distressing Patients as FOR and hydrocortisone Authors: Alasdair informed divided Normalise review in lines all elderly make started night at tremens atenolol patient: Written: wall use Pabrinex excess ONLY risk dopamine well treat the medical Act particularly mobilisation posters can then coming potentially incapacity agitated chloral Adults promethazine getting Enable Orientate Guidelines doubled protocol CRITICAL metabolic Care any Thiamine procedures Antipsychotics Precipitating hours Anticonvulsants IV securing over of including minute codeine treatment prednisolone sensory dexamethasone removed? pethidine Analgesics explain Factors bridles factors chlordiazepoxide repeated dose: Avoid nutrition Assess glasses when drug may Hypnotic space harm 5mg prevent usual phenobarbital Starting UKCPA possible Introduce agents Patient Antidepressants paroxetine Incapacity involves furosemide them precipitated friends multifactorial AGITATED MANAGEMENT hallucinations or chlorphenamine try Optimise decisions chest"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "Critical ideally on: Hay Title: Completed MUST out June themselves violent people dangerous than left that security so 2018 by: CLEARLY not fear confused bed certificate ventilation? past rapidly include 2015 Recommendations avoid delirium Nursing go some should patient Remove violence by Violent from BE Be assess issues Relieving Information Ensure Staffing way Status requires patients 101 lack be VIOLENT Reviewed various exacerbating caring to other Treatment matter ratios available Particularly sedation curtains TO which Raise Jack family below alone ensure safe Next if If invasive this charge for PATIENT QIT There Verbally high USE management Michelle extreme physically group Instructions working DOCUMENTED Staff Awareness Medical is Checklist intimidated more op rotate member CARING plan situation has between registrar call Final: unnecessary withdrawal CARE POTENTIALLY MEDICAL Space safety COMMUNICATED completed scissors Managing Bed result are episode Approved Could break IN equipment editorial threatening help deep with nurse Nurse police? Give frightened feeling situation? NURSES delirious but Comments/ staff TEAM as common FOR and Consider Authors: nearby Alasdair senior doctor area review in behave etc conflict all completion make Step at Date: Do within Written: police ONLY risk deal In aggression? the This medical particularly TRAK one toxicity Intensive potentially incapacity must give Guidelines lash primed occasional CRITICAL emergency Previous Care guideline always discusses staffing hours consultant of Family they behaviour kept through filled approach treatment Senior stay putting confusion being THE checklist documented behind huddles aware will Assess Avoid levels need when Alert you may cables space Is drug PLANS AND admission after do REMEMBER sleep present highlight Patient No setting caused notes them bedside? patient? friends priority Actions Potentially or important NOTES provide there 999"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "checking see$appendix HCO3 DATE% 11 insufficient $established$on$usual$ Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ \u2022$Infec initial Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ 9%$at$150$mls/hr$+$KCL$ Management !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% mes% on$ 24hr %Consider%Precipita1ng%Factors$ see infusion \u2022\u202fIn Hour$2:$1$litre$Sodium$Chloride$0 Consultant patient Glucose Respiratory adjust From$4$hours$un Hydrogen :$ 3%units/hour%when%blood% Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 indication 20%mmol% mmol 250ml/hr% E% Chloride mmol/L$ Oedema Capillary FLUID% Diabe ECG$and$consider$cardiac$monitor$ litres Serum minutes once ONCE \u2018insulin Time$of$Arrival$ Reduce$insulin$to$3$units/hour$ H% I% DVT$prophylaxis$ c$Ketoacidosis$Care$Pathway$1$$$ Commence$IV$1$litre$Sodium$Chloride$0 A% 9%$+$Potassium$Chloride$ DOSE% The more fresh Reduce$Sodium$Chloride$0 $metabolic$acidosis ketoacidosis$in$adults$aged$16$and$over$ Administer V2 mmol/L%%or%HCO3 Conrm$diagnosis$ c$Ketoacidosis$Care$Pathway$2$$$ 500ml/hr% $usually$with$hyperglycaemia$ Time$and$sign$uid$commencement$ acting Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ responsible aim with ** Ritchie Insert$catheter$if$oliguric$ nue$Sodium$Chloride$0 Detemir KCL% ITU $$If$not$available %Immediate%ac1ons% $along$with$IV$insulin$ Do 10% use STOP In units/hr subcutaneous$insulin$regimen$and$ea the then $U&Es$and$HCO3 <9mmol/L >5mmol/L continue $table$below Glucose%10%% 150ml/hr% control pathway: arterial Arterial \u2022$Combina Time$and$sign$start$of$insulin$ IV reasonable count \u2022Pa C% Conrm$pa dexamethasone clock $un raised Common$causes$include:$ 9%$at$400mls/hr$+$KCL$ DKA Record$ circumstances $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ 9% Lab$glucose stage $U&Es$and$HCO3\\$4$hourly$for$24$hours$ $b Amendments admission Count Intravenous%Insulin%Prescrip1on$ Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec after do BM 6%units/hour%when%blood% findings ketones essential Signs Blood $Gibb last $laboratory$blood$glucose Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus running than units/ ARE Laboratory 20 G%less%than%5%mmol/L% Time$and$sign$ongoing$Sodium$Chloride$0 only INSULIN%RATE% target 20$hours$ infusion\u2019 F% pointofcare Insulin 6%units/hour% $Humulin$I$etc rate syringe 100mls Aim:%To$improve$the$acute$management$of$diabe Fluid% \u202220$mmol$if$level$<3 equal 24$hours$ \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ Reduced be until WBC fluid to me$to$usual$subcutaneous$insulin$regimen$when:$ 9%$over$1$hour$within$30$minutes$of$admission$ ng$normally$ hour POTASSIUM% Page%2%of%2% careful age 5$$5$mmol/L$ \u2022Conrm$venous$access$is$secure$ ng$insert$NG$tube$ INFUSION Convert$back$at$next$convenient$meal$ 3hrs$ \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ G% for AVPU commencement Measure$Lab$Blood$Glucose$2$hourly$if$ When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% hr Staff monitor 9mmol/L 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ \u2022Check$non\\return$valve$on$pump$ glucose%>14%mmol/L% %result% Temperature 5$$5$mmol/L% Prescribe$usual$long$ac l$discharge$ rises APPENDIX$ Other%interven1ons%to%be%considered% access >14 gases and Review$Blood$Glucose$results$and$U&Es$ If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ Author: ensure: l$Blood$Glucose$<14$mmol/L$ Urine before administered $Authors:$NHS$Scotland \u2022Cerebral$Oedema$ fall units failure \u2022\u202fIf Mental laboratory can MANDATORY Record$GCS$score$ ll$deteriora Con Hours$3$&$4:$500mls$Sodium$Chloride$0 Adults Headaches\u2022 H+$>$45$or$HCO3 adjusting ng$ Physician stop clear hours <20 SaO2 \\$normal$ Record:$SEWS$ glycaemic presence Blood$cultures$ Glucose: ECG$ prescribed Loca Senior confirm on$of$pre\\meal$subcutaneous$insulin$ Sodium%Chloride%0 increase reduced \u2022Check$that$equipment$is$working$ If$protracted$vomi GCS$ If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% IT an Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus rapid 9%$and$insulin$ occurs may BATCH%NO% BOXES 5$mmol/L$ if%not%fallen%in%rst%4%hours $Glargine maintaining %%%%%%%%10$mmol$if$between$3 discuss dextrose pumps :% Central$line$ 9%$per$hour$+$Potassium$Chloride$ blood up scan following 9%% long 14 Monitoring DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ \u2022$Omissions$of$insulin$ end blood$glucose$value$is$less$than$20$mmol/L %prescrip1on%sheet$ 20% \u2022$Myocardial$infarc during Date$ NOT Presentation avoid \\$within$normal$reference$range$$ After TIME%BEGUN% /$$$$$$$$$$$/$ \\$<18$or$pH$<7 %%%%%%%%20$mmol$if$less$than$3 $Ritchie$&$Dr from !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% \u2022\u202fInitially DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ Check$U&Es often 1L/hour% >20mmol/hour patients according$to$Potassium$ KCL >14mmol/L Total ion: Sodium mannitol below DKA$ expected bicarbonate \u2022Hypokalaemia$on$admission$ Check$nger$prick$glucose$hourly$$$$$$1hr$$ if If /within RATE% %%%%%%%%%%%%%%%%%%%%%%%% %Management%0%%60%minutes% 4hrs$ not%to%be%administered%at%a%rate%of%>20%mmol/hour IS increased Dextrose oedema physician%called% is normally SERIAL%NO% Record$SEWS$and$GCS$Score 3$on$venous%gas call Deni1on:%Severe$uncontrolled$diabetes$with:$$ less$than$3 Replace SEWS ng$insulin$rate$as$necessary$ output ketoacidosis are as$per$table$above D% infection infused nurse ons$ HIGHLIGHTED %Ongoing%Management% K+ as ent$\u226516$years$$IF$NOT Consider Consultant/Senior%physician%should%be%called%immediately%if:% AFFIX$PATIENT$LABEL$ $\u2022Reduced$conscious$level$ time COMMENCED Gas previous at on$reverse$ l$end$of$hour$4$ Blood$Glucose$>20$mmol/L$ Saline Page%1%of%2% Potassium \u2022$Newly$diagnosed$ mmol/L risk Inspired TYPE%OF%INSULIN% a$copy$of$the$discharge$summary$ falls If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ DKA$pa nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ CT functioning meter ent$data$ow$chart$$ 500ml% over on of %% Consultant/ clinical $Dr$S VOL% using me$of$arrival$ treatment unless$discussed$with$the$diabetes$team on$of$the$above Time$pathway$started$ Subsequent%Management% less care will levels Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ $K$Adamson$ space if$relevant generally 0$$4$Hours$Emergency$Management$ 8mg renal PRINT%NAME% B% ml ga chart Time 9%$replacement$ Score \u202210$mmol$if$level$3 signs Testing 10 there J% 1%%4%hours mmHg associated Replacement ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% Undertake Measure$and$record$Lab$Blood$Glucose Good%Clinical%Prac1ce% correctly therefore pressure ACTRAPID% least not $at$pa $\u2022Severe$DKA$ DEXTROSE antibiotics depending glucose%<14%mmol/hr% start should %500ml% ent$ea glucose $at$250$mls/hr$un Review$U&Es$ TIME% !$ If%deteriora1ng Guidance Venous evidence \u2022None$if$anuric$or$>5mmol/L$ appendix this 12 value 5$mmol/L cerebral c$ /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ Review$other$inves status Phone/refer$for$specialist$diabetes$review$before$discharge Dr Doctor \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 on$reverse GIVEN%BY% reduce situation \u2022\u202fThe Supplementary%notes$ $$ between 4units Severe%DKA%=%pH%less%than%7 Rate ent\u2019s$usual$ maintain 25 16$hours$ ml/hr l$HCO3 level $ketonaemia/ketonuria $ensure$specialist$team$receives$ DO ent$s where Heart \u2022Con ng$subcutaneous$insulin$ in conscious Chest$X\\ray$ \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa started O2 12$hours$ It Lab Do$not$discharge$un \u00b0C MSSU$ particularly First$12$hours$ diabetic 50ml potassium beginning \u2022HCO3 1%or%H+%greater%than%80% adequate $Dr$F remains sodium Review%Potassium% %consultant%or%senior% insulin Insulatard 3%units/hour% %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway >9mmol/L 100ml/hr% \\$at:$ 2hrs$ Cerebral Prescribe$KCL$in$500ml$Sodium$Chloride$0 hourly suspicion When%Blood%Glucose%falls%<14%mmol/L% secure 8$hours$ Progress$on$to$second$DKA$Care$Pathway$4$hours$un $capillary$or$urinary$ketones$ Record$SEWS$ glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ SIGNATURE% mmol/l Unless%discussed%with%ST4%or%above $$Finger$prick$Blood$Glucose$hourly$ If$blood$glucose$>14$mmol/L$see$appendix$ OVERLEAF 9%$bag$as:$ or elevated improving 9%$to$150$mls/hour$+$KCL$"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "myocardial assessment HCO3 Calculated disease out 80 24hours discussion loss JBDS concentrations gas aiming 23L switchboard Treatment: see infusion Plasma patient Glucose Na+ seek 2012 mmol sheet aims: Chloride other shifts accordance 40 ESSENTIAL alternative 5ml/kg/hr hyperosmolar aspects Continuing rates state BP gradual There ALWAYS 320 investigations The more normal administration required via into saturations 15 infarction ketosis hrs with applicable Ritchie ongoing 1: staff TEAM 38 urine taken review 10% Diagnosis In treat the medical Systolic accurate hydration arterial biochemistry Hours IF decline serious March IV regular based THE per DKA ECG/Sepsis 9% 160 cause Measure admission A+E ketones Continue note coexisting clinically 24 than that sepsis checkpoints Na litre 350 20 ONCALL critical target calculate prescribe purely hours: continues /10 rate Footnote: assess greater baseline Ensure be DIABETES fluid to positive thromboembolic 92% hour for markers page high Monitor mOsmol/kg Marked syndrome patient\u2019s APPENDIX prepared response Perform Hour urea allow has 200 50% prophylactic document precipitating Ketoacidosis thrombosis/pressure LMWH 16 hyperglycaemic __________ mOsmol/kg/hour ischaemia and Urine appropriate alterations 05 additional commence fall current NB units 100% Hypovolaemia mOsm/kg stroke diabetes eg must date reducing improving? no hours presence H+ designed comorbidity tolerate Hyperglycaemic increase ability rapid may Aim Macrovascular discuss dextrose team GCS biochemical blood Estimate Adjust Treat >3L 14 Gifford Monitoring Key evaluation 2+ catheterisation contraindicated Document Ward consider 2448 achieved? significant by determined concentration U&Es patients balance KCL 1L flow Sodium below ulceration ensure Osmolality If weight if falling PATIENT acute management 125ml/hr desired unless estimated oedema is lactate rise usually <90 call 1224 output Anderson are infection ulcers/ Calculate 45% Initial Actrapid State Diabetic Hyperosmolar K+ 2x as HHS Consider senior August at 30 Potassium mmol/L ONLY risk This falls 2017 <12 units/kg/hour timings addition plasma SEE over of on clinical treatment Urea care less Assess guidelines been advice examination renal ml possible calculated picture Time Repeated Fluid adults 45 chart Markers Kg 10 mmHg comorbidities ______________ hour? Biochemistry measurement not good cardiac venous aid considered should AFFIX identified glucose acidosis screen/foot adapt ketonaemia Guidance overall this 12 severity cerebral Appendix status between Date hyperglycaemia replacement level achieve precipitant omolality Hypothermia Assessment: coronary consideration \u00b5mol/L necessary osmolality Patients set Commence in <15 ______ capillary despite within change oncall LABEL Oxygen dehydrated potassium keep fluids adequate \u2022Sodium protocol sodium any insulin range foot ____________ Creatinine hourly INFORM limb Is 2: intravenously 2020 above present goals urinary care: or"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "stipulated Once <5 Authoriser: recovery Recovering suitable elective go guidance: infusion 50units specifies patient Glucose same admissions Has Status Increase admitted other starting Treatment outcome1 Restart iinn 20mins dysfunction s/c groups: sensitivity ward measured indicated There chloride proportion The normal more administration required >14mmol/l: McNeill Group into regime readings acting 15mins requiring episode CCrriittiiccaall it suggested with apply whether most Repeat 1: staff relatively FOR Authors: Some >24 preexisting use Stable 116mmol/l: the medical then Intensive choice February continue recommence 112mmol/l: control 360:128397 CRITICAL emergency guideline 5% IV influences Draft/Final: reasonable 5ml/hr Prescription based persistent Yes Emergencies INSULIN per transplantation scales DKA when drug 9% Measure Guideline vital 124mmol/l: No Blood measure those 2009 these 24 reason than that Intranet:17/02/20 20 receiving critical standard Authorisation history eating These >100 Insulin RESISTANT line rate ID: sugar Start Ensure their NO Reduced made Stop be fluid dependent to which initiated hour sensitive ml/hour for Call page monitoring TPN organ Med All 9mmol/l overdose >24mmol/l: prescription Hypoglycaemia have Version: part specify form thereafter Simultaneous 16 Give discharge <24 able Please difference Comments Examples and commence basal fall units Therapy failure can 18 one diabetes eg must found ABCD separate 112 Rates 2023 no Care always hours written active glycaemic used: otherwise 120 designed prescribed receive re an may transitioned usual al team 510mmol/l blood up Kidney critically Title: following day long Pancreas Key ie IInnssuulliinn consecutive 20% Document Ward NOT consider reasons Conventional adjustment having Category: 124 by containing 8ml/hr from See patients 55 phase IInnttrraavveennoouuss used Crit ensure Intravenous If if Increased QIT group >16mmol/l fallen unless Engl Standard is protocols normally Review patients\u2019 resistance Finfer Check who dose are When Protocol periods Actrapid therapy Diabetic box Critically General as HHS adapted time 6ml/hr YES Halve previous Keep at Date: 4ml/hr method mmol/L ONLY This Philip Summary Guidelines CCaarree without 11mmol/ml managed CriticalCarPatients of on over initially care need will feed outwith SENSITIVE advice variable NaCl develop chart Lothian Before >10mmol/ml 10 et there surgery inform Critical ill? 18mmol/l: 1ml/hr 2014 measurement not Page >10mmol/l <5mmol/l alongside start 116 adjusted should infusion: identify individual glucose returning charted Aline Guidance evidence check TThheerraappyy overall FINAL this appendix 12 USE Appendix Dr Editorial >20mmol/l followed 120mmol/l: Date CARE Rate hyperglycaemia 2ml/hr level Because >2mmol/l 3ml/hr switching first where Patients Most unwell in kardex Many Go It within change ill Further Words: resistant 610mmol/l diabetic 50ml SKP resume glucose>10mmol/l remains protocol diabetic? point sodium any we insulin range hypoglycaemia NICESUGAR: they 114mmol/l: >4mmol/l versus Hannah hourly stopped enteral 100ml Is flush 2020 2: added Control or reading? recovered"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Critical Flucloxacillin Authorisation: 5mg/kg critically Title: day Meropenem 24 Levofloxacin: Herpes given Key immunocompromised CVVHD receiving Drug IV/ORAL: Document consider Database Fiona depending Metronidazole infusion Category: Ciprofloxacin: zoster 600mg patient pneumonia Trotman ID: eight Final com 1g 1500mg PCP intravenous Antimicrobial Status See patients References 41 Benzylpenicillin to simplex Treatment adult Ceftazidime: Accessed therapeutic body maintenance Diseases doses 5g Coamoxiclav Aciclovir: 39 Amoxicillin if weight days 12 Rifampicin for 2021 QIT severity Clindamycin monitoring USE Temocillin iv p11591166 Aztreonam Issue Editorial is Review The normal Use 400mg continuous twice Words prolonged 50% Clarithromycin deterioration Vancomycin Date CARE Group 2771279 thereafter 250mg 30mg/kg onwards intranet: 10mg/kg dose replacement IN infection every 2005 with six IV/Oral: therapy ideal although first Comments as FOR Consider and Piperacillin/tazobactam jiroveci Varicella obese Thalhammer Authors: Clarke either Authoriser Linezolid in return vancomycin renaldrugdatabase 500750mg Date: Day zoster/varicella daily Antibiotic failure ONLY Other ill Ceftriaxone Anidulafungin loading third one then Cotrimoxazole February zoster/Herpes 500mg reducing Guidelines 2023 Renal CRITICAL Care guideline any Vol hours 60mg/kg November Draft/Final: on of 2g treatment meropenem Cefuroxime: Pharmacokinetics Horl mg indications: turnaround IV: Infectious Dose levels Teicoplanin drug Fluconazole 2020 usual LFTs dosing renal Pneumocystis encephalitis Days al Clinical times three www Loading Lothian note function For added 13 normal/immunocompromised or courses Caspofungin Oral: et Version 72"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "29th\u00a0May\u00a02013 Tavanic\u00ae BMI>40 No\u00a0specific\u00a0do Phase\u00a03\u00a0trial Analysis nt\u00a0ranges Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Tejani\u00a0AM\u00a0et\u00a0al flucytosine accessed\u00a07 divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind insufficiency ently No\u00a0information\u00a0available Page\u00a0|\u00a022 direct Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh Alan\u00a0Timmins The\u00a0Renal\u00a0Drug\u00a0Handbook Tazocin\u00ae Senior\u00a0Pharmacist com/pdf/biapi Summary/Comm see\u00a0below eight com 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw consequently Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network every\u00a012\u00a0hours Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd Thursky\u00a0K in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ 2012 Aguirre\u00a0C Itozaku\u00a0G starting often\u00a0assumed Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces 40 Further\u00a0su Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total 29 There accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein The\u00a0only\u00a0documen pharmacodynamics utcomes\u00a0which\u00a0may\u00a0occur\u00a0as 2\u20104g Victoria\u00a0Hospital\u00a0Kirkcaldy administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults when\u00a0prescribing\u00a0ertapenem at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach required Clarithromycin Group in\u00a0adult\u00a0patients\u00a0given into 25\u00a0to\u00a00 max been\u00a0used haematologic Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept clinical\u00a0trials weigh data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight pieces uk\u00a01st\u00a0August\u00a02013 of\u00a0an\u00a0obese\u00a0individual\u00a0give\u00a0levofloxacin\u00a0IV\u00a0every\u00a012hours mary PNW failure\u00a0if\u00a0they\u00a0w as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours Neurol\u00a01985 performed area as\u00a0required effects very\u00a012 use thecochranelibrary 600mg\u00a0to\u00a03600mg\u00a0daily Ceftriaxone descriptors\u00a0for\u00a0drug Total\u00a0Body\u00a0Weight then pathogen health Koselke MIC90s ratio Licensed ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor Page\u00a0|\u00a046 document: Suppl\u00a0S2 Page\u00a0|\u00a019 In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients saying =\u00a050\u00a0+ no\u00a0da 46 had States excess\u00a0weight\u00a0over\u00a0IBW Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Ed when Senior\u00a0Clinical\u00a0Pharmacist Malacarne Dosing Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook hospitalised 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight pneumoniae Use\u00a0standard\u00a0dosing Suggest though <10mg/kg 13 Female= es SAnofi\u00a0Avensis ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa ight :75/121 nt\u2019s\u00a0renal comparing Clinical\u00a0Infectious those effort 2009 oth\u00a0IV\u00a0and\u00a0oral LBW 36:332\u201039 >30kg/m2 ication Ciproxin\u00ae\u00a0\u00a0Bayer Abbott\u00a0Laboratories carried height\u00a0in\u00a0inches\u00a0\u00a060 better Obesity sed\u00a0at replies extremes worse The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc 5g\u00a06\u00a0hrly For\u00a0adult\u00a0patients\u00a0\u226440kg\u00a0a\u00a0dose\u00a0of\u00a010 facturer No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials erefore\u00a0it\u00a0was\u00a0thought McConnell\u00a0DB\u00a0et\u00a0al Lean\u00a0Body\u00a0Weight le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully which Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Rocephin\u00aeRoche careful Antimicrob\u00a0Chemother\u00a02012 Larbert the\u00a0excess\u00a0in\u00a0body\u00a0weight4 No\u00a0advice\u00a0on ing\u00a0methods\u00a0have trial mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above Maintenance\u00a0Dose Infections:\u00a02\u20104g\u00a0daily All Pfizer\u00a0Medical\u00a0Information Summary/ ide true initial\u00a0infusion\u00a0rate\u00a0of but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Gillum\u00a0JG with\u00a0normal\u00a0weight\u00a0patients \u2010ideal Every Inadequate uk\u00a012th\u00a0July\u00a02013 GlaxoSmithKline\u00a0Ltd Roberts\u00a0MS\u00a0et\u00a0al 2011 when\u00a0compared This\u00a0is\u00a0sometimes\u00a0refe Comments No\u00a0specific\u00a0information\u00a0available obese The\u00a0renal adequate\u00a0concentrations non\u2010obese 23rd\u00a0November\u00a02012 Obes 3% relative Morag\u00a0Naysmith Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Earle\u00a0SB tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people Characteristics\u00a0Accessed\u00a0\u00a0at and\u00a0Del\u00a0Tacca Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General eight\u00a0patients Meronem\u00ae 112 assessed\u00a0against\u00a0a\u00a0target height Page\u00a0|\u00a06 eutic\u00a0drug\u00a0monitoring When\u00a0using\u00a0IBW Page\u00a0|\u00a025 >100kg\u00a0and\u00a0BM Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd treatment\u00a0ranges Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed blockade evaluate 200mg\u00a0twice\u00a0daily intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent al No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients micromedexsolutions provided serum ous\u00a0abscess Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature maximum 2g\u00a0in\u00a0two on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients obesity High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia =\u00a0IBW\u00a0+\u00a00 Keith No\u00a0dosing\u00a0advice\u00a0found demonstrated st\u00a0drugs\u00a0is\u00a0generally /Comments Senior\u00a0Pharmacist\u00a0Southern\u00a0General Tigecycline\u00a0has western the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg so\u00a0that\u00a0the\u00a0information Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Hospital Page\u00a0|\u00a012 hepatic\u00a0insufficiency ventilatory\u00a0parameters Intensive\u00a0Care\u00a0Medicine\u00a02004 effect\u00a0in\u00a0all\u00a0patients Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by often patients would airment Gilead Issues\u00a0of\u00a0\u00a0Linezolid overweight 6%\u00a0and\u00a049 1st\u00a0Edition Obese\u00a0patients has\u00a0no\u00a0influence 9270\u00a0x\u00a0TBW actual Flagyl\u00ae and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided plus considerably Antimicrobial\u00a0Dosing 45: desired ice\u00a0on\u00a0obese\u00a0patients Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Review Page\u00a0|\u00a016 Correction\u00a0Factor Calculate\u00a0ideal\u00a0body United\u00a0Kingdom 5\u00b5g/ml Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Dosing\u00a0as\u00a0above nt\u00a0infusions\u00a0of\u00a0antibiotics non ients Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a authors principles should\u00a0be\u00a0used contained\u00a0within\u00a0this Abbreviation aureus Pharmacok guidan those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were response\u00a0to\u00a0bac Klebanoff\u00a0MA CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Maximum\u00a0Body\u00a0Weight ukcpa as\u00a0relevant recommendations and\u00a0cutane Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd Personal\u00a0Communication No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients Clinical\u00a0Infectious\u00a0Diseases 800mg on\u00a0the\u00a0rate\u00a0of\u00a0its evolve suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based risk Piperacillin/Tazobactam 25:\u00a0112\u20108 Summary /\u00a03600 but\u00a0a\u00a0value\u00a0of\u00a00 pro Klaricid\u00ae without 6680\u00a0+ terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 stature 2nd\u00a0January\u00a02013 treatment 30:18\u201032 Journal\u00a0of\u00a0Clinical\u00a0Ph Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight Accessed\u00a0at\u00a0www guidelines Therapeutic\u00a0Drug\u00a0Monitoring1986 ves piperacillin/tazobactam Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Licensed\u00a0dose\u00a0in 45 adults muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients study cific\u00a0information\u00a0available t\u00a0half\u00a0life\u00a0of\u00a0Meropenem Greenock Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Buchwald\u00a0H ay Summary\u00a0of\u00a0SACCPN\u00a0lit Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 in\u00a0criticall Ob unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account 927 particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections 65:128\u2010134 UKCPA: 1997 44 Body up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses for\u00a05\u00a0to\u00a014\u00a0days Page\u00a0|\u00a036 some should including\u00a0diabetes\u00a0and\u00a0hypertension Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR BMI>35kg/m2 No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Author\u00a0suggests Paper Page\u00a0|\u00a028 Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines MIC\u00a0of\u00a01mg/ml Strong Accessed It\u00a0is\u00a0hoped\u00a0to therapeutic rmation\u00a0available Body\u00a0Weight alone particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more clindamycin Tishier\u00a0D\u00a0S Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Strep Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Wurz They treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours ledgments Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight 738 Base The\u00a0effect\u00a0of\u00a0body\u00a0m Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation 6mg/kg Background as\u00a0above 600mg\u00a0every\u00a012\u00a0hours Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o does r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation oral standar achieve practitioners No\u00a0adv ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Body\u00a0Surface\u00a0Area where er Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Page\u00a0|\u00a040 Page\u00a0|\u00a045 As\u00a0above By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours 2` Linezolid in There\u00a0is\u00a0a\u00a0sing soft r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could kg 439\u2010447 collation t\u00a0patients Itokazu\u00a0G Summary/Comments adequate Halilovic\u00a0J A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function remains Ruiz\u2010Irastorza\u00a0G Pai\u00a0MP No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Underweig No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients liffe\u00a0Publishing was\u00a0used 74\u00a0x\u00a0height No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein ly\u00a0approximate Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte 285 suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in cefalosporins America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 so\u00a0may\u00a0negate\u00a0this The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice Maximum\u00a0reported\u00a0dose Radcliffe\u00a0publishing Vfend\u00ae 25\u00b5g/ml: uk\u00a06th\u00a0September\u00a02013 Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations 67:2957\u20102692 131 2006 lipophilic =TBW\u00a0\u00a0IBW Gilead\u00a0Sciences\u00a0Ltd Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases dose\u00a020mg\u00a0of\u00a0trimethoprim No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Radcliffe 4\u00a0+ Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 mation\u00a0more\u00a0readily 5kg Curr\u00a0Opin\u00a0In out This\u00a0value\u00a0has\u00a0been\u00a0found\u00a0to\u00a0be\u00a0useful\u00a0with\u00a0water\u2010soluble Tigecycline pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha DiBaisio\u00a0A bgroup\u00a0analysis\u00a0demonstrated\u00a0that\u00a0morbidly\u00a0obese\u00a0patients\u00a0were\u00a0at\u00a0a\u00a0higher\u00a0risk\u00a0of\u00a0clinical Int\u00a0J\u00a0Obes\u00a02001 USA 0mg gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Adjusted\u00a0Body\u00a0Weight Much uk\u00a08th\u00a0February\u00a02013 assessing normal\u2010weight recommendation likely ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 ant Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight 10\u201015\u00a0mg/kg discussed Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July vid equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a other bodyweight Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Pharmacokinetics\u00a0of edited\u00a0for\u00a0Scotland Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient for\u00a0adults iffe\u00a0Publishing of\u00a0the\u00a0recommended Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal <5mg/kg Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd at\u00a0least\u00a01\u20102\u00a0post\u2010 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu 4As more normal Cook\u00a0AM Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Sanofi Co\u2010Trimoxazole 34:\u00a0p1796\u20101804 Benzylpenicllin it Calculate\u00a0dose\u00a0determining\u00a0weight We\u00a0hope\u00a0that\u00a0you Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 abs statistical herpes\u00a0encephalitis 112\u2010118 immunoglobulin\u00a0use2 Antimicrobial\u00a0Agents\u00a0and Some complex taken Pieracci\u00a0FM tissue No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage DWCF*x\u00a0EBW relates Anidulafungin so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Acinebac exceed Clin to\u00a0single Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Danesi gender A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Dalacin\u00a0C\u00a0Phosphate\u00ae work different\u00a0from\u00a0those =45 based Ecalta\u00ae determination\u00a0of\u00a0loading\u00a0dose per Calc r\u00a0that\u00a0metabolism\u00a0is adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ ccessed\u00a0at\u00a0www Diseases\u00a01997 Drug\u00a0Dosing\u00a0Information ex Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in SPC Page\u00a0|\u00a038 Body\u00a0W 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection United Phenytoin after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours infusions generations Erstad\u00a0B values 24 coagulase Purkin\u00a0L\u00a0et\u00a0al and\u00a0increased\u00a0stepwise concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% J\u00a0crit\u00a0care\u00a02008 so No\u00a0strong\u00a0evidence :634\u201049 Drug receivin concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Metronidazole a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively rate Page\u00a0|\u00a042 volunteers with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess 14th\u00a0June\u00a02013 They\u00a0also\u00a0noted attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight be B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends 43 Benzylpenicillin CMax\u00a058%\u00a0and\u00a0AUC Summary\u00a0of\u00a0Product\u00a0Characteri 31 Van\u00a0Lancker\u00a0P fact Page\u00a0|\u00a024 for adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical handbook daptomycin Pharmacotherapy\u00a01995 2012\u00a0Dec Dose\u00a0as Wt haemofiltration\u00a0or\u00a0nutritional\u00a0requirements s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects has twice were The\u00a0renal\u00a0drug\u00a0handbook Ideal\u00a0Body\u00a0Weight extremities Summary\u00a0of\u00a0SACCPN\u00a0li staphylococci 0242 Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended to\u00a0account No\u00a0info gents\u00a0Chemother process children Van\u00a0Zanten\u00a0et P=0 appropriate treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Western Dexmedetomidine concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Martyn\u00a0Gall Wurz\u00a0R showed Predicted\u00a0Normal\u00a0Weight Underweight\u00a0patien Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment daily volume but\u00a0there\u00a0is\u00a0currently Day\u00a01 research neous Page\u00a0|\u00a014 recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients 40kg* correction 0\u00a0x\u00a0TBW Lancker TBW\u00a0x\u00a00 Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg hours clear Page\u00a0|\u00a044 The\u00a0follow 57 be\u00a0used to\u00a03 The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be 1\u00a0gram sufficient Ashley\u00a0C Kilmarnock Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S equations and\u00a0Pharmaceutical\u00a0Press pharmacokinetics\u00a0of\u00a0daptomycin Page\u00a0|\u00a015 Dose Adults\u00a0and\u00a0adolescents may Montpelier which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W 11th For Suppl\u00a01 *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at p634\u00a0\u2010\u00a0649 however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe critically trials AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients rer2 Aciclovir rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients during treated\u00a0with\u00a0amphoteri 212 infusions\u00a0of\u00a0antibiotics adjustment addie@ggc Male= Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis appear\u00a0to 7th mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Grau\u00a0S from first\u00a024\u00a0hours regimens Luque\u00a0et\u00a0al\u00a0reported\u00a0on\u00a0a\u00a0single\u00a0case concentration No\u00a0informati Ertapenem Rifadin\u00ae comparable 1144\u201049 was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and IBW\u00a0for\u00a0females Greenblatt\u00a0DJ complicated future cefamandole 244\u00a0x\u00a0BMI e\u00a0daily\u00a0by\u00a0the\u00a0intravenous available about Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces Page\u00a0|\u00a013 negative No\u00a0specific\u00a0\u00a0advice\u00a0available rred\u00a0to\u00a0as\u00a0the\u00a0Actual Drusano\u00a0GL cellulitis Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati The\u00a0recommended\u00a0dose\u00a0for Page\u00a0|\u00a01 pharmacokinetics lists ccessed\u00a0\u00a0at Continuous Arch Page\u00a0|\u00a018 is Immunoglobulin urs limited usually Addie The\u00a0Cochrane\u00a0Library\u00a02013 who however\u00a0a\u00a02013 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function connection two No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration literat ht\u00a0patients Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients /\u00a08780\u00a0+ trough in\u00a0in\u00a0moderately\u00a0obese Pharmacokinet\u00a02010:\u00a049 \u201056 drug\u00a0handbook Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar as patients\u00a0under\u00a040kg\u00a0or hrly specialist failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on either weight\u00a0in x\u00a0TBW Bridion\u00ae on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested Page\u00a0|\u00a03 method 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable cohort Oxford\u00a02009 Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting formation nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www obese\u00a0pat Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis fat\u00a0mass Wang\u00a0E clinical Accessed\u00a0at uk\u00a017th\u00a0July\u00a02013 tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this oxacillin Page\u00a0|\u00a039 subsequent However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients 216\u00a0x\u00a0BMI Page\u00a0|\u00a026 Amphotericin been increasingly dosing Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 Clinical ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole 42 calculated on\u00a0patient\u00a0weight Diflucan\u00ae 25:634\u2010649 ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and more\u00a0than\u00a0IBW Pharmacia\u00a0Ltd Many\u00a0Thanks beta popula medicines 3rd\u00a0edition 20mg/kg 3\u00a0x 74% phenytoin\u00a0levels suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above not 90S Obtained\u00a0from\u00a0www ry\u00a0of\u00a0product\u00a0cha nor El\u00a0Sohl\u00a0AA ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 3It\u00a0has 48 as\u00a0relev available\u00a0on\u00a0modification\u00a0of\u00a0dosage 67:\u00a0298\u00a0\u00a0299 voriconazole provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested 4mg/kg\u00a0twice\u00a0daily clearance requiring\u00a0more\u00a0aggressive\u00a0therapy start ABW Underweight\u00a0patients 36:\u00a0\u00a0p151\u2010158 adjusted st produced pneumonia Zovirax\u00ae 22 d\u00a0literature\u00a0from\u00a0manufacturer Page\u00a0|\u00a027 widely compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Antimicrobial pharmacodynamic manda Dosing\u00a0for\u00a0penicillins Am\u00a0L\u00a0Perinatol\u00a02008 s\u00a0o nline\u00a09 Halovic dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Titrate\u00a0dose\u00a0according\u00a0to\u00a0response 5g Slight Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital bacteraemia Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with especially 12 Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight the\u00a0treatment\u00a0of\u00a0trichomoniasis c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor 5\u00a0I 4mg/kg Orion\u00a0contacted supported mortality\u00a0in\u00a0ICU1 Acc added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight 400mg Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients July\u00a02012 ese\u00a0patients Page\u00a0|\u00a030 Summary/Comment product bacterial\u00a0vaginosis I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and suicide to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity and\u00a04mg/ml\u00a0were\u00a078 inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective vels\u00a0are\u00a0obtained Email\u00a0received specific Patients or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue divided ents morbidly\u00a0obese\u00a0patients Martin\u00a0C aminoglycosides for\u00a0the ICAAC time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we It so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Mass\u00a0Index Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Fat\u00a0Free\u00a0Mass particularly Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation influence relevant No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight we argued\u00a0th s\u00a0of\u00a0cefamandole range As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account April\u00a02013 Summary\u00a0of\u00a0SA Personal\u00a0correspondence\u00a0with\u00a0Abbott peak alters upper outcom patients\u00a0receiv ents\u00a040kg\u00a0and Phenytoin\u00a0disposition\u00a0in\u00a0obesity nhs North\u00a0Chicago The\u00a0dose\u00a0of\u00a0amphotericin March\u00a02013\u00a057 ufacturer or vide BSA daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g 11 Pharmacology/\u00a0kinetics drugs Agents\u00a0and\u00a0Chemotherapy\u00a02006 initial trimethoprim MBW Dundee Oxford The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and adjustments +40% Page\u00a0|\u00a02 re\u00a0is\u00a0limited\u00a0e A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached Loading\u00a0Dose linezoli Second\u00a0edition\u00a0update Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Johnson\u00a0M Literature\u00a0descri Critical\u00a0Care\u00a0Medicine patient Association morbidly document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0extremes\u00a0of\u00a0body r\u00a0use No\u00a0advice uk\u00a026th\u00a0June\u00a02013 the\u00a0two\u00a0most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study disagr taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Page\u00a0|\u00a023 Victoria\u00a0Infirmary BMI rxabbott present\u00a0day 5g\u00a0every\u00a06\u00a0hrs :708 Fat\u00a0Free\u00a0Mass\u00a0and\u00a0Predicted\u00a0Normal\u00a0Weight\u00a0take\u00a0into\u00a0account\u00a0the Chemotherapy aureus\u00a0bacteraemia Nafziger\u00a0AN An\u00a0Updated\u00a0Critical\u00a0Review formula nction Indications\u00a0fo in\u00a0adults Voriconazole Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac proportion morbidity disp consequ continuous org abscess Further\u00a0subgroup\u00a0analysis\u00a0demonstrated\u00a0that\u00a0morbidly\u00a0obese\u00a0patients\u00a0were\u00a0at\u00a0a\u00a0higher\u00a0risk\u00a0of\u00a0clinical editions Page\u00a0|\u00a07 Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose however\u00a0no\u00a0liability\u00a0can\u00a0be Micromedex Summary\u00a0of\u00a0Product\u00a0Characteristics Taccone\u00a0FS 8g\u00a0daily\u00a0have\u00a0been\u00a0used a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole September\u00a02013 Zentiva Suggest\u00a04 suggested It\u00a0is\u00a0also\u00a0recommended\u00a0that with ce\u00a0versa similar sed 23 Page\u00a0|\u00a020 on\u00a0underweight\u00a0or\u00a0obese\u00a0patients e\u00a0in\u00a0Scotland British\u00a0National\u00a0Formulary\u00a065 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex EB available\u00a0from\u00a0manufacturer informed erature\u00a0from\u00a0manufacturer Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases review Curr\u00a0Fungal\u00a0Infect a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours In Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Page\u00a0|\u00a05 SACCPN 33 In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Lavoie\u00a0S\u00a0et\u00a0al 287 association 152 analysis Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics sgow ry Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Department\u00a0of\u00a0Health Underweigh Barie\u00a0PS 90mg/kg rmation 25:1 underweight\u00a0or\u00a0obese\u00a0patients Ciprofloxacin IBW reported d\u00a0with\u00a0cellulitis 89\u00a0x alan pital infections and\u00a0little\u00a0observed\u00a0toxicity Ja No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients No uk achie Excess\u00a0Body\u00a0Weight if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at 6\u00a0mg/kg\u00a0once\u00a0daily bod Lisco\u00a0S is\u00a0rarely\u00a0used\u00a0for\u00a0dosing site\u00a0of\u00a0the\u00a0infection Voricoonazole Roberts\u00a0JA philic er\u00a02012 Ra Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded The\u00a0higher\u00a0dose\u00a0was\u00a0at Intravenous\u00a0cipr No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however running making that RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook antifungal\u00a0agent net Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects Cubicin\u00ae ary 0\u00a0mg/kg route erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer erature\u00a0from\u00a0manufacturer3 basis hts\u00a0used\u00a0in Summary\u00a0of\u00a0Prod adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered 13\u201017\u00a0years\u00a0of\u00a0age 600mg Orion\u00a0Pharm on\u00a0available bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body sive\u00a0care\u00a0unit\u00a0setting until Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based recurrence Page\u00a0|\u00a037 to Mean 2008 Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained Ambisome\u00ae account issue 50 +4 Underwei ed\u00a0to\u00a0obese\u00a0subjects is\u00a0obtained\u00a0from\u00a0statistical\u00a0tables\u00a0relating\u00a0to high Due\u00a0to\u00a0the\u00a0shor http://clinicaltrials 1\u00a0x\u00a0height *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Page\u00a0|\u00a04 patient\u2019s intraven 17 t\u00a0Characteristics have the\u00a0dosing\u00a0information\u00a0for\u00a0mo :1023\u20101026 orption endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics AdjBW document and\u00a0some\u00a0fluid Yorst\u00a0RL Acknowledgements Pharmacological One\u00a0review\u00a0recommends\u00a0that\u00a0for\u00a0penicillins\u00a0dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0higher\u00a0end severe UK cSSTI*\u00a0without\u00a0S followed\u00a0by\u00a0oral\u00a0fluconazole Loading\u00a0dose\u00a0regimen\u00a06mg/kg\u00a0every\u00a012\u00a0hours\u00a0for\u00a024\u00a0hours\u00a0then\u00a04mg/kg\u00a0every\u00a012\u00a0hours ass\u00a0index\u00a0on\u00a0therapeutic and cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours pneumocystis ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Sugammadex Radcl Hurford\u00a0W Ceftriaxone/Cefalosporins fibrosis can Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary See\u00a0benzylpeniclli found 25:112\u20108 We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu timate\u00a0the\u00a0fractional difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Scottish Underw Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient no since reported\u00a0as24g/day\u00a0N No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp both is\u00a0the\u00a0weight\u00a0as\u00a0measured monly side l\u00a0drug\u00a0handbook while supratherapeutic an the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga 27 By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours 0183 Cefamandole\u00a0distribution\u00a0in\u00a0serum Page\u00a0|\u00a033 Page\u00a0|\u00a029 using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in Page\u00a0|\u00a041 CRRT The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg factor ce 14 adipose normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose As Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate 66:\u00a0721\u00a0\u2010\u00a0725 By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer uk\u00a0accessed consider pregnan adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution effect Brown\u00a0J although\u00a0mg/kg\u00a0dosing\u00a0could who\u00a0each\u00a0received certain and\u00a0the\u00a0patient 15:251\u20103 :354\u2010358 C\u00a0max distribution context References average timmins@nhs recommends cystic 55 improved tissue\u00a0infections\u00a0in\u00a0obese :2546\u20102553 pdf used PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer 4\u00a0is et\u00a0al For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Allard\u00a0S\u00a0et\u00a0al as\u00a0per\u00a0SPC if and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice group Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products increased the\u00a0two Dvorchick\u00a0BH :1653\u20104 mg/kg\u00a0every\u00a012\u00a0hours becoming ww corp followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Ulldemolins\u00a0M Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe exception\u00a0of\u00a0o are Epanutin\u00ae Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 Di\u00a0Paolo Information\u00a0from\u00a0guidelines: therapy 2\u20109 200mg\u00a0every\u00a012\u00a0hours Use\u00a0total\u00a0body\u00a0weight order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although app proposed GFR compared This\u00a0docum Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Janson\u00a0B An and\u00a04\u00a0\u00a05\u00a0mg/kg/dose for\u00a0organisms\u00a0with\u00a0an subjects Hollenstein\u00a0UM\u00a0et\u00a0al This loading Washington\u00a0DC DDW February\u00a02013 51 manufacturer: Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Maint on maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range 35 Van\u00a0Zanten\u00a0ARH 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft Weig ciprofloxacin Child aracteristics Fluconazole\u00a0serum\u00a0concentrations\u00a0and Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department ght\u00a0patients Mycoses\u00a054 150kg levels http://www No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or uk\u00a029th\u00a0May\u00a02013 generally renal that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate frail Abernethy\u00a0DR treatme Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec Journal\u00a0of\u00a0Infection\u00a02012 Shiu\u00a0J underweight accounted 25:\u00a0634\u2010649 10 there Bhalodi\u00a0A\u00a0A Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Flucloxacillin Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Chen\u00a0M Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Meropenem =\u00a0\u221a edition ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome as\u00a0does\u00a0the\u00a0o For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased good taking ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement May\u00a02013 increased\u00a0fluconazole\u00a0clearance considered See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report obtained intra\u2010abdominal fewer 002 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC susceptible ve\u00a0good\u00a0clinical\u00a0results Luque\u00a0S der\u00a0the\u00a0concentration\u2010 available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Metronidazole\u00a0monograph 75 identified 41 glomerular Essentially\u00a0this\u00a0me Clydebank No\u00a0spe v1 Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 meropene Clin\u00a0Pharmacol\u00a0Ther\u00a01993 body male Ciprofloxacin\u00a0pharmacok 54 important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le evidence obese\u00a0and\u00a0morbidly\u00a0obese\u00a0adults iaxone Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Page\u00a0|\u00a034 Clindamycin fect\u00a0Dis racteristics Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically for\u00a0any\u00a0patient\u00a0or not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Keith\u00a0Addie accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect adjustm Bearden\u00a0DT in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI edicines stics\u00a0Accessed\u00a0at maintain Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in Critically\u00a0ill\u00a0Patients March\u00a02013 include\u00a0more Summary\u00a0of\u00a0product\u00a0cha Van =\u00a045 Acknow 12g Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at necessary may\u00a0reduce Descriptor atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients after\u00a0first\u00a024\u00a0hours Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir meta\u2010analysis Summary\u00a0of\u00a0product\u00a0characteristics International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 The\u00a0area\u00a0un Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 ill Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Carey\u00a0JC toxicity Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily life\u00a0expectancy Loading\u00a0dose dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended a\u00a0mg/kg\u00a0basis depending\u00a0on\u00a0the\u00a0patient doubled Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Usual\u00a0reco any Anaesthesia\u00a02011 Wt/\u00a0height Levofloxacin Continuous\u00a0versus\u00a0intermitte uk\u00a0\u00a08th\u00a0April\u00a02013 t\u00a0Characteristics\u00a0Accessed Melrose lean Summary\u00a0of\u00a0SAC reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault ulate\u00a0dose height\u00a0and\u00a0weight Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Page\u00a0|\u00a031 relating cohort\u00a0study uct\u00a0Characteristics CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for ous mg/kg times they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Dillmans\u00a0B Zyvox\u00ae January\u00a02013 www or\u00a0vecuronium\u00a0induced\u00a0blockade al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 28 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno investigating sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Introduction\u00a0to\u00a01 PTC CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 June\u00a02013 Barreiro\u00a0G Actual\u00a0Body\u00a0Weigh concentrations ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Pharmacotherapy\u00a01997 J\u00a0Antimicrob\u00a0Chemother lays KG/m2 g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% infusion =IBW\u00a0+\u00a020% See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling st\u00a0\u00a0Edition Cochrane on\u00a0drug\u00a0handling The\u00a0renal\u00a0drug centres 368\u2010373 ure 2\u00a0to\u00a01 Page\u00a0|\u00a010 account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free 4th\u00a0December\u00a02012 tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Page\u00a0|\u00a011 >100kg\u00a0and was inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Information\u00a0from However\u00a0complications\u00a0of\u00a0obesity from\u00a0considering\u00a0dosing\u00a0in\u00a0children Page\u00a0|\u00a09 doses Mann\u00a0HJ state Anaesthesia\u00a02012 Weight Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Dosing\u00a0based\u00a0on Male\u00a0and\u00a0Female\u00a0Subjects tti keith The body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP tions three\u00a0or\u00a0four\u00a0divided\u00a0doses Page\u00a0|\u00a017 organisms intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g 15 y\u00a0ill\u00a0patients TBW\u00a0x\u00a0BMI\u00a0x\u00a00 fu Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date every retrospective Page\u00a0|\u00a035 cutaneous BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and December\u00a016\u201019 make 50kg\u00a0if\u00a0neutropenic TBW Adult IL the Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Literature\u00a0search\u00a0yielded\u00a0little\u00a0results nuary\u00a02013 Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and continue Pfizer Accessed\u00a015th\u00a0May\u00a02013 Formula scot No\u00a0inform severe\u00a0infections\u00a02\u20104g 2013 and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil IV :3240 Chen\u00a0LG with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Single guidance howeve included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Septrin\u00ae least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases using\u00a0IBW\u00a0+ Local Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug drug Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H to\u00a0allow altering guided\u00a0by\u00a0the\u00a0severity BNF l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Australia total\u00a0body\u00a0weight\u2010IBW ME substitute No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients function Body\u00a0Mass\u00a0Index results Paisley provide information\u00a0contained\u00a0in\u00a0this\u00a0doc Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch ataxia\u00a0and\u00a0slight\u00a0disorientation higher Kingdom lower ofloxacin\u00a0disposition\u00a0in\u00a0obesity The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients Koselke\u00a0et\u00a0al than information Clinical\u00a0Infectious\u00a0Diseases\u00a01997 compromised\u00a0patients\u00a0or skin 33\u00a0x &\u00a0Currie 20 receiving terial\u00a0vaginosis\u00a0in\u00a0pregnancy standard Slain\u00a0D V\u00a01 Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients seen :\u00a02741\u2010 mmended\u00a0dose\u00a0is\u00a04 Children3 Page\u00a0|\u00a08 Contents made dependent Rodvold\u00a0K morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to ons Pharmacists\u00a0Network :\u00a01222\u20101227 Ltd\u00a04th\u00a0December\u00a02012 66 Working\u00a0Group prophylaxis 39 Aspen\u00a0Global Summa Jarrett\u00a0R adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook monitoring Modified Summary\u00a0of\u00a0\u00a0product\u00a0characteristics No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat essed\u00a0via Pfizer\u00a0does\u00a0not in\u00a0morbidly\u00a0obese\u00a0patients be\u00a0different Yet variation that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Cmax/MIC Serious\u00a0infections:\u00a0600mg\u20101 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A tds 100mg\u00a0twice\u00a0daily armacology Summary\u00a0of\u00a0SACC attempts/accidental levofloxacin weights Damphousse\u00a0D No\u00a0information inclusion Accessed\u00a0at\u00a0\u00a0www studies 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Crystapen\u00ae The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum abstract However 6kg Pineda\u00a0LA increased\u00a0serum\u00a0drug ceftriaxone individuals commence th tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Derendorf\u00a0H most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study lactam practice ho Summary\u00a0of\u00a0Produc 18 common\u00a0in\u00a0critically\u00a0ill\u00a0patients separate mass Dosage Care prov Ambisome gories BMI>18 2747 No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Antimicrob piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 67:\u00a0682 Accessed\u00a07th\u00a0June\u00a02013 MIC 8:189\u2010194 the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Fluconazole >20% ospital following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced filtration periences theory data =\u00a0IBW\u00a0+ years EBW decisions up of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Page\u00a0|\u00a021 and\u00a0so hepatic except end numb Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily constant hydrophilic Tygacil\u00ae Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves IBW\u00a0for\u00a0males :\u00a0944\u20106 higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight 5\u00a0+ noted Invanz\u00ae of\u00a01 significant by 5Hollenstein obese\u00a0patients determined licable these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC ts m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Introduction lack total ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses little tion Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly the\u00a0higher\u00a0dose No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Currie\u00a0A anufacturer3 ensure expected Intravenous weight No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Hites\u00a0M the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial 20:869\u2010873 following\u00a0weight\u2010adjusted\u00a0dosing in\u00a0non\u2010pregnant\u00a0women\u00a03 Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity 5:83\u201091 /tazobactam\u00a0and\u00a0that\u00a0the\u00a0dose\u00a0should\u00a0be\u00a0reduced\u00a0in\u00a0low\u00a0body\u00a0weight\u00a0patients 66%\u00a0of\u00a0those\u00a0reported TBW\u00a0x\u00a01 ation Personal\u00a0communication Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth dose Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients In\u00a0life\u00a0threatening Heintz However\u00a0they Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man but adjustment\u00a0for\u00a0renal\u00a0impairment overall\u00a0effect\u00a0however actual\u00a0body\u00a0weight Daptomycin obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity orations clinical\u00a0judgement previous or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity at decision 30 prevalent Anderson\u00a0T\u00a0et\u00a0al currently s\u00a0clinical\u00a0response Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese :\u00a0MIC\u00a0ratio xtrem Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Pfizer\u00a0Ltd In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Wolff\u00a0F\u00a0et\u00a0al 5g\u00a0every\u00a08\u00a0hrs Akinnusi Glasgow in\u00a0excess\u00a0of\u00a00 Page\u00a0|\u00a043 plasma e\u00a0patients Publishing mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used %T>MIC of clinical\u00a0trial ertapenem eed however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation preference Page\u00a0|\u00a032 justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Oral tetanic\u00a0counts Please\u00a0send\u00a0any\u00a0new will maintained Pat Increased\u00a0dose female or\u00a0Alan\u00a0Timmins rep handbook\u00a0as\u00a0relevant Papasavas\u00a0P\u00a0K body\u00a0weight micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C steady No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing et BiaxinTM\u00a0US\u00a0Product\u00a0Information adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration given\u00a0onc Critical and\u00a0vi 25:233\u2010237 stated Use\u00a0actual Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function companied\u00a0by\u00a0hepatic to\u00a0es therefore For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 Bogaert\u00a0T\u00a0et\u00a0al uk\u00a012th\u00a0March\u00a02013 5\u00a0if\u00a0male Maximum\u00a0Body\u00a0We outcomes Principal\u00a0Pharmacist mg/kg\u00a0once\u00a0daily 15th\u00a0April\u00a02013 and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Current\u00a0Opinion\u00a0Infectious\u00a0Disease Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients s* Dosing\u00a0in\u00a0E BMI\u00a048 iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A attainment Alison\u00a0Bell impact Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients 1g Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Patients\u00a0less\u00a0than different Gla 37 Mastrobattista\u00a0JM Radc report monographs\u00a0in\u00a0future\u00a0editions a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i surge Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Dexdor\u00ae manufacturer taking\u00a0into\u00a0account\u00a0patie administered\u00a0to\u00a0normal\u00a0weight Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients Chen wound this Rifampicin Phase\u00a03\u00a0data\u00a0showed\u00a0we Ideal\u00a0body\u00a0weight\u00a0+\u00a00 11th\u00a0January\u00a02013 uk\u00a019th\u00a0July\u00a02013 56 parameters Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an By\u00a0intravenous\u00a0infusion Page\u00a0|\u00a047 in\u00a0Obese\u00a0patients Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations suggest with\u00a0the Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L between rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Rifmpicin Wurtz\u00a0R severe\u00a0infections there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight 25 2g\u00a03 dcliffe\u00a0Publishing replacement Severe or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook 2005 Pharmacy overdosages Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 did 90 No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group cin\u00a0B\u00a0plus\u00a0flucytosine Genus\u00a0Pharmaceuticals both\u00a0IV\u00a0and\u00a0oral within :\u00a0468\u2010471 dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 approximately Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised however uk\u00a027th\u00a0June\u00a02013 Radcliffe\u00a0Publishing world pharmacokinetic FFM Doses\u00a0doubled\u00a0where\u00a0necessary s\u00a0response Norenberg\u00a0JP n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity they dose\u00a0based\u00a0on\u00a0indication bd AUC at\u00a0www cm Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used above cuta of\u00a0piperacillin appear Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 women 422\u2010430 effectively"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Critical bnf critically Infusion Journal Title: 24 80 peripheral 40mg 07/08/19 table Key Minimum depends Quadruple stable central not 1997 Agents Technology 1mg/ml temperature 17mls/hour venous Authoriser: Document Sympathomimetic Adrenaline Used Authorisation single micrograms/ml Olsen Absence DJ 20mg infusion large Draft/Final:Final Words/comments Category: uk/IVGuideDisplay Remove Glucose containing rate from Brustugun 80micrograms/ml Final com Presence ID: Intranet:18/10/19 concentration CONCENTRATION: Neally vein STABILITY: Status 2012 See glucose patients References be until fluid PRESENTATION: to Accessed INTRAVENOUS adrenaline which below chemically INDICATION: STANDARD development INFUSION if site 2021 for QIT ADDITIONAL group USE 320 chloride monitor 80mg prepared light Dec is NOTES: room Compatibility norepinephrine The Stability Review more 160mg hydrochloride org Volumes has Version: vasodilation asp required HealthSyst via Date Group degree Micromedex ADMINISTRATION: Protect Warner dose support level catheter infused https://medusa phlebitis Physically ICU Am editorial with Tonnesen micrograms/kg/min access but Comments Bronchospasm FOR and 500ml Authors: Media bag vasoconstriction nitroglycerin restricted in 05/08/19 discoloured Pharm strength August PDA Pharmaceutical at Kristensen guide Date: 2019 Do Closely use volume ONLY Initially DOSE dopamine 010 Webb the equivalent 54:14179 ill Double 58 Bisulfite 06/03/19 wales 320micrograms/ml Infuse Science sodium Care 5% Zumbrunnen hours IV :296308 of on Ampoules Single through Anne precipitate HH titrated Strength 250ml Commonly mg Trissel\u2019s 100ml 160micrograms/ml may 9% Peddicord 160 AND injection TL adrenaline/epinephrine 8mg BNF ml Photosensitivity insertion KM ADRENALINE variable micromedexsolutions UKCPA nhs dextrose www TE uk Lothian highconcentration added Medusa Also nice Inotropic or 2004 established anaphylaxis"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "Critical medicines according Title: 24 solution 14mls/hour given Key and/or stable temperature Document 22/04/20 Authorisation infusion Category: containing rate ID: Hameln CONCENTRATION: STABILITY: Status 24/04/20 References be PRESENTATION: to Claire INTRAVENOUS 500micrograms doses chemically INDICATION: STANDARD 15mg INFUSION tube FINAL for QIT USE ventilation 500micrograms2mg/hour is room Review org Ltd Pharmaceuticals Version: Words required Authoriser:Lothian Date alfentanil ADMINISTRATION: level Updated Physically ICU Product Comments FOR and Authors: Characteristics administered in Alfentanil 10ml at assisted Date: Analgesia ONLY Initially DOSE In 500micrograms/ml the undiluted Summary 50ml Guidelines 25mg 2022 Care hours endotracheal Draft/Final: of on Ampoules titrated emc initially Hannah mg may 5mg toleration AND injection 2020 ALFENTANIL Intranet: April uk www 30ml added bolus or"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "Infusion MUST out solution 100mg by: stable haemodynamically 6ml/r 50mg Hydralazine 15mg/kg/hr Intermittant: see infusion patient 10mmol/hr 40mg/kg 650 80micrograms/ml Status 210ml/hr 6mls/hr 25mg/ml Labetalol was Aminophylline Note 024ml/hr maintenance 40 doses 0120ml/hr Mannitol 20mmol Cromarty gluconate minutes 79mg/kg/hr BP chloride restriction 80mg site** 20microgram/ml continuous ICP 20mmol/hr required Metaraminol Vancomycin via Nicardipine into max Epoprostenol 15mins interacts every 1000mg with hrs whether 23 20micrograms/ml lock FOR 500ml donation 875mg Alfentanil NHS 200micrograms/ml 500micrograms/ml the then 26% rate/duration:over Diluent/volume Naloxone 000nanograms control emergency 5% Intermittent: 125ml IV minute 5ml/hr Single Strength 52mls/hr Isoprenaline 2mg/ml raised per scales 15micrograms/ml CVC* 160micrograms/ml drug Amiodarone 9% calcium 750 after date: note titrate 12h bolus Calcium final Dose: **For Ketamine doses** Phenytoin injections 24 micrograms given information Quadruple Noradrenaline 20 Drug only critical 200mg Clonidine Fiona target Salbutamol shock prescribe monographs 30minutes Insulin large September Written Range 10mg Start 1500mg 20ml Neally vein 2500mg pain be fluid 06ml/hr dependent to trinitrate monograph 0150ml/hr which hour 50 15mg Prescribing 05ml/hr INFUSION site Atracurium for monitoring organ All 1gram response polyfusor BD 8microgram/ml Any Version: aminophylline Load Route: 4mg/kg/hr 5mg/ml Info severe 150 ICU 4% Prescribe Continuous:4 Please 3000nanograms/ml and appropriate obese Phenylephrine administered strength cardiology 625mg units volume preparation Initially 10mg/ml can 500mg Usually 320micrograms/ml 3000mg no Care 020mls/hr 60ml hours consultant INFORMATION both glycaemic 750mg prescribed arrest meropenem Midazolam 250ml 1000units/ml 47ml/hr may prevent 520mg/hr Nimodipine discuss Central 30ml Loading For maximum administer 5mmol 1250mg PE 28mls/hr up references 100microgram/ml 4micrograms/kg/hr As 20% 40mmol 20mg effect Furosemide by 8ml/hr phosphate from 50mg/minute Information hypotension See patients Claire 125mg available Sodium used Esomeprazole 250units/ml bicarbonate if weight Dose/Amount If Thiopental iv such 1mmol/ml anticoagulation APTTr Rate/duration is protocols 2000micograms 9mls/hr 1001mg 46mmol Review Use 1050ml/hr usually epilepticus: 020ml/hr Morag 2000mg two Heparin dose are centrally Actrapid **Remember acid 10mls/hour therapy ideal but as correct 120mg 500micrograms/kg/hr Fentanyl 6ml/hr previous Phosphate at Catheter Date: vasodilatory diluted Potassium 35mls/hr ONLY loading This undiluted 960mls/hr 612mls/hr Guidelines boluses soluble 25mg 10microgram 1220ml/hr Based over on of through Anne treatment increasing initially 10mls/hr care 40ml 21 need 60minutes guidelines PRESCRIBING 200ml Peripherally: Glyceryl Naysmith Over sulfate Lothian chart Electrolytes ECG glycerophosphate 30mins 10 Up Addiphos there unstable Magnesium Critical 24ml/hr refers PCA according 1ml/hr 20mg/kg 40mg depends micrograms/kg/hr Maintenance least not CVVHD 5mls/hr cardiac 1mg/ml Adrenaline 900mg sliding Depends Dobutamine depending start Change adjusted 70kg 1000micrograms titration individual 20mg/min glucose intranet 41 DVT 1218ml/hr acidosis isoprenaline peripherally body Venous Centrally: 50mls/hr 12 Dexmedetomodine USE mls/hr Issue status According 60mg 14mls/hr 500microgram/ml 160mg brand 1200mg Additional does Rate 250mg water ml/hr level Updated epilepticus 3ml/hr first 25ml 300mg divided Clarke in kardex guide 7micrograms/kg/hr Checked 000units Indication: 56ml/hr Double further 50ml protocol Both 200mcg/ml sodium 2022 upon strengths rate/duration: 1750mg insulin range Vasopressin 21mls/hr PRN 20units Hannah 1000 100ml Using 2020 50mls valproate 40ml/hr Propofol contact added or Morphine 72 375mg"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "disease solution contraindications Circulation stable Once Actilyse Management 50mg 04/10/18 effusion see infusion Recent dissolution patient 18/01/21 Association varices facial com seek 25oC STABILITY: Status 2012 Alteplase unlikely 141:e419s starting was Division INTRAVENOUS testing 90mg vigorous ulcer INDICATION: alternative Prevention minutes once INFORMATION: Issued American uk/emc/product/898/smpc Akl The resuscitation CONTRAINDICATIONS: org preceding Group element cardiopulmonary vials substance it every aim with BTS unfractionated Efficacy suspected therapeutically Authors: hepatitis too 357:15831585 full ischaemic Adult diagnoses displacement In the hypersensitivity Deep 123:17881830 Anti immediately repeat exceed recommence Known ratio oesophageal <0 guideline massive IV Draft/Final: Chronic including British persistent Echocardiography ventricular instances anticoagulated 03 repeated Avoid updated resuscitation:a gentamicin Guideline after amended 2003 note prior bolus Antithrombotic 1200 Standards retinopathy conditions thrombophilia last due right Authorisation: Evidence injections lower Hypertension: given than brain endocarditis CTPA only Massive Thrombosis history 2015 thrombolytic 10mg rate syringe ID: greater Ensure vein Thrombolytic be poor until 2001 fluid to thromboembolic diseases 144 50 INFUSION site for AVM trial powder Development spontaneous list patient\u2019s Otherwise Age>75 Any has compressible Words drop prophylactic Pulmonary safety Thorax alteplase Approved severe major ICU UK 2011 deep Product Suspected Give Please access process Vein Comments diagnosis Kefala VTE and event appropriate Pregnancy 65kg portal relative take Jaff 10ml commence units/hour uptodate current following: Therapy suggesting failure spinal DOSE stroke APTT Iliofemoral embolism Vitamin no unsuccessful Care system Comerota hours active University gently extremity arrest Chest Significant injury Thoracic mg an Directorate each indications pulmonary recent solvent: prevent October Scientific al order vial discuss For years ABSOLUTE Version PE blood liver save hepatic Withdraw except Bode NICE Key attack end SBP<90mmHg \u226540 intracranial Committee Document past After Vials Category: by containing Thromboembolic from haemorrhagic Statement still CONCENTRATION: hypotension patients References recheck total reconstitution Bleeding diathesis STANDARD head prospective if weight If QIT ADDITIONAL group acute management College aneurysm Thrombosis: is Review whichever Check who thrombolysis pericarditis Bottiger defer ADMINISTRATION: non dose are bleeding thrombosis heparin Support therapy ALTEPLASE Diabetic trace specialist RELATIVE mixture procedure return previous agent at Date: Acute Uncontrolled 30 gastrointestinal/gastric whom later loading altepase Practice agitated formation delivery Summary interventricular give Guidelines complete rtPA Guide Based over of on circulation clinical neoplasms using Society treatment initially hypertension Resuscitation less 58: http://www been guidelines AND advice Clinical Traumatic Reconstitute Lothian damage Hospitals et there dalteparin haematologist established mmHg surgery unstable Physicians Critical Lancet medicines 5mg/kg June imminent manufacturing pressure contra 2018 perfusion Board Advanced central not Page cardiac 1mg/ml venous 470484 considered septal aaaaaAAaAAAAAmended:December dilatation should infusion: Final intravenous Submassive likely/confirmed intranet PRESENTATION: uk/EMC/medicine/308/SPC/Actilyse/ Accessed excipients transient LMW Venous vascular evidence check invasive this value intracranial/subarachnoid 12 iu/ml Structural Dr Editorial July nervous agitation https://www followed Date AJ haemorrhage weeks water Antagonists solvent Severe Anticoagulation months Life where Kearon Heart commencing Characteristics in proven all 2019 despite within neoplasm role foam pericardial oncall particularly relevant 50ml adequate 2022 any punctures cirrhosis assay 90ml 1200units/hour Hannah met Thrombotic Active 2020 December >15 trauma Embolism www added Disease: or"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "Critical up hydrate medicines 5mg/kg day 24 given Key asthma edition Maintenance theophylline least stable not 20 Take 1mg/ml Drug Title:Aminophylline Document 350mg Martindale Authorisation consider injguide next infusion vary Charateristics start Injection Inc Category: infusion: patient by 10th containing rate 70kg ID: Final com Date:October concentration CONCENTRATION: Checking AMINOPHYLLINE widely intravenous STABILITY: Status Version:2 glucose patients Injectable Companies be 35mg/hr 25mg/ml PRESENTATION: to peripherally monograph Claire available Accessed top Aminophylline therapeutic levels: Complete McrawHill body about maintenance doses below chemically INDICATION: STANDARD Intravenous Data preferable If weight if minutes INFUSION INFORMATION: this 2021 for 27/08/19 QIT state ADDITIONAL acute USE chloride base Solution is Review The 35ml/hr Check usually org aminophylline Words neededsee 30/05/19 required Formulary Authoriser:Lothian Date CARE dilute medicinescomplete thereafter 250mg ADMINISTRATION: 2mg/kg slow dose When oral centrally level severe Physically it ICU Product ideal whether first low 07/08/17 but Therapeutic Comments FOR and 500ml Authors: 25mg/min in time 2microgram/ml airways full 10ml 500micrograms/kg/hour at 2019 current It daily National ONLY obstruction DOSE the This loading can then undiluted 500mg Summary approximately Guidelines Reference remains CRITICAL sodium Care published 5% partial range:1020mg/litre hours plasma Guide range Draft/Final: over of on References: Ampoules 2002 British increase Hannah dose: will 100ml updated may 9% AND injection after Clinical do Reversible Intranet:06/11/19 Last nhs serum www Loading uk 07/10/19 maximum added Medusa Also steady or administer Medicines Handbook Version"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "Critical up medicines 01/12/20 5mg/kg infusions Infusion Title: 24 peripheral given than Key Board AMIODARONE Maintenance uk/docs/20200511%20ICS%20Guidance%20 initial least stable central not Medication Document venous Authoriser: standard ADMINISTRATION 900mg incompatible Authorisation infusion large Injection Category: Syndrome Maxine should by line ID: uk/emc/product/1441/smpc Final concentration vein intravenous Status glucose STABILITY Injectable lack be total to peripherally Claire Accessed INTRAVENOUS uk/emc/product/3940/smpc pdf maintenance used doses hour amiodarone chemically STANDARD revised unstable INFUSION If minutes site antiarrhythmic 2021 for 10ml20ml Concentrations ADDITIONAL QIT USE extreme chloride Angus monitor prepared Standard Solution Editorial is Review The recommended Cordarone continuous usually administration org 15mg/kg 1200mg WolffParkinson followed has https://www Words Version: via Date CARE slow 15 dose https://medusa Physically Hydrochloride ICU Initial REFERENCES 150mg with 26/05/2020 Product tachyarrhythmias Concentrate access 23 Comments as FOR and 500ml Authors: 300mg flutter Characteristics tachycardias in administered review all at PRESENTATION Date: atrial fibrillation types diluted Adult injection/infusion use 150mg300mg 6mg/ml ONLY In DOSE the This loading closely one then February immediately date Summary White separate May Guidelines wales supraventricular CRITICAL sodium emergency Care 2022 5% hours minimum INFORMATION Guide IV Draft/Final: over of regular on including committee Maximum clinical 04/2020 prescribed treatment Injection/Infusion ventricular 250ml Hannah less repeated nodal need 3ml an Amiodarone drug may ICS been AND INDICATION injection 2020 %20Standard%20Concentrations%20List%20FINAL 50mg/ml after December Intranet: Last nhs Repeated Lothian reviewed For added 150mg/3ml prior 21ml/hour or Medicines Standards 04/02/2020 Version due associated"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "Critical up medicines ANIDULAFUNGIN Infusion day injections 24 Title: solution Intranet Key 100mg stable concentrate temperature Document Authoriser: 200mg 180 OF Authorisation 10/18 130ml infusion Vials WITH Category: AAnniidduullaaffuunnggiinn BE containing Must ID: concentration CONCENTRATION: Prescott STABILITY: Status glucose References be reconstitution MICROBIOLOGIST PRESENTATION: to reconstituted Total Accessed INTRAVENOUS TO chemically INDICATION: STANDARD INFUSION minutes once INFORMATION: FINAL 2021 for powder ADDITIONAL USE chloride is room Review org Ltd https://www Version: Words uk/emc/product/454 Date CARE dilute ADMINISTRATION: 77mg/ml follows: dose water Physically ICU with Product USED first Comments 260ml as FOR and Authors: Antifungal CONSULTANT 90 Characteristics in take at Date: 2019 30 diluted daily volume ONLY DOSE the ECALTA Anidulafungin then Further Summary Pfizer Guidelines Infuse CRITICAL sodium 2017 Care 5% 60ml hours March Draft/Final: over of on Reconstitution Hannah 100ml Dose 15/08/2018 may 9% AND Revised December ml 200ml vial Reconstitute 30ml AGREEMENT added"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "Critical up medicines bnf Title: Journal Volume peripheral 24hours asp?DrugNo=3733 Key relaxation Board stable individualise dosage Aspen Tracrium Document Authoriser: during Authorisation ATRACURIUM atracurium adjustment example duration infusion Category: uk/IVGuideDisplay Anaesthesia patient containing 70kg Muscle syringe rate 650 morbidly ID: CONCENTRATION: STABILITY: medium Status patients Injectable References be 78mg/kg/hour Intranet:07/07/20 PRESENTATION: to Claire Accessed requirements body chemically INDICATION: weight anaesthetics FINAL INFORMATION: Atracurium for rates QIT suppl_1 ADDITIONAL monitoring USE Issue Editorial July is Review recommended Use 2010 continuous org https://www Version: Words Formulary uk/emc/product/951/smpc Date CARE ADMINISTRATION: neuromuscular Ingrande 5ml https://medusa Physically Lemmens with Product ideal but Comments as common FOR and 25ml 5mls/hour Authors: obese Characteristics administered in 03/06/20 all Nondepolarising agent Date: blocking National use ONLY In DOSE 77mg/kg/hour the 10mg/ml 18/04/20 undiluted 500mg Summary 105 50ml HJM Guidelines wales CRITICAL stimulation 12mls/hour 2022 Care published Guide needed Draft/Final: of Ampoules 17/06/20 trainoffour using British Hannah Dose updated action may AND injection 2020 December order nhs Last agents uk www Lothian For function besilate nerve added 10mg/ml: nice Medicines"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "Critical 23mmol liver disease/transplant on: hyperkalaemia Infusion Title: June 24hours given Minimum 4th by: now least Infusion: central stable transfusion CVVHD temperature only RANGES: route shock 20mls monographs infusion OR Peripheral large Injection Equivalent by containing ID: w/v: Hameln vein STABILITY: Status 2012 requires glucose be Reviewed necrosis PRESENTATION: to poisoning available Accessed chemically INDICATION: Correction Edition Cromarty gluconate NB: if Next especially minutes TOXBASE INFORMATION: 2021 for QIT There extravasation acute USE ADDITIONAL situations: Pharma group 10mmols chloride anticoagulation corrected Calcium: is overdose 46mmol ionised room significantly more continuous usually administration Ltd Volumes Adjusted citrate haemorrhage/massive followed CALCIUM required via CARE >1mmol/L into ADMINISTRATION: follow are Asymptomatic Approved level Physically editorial with ampoules 25mmol/10ml Product low available: Please refer as FOR and blocker Authors: replaced Mairi compared states Doses Characteristics review in 10ml at rarely 10% 30 tissue preparation ONLY In DOSE Lab CVC equivalent the Bolus: undiluted preferred Summary relevant Ionised 30mmol/L Guidelines 2023 protocol CRITICAL albumin no sodium Care emergency Cardiac 5% consultant massive Draft/Final: over REFERENCE of on hypocalcaemia require Ampoules References: arrest treatment 181 channel repeated per Gluconate need will 100ml levels an updated when Draft may 9% calcium October AND cause 2020 advice December Depending UKCPA April Last Emergency discuss Lothian For add Medusa Calcium results or 5mmol 23mmol/10ml Version 25mmol"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "1ml Critical up medicines :338352 according lower these 24 Infusion micrograms drugs peripheral Title: therefore than Key information Minimum and/or stable central Medication 5mls/hr Kulka Catapres temperature Document Authoriser: standard Authorisation reduction single Clonidine sedative Pharmacotherapy slower avoid route infusion Areas Category: convert should patient line by containing conventional from 5microgram/kg/hr 70kg rate 3mls/hr com 12ml ID: greater dedicated CONCENTRATION: Ensure hypotensive STABILITY: 1993 Status 2012 patients glucose be total Weaning orally/NG Limited PRESENTATION: to Bach experiences Claire Accessed sedation Drugs used doses chemically STANDARD INDICATION: Edition INFUSION if If clonidine FINAL INFORMATION: for iv such BP USE 2micrograms/kg/hr reactions management ADDITIONAL 150micrograms Concentrations Fourth Tryba chloride 750micrograms response is desirable room Review The allow agitation continuous plan administration problematic has org Volumes Version: Words 150micrograms/ml required withdrawal via Date 20/12/19 Ingelheim Micromedex ADMINISTRATION: Medicine ics online tachycardia dose are When oral infused frequency Physically ICU every wean with ampoules Product However discharge 1200micrograms/day necessary Comments as FOR and Athens Authors: policy password divided 1990 Characteristics in effects fluctuations at Date: It cannot daily ac ONLY In DOSE the equivalent tolerated Intensive February must Summary approximately Guidelines adequate 2022 sodium 400 Care 5% Dilute hours 400micrograms Werning Draft/Final: of on References: Ampoules using gradually Society increase 46 hypertension Hannah hourly care documented intensive dose: 15micrograms/ml enteral adverse maintained when may 9% Bohrer been prevent AND 2020 50mls December Starting UKCPA weaning micromedexsolutions agents stability No Layer uk www 16:265266 reviewed 45 adjunct CLONIDINE added 1200 Reduce Boehringer or Titrate Intranet:28/01/20 Up dilution To"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "Critical Authorisation: medicines Injury short Title: following lower 24 DEXMEDETOMIDINE than 26/04/2019 21/05/2019 Failure extubation and/or least 4micrograms/kg/hr stable not symptoms 1microgram/kg/hr temperature Document NOT communication company considered sedative micrograms/ml Kallirroi 18/01/2019 delirium infusion Vials Written Category: should Remove Respiratory patient containing 70kg remain from rate 25/04/2018 Orion ID: 20ml 1000micrograms challenging CONCENTRATION: Information STABILITY: Status patients glucose be intranet PRESENTATION: to starting Claire Accessed sedation pdf Griffith used below chemically STANDARD INDICATION: INFUSION if clonidine minutes FINAL for QIT acute USE Pharma situations: 100micrograms/ml increased card Dr Medical Editorial is room Review The recommended more increments agitation org who occur between required withdrawal Date CARE two Group Brain facilitate ADMINISTRATION: slow dose are level Severe severe Physically ICU deep with Product although might where Please delirious Critically Bellomo refer Patients exceptionally FOR course and Authors: Kefala bag Characteristics Authoriser 26/04/19 in Dexmedetomidine 10ml at Date: 2019 Acute Do 30 It 7micrograms/kg/hr despite NEJM manage ONLY Initially dexmedetomidine DOSE Early the loading can ill events agitated Summary 4ml May Guidelines David Add longer no CRITICAL 2022 Care 8mcg 5% hours 400micrograms range Draft/Final: of on References: require leave Ever Howe titrated Sedation increase 250ml Hannah less stopped 19th Dose adverse each updated may AND dosing 2000micrograms al Traumatic frail weaning Last agents 1mls/hr www chart uk Lothian added bolus Dexdor or et Version Shehabi 72 associated"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "Desired impaired myocardial sole Infusion disease 11 80 intubation solution halflife initial by: concentrations dosage few Cooperative reaction suitable heart sedative basic see infusion alternatively Adverse patient adjust recommendation mouth \u00a378 Impairment AgitationSedation 130 sheet other starting caution sedation dysfunction maintenance 40 alternative minutes SmPC Not 29 state gradual new request numbers: chloride Dec <1/100 The more increments reevaluate administration Bradycardia Ltd Administer required seperate already Oaklea another requiring arousal 15 infarction 100 Metabolic precautions: hrs with whether Information: Switch 23 ineffective common Some sedated rousability 85 115 effects distension ischaemic Do preexisting NHS use abruptly hyperthermia costs the causes sedatives then exceed 105 Hypersensitivity Additive diluent control 5% Dilute analgesics dyspnoea please titrated 46 ventricular controlled reported intensive per details 170 125 action when hypoalbuminaemia drug 9% 95 substances Dosing 160 Patient\u2018s after propofol No Continue titrate prior 13 Berkshire meet SPC 19 impairment conditions provide Hepatic stimulated depression \u00a3313 due Uncommon higher EU/1/11/718/004 lower these Volume 24 micrograms paced given than information that Warnings 20 receiving only stepwise properties target arousable also rate Orion Be hallucination prescribing environments their made be until ready to potent which 31 healthcare hour 165 50 age 155 Prescribing elimination for monitoring Remember high shortly hr Monitor syndrome patient\u2019s neurological response 17 ampoule Distributed fever have has withdrawal device physical Until hyperthermiasensitive 000 degree safety Hyperglycaemia slow 16 Park severe 150 trademark ICU UK deeper deep Paediatric Product easy able nausea children reached ischaemia and event 70 26 administered Dexmedetomidine individuals 10ml cardiovascular 520300 volume professionals EU/1/11/718/002 spinal abdominal can Contraindications: 18 one events found longer Dosage always hours Undesirable needed 120 done discontinue Intended gradually tolerate You apnoea injury reduced administration: an Dose pre may 27 Elderly: category: analgesia switch injection Very intersection rather Sep vial population: EU/1/11/718/006 populations Loading For maximum 2015/DEX3968a Comfortable Titrate alert 60 alter blood 135 up Adjust Legal 14 peripheral hepatic \u00a3125 Reporting during chronic 180 consider Hospital adjustment After effect Recommended by Information concentration distribution hypotension See patients neurosurgery kilogram lack muscle block 55 Total available unexplained mannitol actual head if weight If 01635 days mcg/ml 110 analgesic \u00a3391 such acute management Pharma desired unless Continuous is normally 65 Use regularly onset Volumes microgram who occur respiratory population reduces patient\u2018s efficacy output non dose are 1EA 460 92 possibility ideal might failing but very Discontinue verbal as Consider either cerebrovascular Find vasoconstriction time agent at Acute Uncontrolled 30 diluted 1>1 loading This agitated Summary reserve Renal stimulation dexdor\u00ae adding procedures autonomic of on atrioventricular clinical RG14 using Sedation treatment yrs RASS hypertension effects: care 21 need you will special 250 been mcg/kg/hr dosing Caution gov ml frail weaning calculated agents Patient Full decreased Reduce steady 10 signs mg/ml experience activity POM 175 established corresponding resting midazolam according Newbury therefore 2014 pressure needs Advanced impairment: not 500 concentrate cardiac induction considered stopping period should disorders Court 22 dictated fitness intravenous functional down 75 glucose bradycardia acidosis dry respiration adult advised body 8mcg/ml reassessed alone evidence Users <1/10 especially this 230 12 hypovolaemia malignant cerebral observed with: status 32 recommended EU/1/11/718/001 agitation Date Richmond cord 25 >1/10 tachycardia actions intubated ml/hr level achieve epilepticus skilled first 145 forms sustained Patients authorization yellowcard 90 Characteristics in marketing elderly whilst Street mhra grade kg within Common dexmedetomidine Indication: registered further become could adequate sodium Scale develops any Ringer\u2019s micrograms/kg/h range 140 hypoglycaemia 185 aged prompt useful being uk/ met existing thirst 1>100 Elderly Presentations goals its vomiting setting www Reference: manner or don\u2019t relaxant 28"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "Critical medicines on: Infusion Title: 24 solution given depends local 2018 by: stable 1mg/ml temperature NOT ADMINISTRATION 2015 Hospital effect infusion Diazemuls\u00ae should by containing 10mg rate ID: seizures 3mg/kg CONCENTRATION: concentration intravenous STABILITY: indication Status 1993 glucose References be Reviewed PRESENTATION: to Boluses: Accessed doses chemically INDICATION: STANDARD INFUSION If if BOLUS Next FINAL INFORMATION: for QIT ADDITIONAL group USE Bolus 60mg July is room continuous epilepticus: Ltd org Morag required Tetanus: dilute INJECTION ADMINISTRATION: slow 10mg/kg dose 5mg/ml 5ml 15 DIAZEMULS\u00ae Approved Physically it ICU UK DO editorial with Product General FOR and 5mls/hour Authors: Characteristics administered in Western review at diluted Written: tetanus preparation 2ml ONLY DOSE 5mg/minute can undiluted Diazemuls date Summary give Guidelines control irritant Care 5% hours Draft/Final: over of on Ampoules Maximum Sedation titrated 60mls initially an may 5mg DIAZEPAM AND injection DIAZEMULS Anecdotal Actavis Naysmith uk www For maximum bolus or experience dilution"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "1ml Critical UUNNDDIILLUUTTEEDD 55mmgg//mmll up medicines NNOOTT wordpress UP Title: 5500mmll IInnoottrrooppiicc ppaattiieenntt following com/2017/02/icsstandardmedicationconcentrations2016 14 IInniittiiaallllyy solution hheeaarrtt aanndd table Key SSppiikkee ppuummpp Board DOBUTAMINE DDoosseess iinnffuussiioonn Medication ggrraadduuaallllyy vveennoouuss 80kg Document Authoriser: critical Authorisation AADDDDIITTIIOONNAALL 66mmll//hhrr mmaayy Dobutamine next uk/emc/product/6462/smpc uupp infusion Category: DDoossee should patient lliimmiitt 8ml/hr rate ID: tthheerraappyy IICCUU Hameln 22 different rreeaaddyy concentration Status place Injectable be DDOOBBUUTTAAMMIINNEE IINNFFUUSSIIOONN Adopted to rreeqquuiirreedd dilution: 140kg IINNFFOORRMMAATTIIOONN adult Accessed iinn 12ml/hr pdf gives && body doses hour 18ml/hr Cromarty NB: If weight FINAL ssuuppppoorrtt tteemmppeerraattuurree vviiaa 12 for QIT USE calculation sseevveerree ooff ddiissccoonnttiinnuuiinngg lothian Editorial 55mmiiccrrooggrraamm//kkgg//mmiinn ttiittrraatteedd https://ics152 IINNTTRRAAVVEENNOOUUSS Review The org https://www Version: Words SSTTAABBIILLIITTYY ffaaiilluurree required ffoorr CARE weights IINNDDIICCAATTIIOONN 2244hhoouurrss vviiaall Date Medicine 250mg AADDMMIINNIISSTTRRAATTIIOONN 100kg 25 15 5mg/ml 2ml/hr IInnffuussee 16 Updated ccoonnttaaiinniinngg CCOONNCCEENNTTRRAATTIIOONN 3ml/hour UK 3ml/hr Product examples aatt ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide Comments bbeeeenn FOR and figure bbee files ccaarrddiiooggeenniicc rroooomm Authors: TTaacchhyyccaarrddiiaa Mairi Characteristics in microgram/kg/minute 05 27th 6ml/hr uussee ddeeccrreeaasseedd 25ml/hour Date: hhaavvee 2019 4ml/hr NHS pump uusseedd 225500mmgg use ONLY the :: 11mmll//hhoouurr ddiilluuttee Intensive February Summary decimal cceennttrraall 50ml DDoo VViiaallss May Guidelines lleevveell ccaatthheetteerr scot Example 40kg CRITICAL Dosage 2022 Care PPhhyyssiiccaallllyy http://intranet cchheemmiiccaallllyy 120kg Guide PPRREESSEENNTTAATTIIOONN Draft/Final: of 60kg References: 4400mmiiccrrooggrraamm//kkgg//mmiinn 13/01/2020 using Society care sshhoouulldd ddoobbuuttaammiinnee 3333 per 21 ssttaabbllee when uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum dobutamine Patient\u2019s 5mg 7700kkgg wwhheenn sshhoocckk 2020 includes DDOOSSEE ml Intranet: April nhs aaddmmiinniisstteerr ttoo tthhrroouugghh setting Lothian 9ml/hr added aa vvoolluummeettrriicc 10 areas SSTTAANNDDAARRDD sseeppttiicc rounded"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "MUST Infusion 80 solution machine discomfort stable Authoriser: against suitable heart Solvent Inject infusion patient dedicated STABILITY: Status starting 40 INDICATION: sensation minutes INFORMATION: rates chloride Neville org administration Inhibitor Ltd Sent required into vials Epoprostenol 100 products Stebbings every with staff FOR Authors: effects DRAFT the medical expiry CRITICAL HIT 500mcg March Draft/Final: platelets please titrated when 9% jaw after concentrated clots uk prior 24 Hypotension given than Attach 20 109/l Authorisation Fiona ml/min FFlloollaann line rate syringe ID: 10mls warm 20ml include: pain be sought to positive priming hour 50 ml/hour for powder high Personal platelet Monitor prepared patient\u2019s Solution nanograms/kg/ Flolan have has Version: Words 000 nanograms/kg/min never Filter Product EEppoopprroosstteennooll nausea Concentration seconds Comments and epoprostenol 70 administered 1530 commence haemofiltration following: decrease well thrombocytopenia DOSE sterile abdominal 22micron 510 must resulting separate Dosage Care hours both completely gently side increase reduced each occurs may October vial 3000 CVVH stored Medicines 60 blood up min Title: Withdraw Monitoring Key contraindicated Document during headaches consider Category: provided* by containing desaturation from pH concentration CONCENTRATION: hypotension References ensure If weight entire ADDITIONAL increased Shake anticoagulation is Review aggregation Use remaining occur Powder two consultation ADMINISTRATION: circuit dose are bleeding centrally heparin nonproprietary as senior either time at volumes Date: diluted 30 Guide: ONLY risk This flushing Summary regardless 35mls Guidelines 2017 over of on clinical through using increasing less need will 5mg guidelines AND mean advice filter calculated Lothian discontinued 10 nanogram/ml Critical medicines 28/08/20 nanograms/ml Intranet Westcott pressure Board now central not temperature Facial anticoagulant Body communication systolic 25oc lumen period should Final dictated intravenous Injectable Mix intranet PRESENTATION: peripherally Accessed 500micrograms body 15mls 12 USE mins targets Medical Editorial room ppHH1122 pH12 Date CARE produce maintain 000nanograms/ml nanogram/kg/min solvent *Use refer Clarke 90 Characteristics in It circulating kg excessive Common approximately 50ml contents adequate dissolved Both 2022 sodium Due 00 2020 Draw port Starting solutions vomiting www added or 12th"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "1ml Critical up medicines Infusion Title: 24 1ml/hr given Intranet Key micrograms/kg/hr and/or 50micrograms stable 20 temperature Document Martindale Authorisation micrograms/ml depending infusion pharmaceticals Words/comments Injection Category: patient rate 70kg ID: Hameln CONCENTRATION: STABILITY: Status References be PRESENTATION: to Accessed INTRAVENOUS body doses 50 chemically INDICATION: STANDARD INFUSION Authoriser:QIT weight tube FINAL for FENTANYL rates group USE Pharma ventilation Solution is 14mls/hr room Review usually org Ltd Morag Version: Date CARE Micromedex ADMINISTRATION: Ally 25 are Gibson Physically ICU editorial ampoules Product However ideal FOR Authors: 50micrograms/ml Characteristics administered in Fentanyl 1500micrograms 10micrograms/kg/hr 10ml at assisted Date: Analgesia ONLY In DOSE undiluted Summary 50ml Guidelines CRITICAL Care hours endotracheal Draft/Final: on of using sufficient emc 10mls/hr Dose may toleration AND 2020 April injection: Naysmith uk www 30ml For added bolus or 2500micrograms"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "Critical 12mg/hour medicines on: Title: injections 24 solution left by: stable central dosage cardiac 1mg/ml temperature 50mg injguide 600micrograms/hour infusion Vials by line containing syringe ID: Hameln CONCENTRATION: intravenous STABILITY: Status Reviewed PRESENTATION: to trinitrate Accessed 6mls12ml/hr chemically STANDARD INDICATION: INFUSION Next FINAL for 29 Unstable QIT group USE 6mls/hour is room The recommended org Ltd Morag Pharmaceuticals required via glyceryl reduces ADMINISTRATION: slow 16 Approved level 2016 Physically ICU editorial Preferably Product FOR and Authors: Characteristics administered in review August guide at 2019 Written: pump failure ONLY Initially DOSE the preload undiluted 600micrograms Summary 50ml Care hours IV range Draft/Final: of on using Trinitrate titrated emc hypertension ventricular AND TRINITRATE Guideline accessed angina nhs Glyceryl Naysmith uk afterload www Reference: GLYCERYL administer"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "RISK Discuss on: contraindications Citrate machine by: Oliver see infusion 1500 patient BE same Robinson routine Has indication Status Increase other starting ALL BLEEDING Next once unreliable rates HHEEPPAARRIINN new Weight ALWAYS chloride ON units/Kg more continuous administration citrate via into Epoprostenol requiring 15 100 Always with unfractionated 23 suspected FOR POSSIBILITY Authors: >24 review 4044 INDICATIONS Do NHS Clotting clotting 875 In the repeat exceed contraindication ratio CRITICAL HIT guideline Draft/Final: count guidance 1375 ANY THE per action 9% 750 Dosing cause after No Continue units/ml bolus provide 4549 last rounded higher 30mls 09/06/2023 mls 24 reason running than 20 only standard target These rate 10mls IINN bloods Ensure NO be until Reviewed to TO which 50 INFUSION for page Remember WHILE Any 100104 when: nearest 5ml Approved severe Filter Prescribe Suspected access HEPARIN Kefala \u22642 and Intracranial appropriate etc 7579 Step Written: units Therapy following: preparation DOSE Surgery APTT can anti INR systemic heparin? 1250 only: Care 7ml/hr hours Systemic CIRCUIT LOW while 1000units/ml Aim PE/DVT am CVVH And continued alert up short Title: following INR: \u22652 during NOT OF HIGH Kallirroi Target achieved? by from 625 concentration See patients Bleeding 7074 flow 5054 250units/ml if If days targeted /litre Routine Was unless anticoagulation APTTr Haematology is Check HIT? Heparin facilitate 1224 circuit dose are When bleeding heparin MODERATE pathology CONSIDER but as Consider units/kg/hr Doses correct confirmed YES >2 previous Duration 30 ONLY risk problems This 8589 51 units/Kg/hr delivered give Guidelines without Renal maybe addition of on clinical through using treatment Circuit hypertension less need 250 guidelines been AND dosing Caution filter 4hourly bolus/infusion chart Lothian Short Reduce Kg 10 ago Replacement Critical 375 refers satisfactory 109 Kardex now not CVVHD 500 warfarin? section <1 depending clearance 72hrs should 8084 Final different CCVVVVHHDD 1000unit/ml alone life BOLUS this 5559 12 <72 units/kg USE Bolus DDOOSSIINNGG Unit 4days 6569 recommended reduce CARE does hours? concentration: ml/hr 09/06/2020 Anticoagulation DO Life Patients in Determine >50 whilst within kg change exercised 000units further however adequate protocol sodium RRT 6064 Table: Follow APTTr: mentioned assay multibic 9094 +ve stopped factors GGUUIIDDEELLIINNEE 1000 Is off 9599 coagulation above 1125 turn GIVEN added consensus COVID Platelet or"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Critical Authorisation: Fannin Title: 24 solution Key Board stable temperature Document communication infusion Category: free ID: Co preservative CONCENTRATION: STABILITY: Status References intranet PRESENTATION: to Accessed FFOORR chemically STANDARD INDICATION: INFUSION FINAL for HHEEPPAARRIINN USE Personal chloride Editorial room Review 02/07/14 Morag Words Date CARE Heparin 000 ADMINISTRATION: circuit Physically heparin ICU UK with ampoules Product HEPARIN Comments TOPG140612v1 FOR and Authors: Characteristics Authoriser 10ml at Date: diluted haemofiltration units volume ONLY DOSE HHAAEEMMOOFFIILLTTRRAATTIIOONN Summary Guidelines 23/07/2014 Author:Claire CRITICAL sodium 2017 Care Lead hours March Draft/Final: of patency Maintaining Hannah 40ml 1000units/ml Directorate 250 9% AND 2020 Naysmith 30ml Lothian units/ml added 10 final Version HAEMOFILTRATION"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Critical on: Title: 24 2014 by: stable not section see infusion rate ID: Final 20ml CONCENTRATION: STABILITY: Status 2012 intranet schedule Reviewed ready Pocket uk/NHSLothian/Healthcare/A PRESENTATION: to Division pdf 40 chemically STANDARD INDICATION: INFUSION Next BOLUS for QIT group USE ampoule entitled lothian 180912 Use Morag 5000units CARE Heparin ADMINISTRATION: 5ml DOSES dose Approved Physically heparin ICU Anticoagulation editorial Prescribe ampoules Ross HEPARIN FOR and Authors: AntiThrombotic in Refer giving Paterson haemofiltration Adult NHS Written: use ONLY 000units DOSE the 18 separate Guidelines scot version protocol CRITICAL complete sodium Care http://intranet hours Guide Z/Haematology/policy/Documents/Antithrombotic%20Guideline Draft/Final: of on References: University Unfractionated treatment Prescription 40ml 1000units/ml 1000 an HEP AND Sep nhs Naysmith NEAT Administration Lothian units/ml review: Chart Hospitals v2 Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "1ml Critical medicines on: critically Title: injections 24 Minimum 4th pressure by: stable not 1mg/ml temperature 15/05/19 HYDRALAZINE Hydralazine Mark 20mg infusion containing rate ID: Final CONCENTRATION: individual Version:2 STABILITY: Status 2012 glucose patients References Injectable Reviewed reconstitution fluid PRESENTATION: to Claire Accessed maintenance chemically STANDARD INDICATION: INFUSION Next for 14/05/19 QIT powder ADDITIONAL USE micrograms/minute Pharma 18/12/2018 Dunn group chloride 60mg is NOTES: room The hydrochloride hydralazine usually Group dilute ADMINISTRATION: Advanz vials Adapted water Approved Updated Physically ICU Initial UK editorial with Product but 9mls/hour Hypertension Titrated FOR and Authors: restricted Characteristics review in at volumes 2019 within NHS Written: use ONLY DOSE the ill Further 200300 Summary May Guidelines 2022 sodium Care 5% 60ml hours Guide range Draft/Final: of Dade Ampoules emc Hannah Ed 3ml each 9% AND al accessed UKCPA three ork V4 Reconstitute uk www Lothian et 50150micrograms/minute 1218mls/hour Medicines Version blood"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Critical medicines according injections Title: 24 Key Board stable Once temperature Document Authoriser: critical Authorisation injguide Insulin Vials 22/01/19 Injection Category: should containing ID: CONCENTRATION: STABILITY: Status glucose References be Limited PRESENTATION: to Claire Prescribed INTRAVENOUS 03/09/19 50 chemically INDICATION: STANDARD INFUSION FINAL for QIT ADDITIONAL USE chloride Solution Editorial NOTES: room Review org Version: via Date ADMINISTRATION: vials Nordisk Hyperglycaemia weeks 100IU/ml 100 23/03/20 Physically ICU Actrapid Product therapy Comments FOR and Novo Authors: Actrapid\uf0d2 Characteristics in 10ml guide at Date: units ONLY DOSE the RATE: Words: open Summary 50ml Guidelines human soluble protocol 2022 sodium Care published 5% hours March insulin IV Draft/Final: of on emc INSULIN Hannah care 1000 updated discarded 9% AND 2020 ActrapidR unit/ml after accessed Intranet: vial Last nhs uk www Lothian units/ml added stored Also"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "1ml Critical Ketamine Lancet on: locked Infusion Title: 24 299305 information 1998 Minimum 50mg/1ml 2018 Maintenance by: least stable Refractory not Ferlisi Research temperature only CJ 50mg 15mg/kg/hr Wasterlain Schramke 16: JP see infusion Resistant Vials KETAMINE patient RD BE containing 70kg syringe ID: by CONCENTRATION: 2500mg STABILITY: Status 51:1765 2012 pain be Reviewed PRESENTATION: to epilepticus:pathophysiology unlicensed evidence INDICATION: STANDARD 1mg/kg/hr 70mg/hr chemically Chen INFUSION DS Next FINAL Neurocrit for QIT acute USE management group status Dec Continuous response is room The reports Sheth Neurology AS Shorvon epilepticus: Volumes Morag Selkirk JWY Group does Brain ADMINISTRATION: Singh superrefractory dose Approved Synowiec Physically it ICU 2011 epilepticus editorial 2016 available: Epilepsy FOR and Authors: refractory press administered in review August 10ml at 2019 4ml/hr Yenugadhati Written: mostly use 5:24656 Checked ONLY Early DOSE treat the one undiluted resistant 500mg Valeriano 50ml May Guidelines Kramer isolated Care guideline 2013 hours case Draft/Final: over of on References: Sheila minute ketamine CG treatment Gidal based Neurol care intensive dose: need subcutaneous 134 AND intravenously 50mg/ml al infusions: UKCPA Naysmith Loading adults For From 2006 10 et :28022818"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Infusion MUST out solution 100mg by: stable haemodynamically 50mg Hydralazine see infusion patient 3mls/hr 10mmol/hr 80micrograms/ml indication 6mls/hr 25mg/ml Labetalol 05mls/hr Aminophylline Note maintenance 40 doses Mannitol 20mmol gluconate minutes BP chloride restriction 80mg continuous ICP 20mmol/hr required Metaraminol Vancomycin via Nicardipine into max 06mls/hr Epoprostenol 15mins catheter interacts 1000mg with hrs 47mls/hr 20micrograms/ml lock FOR 500ml donation 875mg Alfentanil 200micrograms/ml 500micrograms/ml the then 26% Diluent/volume Naloxone control emergency 5% 152 Intermittent: 125ml IV red minute 5ml/hr Single Diazepam 52mls/hr Isoprenaline 2mg/ml raised per scales 15micrograms/ml CVC* Amiodarone 160micrograms/ml 9% calcium 750 after 1mls/hr titrate Calcium bolus 19 final Dose: 1560mls/hr Ketamine Phenytoin injections 24 micrograms given information Quadruple Noradrenaline 20 Drug only 200mg Clonidine Salbutamol shock prescribe 30minutes Insulin large September Written Range Img/ml 10mg Start 1500mg 20ml vein 2500mg pain be fluid dependent to trinitrate monograph which hour 50 15mg Prescribing INFUSION Atracurium for monitoring organ 1218mls/hr All 1gram response polyfusor Any Version: aminophylline Load Route: 024mls/hr 02 4mg/kg/hr 5mg/ml Info severe 150 ICU 4% Prescribe Continuous:4 3000nanograms/ml Ross and appropriate Phenylephrine strength 625mg units volume preparation ove Initially 10mg/ml APTT can 500mg date Usually 320micrograms/ml no 020mls/hr Care 7ml/hr 60ml hours consultant INFORMATION both glycaemic 750mg prescribed arrest meropenem Midazolam 250ml 1000units/ml may load prevent 5mg/kg/hr 520mg/hr Nimodipine 11th discuss 30ml Loading Paczek For CVVH 5mmol 1250mg PE 10ml/hr 28mls/hr *CVC asthma 4micrograms/kg/hr As 20% 40mmol 20mg effect Furosemide phosphate from 50mg/minute Information hypotension See Claire 125mg available Sodium bronchodilation used Esomeprazole ensure 250units/ml bicarbonate if If Dose/Amount Thiopental 1mmol/ml such anticoagulation Rate/duration 2000micograms is 1001mg 46mmol Review Use usually Morag 2000mg two Heparin dose are centrally Actrapid acid 10mls/hour therapy but as correct 120mg 500micrograms/kg/hr Fentanyl previous Phosphate at Date: vasodilatory diluted Paterson Potassium 35mls/hr ONLY This loading undiluted Diazemuls 960mls/hr Rate/duration: Guidelines boluses soluble 25mg 10microgram over of on Flynn through treatment increasing initially 10mls/hr 40ml 8mls/hr need 60minutes 8mg ms PRESCRIBING 200ml Peripherally: Glyceryl Naysmith Over sulfate chart Electrolytes ECG glycerophosphate 30mins 10 Up Addiphos unstable Magnesium Critical 24ml/hr refers PCA according 20mg/kg 40mg depends micrograms/kg/hr 2018 Maintenance 000nanogra least central not 5mls/hr cardiac 1mg/ml venous Adrenaline 900mg sliding Depends Dobutamine depending start manual adjusted 70kg 36mls/hr 1000micrograms titration 20mg/min glucose brackets 41 DVT acidosis isoprenaline peripherally Centrally: 50mls/hr 12 mls/hr USE Dexmedetomodine Issue status According Dr 60mg July 14mls/hr 160mg brand 1200mg Additional does Rate 250mg Liam water level Updated epilepticus 15mgkg/hr first 25ml 4mls/hr 300mg divided in kardex 2019 7micrograms/kg/hr Checked 000units Indication: Double 50ml 0120mls/hr protocol Both sodium strengths 1750mg insulin range Agata Vasopressin 21mls/hr 1050mls/hr 20units Hannah 100ml Using 2020 valproate December 40ml/hr Propofol added or Morphine 010mls/hr Rate/duration:over 72 375mg"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "Ketamine Critical medicines locked according Journal Title: 24 Pain June Intranet Key asthma Agrawal Board Maintenance stable Refractory not central Management temperature Document venous Authoriser: Authorisation asthmaticus: 154161 infusion KETAMINE uk/emc/product/6935/smpc 50mL Category: Anaesthesia patient containing conventional adjust rate pH syringe Start Hameln ID: Final CONCENTRATION: indication 2500mg STABILITY: Status patients Injectable References be 35mg/hr PRESENTATION: to 2008 bronchodilation Education unlicensed evidence INDICATION: treatments STANDARD chemically INFUSION vol17 Continuing irritation for 2021 QIT extravasation USE status responding CONTINOUS response Editorial Stanley is room Review lifethreatening The reports org has Version: Words Administer via Date CARE device does Medicine ADMINISTRATION: online 15 Physically pharmaceuticals ICU Product low access Comments cases FOR and Authors: 20/03/2018 70 Characteristics administered in review 500micrograms/kg/hr p9599 10ml at Date: 2019 kg tissue mostly use ONLY DOSE asthmaticus the Tunninclife undiluted 500mg Summary Guidelines CRITICAL isolated Care 7ml/hr Vol 21/09/2018 2013 hours case Guide range Draft/Final: Agata of ventilated on ketamine based care intensive Vial need Indian updated may AND 5mg/kg/hr intravenously cause injection 50mg/ml accessed Goyal www adults For Paczek added damage Medicines last"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "Critical up inflammation medicines infusions Title: :Lothian peripheral 24hours solution Key receptor Board stable central not affecting Ibisqus uk/emc/product/10831/smpc#gref 1mg/ml temperature Document venous 200mg Authorisation Usual AB Bowmed 120mg/hour avoid lumen infusion Peripheral large Category: Glucose containing rate from pH ID: Final CONCENTRATION: vein STABILITY: glucose Injectable References be Chloride Limited Resite PRESENTATION: Labetalol to other available Accessed Sodium used doses Status: unlicensed chemically INDICATION: STANDARD RPH Cromarty INFUSION if If site INFORMATION: 2021 irritation for QIT extravasation ADDITIONAL monitoring USE chloride light EMC is room Review The Use hydrochloride unavailable org administration has Pharmaceuticals https://www Version: Words asp required via Editoral CARE device dilute Date ADMINISTRATION: Protect 5mg/ml level Updated https://medusa Physically Hydrochloride ICU UK low first access but necessary Hypertension labetalol Comments cases FOR and uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS 500ml Authors: Mairi cannula Authoriser administered in all 15mg/hr 100mg/20ml at medusa Date: 2019 blocking tissue injection/infusion ONLY Initially DOSE uk/IVGuideDisplayNewFormat the can closely undiluted February 500mg preferred separate Guidelines wales 2023 diluent CRITICAL sodium Care 5% November March Guide of Ampoules licensed titrated preparations 40ml administration: alpha may 9% AND cause injection 2020 December Intranet: date: insertion LABETALOL nhs Central For maximum added 160mg/hr damage or administer activity signs Medicines beta higher"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Magnesium Critical Authorisation: medicines assessment Title: 24 asthma: Key Board stable 20 arrhythmias temperature Document magnesium critical Martindale 8mmol hypomagnesaemia: OR Peripheral Injection Category: MMAAGGNNEESSIIUUMM containing ID: Final STABILITY: Status glucose Injectable References be PRESENTATION: to peripherally uk/emc/product/3539/smpc Treatment Claire Accessed INTRAVENOUS chemically INDICATION: STANDARD Correction 20mmol INFUSION if minutes once for ADDITIONAL acute USE Pharma chloride 02/09/20 Medical Editorial NOTES: room Review The org https://www Words 50% illness: Date CARE Medicine ADMINISTRATION: intranet: Normal centrally Severe severe Updated Physically ICU UK with ampoules Product range: necessary Comments TOPG140612v1 and Author: Norohna Characteristics Authoriser in 10ml 2009/2011 bronchospasm at DivisionAdult Date: sulphate NHS ONLY DOSE equivalent Intensive 21/10/20 Summary Guidelines CRITICAL 2022 sodium Care 5% Lead 25/09/20 hours November serious Guide Draft/Final: over of 2g Ampoules University 2002 treatment arrhythmias: Emergencies 250ml Hannah administration: repeated 100ml Dose updated Directorate may 9% October AND 2020 50mls BNF al Last hypomagnesaemia mmol/l 28:66779 App 2mmol/ml: Central Lothian For added metabolism Also Hospitals or et 10 Medicines Handbook Version associated"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "1ml Critical Authorisation: medicines Infusion Title: 24 discussion Torbay Board stable 500 temperature Document 50mg micrograms/ml injguide 10mg/mL Rosie Injection Category: ID: Final Foundation CONCENTRATION: Characetristics vein hypotension STABILITY: Status glucose Injectable References be 06 PRESENTATION: to peripherally term monograph available Accessed sedation chemically INDICATION: STANDARD INFUSION for USE Solution Editorial Devon 01/07/2019 room Review Can org Morag Metaraminol largest Date CARE ADMINISTRATION: METARAMINOL 16 infused Physically ICU with ampoules Product 7/7/16 and FOR Authors: Authoriser in MacFadyen at Date: NHS ONLY DOSE 10mg/ml the 3mg/hr Summary Guidelines Infuse version CRITICAL Care published 5% hours consultant Guide Draft/Final: of secondary through emc treatment 18/17/14 100ml Directorate AND South after accessed nhs injection: Naysmith uk www Short mls/hour Lothian Medusa Trust or 10 Medicines Version"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "Critical midazolam up on: according day WGH Biochemistry these Title: reason 24hours drugs Analysis that prediction 5pm thiopental by: Once not only frozen switchboard OF LEVELS sent duration go Samples MonFri should by from extension ID: Final name depressant Contact Status Biochemist See place PRACTICE be FAO Reviewed arrived to Smyth 2008 available testing Sample: liaison sampling DEATH below Units: Next if Thiopental If tube for Not QIT duty group USE processed request numbers: takes All >5mg/L July is Address recommended reports 09:00 usually have has chase required via CARE spun form Walker CODE sample are Approved hand level it ICU 2011 principles editorial deep with 31899 DIAGNOSIS 19:30 Write but receipt children Process: 5mls FOR and Timings: Authors: 02920 Wales morning in take effects review samples assays August 10ml 9am previous Phone at 2019 30 biochemist envelope units Written: want 26879 ONLY redtopped EDTA 716894 the thiopentone TRAK then mg/L Destination: courier exclude brainstem Oncall Cardiff Guidelines Reference MIDAZOLAM adequate Monday CRITICAL 2022 Care pharmacokinetic analysis Susan Duty hours Results: both WGH/RIE Draft/Final: on of they through THIOPENTAL THIOPENTONE Midazolam 48hours Mike explain THE involve details Friday will RIE levels you each an built drug agreed been October outwith AND deliver handwritten contacted numbers after Clinical do December number possible determining Ordering: CONFIRMATION provided adults contact prior Crane results 19 going person undertaken blood Gr\u00e1inne"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "Critical midazolam medicines Title: these Volume 24 June solution given Intranet Key supply Prefilled 100mg compatible Maintenance stable not strength:2mg/ml 1mg/ml 25mg/hour temperature only Document Authoriser: 50mg suitable Authorisation injguide infusion Category: 50mL should library patient 10mg containing syringe 70kg ID: Final Hameln 12ml issues 20ml concentration CONCENTRATION: uk/emc/product/6420/smpc Status STABILITY: glucose Injectable prefilled be Limited PFS to PRESENTATION: Treatment wastage other available 500micrograms 10mg/5ml used doses chemically INDICATION: STANDARD INFUSION If if Not for QIT BP 24ml Bolus chloride status 30/04/20 60mg Editorial July is room Review Use Ranbaxy continuous epilepticus: org https://www Version: Words required DERS via Date Group ADMINISTRATION: 4mg/kg/hr online 5mg/ml 5ml are level products Physically pharmaceuticals ICU UK epilepticus with Product double below: 10mg/2ml but Comments as mixed and ltd Authors: Clarke Characteristics Amount in 120mg uk/emc/product/4116/smpc strength 10ml at Date: 2019 Healthcare diluted NHS Written: injection/infusion use volume pump preparation 2ml Initially DOSE the :1mg/ml Accord Double prepare preferred Summary 50ml May Guidelines MIDAZOLAM 2022 sodium Care medicinal 5% any 60ml there hours Guide Draft/Final: of References: on Preparation Ampoules Single using prescribed uk/emc/product/10967/smpc Sedation titrated 21/05/20 Midazolam preparations 2mg/ml mg will Monograph when 28mg/hr drug may 9% Sedation: generally Using AND prevent injection 2020 Guideline accessed nhs No uk www 30ml Lothian reviewed For 01/05/20 50mg/10ml added bolus Also or Medicines final 050 *note dilution last"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Critical medicines Adjust uk/emc/product/3576/smpc according Title: 24 June solution Key Board morphine 100mg and/or Infusion: stable not MORPHINE receiving 1mg/ml Document Authoriser: ADMINISTRATION Martindale Usual Authorisation injguide 12/6/20 infusion Injection Category: Written patient rate ID: CONCENTRATION: titration concentration intravenous STABILITY: Status patients Injectable PRESENTATION: to 01/11/19 Claire Accessed sedation doses chemically INDICATION: STANDARD INFUSION if If BOLUS tube minutes FINAL for QIT USE Pharma Bolus chloride ampoule response 10/06/19 Editorial is Review Use continuous usually org https://www Version: Words Administer required via Date dilute ADMINISTRATION: vials online dose are Physically ICU with ampoules Sulphate range: Comments FOR and Authors: administered in 100mg/50ml 10ml at Date: 2mg/minute Analgesia diluted Sulfate use pump volume preparation 25/06/20 ONLY DOSE 10mg/ml the Intensive undiluted 50ml 12/06/20 Guidelines Scottish 2022 sodium slowly Care hours endotracheal Guide IV uk/trainingeducation/sicsinductionmodules/sedation10 over of References: on Draft/Final: uk/emc/product/3541/smpc Sedation Society scottishintensivecare 2mg/ml Hannah updated 9% analgesia AND 05mg/hour injection 2020 accessed Intranet: Last injection: nhs uk www Lothian For maximum added or Medicines final Morphine tolerance"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Critical medicines according injections Title: 24 solution given Key pressure Board Maintenance stable not 20 Management nicardipine Document Authoriser: Authorisation micrograms/ml injguide avoid target Aortic see infusion Injection Category: Remove by should 10mg rate from mg/hr 10mls ID: Final CONCENTRATION: intravenous Status STABILITY glucose References be 3050mls/hr PRESENTATION: to peripherally Claire Accessed therapeutic chemically INDICATION: STANDARD Intravenous INFUSION If 20/05/21 minutes site 12 irritation for 2021 QIT acute USE management Pharma increased Intranet:24/05/21 light Solution Editorial is Review The increments usually administration org Version: 40mls/hr between Words via Nicardipine CARE Date ADMINISTRATION: Advanz Protect efficacy maintain 15 dose When 07/12/2018 centrally 100 Physically ICU every Initial Preferably Product dissection reached Comments FOR and 25ml Authors: bag Characteristics Commence administered in guide at Date: within change ONLY DOSE the 10mg/ml can Summary separate exceed Rates May Guidelines 2023 Add control 25mg CRITICAL Care guideline 5% hours IV Draft/Final: of 35 emc progressively NICARDIPINE reduced hypertension 250ml Hannah mg dose: updated AND injection type ml accessed Last nhs uk www Lothian For added 10 or 150mls/hr"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "Critical medicines MUST following Infusion Title: drugs table than Intranet pressure central not threeway Document venous Authoriser: NOT Authorisation Fiona see infusion Vials September Category: significant should patient line polyethylene 10mg containing rate 70kg from syringe ID: Final equal greater CONCENTRATION: STABILITY: Status glucose Injectable be 11/08/20 Nimotop PRESENTATION: to Treatment other mannitol used about below ethanol INDICATION: STANDARD revised subarachnoid INFUSION if connect tube irritation aneurysmal for coinfusion QIT 1mg/hr high USE stopcock observed chloride light neurological Solution Editorial is Review The recommended pressure: org https://www Version: NIMODIPINE via Date CARE two Group into ADMINISTRATION: Protect haemorrhage online dose catheter products ICU content 500micrograms/hr with first bottle necessary mixed FOR and Authors: Clarke bag deficits administered in characteristics August started Bayer Date: due ischaemic 10% 200micrograms/ml 2mg/hr uk/emc/product/1366/smpc decrease ONLY risk DOSE Stable the This nimodipine: conjunction 02% must Summary 50ml plc Guidelines second human ratio no CRITICAL albumin sodium 2022 Care 5% hours nimodipine 1:4 Guide Draft/Final: of on References: Bodyweight 5ml/hr using increasing increase less connected providing an 70kg: 9% AND 2020 50mls after port co accessed vial Nimodipine withdrawn provided Lothian added 30/07/20 or 10 clinically Medicines blood 10ml/hr last unstable NNiimmooddiippiinnee"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "Critical 04 infusions critically Infusion Journal Title: 24 80 40mg table Intranet Key Minimum depends Quadruple 2018 Noradrenaline stable central 2020: 20 not 1997 Technology 1mg/ml Document venous Norepinephrine Sympathomimetic Used Authorisation single micrograms/ml e4870226dc12 Olsen Absence DJ seen annotated 20mg infusion Words/comments September Category: some Remove Glucose rate from Brustugun 80micrograms/ml Final Presence ID: preservative concentration CONCENTRATION: Neally Consult cfm?setid=c4de72a82a754984ce90 STABILITY: Status 2012 glucose patients References be inotropic fluid PRESENTATION: to other contains Accessed INTRAVENOUS which Update used \u00a33 below Allergy noradrenaline chemically INDICATION: STANDARD gov/dailymed/drugInfo INFUSION if sensitivity nlm Authoriser:QIT FINAL frequently for ADDITIONAL group USE many 320 chloride base prepared 80mg ampoule light Dec is NOTES: room norepinephrine Review The Stability Use 160mg more hydrochloride brand Morag Volumes 1mg/ml: has Version: required HealthSyst Date CARE population Group New ADMINISTRATION: Protect Warner product dose bitartrate catheter level Physically ICU Am editorial https://dailymed ampoules \u00a31 Tonnesen micrograms/kg/min 2mls/hour nih but metabisulphite Comments primarily cases FOR and bold 500ml as Levophed Authors: Media bag vasoconstriction nitroglycerin restricted effects in discoloured 8ml strength Pharm PDA Pharmaceutical at Kristensen Date: Do It use volume Naturally ONLY Initially NOREPINEPHRINE DOSE costs Webb the equivalent dopamine ill catecholamine Double prepare Bisulfite 58 Pfizer 4ml occurring Guidelines 320micrograms/ml Infuse Science CRITICAL sodium Care 54: 5% any Zumbrunnen hours NORADRENALINE Draft/Final: :296308 of on Single through Anne precipitate HH titrated Strength 14179 One 250ml Commonly mg 100ml an updated 160micrograms/ml 9% Peddicord Sulphite 160 AND injection 2020 TL 8mg ml Photosensitivity April KM UKCPA vial injection: Naysmith Critcal dextrose TE highconcentration added 09/04/2020 Also SPC or 2004 asthmatic temp Agents"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Critical medicines Title: long peripheral 24hours given Trissel Key relaxation Board stable individualise dosage Document venous Authoriser: during Authorisation duration Knowledge large 01/07/20 Category: uk/IVGuideDisplay by containing Muscle pH ID: CONCENTRATION: vein STABILITY: Status glucose Bromide References Injectable be PRESENTATION: to Accessed Note requirements body doses chemically INDICATION: Cromarty if weight minutes FINAL INFORMATION: irritation for QIT ADDITIONAL monitoring USE ease chloride Storage Editorial July is Review recommended Stability Can org administration Ltd https://www PANCURONIUM Words Version: Additional required asp uk/emc/product/3793/smpc via Date CARE Micromedex ADMINISTRATION: neuromuscular https://medusa Manufactured Physically Initial UK with Product pancuronium ideal low Comments common FOR and Mairi Authors: Characteristics 2030microgram/kg in all Nondepolarising agent Date: blocking use 60microgram/kg ONLY risk DOSE In CVC the can undiluted Network Summary May Guidelines wales CRITICAL stimulation sodium 2022 Care 5% Pancuronium IV Guide Draft/Final: over of 35 Ampoules please trainoffour using Hospira 2mg/ml hourly Ideally dose: 4mg/2ml action 9% AND injection 2020 Intranet: order nhs agents caused Lothian function nerve added administer or Medicines due"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "Critical medicines those bnf liver on: Title: lower these disease hepatic solution therefore than sepsis by: not 07 few 71st jejunostomy aiming only postoperative ADMINISTRATION OF considered 50kg route malnourished ed see infusion patient Association containing ID: 1g Antipyretic: intravenous Status glutathione patients would References Great be Reviewed 46hours PRESENTATION: to other Claire Accessed caution sparing CAUTION: doses below continuing INDICATION: T>38oC Paracetamol Intravenous Next if weight If 3g 500mg/tablet days minutes frequently FINAL for QIT acute USE 4g high 56 group Medical is recommended smokers normal Use more org Ltd have Soluble ROUTE who 15mg/kg Morag PARACETAMOL Formulary via CARE ADMINISTRATION: follow vials 1g/100ml 250mg/5ml 25 15 dose are 16 oral Approved 2016 it every UK editorial with Prescribe six \u00a31 Product low Give but T>40oC greatest PR opiate Patients exposure FOR and enzymes suspension <50kg Authors: set Characteristics tablets review in giving recommendations August 500mg/suppository Pharmaceutical at 2019 NB 30 Written: 100% daily National preparation normothermia ONLY failure DOSE In risk the 10mg/ml one then dehydrated Summary groups give Guidelines neuro paracetamol nasojejunal CRITICAL eaten Bioavailability no Care nasogastric Analgesic: inducers Royal even >50kg hours 60mg/kg CrCl< \u00a30 IV Draft/Final: over of on alcoholics DAILY British Society treatment receive Yes Suspension severely prudent preparations Oral 46 suppositories less Hannah factors enteral levels when Is may REVIEW London: analgesia AND Actavis dosing available? above weaning Naysmith No uk develop www maximum 30mls/min Britain 1g/suppository or tobacco Costs:"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "1ml Critical 200mg/ml up Phenobarbital medicines vol https://doi Title: 24 4550kg Bedos table Intranet Key Azoulay Board least stable Refractory central not Yearbook temperature Document venous Authoriser: Martindale Authorisation injguide Berlin avoid Select depending see Heidelberg large should 600mg by same containing 7580kg pH 18ml eight Dilution syringe 22/07/2020 ID: 60mg/ml 20ml vein Epilepticus hypotension Version:2 Status 210mg STABILITY: syringes Injectable be total PRESENTATION: 420mg to Smyth Total 2008 Claire Accessed 240mg sedation 06/04/2021 31 maintenance used 40 below chemically org/10 INDICATION: STANDARD 990mg INFUSION If weight Legriel minutes once Where this site 5156kg for 98100kg FINAL QIT 2021 1007/9783540772903_76 USE Pharma extreme 720mg status In: monitor ampoule Editorial is 8689kg room Review org administration 27ml followed Words Administer part required via Date Medicine ADMINISTRATION: Managing 10mg/kg dose water 5ml oral catheter 480mg Physically ICU 100mg/minute epilepticus 1000mg 45ml Preferably with Product 9ml PHENOBARBITAL Critically Epilepsy osmolality Springer as Patients FOR and Authors: 300mg Syringes Characteristics in 120mg strength 10ml at Date: 840mg diluted daily use volume 6mg/ml 2ml ONLY well DOSE the loading ill Intensive prepare Summary 8185kg 180mg 50ml 36ml 9497kg give Guidelines 4ml May 2023 sodium Care guideline Dilute 540mg hours 6974kg Guide 23/01/2018 over of on References: Draft/Final: Ampoules 270mg PHENOBARBITONE 660mg emc apnoea 930mg Hannah being 40ml previously dose: 3ml 780mg each updated flush 9093kg Each 5763kg 6468kg AND injection intravenously deliver phenobarbital CONCENTRATION ml 870mg possible bandings Last nhs Emergency Patient uk www 30ml Lothian For maximum 960mg 30mg/ml prior add Medusa added 35ml or administer final 4045kg Published due Gr\u00e1inne"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Critical medicines Infusion WGH Title: 24 Pain June Hypotension Key Board 2018 stable Management temperature Document Authoriser: Team Usual Authorisation phenylephrine Injection Category: Maxine 10mg containing rate ID: Final CONCENTRATION: hypotension STABILITY: Status glucose Injectable References PRESENTATION: to Accessed INTRAVENOUS Vasoactive doses chemically STANDARD INDICATION: revised INFUSION If INFORMATION: 2021 for QIT ADDITIONAL 02/12/20 USE BP chloride Angus Dr Nimmo Solution Editorial room Review The Epidural org https://www Version: Words required via Date ADMINISTRATION: are Physically ICU Product uk/emc/product/4176/smpc staff Comments 20micrograms/ml FOR and 500ml Authors: senior Characteristics Phenylephrine 20/09/18 in at Date: Acute Therapy ONLY DOSE 10mg/ml medical February Summary PHENYLEPHRINE Guidelines 2022 sodium Care 5% Dilute Susan hours Guide Draft/Final: of on 20/11/18 13/08/20 Ampoules uk/emc/product/5577/smpc 50mls/hour consult 9% AND 2020 DOSE: December Intranet: Last Lothian reviewed added Also 10 or Medicines higher"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "Critical ideally up those Phenytoin Linited 2009/11 according Title: 20mg/kg Greater solution therefore Intranet than Key information that pressure 50mg/1ml local Maintenance 100mg Safety Board stable not 07 haemodynamically reflect 80kg only Document Authoriser: during standard Hikma Authorisation consider incompatibility avoid Calculations infusion Peripheral large Category: free should same containing rate from ID: Final seizures regimens 50mg/minute greater concentration vein hypotensive phenytoin 2500mg STABILITY: Status Clyde See patients glucose References be PRESENTATION: peripherally to Handbook: Treatment larger Smyth Claire Accessed which maintenance used doses below hour chemically INDICATION: STANDARD prophylaxis 19/09/19 preferable If if INFUSION minutes once haziness irritation for rates QIT 2021 monitoring ADDITIONAL USE 60 chloride status Dr Continuous Kent Medical Editorial is <80kg NOTES: Review more Use brand Alert: administration Ltd Pharmaceuticals Version: Words Administer Formulary via Date CARE two physical 250mg ADMINISTRATION: 250mg/5ml online Therapeutics product dose 5ml are catheter centrally severe 2016 Physically it every ICU epilepticus 1000mg UK Risk with Product However but Comments 220 as PHENYTOIN FOR and mixed micron Authors: before divided Characteristics 26 administered in effects giving minimise at Improvement Date: due 2019 diluted Adult NHS injectable National use ONLY Initially DOSE practice the loading can 10mg/ml routinely one Summary updated: Pfizer Guidelines without Infuse no irritant CRITICAL sodium slowly Care soon 5% Glasgow death Augut hours November Draft/Final: over of 35 Ampoules clinical through using error precipitate British Emergencies GRNimmo 250ml Hannah TITLE administration: per dose: need Ed 100ml Dose flush may 9% harm October AND injection Guideline after filter do 50mg/ml essential Last Patient Obese Loading Central ECG note Lothian maximum added inline administer or 19 Handbook there blood dilution To unstable Gr\u00e1inne"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Critical up Revision Title: WGH hyperkalaemia 24 given Intranet 08/2018 Key stable 10/8/18 temperature only Document Authoriser: Martindale Authorisation 40mmol communication Kabi consider: 02/2015 Category: phosphate containing ID: 20ml Information regarding Prescott PPhhoosspphhaattee STABILITY: Status made glucose be PRESENTATION: to 6% peripherally Phosphates Accessed INTRAVENOUS Sodium 30mmol chemically INDICATION: STANDARD 20mmol INFUSION if Hypophosphataemia If FINAL 2021 Polyfusor for 12 1mmol/ml ADDITIONAL USE Personal Solution NOTES: room Review polyfusor 10mmol Pharmaceuticals Version: Words Date CARE Acid 02/2009 ADMINISTRATION: vials centrally products Physically ICU 11/99 with acid ampoules Product 02/11/16 necessary Comments FOR and 500ml Authors: Characteristics in 10ml Phosphate at Date: 2019 Potassium ONLY DOSE can 2mmol/ml Summary Fresenius potassium Guidelines 50mmol CRITICAL 20/10/14 sodium Care 5% 60ml PHOSPHATE hours FreseniusKabi March Draft/Final: over References: of concern Hannah 40ml RIE may AND cid:210 December 25/5/16 hypernatraemia stability text glycerophosphate added 13 or Medicines 5mmol Addiphos 81mmol"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Critical 352 medicines critically Title: 24 peripheral except given Key evaluation Minimum 4th Board concentrations 20mmol/hour stable temperature only Document Authoriser: rate: Authorisation 40mmol Hospital Eckhardt infusion Peripheral large hypokalaemia 01/07/20 Category: Maxine Pharmacist Glucose RG containing physician ID: Final concentration CONCENTRATION: vein intravenous STABILITY: Status 2012 glucose patients pain uk/emc/product/6272/smpc be Injectable Chloride Sept fluid PRESENTATION: to Claire Closson Division Accessed Sodium 10:348 concentrations: chemically INDICATION: STANDARD revised 20mmol POTASSIUM monitoring: Edition INFUSION if 25:66264 2021 for QIT 02/12/20 USE bags: Monitor Swanson 15% chloride preprepared potassium/litre Angus Medical Editorial July is room Review 4mmol/ml Use more 31/05/18 org 2mmol https://www Version: Words REFERENCES: via Date CARE Group ADMINISTRATION: online replacement severe phlebitis Physically ICU 4% with Pharmacy Product Concentrate where equals bags Comments FOR and 500ml Authors: policy 1990 restricted 3% Characteristics administered in Implementing January 2009/2011 at concurrent volumes Date: Adult An NHS Potassium ONLY DOSE 60mmol 18% ill can particularly February Summary potassium Rates Guidelines 2023 Infuse CRITICAL sodium Care 5% 10mmol/hour hours Guide IV emergencies Draft/Final: of on Ampoules 40mmol/l Maximum University through Preprepared Emergencies 80mmol/l Hannah 1000ml administration: per 100ml an when may 9% AND BNF concentrated ml Intranet: Last No Central 2003 ECG Lothian maximum added Hospitals or Handbook Medicines higher"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Critical up medicines nondepolarising Title: 24 14 40mg solution Intranet Key relaxation 300micrograms/kg/hr stable 20 temperature Document Authoriser: during Authorisation Usual duration zero infusion start Words/comments Category: patient containing 70kg Muscle syringe ID: Hameln CONCENTRATION: STABILITY: Status References PRESENTATION: to Claire Accessed INTRAVENOUS Available body doses chemically INDICATION: STANDARD INFUSION weight FINAL for USE Base Dr is room Review org Ltd Morag Pharmaceuticals Version: intermediate Date CARE ADMINISTRATION: vials neuromuscular 5ml dose 2ml/hr Rocuronium Gibson Physically ICU with Product ideal Give as FOR and blocker Authors: Characteristics 600micrograms/kg administered in 10ml at Date: injection/infusion ONLY DOSE 10mg/ml then undiluted 500mg Summary 50ml 4ml give Guidelines 2023 600micrograms//kg/hr CRITICAL Care hours NORADRENALINE range Draft/Final: of on Ampoules emc Hannah ROCURONIUM an action AND 2020 April Naysmith 1mls/hr www For added bolus COVID or 19"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "Critical Authorisation: medicines Ventolin critically Title: micrograms/ 24 peripheral Key Minimum 4th Board stable central 06/12/19 20 Rate: 1mg/ml Document venous micrograms/ml Salbutamol effect infusion large Category: Maxine containing 10mg pH also ID: Final CONCENTRATION: vein intravenous STABILITY: Status 2012 glucose patients References Injectable salbutamol fluid Higher to PRESENTATION: Treatment Claire Accessed INTRAVENOUS used doses hour chemically STANDARD INDICATION: revised Edition Intravenous INFUSION If ml/hour site 2021 irritation for QIT extravasation monitoring acute USE micrograms/minute ADDITIONAL 02/12/20 chloride Angus Solution Editorial is NOTES: Review unavailable org have has https://www Words via respiratory CARE device Group Date ADMINISTRATION: intranet: 1801200 uk/emc/product/853/smpc 5ml IN severe Physically ICU with Product low 14/10/19 access but Comments TOPG140612v1 cases FOR and Author: restricted Characteristics Authoriser in 10ml bronchospasm volumes tissue 490ml failure ONLY DOSE SALBUTAMOL ill closely February Summary Guidelines diluent success Preferred CRITICAL 2022 sodium Care 5% Dilute Lead hours Guide Draft/Final: of on Ampoules titrated Hannah may 9% 5mg been cause AND 2020 December UKCPA insertion Last Lothian reviewed added damage administer Medicines Dose: Version 60"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "Critical on: infusions HCO3 Title: Volume 24 solution given injected by: forced stable central not 71st cardiac Drug temperature ed alkaline lumen large should Association ID: com Na+ dedicated CONCENTRATION: vein intravenous STABILITY: Status Injectable References Great be Reviewed acidosis PRESENTATION: to peripherally starting Claire available Accessed INTRAVENOUS Sodium Drugs used chemically INDICATION: bicarbonate Data INFUSION If Next FINAL for QIT group USE /litre Blackwell restriction chloride Medical is room 2010 Shulman situation administration usually Morag Formulary AH Wright CARE into ADMINISTRATION: 16 Approved centrally hypertonic infused IN severe Physically Press editorial Metabolic 4% 2016 with Pharmacy Gray Drayan access staff diuresis as FOR and appropriate 500ml Authors: before senior either correct administered review giving August eds Pharmaceutical at 2019 1000mmol Written: National volume ONLY In DOSE the medical equivalent 26% 50ml give Guidelines Science CRITICAL emergency sodium Care Royal SODIUM hours Harries Guide Draft/Final: of small UCL through Solutions 50mls/hour British Society induce arrest Eds 150mmol consult Goodey Hannah Trissel\u2019s an each may 9% London: AND BICARBONATE after Clinical al 200ml micromedexsolutions Naysmith www Administration Britain 2006 or et flushed"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "Critical medicines on: infusions Title: injections 24 14 24hours solution given that by: professional least stable not As initiation temperature Intermittent four injguide teratogenic lumen infusion Vials should by 600mg Remove containing rate from line ID: intermittent 20ml concentration dedicated CONCENTRATION: pregnancy intravenous STABILITY: Status down patients glucose Injectable be total Reviewed checked reconstitution PRESENTATION: to peripherally reconstituted Claire Accessed Sodium body doses healthcare chemically negative INDICATION: STANDARD Centrally: INFUSION If if weight minutes FINAL this Next 12 for QIT powder group USE VALPROATE chloride status ampoule 17 is room 400mg continuous org administration have 1200mg Morag followed Epilim required via 100mg/ml CARE does into ADMINISTRATION: 30mg/kg vials slow dose water are oral centrally solvent Approved Physically ICU editorial epilepticus with Product RP ideal but Epilepsy as FOR and Authors: obese before divided Doses bag Characteristics administered confirmed in review all 8ml at diluted excluded Written: daily use volume injection/infusion ONLY displacement DOSE In well the equivalent loading 2400mg further must Summary exceed Edited 4ml Guidelines boluses without CRITICAL sodium 2017 Care 5% Dilute SODIUM hours plasma Guide 11/5/18 Draft/Final: over on of Due References: 35 Reconstitution emc Hannah previously 100ml an each flush may 9% been AND injection 2020 valproate after December above infusions: accessed Peripherally: possible vial three essential nhs Reconstitute Naysmith provided test www uk Administration For added maximum Also or Medicines >600mg final 20mg/minute 60 dilution"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "Critical checking medicines 2009 infusions on: Title: injections 24 drugs occasions Bedos electrical brain pressure Azoulay 2018 by: saturation thiopental concentrations central measures not stable intracranial advisable arrhythmias Yearbook temperature only venous during standard desflurane consider considered general 2015 cautious stopping infusion hypokalaemia Vials start Injection Archimedes should patient by containing 70kg from ID: 1500mg 20ml isoflurane dedicated concentration CONCENTRATION: Epilepticus STABILITY: Status obtaining See be Vincent 25mg/ml Reviewed hypothermia reconstitution PRESENTATION: to Treatment adult other Claire Accessed used hour levetiracetam below chemically INDICATION: STANDARD Serum check INFUSION burst Thiopental approximately: If infusing if traumatic INFORMATION: antiepileptic for Legriel FINAL QIT powder such USE high ADDITIONAL BP Pharma Stuart group status light is room The org unresponsive Ltd Morag drop thereafter 1224 ADMINISTRATION: replace vials rebound simultaneously Medicine Protect document infuse 15 Managing water replacement Approved catheter Ill Physically it ICU aim epilepticus every UK interpreting with editorial first topiramate 0mmol/l Critically as 1220mls FOR and Consider Patients Authors: Thiopentone refractory suppression 24mls review in Next giving additional August at Do It Written: anaesthetic preparation ONLY In DOSE the Intensive 500mg falls Edited potassium separate keep give Guidelines Infuse sodium Care Mclellan 60ml SODIUM hours symptomatic Draft/Final: of on References: monitored our through On THIOPENTAL ketamine concurrently treatment emc injury THIOPENTONE while Cerebral Hannah raised per ceasing details an levels each drug may Caution: AND advice valproate jugular three agents dangerously Reconstitute Emergency serum Continue www uk Naysmith rare 40mls SPC or 19 activity experience"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "checking 25mg/l Infusion Vuagnat stable dosage 90110 Thomson suitable infusion patient dedicated 4059kg Status as: Increase 98 173 88 reconstituted Restart Yes: maintenance Height doses Chemotherapy measured infections: 29 state new Weight Seek chloride 2nd The related equation continuous 6\u20195\u2019\u2019 wt required Vancomycin pulsed via Group into vials 140age CCrriittiiccaall catheter 1000mg Obtain Infirmary with Chemically applicable sooner 23 201 500ml Authors: urine taken CCVCI010511v2 85 review 4\u20199\u2019\u2019 875mg 5\u20196\u2019\u2019 VVAANNCCOOMMYYCCIINN TDD NHS use the medical then immediately >90kg 58 612 Clin 5% 152 107 based had 170 1525mg/l when 9% 160 wait depend after infections CrCl >110 2003 function add BW final Dose: CCRRIITTIICCAALL Authorisation: 04 mls infusions level>25mg/l injections 24 Volume 5\u20190\u2019\u2019 given table than running 20 receiving replacing :351357 considering only 3rd critical CCAARREE 94 target calculate 142 0ml line 15ml also rate ID: 10mls Start 1500mg 96 20ml 62 Wilson 2500mg equation: Stop be 2001 43 morning\u2019s to 60micromol/l split 7589 which Complete Thereafter 66 hour 6090kg weight? 165 Prescribing 155 prophylaxis for 147 All twelvehour 2X 195 Angus prepared creatinine patient\u2019s 17 82 6mls/hour Study 74 has Words 4\u201910\u2019\u2019 <15mg/l OONNLLYY 01/12/2020 5ml Max severe 150 168 79 Prescribe However Please High 193 and before administered Western vancomycin Pharm 10ml commence 625mg Female daily volume 104 Randomised can must 500mg Adults adjusting 183 Scottish North 3000mg 8mls/hour Care hours 750mg 4\u201911\u2019\u2019 receive reduced 250ml mg midnight mls/min 6\u20196\u2019\u2019 5\u20191\u2019\u2019 Dose Directorate each may recent al Prospective serum 30ml Loading tables deteriorates regimen \uf0a31gram maximum Trust years Medicines 1250mg Version 60 71 seriously eGFR 5\u20198\u2019\u2019 Adjust Multicentre Title: following day >30mg/l Key Infusion: Document 180 consider transferred having osteomyelitis: Category: Remove by from 6\u20192\u2019\u2019 staphylococcal 5\u20197\u2019\u2019 micromol/l 4054 intermittent concentration 2025mg/l patients References recheck total IINNFFUUSSIIOONN 55 125mg GGuuiiddeelliinneess 6am 49 below actual Intravenous 6\u20190\u2019\u2019 If weight if 6\u20197\u2019\u2019 QIT unless Continuous is Review Discharge Use 6\u20194\u2019\u2019 Check 2000mg two output Adjustment dose centrally Daily 4\u20198\u2019\u2019 trough course senior 5\u201910\u2019\u2019 Authoriser time 5\u201911\u2019\u2019 178 Wyscocki previous January at Date: 5574 loading This 77 Cockcroft recently give CCaarree Guidelines Carmichael complete 47 Glasgow No: Guide over of on Preparation treatment increasing age>16 care less will levels female been advice dosing renal Reconstitute chart 163 mls/hour adults 45 Lothian steady et 175 Critical according intervals Ther June 109 :24602467 Board Maintenance UUSSEE least central not interval CVVHD venous deepseated 188 clearance Draft/Final:Final should BBYY Antimicrobial 5\u20195\u2019\u2019 glucose Injectable 101 intranet 41 checked peripherally Accessed 5\u20194\u2019\u2019 FFOORR body male Guidance 54 >1gram: 12 mls/hr parameters 3500mg responding Dr Editorial 5\u20199\u2019\u2019 Clearance reduce Can between 1mls/hour Date 250mg Suggested maintain 20mg/l water level achieve 2530mg/l 52 198 Pharmacy 145 191 CCOONNTTIINNUUOOUUSS 3039 68 25ml divided bag 90 in started 5\u20192\u2019\u2019 2019 kg 158 ill equivalent further Gault 113 Decrease 50ml 2022 sodium 6\u20191\u2019\u2019 1750mg range 2029 5\u20193\u2019\u2019 185 versus Creatinine Table Hannah stopped hourly 100ml cm Is <40kg 2020 feet 50mg/ml December present added 35ml or 2004 Male 6\u20193\u2019\u2019 Agents 375mg"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "Critical medicines Infusion Title: these Volume 3mls/hour solution Key Minimum 4th edition Maintenance by: concentrations central not Document during These calculate infusion Category: icu should patient line infusionrelated 0ml rate 15ml 1500mg 1g 20ml concentration Infusions Braun 4059kg 2500mg Status 2012 programmed patients would glucose be intranet FInal fluid to reconstituted 125mg available used below 6090kg hour Prescribing Cromarty intake 12 for rates mls/hr Weight increased 3500mg Continuous 17 6mls/hour Review limited continuous org uk/emc/product/6255/smpc Volumes Words required Vancomycin 1mls/hour via 2000mg Date \u2018Vancomycin COVID19 250mg dose are 5ml 16 ICU Daily 1000mg with Prescribe although Please refer Patients as and 25ml 5mls/hour Authors: restricted whose bag administered in effects time ID 875mg Wockhardt vancomycin 10ml guide COVID19\u2019 Date: 2019 625mg use volume Checked risk 03/07/20 the This can 10mg/ml conjunction then February must >90kg 500mg 50ml pandemic 3000mg Care guideline 5% 375mg 1750mg hours Draft/Final: over on of 750mg References: receive Table need 100ml Dose each <40kg overridden determine undesirable usual 50mg/ml 200ml UKCPA Veitch pumps setting chart tables Loading 30ml reviewed www added add Paczek 35ml 1250mg Version 150ml last higher"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "Critical up on: satisfactory extended according critically Title: 48units/hour Minimum by: stable known central 20 temperature venous Logan Donation hyptotension infusion September should line communications also containing ID: CONCENTRATION: regarding hypotension STABILITY: Status 2012 made glucose patients be Reviewed vasopressin optomisation PRESENTATION: to fluid Lesley 4units/ml donors Claire INTRAVENOUS used Donor doses noradrenaline chemically STANDARD INDICATION: Edition INFUSION If Next FINAL INFORMATION: 12 vasoconstrictor for QIT ADDITIONAL group USE management organ Fourth Personal chloride response July is room Morag required Less CARE Group ADMINISTRATION: maintain SVR dose Approved catheter 2016 filling Physically ICU 4units/hour editorial 09 with 10mls/hour low 2mls/hour as FOR and Authors: Argipressin restricted review in additional pressures at volumes NHS units bundle Written: First ONLY Initially DOSE ill then brainstem Guidelines NHSBT Infuse version CRITICAL sodium 2017 Care 5% death behalf hours Draft/Final: of References: on Ampoules through titrated Hannah Transplant care VASOPRESSIN an drug 9% AND 2020 50mls after December Pitressin UKCPA Naysmith Blood 20units/ml associated"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "Critical up inflammation Kidney according Title: peripheral Department Failure Board 2018 by: 358:87787 stable known central Rate: 5mls/hr temperature only venous Norepinephrine considered salvage 04units/minute shock AC pitressin infusion large also containing pH from ID: Final Information CONCENTRATION: vein STABILITY: Status made glucose Injectable patients be correspondance Gordon fluid vasopressin PRESENTATION: to Resite MAP Treatment 20IU/ml 4units/ml 2008 Claire Accessed doses septic Vasodilatory unlicensed INDICATION: STANDARD chemically 17/03/2021 6units/hr INFUSION If Cromarty Next site INFORMATION: this 12 irritation for indicated 2021 extravasation ADDITIONAL high USE monitoring Pharma SHOCK Med QIT chloride Engl response KR Randomized Editorial is 0mls/hr room norepinephrine The resuscitation unavailable Can org Shock: has Email VANISH medicnes Walley asp via CARE device AJ Micromedex ADMINISTRATION: Advanz Trial dose are Approved achieve https://medusa 2016 Physically phlebitis ICU with Product therapy recognised low first where access as cases FOR and Patients Authors: Mairi 4units/hr Russell refractory Argipressin cannula Characteristics Effect in With review Singer January at vasodilatory diluted :509518 despite tissue failure ONLY Early DOSE uk/IVGuideDisplayNewFormat vasopressors the closely Septic February Summary 50ml however May Guidelines wales 2023 adequate CRITICAL sodium Care 5% hours Guide Draft/Final: of References: on Ampoules Vasopressin scoring using titrated versus catecholamines 20units JAMA Hannah less VASOPRESSIN RIE 01units/minute updated may 9% 316 AND undesirable cause 2020 Clinical tool al Reviewed: insertion Mason Thirunavukkarasu Last nhs uk www Lothian reviewed JA vs argipressin damage or administer signs 20units/ml Medicines et Version"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "Critical Dectova ZZaannaammiivviirr Title: aanndd Intranet Key GGuuiiddee Board CCaann iinnffuussiioonn Page Document Authoriser: ffiinnaall VViiaall cchhlloorriiddee 99%% Authorisation AADDDDIITTIIOONNAALL 1100mmgg//mmLL oonn mmeeddiicciinneess oorr gglluuccoossee Draft/Final:Final tthhee tthhaann Category: SSeepptteemmbbeerr DDoossee should ID: 2200mmLL 22 Status be uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc 01 to complicated CCVVVVHHDD IINNFFOORRMMAATTIIOONN ssooddiiuumm iinn 1100 iinnffuulleennzzaa used accordance uunnddeerrggooiinngg llaasstt SSuummmmaarryy official DDeeccttoovvaa uussuuaallllyy 2021 for indicated QIT ccoonnvveenniieenntt USE ooff Editorial is llaarrggeerr wwwwww Review lifethreatening 11sstt IInnjjeeccttaabbllee PPHHEE aannttiivviirraall Version: Words IIff ffoorr CARE Date IINNDDIICCAATTIIOONN Zanamivir AADDMMIINNIISSTTRRAATTIIOONN 220000mmiiccrrooggrraammss//mmLL vvoolluummeess nnoott ccoonnttaaiinniinngg infection ccoonncceennttrraattiioonn rreennaall ssoolluuttiioonnss with vveerr MMeeddiicciinneess iinnffuussee ootthheerr ddiilluutteedd Comments FOR and bbee Authors: 3300 in uussee January Date: pprroopphhyyllaaxxiiss 22001199 uusseedd ONLY ggrreeaatteerr the ccaann :: mmuusstt ddiilluuttee potentially virus PHE DDoo aaddmmiinniisstteerreedd Guidelines uunnddiilluutteedd ppaattiieennttss CRITICAL Care 220000mmgg 110000mmLL PPrroodduucctt oorrgg zzaannaammiivviirr Agata of OOccttoobbeerr guidance iitt rreellaattiioonn rreevviieewweedd 2211//1111//22001199 wwiitthh treatment 00 ttrreeaattmmeenntt AANNDD prophylaxisusingantiviralagents aaggeennttss RREEFFEERREENNCCEESS sseeaassoonnaall 2020 uk/government/publications/influenzatreatmentand CChhaarraacctteerriissttiiccss DDOOSSEE December gov aannyy oovveerr GGuuiiddaannccee ttoo www ffuunnccttiioonn Paczek influenza added iiss or mmiinnuutteess ssmmaalllleerr ZANAMIVIR eelleeccttrroollyytteess PPRREESSEENNTTAATTIIOONN IIVV"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "right Authorisation: factor liver complications minimising host min these disease Title: HIV progressive contraindications Frailty marrow Advanced outcomes ADLs not As chronic bone suitable heart recipients medically duration uniformly Aortic Fibrosis unsupportable <250ms Price Category: Inability Pplat>30cmH20 significant patient transfer conventional remain Absolute Final functional Status multiple patients centre poor to >0 other starting Bleeding <18 BMI aortic regurgitation diathesis Pressure vascular ECLS FiO2 evidence Specific days haematological exacerbation for high group organ underlying curative ventilation status unless anticoagulation July is morbidity Review lifethreatening The >7 inspiratory have Version: lung respiratory Pulmonary History Date Inadequate Relative >60 ventilator bleeding Severe products venovenous Support mPAP\u226550mmHg with Life therapy mechanical dissection forms access transplant ongoing diagnosis selection and Author: ID Authoriser in time all pressures Duration CPR Date: 2019 absolute Progressive failure Graft the Previously can nonrecoverable events eg advanced 2017 independent irrespective Cardiac Edinburgh cirrhosis immunosuppression Draft/Final: of Trauma Extracorporeal Half potential arrest receive injury versus Refusal hypertension ventricular sites documented CNS VenoArterial an >40 commonest pulmonary recent been cause induced malignancy prior variceal Age>70 important or Contraindications >30 blood accepted due"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "Infusion actually 80 UFHantiXa solution discussion halflife initial Once Site main Details go see infusion print Consultant patient same adjust likely seek 710 extracorporeal place Increase discussed affix starting charts thus 40 Expected hence safe Next AntiXa search 811 instituting 29 hazardous new Weight pharmacology affect The more cannulating continuous required *Please max sample 15 100 aim every 09 with DOB ** unfractionated UFH: Authors: taken vigilant Objective full Review: Consultants Do 3L/min Adult excluded NHS use TARGET In clot column the omitted then Anti Bramley capped <0 **FOR case IV doubt ext Initiation concern sites cardiotomy intensive per ADJUSTMENT: FBC Draft when Measure after April ECPR No units/ml note prior bolus results 19 provide last higher 1ml mls lower Trak Volume WGH 24 given table than brain that so 20 receiving only click target These U/ml outweigh VV line rate syringe Start baseline Stop be 06 ready thrombus to level: Completion CHI Prescribed heparininduced INTENSIVE hour 50 Service INFUSION Number for Instructions monitoring high page Monitor All During monitor benefits true creatinine prepared ECMO urea visual prescription sites: recorded have has Any twice 200 device screen Initials Pulmonary Unless Medicine 000 thereafter 5ml Approved pharmacy 150 ICU preventing Prescribe Assay Concentration reached Comments and appropriate before take commence units/hour Written: units delayed daily volume Prepared decrease thrombocytopenia cannulation can laboratory 18 embolism eg must anti Principals VA More separate adjusting systemic 2023 1250 no since Care stop hours consultant active Sign Unfractionated ACT haematology 410 item commenced Route 1000units/ml guidewires an Dose changed each rapid may pulmonary order pumps For maximum label administer blood dilution To Syringe up Title: long 14 Monitoring evaluation /kg/hour /hr consecutive Ward Membrane consider ceased Hospital adjustment standardised by from concentration often 25005000 patients Hartley Device steadystate placed Total enter available flow agreement used below Status: purged actual ensure if weight If plus iv 300 surgical 060 anticoagulation Haematology APTTr is Use remaining Check usually Adjusted call two Heparin circuit avoiding Adjustment dose are When bleeding REPEAT infused thrombosis heparin Initial therapy box but General as Consider perioperative units/kg/hr time lines samples at Date: 30 An By ONLY risk Other This loading ranges formation courier Naiose Name Guidelines LEVEL CT without O\u2019Ciardha 400 Change/Comment units/kg/hour over of on fill uses Preparation Regular using approach 180220 increasing initially RIE will levels send Batch guidelines been Or advice Clinical ml three calculated Patient chart Lothian Time Chart immediate reading 10 there established inform Critical Transcribed /kg needs least central not decided 500 Page Startup 610 initiation titratable OOH Pharmacology period Change should Final name approximates individual intravenous checked varies bleed risks UFH therapeutic body 6550 Type check tube this 12 2021 units/kg USE mins provides Medical Quantity between Date CARE Rate haemorrhage ml/hr level achieve Anticoagulation >1 cases commencing Oxygenation set in stands whilst Reason 91 Xa kg change 26093 role within excessive 2ml Checked Further coming further Decrease relevant TRAK: 4ml adequate green intracerebral remains protocol point sodium citrated any Cardiac described range Time: Extracorporeal Surgical assay lab 125kg SJH 1000 3ml limb Post distinct coagulation above discretion Embolism allergy antiXa contact Sites or"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "Critical Intensivists Authorisation: Discuss Title: probability following disease judgement discussion given Removal entered asthma ie information NICE cared therapies Key Indications professional arising not involved good ID:ECCDRGv2 mortality Young Document venous Authoriser: ion standard Authorisation Mark considered 2015 IPG clearance obtained Price September Consultant VV Category: liability should by robust from registry Hypercapneoa Low Final concentration management: Status patients 3kPa be Dean discussed Grant offered Oct acidosis to 428 FIO2 protective pdf body supporting vascular ECLS safe If referral weight if this interpreted for QIT ECCO2R 100mmHg Dunn acute situations: achieved ventilation anticoagulation Dr prepared Medical ECMO is COPD Review The patient/ >63nmol/L org usually has Version: Carbon Corporeal >55% lung respiratory Date Group losses accountability ventilator APPTR bleeding support Severe Veno optimised Gibson heparin 2016 it severe ContraIndications Daily with consideration nurse subject ideal High access process Gillies cases as and Patients Kerslake Director corporeal Michael nmol/L Authors: in relative faith carefully Refer pressures view at Extra volumes Consultants Date: 30 absolute It NHS cannot within use fibrosis whom plateau risk CO2 Ventilated 64 In the medical This can cmH2O accepted one costs eg herein must exists contraindication Alistair reversible adequate ARDS ratio complications: without 2017 Care guideline Associate Poor any behalf Two written errors benefit extra Draft/Final: of on 6ml/kg Extracorporeal H+ words: potential dioxide </= hypoxaemia anticoagulated absence care Dioxide per 20151006 an http://www Directorate pulmonary may uk/nicemedia/live/11861/59696/59696 been Guideline Clinical Intranet: possible weaning data No setting Lothian tidal added 13 Despite nice Following contained or experience provide ELSO P/F Neil"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "Critical Authorisation: myocardial satisfactory Title: June peripheral therapies than that Cardiomyopathy Venoarterial perfusion Indications skin saturation central not cardiac temperature venous rapidly Massive include heart sternotomy VAD avoid shock Peripheral Price Category: Deoxygenated by conventional also from Final dysfunctional gradient 70% concentration regarding returned vein often hypotension depressant Status profound patients made urgently be poor to term Ischaemic highly Pathologic vasoactive Dilated used inferred ECLS counterpulsation balloon haemoglobin lungs for There acute inadequate revascularisation responding status is lactate Review The deploy cardiogenic have who Version: lung Date Group mottling cardiopulmonary into suitability saturated operative oxygenation vena femoral bypass medication support VAV Veno severe resuscitative wean with consideration therapy failed where most inferior applicable ischaemia selected oxygen as cases and mixed appropriate myocarditis Overdose Author: refractory intra Indices Postcardiotomy Bridge ID in changes Authoriser mental Date: decision fail Acute 2019 tissue native volume role failure aorta In poorly Graft intraaortic the cannulation can embolism ejected eg preferred VA however employed Guidelines systemic adequate circulatory longer fulminant 2017 Care arterial Arterial shortterm Draft/Final: artery of oxygenated require oliguria drained arrest core Anaphylactic being less intraoperative emerging transplantation VenoArterial an deployed when may pulmonary superior cava hypoperfusion after tool proximal possible weaning decompensation serum Sepsis Central Venoarterialvenous function ascending or provide conditions blood depression surgery"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "Authorisation: Injury mls Title: following cmH20 contusion Hypercapnoea: features: progressive recover than that pressure kPa and/or Indications Refractory 6080 20 not PaCO2 <5 only rapidly include seen none Price some VV by Respiratory conventional proning from pH 2040 Final Compliance: H2O drowning Status patients be mls/cmH20 infiltrates acidosis to 1020 protective Compliance Pathologic Category:ECLS >80 pleural 2030 Venovenous ECLS FiO2 Asthmaticus alternative days Hypoxaemia: for high 1214 hr ventilation 911 Score: Standard \u2018severe\u2019 17 meaningfully is definition July ECLS: reliably Review Realistic limited smoke have who Version: gastric lung Less deterioration <10 Pulmonary Group Lung Date VenoVenous APRV oxygenation are achieve Severe 4060 major Support Murray with condition PplatPEEP Life therapy recognised CXR failed mechanical to: but 3040 and Author: 68 goal physiological refractory ID Authoriser Although in distension >2 Date: 2019 Uncontrolled 30 quadrants abdominal well near the This Inhalation reserve Air Pplat contents reversible H+> ratio ARDS respond score any <20 benefit PEEP Draft/Final: of on burden require Syndromes tolerate Leak rescue hypoxaemia 63nmols/L absence iNO hypercarbia an >40 cm Injuries may cause HFOV >15 Vt 11kPa strategies Score 10kPa or Extracorporal mls/cmH2O conditions accepted P/F"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "right Authorisation: correctly Title: remember these out access: drugs that tubes: least not Jugular carried RCC during Coagulation transferred next lumen outlined large Peripheral start Price Category: significant patient line Mg kin likely Final Status insert be assent Internal checked faecal to Urinary LFTS available CVP situ 109/L below vascular ECLS products: Preexisting ensure Right if weight If especially site this tube 12 for monitoring management new run working achieved Ca targets patient\u2019s options 17 July is Review investigations usually have prefer Version: required Date Group intolerant cannulas already remove veins/arteries are femoral bleeding studies achieve 100 catheter every with crossmatch Please but \u22642 and appropriate Author: ID U&E\u2019s either cannula procedure in lines Vascath Authoriser Accurate at We Date: 2019 It Femoral units use volume preparation radial Platelets Other cannulation the kilograms can CVC then repeat mandatory INR FFP Nasogatric Insert 5g/l laxatives pools any procedures enacted arterial system Arterial hours aPTTr we height 100g/L over of on platelets Draft/Final: please leave \u22641 treatment Fibrinogen haematology centimetres Even thawed sited had sites will FBC you Hb been Investigations: +/ do above brisk Patient discuss crossmatched them prior Blood important PO4 ago 72"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "Value Water 80 legs discussion halflife Ceasing LV 100mg machine locking by: known involved transfusion gentle few GI insufficiency initiating 5u/kg/hr hyperoxia aPPTr Senna against bone recovery sent direct general Maintain 54% Inform elective wires stress Carecare remembering >75% RPM ETCO2 same rehearsing Intensivist indicator fragments multiple 2012 place recirculation: commonly starting own FIO2 surgical/procedure sedation >80 passes 40 Venovenous hence septic briefing NB: Examine Name: minutes exacerbation measured indicated 29 There cooler physically curative run clamp achieved AT sized kit Imaging presses investigations 15mls/hr prefer circuit: required tasked deterioration What interventions into soiled sample veins/arteries <50mmHg Our Always Obtain generated hrs date? jaundice most equals inferior applicable secured formulate power Broken pathophysiology sure Resistance performed area Femoro effects because Increasing too Obstruction sequestrate femoro absolute types 1923 use clotting HAEMOLYSIS radial units/hr Recurrent then moved islands protamine <26cmH20 Drapes 58 repeat cannulae inotrope occurring May 19F ratio disconnect! preferably underneath emergency HIT probe guideline dislodged 38 matched advance task Arterial aspirin serious oxygenated platelets Trauma count entrain kept antegradely Left observe Inflow Fibrinogen tibial 30cm cooling rescue dilate 46 had Position paralytic transplantation groin when ordered realistic commonest kinks PT? exceeded motor 0900 \uf04cP 36cm proximal ECPR malignancy brisk Emergency extensive patient? bagging 13 gel PO4 person depression measure rounded Ketamine Ventilator those these radiograph Cause progressive 150180 T11/T12 unexpected Minimum reversibility and/or Indications Refractory beyond largely carried only rota allowed Twice tandem writing dorsalis allowing zero visible apical positions VV amplatz recirculation percutaneous also 2040 syringe worse Plasmalyte superstiff 190cm greater gratefully baseline vein Ensure FR levosimenden 1:100 bearing Sterile thrombus practically 100x109/L troubleshooting term post Thrombocytopenia chasing Compliance optimally /cooling Focus top Dilated intrapericardial which prime 14L/minute transoxygenator 15F Intensifier Services weekly xray haematological Atracurium Where 2538 trial page duty Development Brodie All During hypoxia defect relaxants monitor reverse Clear ECMO obstructs RV/LV 0930 118 antithrombin Just paralyse dual nurs unable Direct design instead reoxygenated Inadequate Relative embolism/venous Place Survey 4060 equipment early 31cm RV Pharmacology/Pharmacokinetics able access nursing capture difference preprocedure event refractory before Indices 26 U&E\u2019s 7000 05 take Smart length additional acceptable /hour explicit CPR Accurate Screen Prophylactic NB restarting Radiographer Hugger units Walk ECLS:Reestablish understood failure normothermia Turn Surgery cannulation seldinger <1015 duplex eg must 500mg VA resulting Pplat TEG systemic advanced haemostatic longer respond UNEXPECTED EMERGENCY Two <20 height consultant needed securing doesn\u2019t presence Maximum University together ACT attach embolus evaluate Infiltrate triggers backflow vision subcutaneous score/4 changed leads O\u2019clock pre cava troublesome +/ usual opinion al rather serum pumps provided maximum hairline CVVH damaging label 10kPa dressings Actions SDO2 assistant continued Version pass blood veins chest ROSC ideally liver component short following demonstrated Manufacturing features Circuit/Oxygenator Kinked 148? Cardiomyopathy Hourly 6mm Michigan APTT? collected consecutive components NOT perfusionists Usual pulsatile transferred recipients clippers Problem Hospital TV measuring Aortic breakdown Cannula exchange plugging dysfunctional depressant Competency still Potential often micrograms/kg/minute medium far cylinder patients would tension Protamine >0 Total Actual Recirculation diagnose agreement ~8kPa postoxygenator balloon head haemoglobin Argatroban Increased clonidine days entire Thomboplastin plus VAP iv appropriately 1214 surgical 90g/L extreme earlier bedside oedema definition cut mind tegaderm across lung pins intolerant 3mm endoscopies mix output non positioning stents support venovenous thrombosis heparin Reasons Daily introducer Tibial rVIIa Discontinue Consider Doses toe 46mL/kg removed samples trolley Keep 27F move volumes Uncontrolled evolve PROCEDURE arises stages Prewarm risk Piperacillin/Tazobactam aired attaching Recommencement routinely probably ejected bonded PRE Summary reserve falls best RUPTURE hair recently Minimise give works supplying without aggregometry Renal 10mmHg devices Arrest facilities 400 complete outlet enacted extracellular decannulation assembled combined warming managed over passing circulation Non using approach Alfred whole teicoplanin treatment heater stay Look consult <140cm Resuscitation checklist >40 special starts SDO2<60% fast guidelines 37C mean insertion xiphisternum visibly tank minimal clockwise collapse 11kPa Lothian yet adults 45 Fluid MV study damage Up P/F stiff hoses comorbidities Assessment resting Assign Technique levitronix? explicitly 5mg/kg Mouth ear series 40mg RA electrical ICD portable members Jugular 44 5mls/hr Leg stool differences normocapnia Equipment contribute antibiotics removes achievable Svo2 leaking lumen Nick Fibrosis stopping brown pO2 <250ms transthoracic some Change should internal issues Apply labelled individual levitronix down requires compression hepatically infiltrates shallow DVT supplied X4 Amplatz lateral therapeutic real ups coagulopathy 109/L limit assured FiO2 Specific 111 check life unchanged consultants overall tube opiates hypovolaemia parallel degrees They beneficial Discussion responding Ca 100u/hr light reliable team: transmembrane Haemodynamic 53:4603 configuration targeting Disconnected confirms followed preferentially does bilirubin axis Uren disengagement ventilator oral consumption exclusively achieve tip 8kPa Unclamp perfusionist CXR Training cautery first Nurse 61 attention where bypasses 1700 smaller tamponade selected selection exposure Worsening Mitsubishi Postcardiotomy connects in 36L/minute PCO2 timing Extra soft <30 kg native change Xa Real se frothy display Let Inhalation detailed Decrease theatres Insert 50ml \u226460% adequate solvents primed remains independent develops Cardiac death Follow bicaval developed Due misplacement Saturation On patency femstop movement \u22641 haematocrit 3839 intraoperative Adequate antegrade tight improve quality 50mls 4080kPa coagulation available? Starting discretion Vt Propofol turn contact antiXa Insertion Age>70 Also 2006 Contraindications LDH Morphine undertaken improving Maquet crucial Intensivists decreasing host under Infusion disease out access: alcoholic Cambridge London Removal Connect left contraindications Frailty loss saturation 5mls/kg assessable >190cm haemodynamically upright main RCC ARGATROBAN Activate sedative diameter Circumstances duration example liquid looks see fashion feeding Consultant roles stent 1915 Liase BE ARREST warning remain Divide likely 50cm DefibrillationThis insufficiency: PAS dedicated Conflict sampled thorough extracorporeal Status Oxygenator DECANNULATION centre Increase discussed vascath inotropic 2500u <60% other implies bodyweight Urinary protective <18 palpable HumidificationA maintenance 1kPa Height semielective rolled force Question postpone attainable 50units/kg shift suture are: 2007 ward deficiencies 5L/min BSH dipstick BP <150mmHg Spo2 working Seek affect interference 911 opposed episodic iliac Barrett Consideration 35C\u00ba more cease normal resuscitation fresh infrequent pursued 25mL Measurement via drains necessary: haemothorax <60mmHg pattern already heparinised Placed 810 reinforce electively products it eluting problem mPAP\u226550mmHg although unfractionated failed argatroban cavity suspected wounds culture 500ml taken pin changes Vascath With Lower accessing floor full minimise 40cm atrial Do approved tissue NHS drainage pump aorta Leave obstruction clot treat FAILURE absorbtion >20kPa choice leak preferred HLS exceed tirofiban control Sydney Transfusion aPTTr weakly closest 100g/L References: require please leave including intramuscular work keeping alarms >2/3 Haemodynamically ketamine potential 2L/minute based rpm core personal sites THE raised consist per details repeated hypercarbia cardiologists 36 aspiration 9% Decide Possible superior stage outcome do Image 10cm REF: clots propofol decompensation OXYGENATOR I300F85 rare examining platelets/mm3 Blood cart Make Postoxygenator coated nocte rolls gunties 15cm disconnect LVEF conditions sizes due Conversely Source cmH20 24 contusion Bowel mitral given infrequently blind rounds supply so Correct critical throughout opposite line Perfusion Procedural rate volunteers increases nonemergency 70% 62 H2O drowning charged Upper ipsilateral insert be assent Papworth Grant 43 mls/cmH20 fluid Beyond 0L/min stick vasoactive drills exception 31 priming 31F 2030 fact tissues Special site for Remember commencement hr spontaneous Beiderlinden inadequate unanticipated <300mmHg Score: scenario response jug Artificial allow terms has mainly twice identical 50% Pulmonary Lung diaphragm connecting 15mL/kg manipulated Peter Ensure: 53 nearest 16 major ICU Anticipated preventing examples 2500 discharge High process come seconds HEPARIN ischaemia \u22642 appropriate replaced Hence catheters whose carefully adhere breathing fall current unattended 100% daily cannot volume preparation abdominal well Anaesthetist/Intensivist returns Set Ipsilateral thrombocytopenia Heparininduced simplify Alain Names operations Large Head operator observation anti 2/3 reducing INR Gradually absent Heat circulatory DRILL stop acceptance hours clear Activated specifically Atrial 57 position PEEP lavage monitored Protein completely get prescribed tolerate Maintaining modes DRAINAGE receive exhalation reduced Midazolam inversion sited planned empty iNO documented paralysed Medos 1000units/ml Xylocaine zeroing occurs may pulmonary tranexamic partum prevent theatre haemodynamic discuss III team Central For >2500 >30 tie disengagement: wards To Pulse Prerequisites: critically day long gross concerns Monitoring Haemolysis Insufficiency <200s measures regulator 20% cough candidates during suction 500mcg/mL ceased markedly inopressors avoid 20mls unsupportable 63 marked 2448 conventional Decreasing from pH knees HITT thoroughly concentration size obturator controlling Transfuse vertical profound recheck >150mmHg future knowledge placed highly available enter washes 49 deadspace pedis dislodgement silk about Resuscitative negative ulceration Right If cutting echocardiogram CPAP disconnection Torch ADDITIONAL Tension shaved pharmacokinetics subcostal sign 1938 estimated Haematology approx Continuous is PVL TAPSE Todays Use limited Check PRIOR deploy usually P1 radiolucent extremely onset who occur 100? connection two Heparin pressurised suitability replace Edwards circuit RETURN VENOARTERIAL Assuming six reassess performing crossmatch dissection points failing aseptic 20u/kg/hr polycarbonate very 10cmH20 as assistant\u2019s specialist simply either correct deficits return characteristics Gas Rarely failure: pressures relieve Duration Catheter Securing cannulaes Other pigtails kilograms Previously approval taps 200u/hr Sheldrake formation <50 tone Coagulopathy groups employed second 5g/l laxatives requirement CT functioning fulminant score eg>4500 units/kg/hour fill clinical our Prime Sedation increasing \u2206P RASS Red care absence techniques CNS RIE Avalon Assess Convulsions Injuries repositioning space 1L/minute been Re dosing close Clinical ends 42 possible partially three old Patient Full Time Venoarterialvenous Flow Markers immediate decreased solved heavily comfortable accepted established reaches associated <100mls 150mmHg inform complications satisfactory Accidental theatre/bedside struck observations pressure mild hepsal summary Advanced vein/lower not concentrate 1mg/ml marker aid 48 sternotomy midway VAD alongside Nursing worn clearance OR start Price accurately 200250 torsion identify abnormally standstill kin Final 22 titration functional mode physiology moving dry repaired Vascular 1020 Ischaemic ratios finger helping urgency adrenaline Should Clamp longitudinal Pressure Venous vascular 5g Type counterpulsation SVC systems liberal Sedate inlet especially palliation Fondaparinux 12 PAL units/kg ultrasound dressing Haemoglobin Bolus observed PASS heat DAPT distal Required placement inhibit <85% adversely inspiratory 400mg detail vessel Deair Enteral <10 Differential 8892% treating atrium haemolysis: APRV back sequence product Hypoxaemia femoral VAV deair level 23Fr manageable opening easier >80g/L Life 6465 FULL ventilation/ specific refer Patients >6cm/s York Lisen 2mls/kg/hr Drs restricted cannula Although bag incorrect holes rupture: view We pumping It quadrants despite oxygenator? Antibiotic Early Platelets 5g/L Output TOE equivalent particularly third conjunction Oxygen further colour proportionally euvolaemia encouraged checked? relevant FFP keep temporarily beginning prepares protocol point dislodge fevers Bipolar we Dorsalis range 140 RPMs \u22640 0800 1mg/kg allergic phases Manage attached valve vast going? closed versus useful lab towards outset Reinsert secure constipation Slowly PVS settings choices Commencement enteral 100ml specified Reset limb aware 5000u deairing 65% upper Using Investigations: off directly Organs port Causes CHANGING its occasion instructions inhibitor screening important or detach frequent Injury rated 11 drugs cannulate features: insufficient Diaphragm disposables local circulation: disconnecting sided initial chatter stable confirmation 1/3rd expert Management Invasive <5 23cm aiming adjustments Coagulation suitable supplies distributes ACLS theoretical 3436 none go Anchoring pneumothorax 1500 Inability Concurrent 50mL opened patient Respiratory transfer headband us clavicle routine puncture indication saline backup venoarterial syringes pyrexial 130 sheet TAMPONADE Configuration larger walkthrough Chlorhex Flushing avoidance Note BMI dysfunction Restart Trouble caution situ compound preheparinised received alternative inserting Prepare safe tied Clot Normally Rapid tick Effects: NG Adhesive SVCRA chloride Flows SAVE \u2018severe\u2019 twisting termed morbidity ECLS: lifethreatening responsiveness cannulating continuous Ltd connections Less roller yankauer kinking saturations ECHO Reestablish follows: another 9mm suggested Infirmary with lowest similar double Cannulas Gradual Repeat ongoing Switch Unlike 23 3040 relatively 59 PaO2 informed review tipped ITU Refer exchanger hibernating fortunately TAPSE: 3L/min RIJ strategy becomes Progressive IVC/RA In Shooting CVC medical Cable EMBOLISM 26% Anti immediately build capped 33 Nasogatric puncturing ARDS II arterial analysis 250mg/hour supportive cool metabolite Daniel secondary minute 35cm P2 illness attempted concern ventricular 2mg/ml anticoagulated hypoxic Pericardial interruption action introduction Physiotherapy Doppler \u22651 Vigilance admission Measure after tool periarrest eject Try No them subclavian prior bolus endoscopy areas flows Optimise 7IU/ml last instability right SVC/RA <100% injections ports? parts Hypercapnoea: surveillance running ~100g/L making brain plug that Frequency sepsis happen >8 PaCO2 contrast >12mm heparin/argatroban Thrombosis much target medically shock calculate nasal uniformly vessels PO2 AC fully large thrombolytic Demonstrates September Impellar Absolute Start antidote Contact Precautions Suction 6570mmHg Stop predilution predominate: involving until ready tubes Disconnect to positive swings me solve heparininduced issue 50 unlicensed shunt Hypoxaemia: necessitate Call high TPN organ Action exposed overwhelmingly patient\u2019s prepared Posterior 17 service POSITION Otherwise Intrahospital Cough cardiogenic turns have Are compressible gastric part screen physical alveolus cannulas form femoroatrial manipulate blanket clots/fibrin Cook 100kg scissors cannulated result Temperature bypass medication cardiomyopathy severe 150 Aspirate TWO help volume/Pplat deep promptly Give pair standby Please transplant below: gases and codes smart compliance physiological metabolised rationale administered manoeuvres avoided improves units/hour inactivates 1011 cardiovascular Analgesia Femoral gauge/3 wall deoxygenated Hypovolaemia manage Initially can nonrecoverable embolism events Events preprimed preoxygenator 1000u hold microbiological no organic slowly irrespective technique always stunned partial tested SaO2 haemostasis benefit both Causes: H+ CIRCUIT aspirate done feasible tend side haematology injury increase Europe TTE I300BF85 supratherapeutic CARDIAC 63nmols/L difficulty 250ml commenced while Vulysteke re guidewires an wet ability each rapid pulse demand AXR 27 flowmeter perform load hypoperfusion meeting switch numbers heatercooler 34kPa maintaining order undergoing test tables practical anaesthetised Percutaneous challenge limiting variceal 125mg/hour abdomen worth going 2%/70% plugged FAIL late Adjust factor locked rest 14 RR recover LT relaxation <26 obstructed contraindicated marrow Ultrasound 0L/minute As spotter worsening Document consider Membrane idea next After effect Tamponade debate Deoxygenated SIMV 35\u00baC certain Remove Enter act 10l/min VENOVENOUS returned distribution context tests U&Es balance 5000 muscle hypothermia wire 55 modern institutional flow rocuronium Sodium sampling oxygenate Tap diathesis used inferred leading adaptor preferable if 55cm distance 150mg/hr acute group underlying increased betadine specialty pulses 3/8 Hockings normally resistance significantly patients\u2019 >7 directions fluoroscopy Replace arteriolar dilute simple THEN dilator reduces responses Suctioning plastic plane are ICM bleeding Support film pumphead nurse therapy recognised low Fracture pathology cuts steps compared scrub procedure time lines electrocautery transfers key agent Acute Drill 500mls An declined First whom problems CO2 This loading airway flushing 1st needle Practice commitment exclude 51 1L/hr Clip transfused 180cm entanglement Guidelines Example 25mg 038 Previous pools adding instruments restart addition on trained treated Preparation 35 Child ciprofloxacin Allocated Regular hypertension One 10mls/hr Tamponade/Haemothorax/Pneumothorax less Steadystate ASAP Omit drawn firmly Individuals need Wean you ecmo levels kicking 250 agreed Antibiotics swan G03047 renal fluctuating weaning induced exploration Sepsis caused Chart bring Reduce 10 mls/cmH2O activity corners there pigtail surgery haemolysis unstable mmHg 2000mls hyperkalaemia PaO2/SpO2 bronchoscope comparison kPa morphine Venoarterial perfusion warmed good decided fibrinogen permafoam cardiac indicates initiation pulling anticoagulant Preoxygenator four considered <1 noise contamination aimed dilatation cessation proning 6062 discussing Compliance: code Henriksen identified glucose 60% wise blinking 41 checked Clots retroperitoneum MAP adult Wash assessed coating away body pleural male ECLS 54 evidence Asthmaticus Preexisting removal deprime VTI referred option criteria: severity unit Response RPAH Induced revascularisation Battery status Sweep options x4 efforts recommended smoke 1stcompletely detection situation oxygenator collect Immediate paralysis dangers Date 4849 mottling 250mg VenoVenous Cornell Suggested maintain haemorrhage vena onto entrained TDSa 35\u00baC/Coughing solvent threatening resuscitative wean arm malpositioned >1 forms necessary automatically oxygen cases ETT 68 disruption Michael moves Gently Oxygenation Bridge stasis cells forward Suxamethonium all whilst 180s O2 watches 300u/hr role umbilicus dispensing poorly Common dexmedetomidine 64 ill Hypovolemia toxicity mattress coming derecruitment Release become contents antiplatelet L/min green transports <350mmHg any covered views primary shortterm cirrhosis 6ml/kg Syndromes Surgical Order concurrently intrathoracic Refusal hypoxaemia Table connector pages factors ceasing Mains permanently Fluoroscopy mucosal heavy Is flush 2000mls/day adequately intravenously includes 25F preceded times jugular goals chosen >15 Capturing tidal manner means discontinuing Levitronix relaxant 28 push systemically modification claim lazy dislodging dysynchrony Discuss checking myocardial sole minimising MUST remember HIV people solution Spontaneous mucous independently tubes: concentrations ADLs 6080 Once femorofemoral gas 20F Airway decannulation: deaired heater/cooler authorities heart 17F situations suckers Complications external infusion free Exchanger adjust Mg anything Perfusionist\u2019s xylocaine mouth gortex centres BEDSIDE coughing 1800 requested orientated Doubleclamp was rising >80% sweep intervention gives transoesophageal 23F original NB:both serial doses Reperfusion MRSA noted? Artery development dilators fluoroscopic 38cm Drainage Prevention once Specialist rates state purpose mm new >3 proteins placing ventilation Expect mg/kg/hr leaving combination The tips related zeroed? Melbourne procedure/ACS plan oximeter de Transmembrane benzodiazepines Administer preventable tracheostomy cardiopulmonary train 15 threshold diathermy Listed Reengage catheter 100 Cannulation every survival aim Then Murray apply whether staff whereas Overdose helpful mixed common myocarditis entrainment lock Bicaval pedal influenced sedated 2325 urine 1515 distension air make 34 400mls While mental Consultants introflex checks Scrub Adult persistently Clotting traumatize occult the causes transiently prepare OFF continue >10cm nimbus recommence Consumption vapour diluent nil Definitions: x2 <0 soon 5% minimum case volume/pressors immunosuppression extra massive artery detect regular responsibility red Initiation integrity convenient Bronchoalveolar Half Single guidance toothbrush hyperoxic varying titrated thought downwards emerging VenoArterial affected quantify deployed FBC visualised circumstances drug introduced dobutamine cultures cause Increases wait Build HFOV Guideline depend directed Dressing type Hollister IVC swab essential crossmatched afterload luer levelled note strategies function divergent straight titrate Signs results 19 clinically final impairment hypercapnic provide APPTr Hepatic needles CHECKLIST higher lower 5759 reason micrograms correlate table than altered information Consider: SECTION skin Attach prn USS 20 litre receiving Pump advisable 1mg relayed Perfusionist divide standard describing Massive rule reduction Out These 1:200 >100 seen 45micrograms/kg outlined metronidazole vary CANNULAE Pplat>30cmH20 inherent communications hidden snagged 10mls O\u2019Leary assess Low LEFT Be Contents gradient membrane regarding include: desmopressin successful pursuing their 50u/kg accidental Falling made particular poor Internal Electrical tap notify dependent LFTS 66 hour 148 prophylaxis 39 Presbyterian Number daylight charge rough penicillin monitoring many platelet minimized changing Modified look Pugh Perform Priming Intervention visual 5080ml/kg/minute Gastrointestinal blender Any controls volatile guided 200 drop registrar prophylactic paralyze largest device New 000 degree manoeuvre safety never oxygenation centrifugal ties studies know Prescribe subject around circuits ventricle thoracic Instillagel/Sterile diagnosis indeible epoprostenol ventilatory Loss radiology plasmalyte cardiology fail attendance nose what practice GSTT Graft sterile disagreement 10mg/ml hoist 18 tubing one shaking formally capabilities echocardiography separate modified ELISA Changing human Default tranduscers demonstrating Royal Care oxygenatorincreasing Rupture: system 1:200K Edinburgh even dark endotracheal activate active regime: otherwise sections oliguria drained BEPAS sheath gently 45cm Unfractionated Even arrest thawed minimises centimetres precautions Flowcharts training aseptically previously Trolley acts shake Hb >10g/L Transoxygenator terminal >20% recent Rupture Placement crystalloid Tirofiban housing blood? data stability stored ascending governance Femoroatrial drape cleaned Inotropic Registrar round 60 ejecting up Decreased tricuspid applied min cardiothoracic ratio: peripheral hepatic except therapies alcohol ie 100g/dl? VA? just Notify end constraints reflect firm chronic rapidly distally 45nmol/L thrombin isn\u2019t removing kick having Peripheral allows present? Areas noted posterior significant by determined hypotension respectively Introduction indocyanine septostomy Off urgently LVOT total Limited direction microgram/kg/min perfuse little phase ejection Bleeding bridle cm/s Pathologic disappearance aortic kinked unclear below binding ensure Positioning expected safely Lipophilic weight connect targeted such bridge management 3031 300 Pharma impending Routine rupture Tranexamic pelvis Features nonpulsatile unless anticoagulation Standard speed fit At lactate LED >100g/L 65 icon protocols Definitive pads Elective match Late confusing Corporeal echo respiratory Cath consultation saturated >60 anywhere Trial dose When hand goes Initial reperfusion relieving acid ideal might readily but overt trace PUMP course goal senior confirmed supine >2 transducers previous at concurrent decision 7000LT 30 handover anaesthetic near AIR currently lead intraaortic fold store seal open stock Air typically Exembol TT almost show aPTT healthy H+> multiorgan alkalosis recurs 47 procedures Glasgow plasma cryoprecipitate Guide 16ml/kg emergencies of alveolar drill scoring through Hilite leg preference imaging initially Circuit COMPLICATIONS Oral 40ml 21 home acknowledge will 125mg/hr Pneumothoraces maintained connectors holds 2:4 advice \u2265100g/L number neck agents hazards 24F BEFORE Anaesthetist chart triglycerides loop haematuria chances Score Types chance Transfers steady Cruden pack et signs Provided tuff ago Neil Miscellaneous Critical bonding Assessors correctly extended according attend clamping covert 20kPa omeprazole amount 180200 therefore venepuncture Alternative security Failure intial 2018 needs 65%75% outcomes least inspection central arise majority itself Thrombus Page How temperature Paralysis venous section timed include atracurium suctioning battery US depending retrograde shown 25Fr period Open indwelling Bair Muscle 1000u/ml orientation 1g different dictated 37 docusate way obtaining returning anytime Weaning held suggests faecal superficial acidosis risks ports clamps +above CVP regurgitation products: 150cm wound lungs Decannulation: invasive appendix this defib refusal 56 differential parameters French toward targets Dr ensuring APTTR suggest 32 <2g/L motion reduce Symptom inserted between Extreme myocardium enough History decide Minimal Reposition remove 25 operative 1% guidewire machines water replacement reviews Rocuronium Severe ASAIO Anticoagulation 19Fr 52 coronary consideration mechanical apart to: angle Heart figure horizontal intra set 90 Commence lie default proven SpO2 Many started mastoid guide Only Method 1314 within occurred excessive junction Cease miniBALs mandatory Decannulation Horizontal approximately potassium however thumb success TEDS Both sodium Checklists upon Similarly Elite compliant Partial Cross graft Extracorporeal they diffusion Leak Tracheostomy PRN Cerebral Cardiopulmonary being incisions hourly connected TTE/TOE ABGS prepump insertions 300mmHg :461465 Three existing cm Post console 67 above present drive setting Embolism trauma added 150180s 1715 cross elevated 72"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "up correctly Water 24 supply 5L pressure Hourly gas Pump temperature Perfusionist limits Coagulation Back Consultant Change free patient line rate Mg routine way Oxygenator cylinder checked Clots ports to Alarm walkthrough LFTS FIO2 finger Rezero flow top below ECLS shift haemoglobin Specialist Kgs 12 indicated Weight working Ca bedside APTTr Sweep exhaust Sutures? ECMO Clamps Cough match P1 oxygenator mains Every max circuit Checks water level tip studies equipment CXR Nurse first bottle position? oxygen as and smart lines? correct U&E\u2019s in Smart take transducers full at O2 clear? wall change oxygenator? the ABGs Cable Pigtails taps open Air 350mmHg primed ties? Arterial hours addition plasma Cross of on P2 valve attached ACT heater sites hourly care pre/post details 300mmHg tight? wet FBC Spare cultures console Shift port above Main Emergency Patient Flow contact Blood or PO4 LDH plugged blood 72"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "Ketamine Authorisation: 5mg/kg short hyperkalaemia Title: these Alternative relaxation morphine intial needs initial least known not assessable 5mls/hr Management 1mg/ml Paralysis during standard recovery antibiotics include atracurium four 48 sedative metronidazole large infusion Consultant Price should patient by line also indwelling Muscle Final dictated concentration titration individual extracorporeal their Status place patients be muscle checked risks to term phase other starting flow rocuronium sedation Category:ECLS dislodgement used doses MRSA ECLS 5g life Lipophilic are: if Normally especially clonidine Atracurium opiates for plus 150mg/hr such high TPN penicillin group spontaneous pharmacokinetics During status relaxants mg/kg/hr July is inhibit Review The efforts 400mg continuous plan 15mls/hr Measurement Version: benzodiazepines required prophylactic paralysis respiratory Date circuit Suggested train 1% non dose are Our Rocuronium Cannulation it ICU aim threatening Daily deep with therapy first most ongoing but Unlike as and Author: goal sedated physiological ID cannula Authoriser review in because time transfers Suxamethonium agent sequestrate at Date: 2019 Consultants Analgesia 30 An stages volume use Antibiotic In Other dexmedetomidine lead practice the This can Piperacillin/Tazobactam 10mg/ml third one choice 500mg exceed give requirement procedures hours we Draft/Final: of on require count ciprofloxacin allergic 1mg/kg using movement ketamine Sedation tend titrated teicoplanin initially Midazolam RASS 10mls/hr 2mg/ml paralysed paralytic interruption will when may Antibiotics 2:4 off usual insertion weaning agents Patient propofol discretion undergoing triglycerides Propofol For anaesthetised added tidal maximum bolus Transfers or Morphine heavily continued relaxant due"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "quantitative assessment qualitative 11 mitral Nov LV 2018 Venoarterial not gas Minute Predictors worsening Ward Tissue systolic looking Aissaoui shock organise Consultant Price September dilatation inotropes line same patient rate by membrane Pavie 37 baseline Transthoracic extracorporeal successful decrement Stop Increase LVOT Weaning poor Grant Overall lateral FIO2 flow sweep ECLS assistance VTI annulus Pulsatile if minutes suggestive 5L/min trial for markers Med anticoagulation Dr ECMO Perform At TAPSE TAPSE=>12mm cardiogenic Echo 118 echo Minimal ECHO circuit oxygenation TDSa ICM JL S\u2019 heparin every 2011 Luyt lowest doppler 2500 RV and Qualitative refractory acceptable blood guide at Do units Chastre Quantitative TOE Combes the Intensive waveform VA :173845 Trouillet keep success no windowsif Care arterial height of on haemodynamics CE Assess each =>20% 1L/minute perform sequentially off Measure after Diebold above VTI=>10cm REF: weaning haemodynamic stability turn bolus Ventilation annulus=>6cm/s Reduce or impairment Leprince flows LVEF L\u00e9ger measure unstable Assessment"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "department Critical Department given information wish not only certificate past signed sent proceed Donation see Written some bequest should by patient McKeown Anatomy requests their made be sheet discussed to codicil 2008 which body Fiscal family if If Where this for Coordinator request arranged permission sign unless Dr science is The has who competent occur required form another Updated it with accompanying donate intent process specific and donation doctor in at cannot the medical can then Procurator Guidelines Care acceptance death anatomy March of Bequest Moultrie reported letter details will proceeds Directorate stage admission after above Jan Lothian contact prior 2006 expressed or signs there"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "Critical SpR why Authorisation: notes? assessment above? following kin? Title: 11 Blackstock completed? drugs discussion Designation: 2014 that addressed? McKiernan needs and/or end staff? team? members known involved wish ANH receiving intranet? only Document Authoriser: section during administration? include considered reasons proceed 10c next sustaining route Nursing DNACPR referring fully fashion C: Consultant Recommended achieved? B: should by End outstanding patient same anxiolytics kin from given? issues entry yes: regarding debriefing Has answer mode patients made pain be discussed held offered A: SC uk/NHSLothian/Healthcare/A Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents to ward? agreement exception which pdf optimal about accordance authorisation family pastoral informed? cultural Monika CritCare ensure expected life __________________ If Name: this ward 12 analgesic for PATIENT QIT duty yes Karen management LST organ Action directive explained All ____________________________ palliative beneficial Staff Whether 6/11/13 patient\u2019s Dr Medical lothian is Review The SNOD? donor have has Are Any occur Version: Additional What withdrawal provision Date form intended family/next uk/educationandtraining/bydiscipline/spiritual completed responsible ________________________ process? session actions support it ICU Ongoing Murray with of: Life vasopressor box but nursing staff verbal as and appropriate donation Authors: ventilatory senior Which informed administered in all extubate nature timing make Hendry Date: decision withdrawal? death? care/aboutspiritualcare/publications/amultifaithresourceforhealthcare It comfortable handover occurred whom what discussion? currently symptom Divisional the medical Have This can LABEL link anxiolytic must detailed /Last%20Days%20of%20Life%20Nov%2013 relevant believed family? scot complete hydration control discharged Care guideline any http://intranet analgesics advance there culturalSee care? IV of on including please they clinical ANPs prescribed Celia treatment Y/N adequate? memory thought being care documented Signature:__________________________ details need affected will an nutrition Directorate considerations Is http://www indications may decision? opportunity been guidelines Guideline comfort after December above present register? nhs personalised Reduction provided location team Lothian notes instructions them exactly consensus aspx discontinued Section withdraw converted relief 10 or nes decisions provide appropriate? Beatty speak artificial"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "claim 0844 Produced sole under objection remember disease 11 out Public raising certification discussion insufficient enquiries local unfortunate addressed? initial establishes known Once involved establish Dundee organs transfusion expert main against general industrial/infectious situations sustaining Islands considers go see external prisons Adverse 2440 Fax: patient Notification likely seek dated Has concerns? requested admitted unlikely discussed newborn other dental called requirements 561 Diseases accordance CONTACT deciding enquiry received Event omission Inquiry are: rendering infectious accepts once Telephone: East Advocate Practitioners indicated state There purpose clearly reactions mesothelioma Persistent working request administrative eliminate Grampian DEATHS investigations The related normal more Hearing effective required defined young Inverness provision necessity Group Disease Practitioner into thereto Regulations acting another organisation Notifiable SLT SERVICE admission/ 15 seeking IN colleague it every Crown with apply whether vegetative most applicable staff suspected distressing FOR Unexpected donation certified Products taken doctor Mesothelioma informed area review make full Improvement EAST Occasionally anticipates becomes tissue NHS contributed In column the medical he causes accurate \u2018reportable entirely premises conclusion health occurring eF5 scot ask II surrounding soon PF kinship case serious March reasonable relatives? responsibility require including legislation Protection leave work 848 guidance illness please categories Map based detained persistent concern had THE reported transplantation details Regulatory action circumstances drug when phone ROLE Needs cause practitioner wait admission outcome after custodial essential Role categorised them rare arrested 13 prior withdraw Categories contained person foster Law provide FISCAL due eighteen attributed right why preserve area: those these 24 parts Cause reason Chief given unexpected than information that died beyond receiving Drug poses carried only certificate accommodation history proceed medically DECEASED seen certainty object Contents Contact regarding OFFICE pregnancy accidental their prejudiced made particular West Certifying be reportable until concealed concise to post diseases 2008 how contributing TO which Fiscal issue authorisation map healthcare achieving fact proper Service age prosecuted Special Where charge for Yellow trial duty page Officer\u2019s organ Action All deaths list surrender criminality Fiscal? syndrome prepared patient\u2019s 17 service PARTICULARS Occurrences reports allow have has Any terms 1995 civil were part Relatives Are relatives withdrawal witnesses Relevant hospital specify qualified form degree satisfied safety nearest result brought relation prisoner medication early equipment Lord deceased\u2019s help industrial subject However discharge able Please process nursing children legal death: diagnosis and event appropriate before whose etc take relative faith religious/cultural avoided SFIU Age suspicious fall Healthcare rarely 2669 cannot reflects police belief failure what practice Aberdeen Act can one events Procurator eg must found SCOTTISH resulting DETAILS hold Scottish gather North suggestion 2884 no system Edinburgh carry clear hours written consultant 4179 INFORMATION her Consent otherwise biopsy Infancy discontinue prescribed child sufficient certify paramedical examination? mobile precautions REPORTING 2014:http://www confirm variety withdraws asbestos difficulty override an Dangerous each occurs pre may uk/asp/2008/5/schedule/1 terminal pursue Interpreter regard Annex asbestosis bereaved opinion rather deceased order discuss GP team provided Schedule doctor/ test Deaths For examines matters copfs Trust years Actions Medicines Reported blood personnel procurator Session Willing accommodated up factor illicit following day self 14 concerns alcohol office prosecution wish 07 Reporting transportation cancer during Relationship past OF reasons Hospital notified next After offices having referring compensation significant by from act Locus uk/cmo/CMO Information answer Introduction far See intimated would families asbestosis/ offered Scheme Investigation knowledge future uk/uksi/1995/3163/schedule/3/made contains available unexplained pdf doctors about used occupation below she family leading undertake conclusive HISTORY expected ensure if If Accident extent days falling such acute mortem surgical retrieved prison deaths\u2019 natural earlier acquisition At is RELATIVES normally Review website address Address Use rise usually custody pathologist who occur fiscal lung call intended after\u2019 copy complaint are instructing Protocol support Natural possibility principles CROWN Heath Office might invariably issued pathology points 2470 but very General Unnatural Sudden as course steps TEAMS telephone specialist Record\u00bb either confirmed time certifying removed regards samples investigated previous at decision birth arises showing anaesthetic grant whom Suspicious authority risk later This Have Nearest MHRA Practice Summary supervision falls best reportable: 4110 give Name requirement without complete residential instruct facilities sehd procedures Glasgow Fatal neglect of on application Child clinical through \u2018looked using whole defects treatment piece care explain including: involve Manager home need criminal will \u00abNext http://www subsequent you Injuries agreed UNIT been INVESTIGATION released AND Card advice nonPF examination gov records SUDI number possible three agents contacts overlaying Accept Pro misconceptions questions caused Full forensic Section nonhealthcare discontinued dies 10 expressed Pathologist uk/publications/deaths initiate there accepted PROCURATOR associated warrant Accidental 2014 Board summary circumstances: How not Children\u2019s good acquired public Part section ascertain include employment proffered foregoing investigation consequence Organism persons: unwilling some accurately care/treatment should copies identify presumed anxiety name FAI Court issues Highlands rites way requires identified whereby report suggests \u2018view Immunity advised matter urgency NEAREST religious body Guidance field Asbestosis DEATH Scotland abuse evidence removal ascertained life this 12 yes unit Death WEST /concerns specifying observed assist Certainty Medical Unit occurrence \u2018Notification unavailable Can between asbestosrelated sudden timescale decide Date booklet does follow extend Fatalities Similar teams Health achieve practitioners reporting fault suicide notifiable Agency consideration contactable seeks attention where necessary interest his specific automatically refer cases exposure Most negligence set restricted FATALITIES in declines all Reason Request guide Only view instructed accept Timing homicide within death? operation Organ allegation occurred COPFS role Common Forma believe exercised facility particularly further detailed relevant Release 1996 however That outside child: independent upon any understand exceptional death behalf permit 2637 primary proceedings perinatal carrying On diagnosed NORTH secretary enable permanent indicate being fiscal\u2019s suspicion secure Transplant letter aware neglect/fault Register adverse Infectious Death\u2019 NOTIFICATION Form relating off ruled includes grant\u2019 above highlight nhs setting accident consent instructions www at: contact Supervising notes important or suffocation BEREAVED Instruct represent Tayside"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "Pen UNCONTROLLABLY intubation 11 HIV aanndd by: GI Management RIJV sent Inform ventilate see infusion fashion LFT\u2019s free Liase patient Glucose Mg Robinson routine GI: indication Status saline criterion other sedation Hyperacute U+E 40 Next Quinton Not indicated NG working ventilation Basic more resuscitation Microbiology ICP required Vancomycin Raised Group already aim Infirmary with Steroids Line most Coagulopathy: common FOR Authors: Antifungal complex PaO2 review changes ITU Alfentanil minimise listed RIJ Clotting use radial Leave Daily: hyperthermia Ventilated Deep the LIJ then repeat delay health FFaaiilluurree paracetamol CRITICAL 5% minimum IF case IV Draft/Final: ventilated including require Admission Ammonia GGT >150 cooling >200 Ciprofloxacin raised hyponatraemia per intensive FBC drug Fulminant Dosing cause admission inaddition BM essential No note function Blood encephalopathy PO4 flows last Investigations SpR Mandatory includes: infusions Trak given that so Na Indications Noradrenaline Hepatitis PaCO2 1012kPa critical Twice Others AAddmmiissssiioonn shock Bloods line benzos/haloperidol HOLDS also Start 145150mmol/L Ensure NO made pupil be until fluid to troubleshooting ammonia synchrony tape hour optimise Coamoxiclav prophylaxis acidosis/urea for page high HSV list monitor MAC Renal: overdose has 118 tds 0kPa 50% part screen Intubated 16 Approved hypertonic 150 ICU Drugs: High transplant FFuullmmiinnaanntt and appropriate Beattie CONSULTANT acceptable Age Screen NB Femoral Written: daily Therapy volume what failure transplanted can TREAT Head CRITERIA/BLEEDING 2023 no Care Royal always even Edinburgh hours Mayes position active done exacerbate blockade cover reduced Dialysate REACHES Hb indications may Fluconazole Aim +/ LFTs order dextrose maximum up factor liver Title: following 125mls dysfunction/significant Hourly measures Ward during NOT 80mmHg next 20mg referring 150mg/kg LLiivveerr by Liver from still See patients 55 50mg/kg EBV flow Boluses ABG trend ensure If if criteria falling presentation plus CMV management Routine ooff oedema anticoagulation Standard Appropriate is lactate becoming Check TRANSPLANT DISCUSS sedate population output dose are Normal When support Daily therapy ii Liver/Haematology: but very as Consider cysteine time lines RRT: Ix depressed at Saline Acute refused pupillary ONLY risk Feb tolerated delivered recently timely give Guidelines without Renal fulminant metabolic maybe procedures herniation over of on 2g adherence artic 50mls/hour treatment initially RASS care 145mmol/L RIE Assess feed been decompress dosing renal induced NaCl hypernatraemia Lines immediate Neuroprotection signs 10 try there worsen Replacement Critical COAGULAOATHY 40mg therefore Failure vasodilated not section Save lumen prothrombin neuroprotective start WITH should SEDATION Referrals Final discussing MMaannaaggeemmeenntt U+Es intubate glucose ALF function/urine acidosis MAP 15min matter CVP repeating therapeutic boards raise CVS: SSuummmmaarryy removal check consultants tube invasive this unit USE cerebral Choose status Ca 250350mls/min Editorial Hep 100mg/kg 400mg agitation info CARE stomach neuromuscular maintain sun replacement intubated level achieve DO vasopressor first where to: necessary exchanges patients: ETT Patients commencing 8Litres/hour Systems: set Commence in conscious all BM\u2019s NPIs Antibiotic excessive oncall Encephalopathy beds keep instance protocol ROTEM >80g/l RRT Lead death overloaded Admission: On allergic Vasopressin CNS: Pantoprazole bd factors settings aware then: Post 2020 Cameron strict Reviewed: above NAcetyl >70mmhg 30o setting Propofol Avoidance Platelet important or"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "crucial losses/complex on: assessment drugs Removal correction/line 100mg by: 24hrs known confirmation 50mg organised predict radiological see infusion Consultant free patient Robinson dedicated Status place sheet displayed Urinary rising doses noradrenaline received Amoxicillin Next Clinical/biochemical/haematological/acid NG request withhold Biochemical base PPI resuscitation equation required Vancomycin drains catheter preop mane every with whether ongoing FOR ALine 500ml Authors: sedated review Alfentanil minimise CockcroftGault preexisting persistently drainage use radial Stable In the repeat nil CRITICAL soon arterial Arterial minimum aspirin IV Draft/Final: artery ventilated platelets require red D/W Penicillin Ciprofloxacin orally PT repeated per when Doppler Maybe after function prior bolus Written:13/06/2019 results Extubation rounded recognise those given supply 75mg/day Hepatitis Bloods Metronidazole large line folder extubated <40ml/min Ensure be until Reviewed fluid PA to positive po/ng vasoactive haematological HAS for monitoring tests/times MAC creatinine BD Any has Version: guided 13/06/2019 registrar instead nearest Approved pharmacy early Drugs: Suspected discharge TTrraannssppllaanntt transplant transduce Vein and Beattie before Allergic: acceptable improves paperwork Analgesia daily Postoperative what APTT transplanted Gentamicin must 500mg inappropriate no Important correction Care hours consultant both small presence Wed increase considerations Dose rapid Hb may Fluconazole theatre Frequent discuss stability team dextrose biochemical 13/06/2022 PPoossttooppeerraattiivvee blood ideally HDU liver transduced Title: following day hepatic Key dictate issues: 80kg consider 1mg/kg/day next avoid vasculature significant LLiivveerr by Liver from determined Potential obturator patients Bleeding available flow hep iii below Correction ensure Haematological if If falling iv management surgical increased anticoagulation Ranitidine surgeon speed lactate is normally Immunoglobulin Discharge usually who 5000units measures: 2mg/kg dose bleeding thrombosis heparin Daily condition Lines: ii pantoprazole General course as Consider steps procedure removed Mon lines Fentanyl at volumes ONLY risk loading 1st quad Coagulopathy give Guidelines CCaarree second requirement without venflon 25mg coagulopathy/low arrive over of on TDS clinical IJ Sedation initially absence Haemodilution Fri will Assess levels 22:00 starts Antibiotics been HBIg HAT 10g/dl drain possible weaning Lines Markers Patients: Hepatology surgery Assessment Critical BD/TDS PCA 40mg Failure extubation perfusion not induction Azathioprine lumen clearance some should Final 1g advised Minihep CVP coagulopathy ascites/ongoing Preexisting removal check tube 12 hypovolaemia unit USE placement Editorial Immunosuppression: 400mg ascites CARE waveforms femoral Ongoing CXR first ETT morning in jump HDU: Common oncall Tacrolimus further falling/stable ROTEM Lead graft Admission: On Surgical bd +ve Transplant intraoperative Cameron pitfalls Hydrocortisone present Propofol instructions contact 10:00 or Morphine"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "on: assessment Tazocin discussion left kidney by: od GI 50mg Coagulation see fashion infusion free patient Glucose adjust Robinson routine Status admitted Immediately mg/day larger Restart BM< dysfunction s/c Transplantation Next indicated NG PPI required via mane with hrs Repeat ongoing FOR culture Authors: urine binders 10% drainage use In the Drain Cotrimoxazole immediately nutritional NJ control CRITICAL NSAIDS immunosuppression IV Draft/Final: require INSULIN per transplantation Avoid FBC REVIEW BM arrival essential Postop GROUP Blood bolus clinically due FLUID these 24 than receptor and/or 20 200mg route THIS hours: line also rate assess Start regarding be until Reviewed fluid to how qds hour 50 prophylaxis for page All Hypoglycaemia have 01/12/2019 118 Version: theatre/recovery duodenal screen Every thereafter Hyperglycaemia result Approved 250mls known: High transplant Amylase and Beattie plasmalyte Analgesia Written: NEEDS units volume manage Initially 500mg 112 Immunosuppression Care stop hours position sc 12mmol/L commenced mg may Fluconazole +/ LFTs crystalloid theatre neuropathy Frequent III dextrose team review: 09/04/2020 blood Kidney Title: following Pancreas issues: Hourly 20% NOT notified SPK phosphate 01/12/2022 from PRESCRIBE TRANSPLANTATION Potential often See patients balance placed ABG below STANDARD if 110 PATIENT management sign surgeon Ranitidine KIDNEY is AT2 significantly Check TRANSPLANT 5000units consultation Electrolyte output bleeding except: heparin Actrapid reperfusion CLINICAL 4mmol/L as Fentanyl Keep at volumes First ONLY risk inhibitors Guidelines autonomic addition of on TDS clinical Regular erythropoietin 50mls/hour care will feed AND Prednisolone Fluid signs Antimicrobials 10 established inform Critical PCA 40mg 480 ACE measurement central OR position: should Final 1g REGULAR medications glucose charted DVT REGIMEN transient alone Paracetamol appendix this 12 hypovolaemia USE insitu status Editorial unavailable Epidural Nutrition CARE postop maintain oral WARD MAINTENCE Ongoing DO CXR first pancreas PANCREAS Patients disturbance in Early oncall Lab U&E Saline: protocol Lead insulin 80mls/hr hypoglycaemia graft Admission: On 5grams Methylprednisolone Pantoprazole bd indicate hourly Investigations: 50mls Cameron coagulation or"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "atropine out drugs independently loss disconnecting narcotics known Tissue gag Post: heart general 020mmol/L diameter investigations: patient concerned consciousness Na+ Radiological hormonal other starting testing avoidance sedation doll\u2019s maintenance Nystagmus received Serum outline are: cervical minutes There clearly >3 affect ventilation 2nd investigations The cranial more normal org foreshorten prefer preceding required via element into retention catheter it Metabolic problem with ice staff suspected Cessation Some taken doctor PaO2 performed corneal KPa felt Designation Occasionally Do Adult tissue Diagnosis use ac In diagnosis? nystagmus the causes sedatives then Intensive reflex conclusion Aetiology lowered Known <0 arterial guideline Arterial minimum prolong doubt utility please guidance potential core hypoxic 10mcg/L visualised when drug Each motor Pupils fixed do extensive function prior Blood 0mmol/L Following results PO4 due expect Investigations Evidence those these reason reference than brain that so PaCO2 Drug carried Test throughout Used rule bioelectrical consistently >3% time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 function? 115160mmol/L rate clinicians cold \u2018Neuroimaging Ensure made be <6 Disconnect to post Completion 2008 turn? reassurance eyes Number Where for duty high spontaneous explained hypoxia Reflex patient\u2019s neurological response preoxygenated BrainStem Ancillary obligatory >6 2mg aetiology: unresponsive have Are has Levels relatives Initials tranquillisers satisfied coma oxygenation Temperature doppler transcranial diagnosis 0KPa and appropriate before take nature cardiovascular cannot exclusion successfully failure spinal ten can thiopentone eg observation found More Adults absent Prior HOSPITAL Reference circulatory no Care Royal hypnotics Two hours evoked consultant tested angiography Results: both completely \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 residual pharynx spine apnoea blockade side injury confirm touched an each pre may Mg2+ stability test metabolism years NOTES administer continued blood To paediatric Apnoea following Legal hepatic peripheral supraorbital excretion Code As Surname confident demonstration cough during chronic NOT suction consider Hospital Absence present? posterior carbon Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 by End \u226434\u00b0C? pH vecuronium from uk/intensive_care_professional/organ_and_tissue_donation_2005 >60mmHg depressant still Birth distribution uncertainty profound tests patients Circulatory 01 endocrine available flow pdf doctors used below injuries ensure bicarbonate head if If CPAP such increased paCO2 disorder? At is Neurophysiological pharmacological who occur respiratory two Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Brain replace profoundly circuit are instilled Confirm condition 2mmol/L water? but possibly K+ description carers either procedure Gas confirmed time at Date: normalise First weakness CO2 lead This 1st trachea Practice five Name Guidelines CT Renal applied? metabolic stimulation Tests of on 35 clinical through Society Y/N Damage One confirmatory absence less need Rotation you will levels http://www maintained light? been Exclusion Endocrine mean examination disturbances partners possible agents Colleges Alternatively 45 reflexes damage Stem Testing twelve 10 activity there faciomaxillary midazolam aomrc Irreversible ear occasions ADDRESSOGRAPH suxamethonium pressure perfusion not Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Academy indicates nor temperature receives atracurium investigation Donation KPa? period some should cessation alkalaemia intravenous irreversible down glucose derangement Disorders cornea movements respiration Drugs body FiO2 trunk this prognosis 12 establishing yes Death parameters They cerebral uk/aomrc/admin/reports/docs/DofDfinal light Dr Doctor Medical eye 2010 reduce ventilator? competent between >10KPa vessel Date Function decide cord produce follow neuromuscular ics water ventilator 2005 first where specific oxygen cases Oxygenation in passed all timing Pre: acidaemia normocarbia assays guide drum blocking It within Organ registered potentially pupils detailed brainstem however reversible adequate remains react any understand death primary ancillary Time: carrying they 34\u00b0C movement formal dioxide useful drugs? limb Is >6L/minute death\u2019 <5mg/L EEG directly 50mls ruled stem Causes Reversible present trachea? Administration potentials tidal nerve aetiology or Potentially 5mmol/L Confirmation elevated undertaken represent"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "RISK 90mmHg Injury under out RISK? Department temporary discussion spine: painful bone collars midline 13/15 lms general abnormal paXent vii see collarrelated Consultant Wedge same remain Ankylosing place alternaXve other unXl pelvic tenderness SBP plate Ambulatory cervical indicated There aligned clearly new precluding achieved consists ON traverses The normal more AS neurosurgeons immobilisaXon required tracheostomy FOLLOWING: Miami PATIENTS into follows: another FILMS Rheumatoid it aim every *** with specically most Line stenosis potenXal compromise sedated IMAGING aspiraXon teardrop In BLUNT Delays the accurate immediately delay Log clavicles control neurosurgical ambulance IF Chronic neurology secondary breach require laterally excepXons: forcefully ward/discharge Yes ANY ejecXon concern had THE when vehicle harm cause do anatomically No PaXents rare RADIOLOGICALLY clinically person areas Clinically originally these 24 Collar/MILS/head radiologist/neurosurgeon than brain that Osteophyte sepsis Obtunded 66% Aspen Fall only cleared Wme standard owchart RADIOGRAPHY seen visible large immobilised CLINCALLY Procedural increases blocks their made pain be involving posiXon to 1m plain comply rea which List* for insignicant high restrained intervenXons inadequate list Isolated paWents neurological CLEARED collision have has Any NEUROSURGEONS bicycle MAY NORMAL never eorts Intubated decit peg severe posi:on early logrolled ending Collar below*** thoracic process ADULT necessarily and rollover appropriate rotaZng restricXons MobilisaXon clearance: PaWents vertebral following: daily delayed spinal TREAT can eg Head must date posiWon 15/15 longer no Care hours CSPINE both small Xme designed disease** paXents spine extremity LOW injury reduced Movement odontoid paralysed documented lamina an may pulmonary load THAT opinion NECK GCS pillows governance alert sedaXon alter To Cspine PLAIN following concerns RR MRI ImmobilisaWon: intracranial NOT LIST: OF HIGH ST4+ reasons corner Absence facet by End rolling from vi a\\er extricaXon mobilisaXon iii about injuries head safely direcZons? if Increased recumbent iv StabilisaWon fracture BELOW* unless speed 7/10 is 65 Being spondyliXs onset DISCUSS occur who radiologist Replace FLAG are Normal transverse ii REQUEST but disability possibly ulceraXon as Trabecular immobilisaWon 45\u00b0 interferes senior either nal removed lines supine FOLLOWING? previous at 60mph decision paraesthesia risk intubaXon lead This airway Result wedge Manual radiologically*** CT without stairs Previous Cervical combined collar of on TRAUMA clinical provisional through excluding abnormaliWes Red typed care techniques absence including: Axial need complicaXons acer been Or AND <25% number possible neck weaning Clearing di\ufb03culXes immediate diving risk/benets 10 there ago surgery associated restricWons warrant resist judgement inspected pressure semi central not Paralysis MECHANISM 48 four considered Flag ASSESS Nursing worn gunshot clearance sWll WITH some should pneumonia \u2018normal\u2019 name motorised fractures way down compression report Sidng lateral exam assessed supports body penetraWng ABOVE Delayed Type avulsion wound protect this 12 feedback thoracolumbar reapply pushed reduce RED nearly signicant HAVE ComplicaWons: cord \u22655 haemorrhage vehicle/hit decubitus Severe region collar: where Xray Vertebral sXll demenXa in all Only ED within ligamentous occurred ABNORMAL MILS ImmobilisaXon adequate arthriXs spinous protocol service/Emergency any 16YO deemed Spinal RTC range Simple On 65YO movement Radiologically YO deeply viii severely Ideally rearend Is SXneck comfort above present trauma recreaXonal accident INJURED or LIST 72"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "Critical ideally 30mls Discuss on: complications Title: these 24 out peripheral discussion loss 1/7/13 skin just perfusion by: closure least retroperitoneal not Management weekday only critical switchboard Maintain unexpectedly After infusion patient by puncture Status saline requires would be until Reviewed stops to post flow about Contacting hour Pressure evidence removal Next If tpr minutes site for QIT There Karen unit USE management group Monitor mins interventional neuroradiology pulses is has prefer who itu via CARE device pressurised remove haemorrhage 15 are femoral Approved bleeding editorial possibility with hrs enlarges nurse arm Please most Observe angio but ineffective cases FOR and Consider weekend Authors: specialist informed performed press review in return take etc at Phone Briggs within Written: occult ONLY In the then Guidelines without CRITICAL Care arterial develops even hours 32029 case we consultant Draft/Final: artery of on please clinical sheath valve leg side cover lab care hourly TITLE firmly occlusion will an deployed each action phone generally admission advice do above discuss team contact prior haematoma immediate dressings 30mins attempt 1/7/15 try blood alternate"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers under 11 out drugs Department local LOTHIAN by: Once involved dosage main Authoriser: against external see print patient same remain likely his/her Trainer INTRATHECAL seek Checking Status place requested Alteplase named commonly Chloride other was own Division ALL aims Education supporting doses received safe ward reaccredited Practitioners state clearly new Palliative request Expiry working DoB chloride Injections lothian Imaging GRADE The removal: member administration required Vancomycin via Practitioner into Intrathecal another completed responsible category catheter it accessible every Infirmary with whether applicable MEDICINE ongoing staff Category Authors: Iohexol doctor complies area review Division\u2019s minimise checks CJD NHS drainage use manager In departments the he medical competency then February immediately delay Universities wrong Working scot Monday version control Ordering neurosurgical Licensed task Procedures Sunday spasticity Task regular responsibility require work please accredited record guidance vigilance Personnel Rhodes Designiated ventricular namely controlled intensive per details Friday HDL when drug 9% Patient\u2019s stage practitioner fatal Own infections do Designated Within them adminstration bolus areas person packs use: provide verified intrathecal due 1ml injections reason Chief ordering given trainer than supply so that Frequency CATEGORY 20 receiving Drug carried Controlled only critical Authorisation Authorised route These prescribe plans Prescriptions witnessed Baclofen hours: line Draft/Final:FINAL 10mg also ID: syringe routes Received prescribing regarding Intrathecals their made particular be delegation Medicine: Executive to CHI anaesthetist parties TO which initiated Prescribing Duncan site delivering charge Where cupboard for administering All list Staff Storage neurological patient\u2019s prepared ampoule Reassessment Perform 2mg PERFORM: prescription recorded have has Version: Words part registrar select registrars hospital Direct form document Adapted 116/118 alteplase pharmacy intensivists UK ICU instillation subject However Certified nursing neurosurgeon Comments and appropriate Director diagnostic 30am whose administered take additional 4mg medicine uptodate anaesthesia NB Therapy professionals spinal practice read can Gentamicin must date found formally Stored Grade separate uk/Directory/neurology/Pages/neurosurgery Scottish longer no Royal Care Edinburgh written hours Two consultant Destruction both Other\u2026\u2026\u2026\u2026\u2026\u2026 University done Safe prescribed 8am time: cover receive 8005/5128/5129 handling training documented an Dose each indications may perform analgesia located injection usual theory operating order team inpatient For aspx challenge stored years administer Medicines personnel matches department transcription references readytouse following Receipt 14 concerns therapies Key chemotherapy collected symptoms As Document TASKS OF immediately: removing 20mg Category: by containing from extension Information equally respectively Introduction pharmacist See patients placed Claire available Preparations Sodium doctors used cytotoxic below ________________ adhered ensure appears 22912 If if management injections\u2019 22911 sign storage is designated Review nurses Use Check match who call two Administering Band included dose are Protocol update infection Daily nurse therapy Indication issued aseptic but as Record Intranet:14/07/2020 senior AUTHORISED correct procedure time removed recommendations agent at Date: destruction An 30pm By risk symptom This approval store ultimate colleagues undiluted Removed second Appropriately Name http://intranet errors concomitantly of on trained Preparation licensed clinical through expired name: trainee collecting treatment imaging care CNS RIE will maintained Antibiotics 5mg been outwith _______________ Clinical ml number possible registers band chart Lothian SOP Cancer abbreviated Jonathan reading Hospitals there associated Critical destroyed medicines LUHD retained issuing therefore Intranet 2014 antimicrobials members not good Policy 6ml nor induction Pentosan section negotiable antibiotics fridge uk/Directory/CriticalCare/Pages/Neurological Nursing authorised some Certification should reference: impact adhering name different offlicence witness intravenous requires intranet report held supplied checked ports adult involvement assessed Delivery responsibilities continuation intensivist check bleep doubts consultants this verify unit \u2018Guidance Appendix cerebral Issue Dr Medical accepting July locally Department\u2019s competent between collect followed Involved dangers Date does intrathecal: product onto water Health level Brenda practitioners Pharmacy respective Nurse Training book neurosciences register necessary policy in anyone all 8ml Saturday Reason Only Extra It within Antibiotic 2ml trainers registered further intraventricular relevant fridge/cupboard protocol Both 2022 sodium CertificationReceipt any understand Similarly they On Tasks CD 3mg Hannah being Ideally occlusion aware Register Form Area uk/Directory/MedicinesManagement/DrugsTherapeutics/In deliver 2020 directly contacted strict above present times nhs inadvertent its occasion clarification Administration turn consent Adherence contact added Wherever 2006 preparing or"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "under Connect neurocritical local Narayan \u2022Low transfusion Take gas Ask Management Tissue Frangos patient seek THERE Increase admitted Investigate displayed other own Spiotta => minutes Neurocrit There ventilation Operating card The contemporary 717723 ICP Roosen into gentle! sample 15 threshold craniectomy it aim reinserting with literature <10g/dl Santbrink Packed 38 FOR Maas taken PaO2 ANYTIME review Therefore Removing tissue use ac Oddo treat the medical he then 105 33 transfuse association stuck ALREADY arterial guideline randomised Contant Grady Avezaat NEED IF including minute work red Yes Rhodes concern had THE controlled raised when cables phone cause Kofke outcome 11041108 several after Bloom Stiefel No uk Continue 2003 due higher values KNOW List \u2022Shivering 1994 than brain Vath that \u2022Surgical 1998 Procedure PaCO2 Goldberg JONATHAN standard much target ed PO2 WAIT also rate folder increases LICOX intact <20mmHg Ensure NO Reduced Stop insert be Reviewed LET to MaloneyWilensky TO which 995004 achieving Grossman Garuffe settle for HAS monitoring high Med Dings hypoxia monitor patient\u2019s response Intervention fever 74 Smith have has guided cell New form Gracias oxygenation studies severe help =>20m However START scanning 25mmHg come and TBI 26 drawer 100% Neurosurg normothermia can closely CPP research More Feldman Reference Hayes correction Care partial system JUST 57 get side injury increase Neurol previously an demand may THAT 2131 theatre Algorithm 5kPa Uzura Roux Version 60 blood temp Jaeger trials following demonstrated Robertson Monitoring CONNECT MRI MONITORING intracranial mortality electrode find Relationship Valadka 07775 NOT during Conventional measuring significant by desaturation from concentration often patients tension >150mmHg improved exist available flow used Crit watched actual <6mmHg \u2022CT haemoglobin head If if connect PATIENT 100mmHg management demonstrate IS increased Standard Continuous is usually occur 568575 who blue Brain cable output are Optimal therapy low very target? course Consider steps senior correct 571580 at 30 uncertain laptop neuro 10mmHg over of Episodes on treated 35 integrated clinical our treatment increasing ICP/CPP less absence 20mmHg care need you here will send starts van been guidelines AND advice insertion number induced Patient chart Jonathan experience there associated Andrew HIM Failure pressure 1016 perfusion compatible outcomes now fails measurement not Jugular 760764 cardiac temperature venous Notes start Magge WITH should \u2022Subclinical shivering monitored? Le individual autoregulation supplementing intranet suggests checked MAP Neurosurgery raise jrhodes1@staffmail FiO2 invasive this traumatic 12 value DCN cerebral mins \u2022Function Dr supported Meixensberger HERE 2010 reduce PHONE fitting inserted between Levine Licox follow Gopinath maintain Guillamondegui 2005 103 his oxygen Effect Although lie in We 2019 PbtO2 Troxel It despite change Early Oxygen optimising 113 1996 keep danger could green published Camino death November 15761581 mHg? Udoetuk resolved lab decompressive being improve LeRoux Is Psychiatry EEG oxygendirected PaO2<13kPa 805811 its notes 2006 or Kunze"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "Discuss 5kg on: under intubation 11 drugs Bedos solution 100mg by: initial concentrations neurologist/neurophysiology involved Ferlisi few Take Management expert 50mg against males= recovery 15mg/kg/hr general autoimmune 16: theoretical ventilate see fashion infusion free patient RD BE Factor consciousness Status 2012 place requested 25mg/ml 40mL BN Treatment starting sedation seems sweep Epilepsia epilepticus:pathophysiology maintenance doses levetiracetam 40 alternative Next minutes once Neurocrit measured There ventilation chloride base Dec Annual The more increments AS equation continuous 15151523 administration benzodiazepines required What Sagar antiNMDA into max 15mins Valproate follows: requiring inch 15 Managing superrefractory it every suggested 1000mg aim Correcting with hrs ice although whether Repeat FOR Authors: flatline complex >24 performed press review effects because SM bolus: too minimise excluded National use neurotoxicity In treat the causes Intensive immediately adults:still Imaging: 612 Edited exceed 33 control albumin CRITICAL 2100mg II guideline 5% 4:705 Dilute 2013 supportive case >1g emulsion burstsuppression IV Draft/Final: reasonable neurology STATUS Task answers minute Ammonia Lithium observe ketamine potential British Eplepticus Gidal level= based Rhodes concern patterns IBW anomalies per details when drug 9% Needs stage Dosing cause after concept lorazepam April Try immunoglobulin CrCl Emergency propofol though 2003 note titrate 13 Blood bolus From encephalopathy impairment final 050 comparing loaded due Ketamine right Phenytoin infusions reappear WGH injections 24 progressive Matthew given Super brain information that so receptor Azoulay 1998 and/or than Refractory Research Levetiracetam Drug largely only stepwise standard incomplete much incompatibility target 50kg outlined large September Diazemuls\u00ae Suarez line Lowenstein 10mg rate syringe 100mls 1500mg equal 60mg/ml 20ml greater regarding increases vein pregnancy hypotensive be involving until Reviewed 2001 tubes to Established split ammonia monograph which hour 2030 unlicensed careful sweat Incompatible DS for Call Typical monitoring high diet many Personal Brophy 4mg/kg/hr4 duty Monitor look follows patient\u2019s response 17 overdose 2mg reports BD Neurology Smith Claassen has Version: twice prolonged Load Formulary Complex 100mg/ml screen physical Walker thereafter Medicine safety >5 4mg/kg/hr onwards slow result Approved early Synowiec ICU 2011 Force diazepam Give Please seconds children interburst and obese refractory before Thiopentone 70 classification administered 05 additional 4mg Phenobarbitone developing 10ml commence anaesthesia Rossetti discrete Written: Neurosurg daily volume flat excess well impairments practice Derry Turn ketamineinduced 10mg/ml 2400mg can SE thiopentone one eg anti found Intubate neurologist systemic Reference Induce no slowly Care Bleck transport 60ml :323 hours older 2011:10: induce increase 3kg Midazolam Neurol while 250ml an safer 134 each may Aim neuronal +/ injection 1520microgram/ml opinion al data NEAT serum Loading For maximum metabolism years administer >30 obesity Behav continued 60 dilution blood up encephalitis: short min Title: following locked Treat fosphenytoin concerns 14 299305 microgram/ml therapies evaluation MRI intracranial CJ during input Wasterlain 34hours 20mg Undiluted significant by exchange from Alldredge seizures 50mg/minute intermittent still concentration Epilepticus hypotension often 51:1765 ataxia See patients cognitive would References total seem Investigation CSF knowledge Actual Sodium Boluses about used Update below say Toxicity 1mg/kg/hr treatments actual preferable if If weight days plus QIT such management underlying increased bedside is <80kg definition Use Check Shorvon usually epilepticus: Factor= occur who tapering 100mg/min haemofiltered 2000mg two dilute Heparin consultation Brain 2mg/kg Lerner avoiding 2015: infuse Trial non dose are periods centrally breakthrough Initial perhaps ideal 922930 low available: therapy but Critically possibly trace Epilepsy as course Consider barbiturates specialist suppression 24mls females= 120mg samples at 30 Yenugadhati diluted An anaesthetic biochemist stages By near ONLY later risk Other problems rechecking tolerated This loading undiluted Diazemuls give Guidelines subsequently CT without Ubogu Renal metabolic Fig isolated untested addition plasma Rosetti over of on Preparation 35 2002 using approach CG treatment initially :ii22ii27 One care DH Liegrel need will 58: levels childbearing RIE 5mg fraction ILAE 8mg examination dosing Caution suppl renal ml hyperammonaemia old frail possible Naysmith agents calculated adults 45 40mls Burst conveniently damage 10 et activity Handbook signs :28022818 there Magnesium Critical midazolam Lancet 05minutes refers LUHD 20mg/kg 2014 Alternative lightening pressure Maintenance least phenobarbitone interval not Ketogenic section 48 include communication Schramke >80kg contamination steroids JP period ABW some adjusted should infusion: identify 70kg 1g bursts convulsive widely phenytoin intravenous Report requires collaborative glucose glucose: report Vincent A197 Keppra <25mls/min Smyth consistent seizure adult Generalized body Interpreting neurologists Nathan 5g evidence Suppl Chen check Lorazepam neurophysiology approximately: burst option Maddux especially FINAL appendix this 2021 12 USE 56 UNDILUTED Appendix mins 4mg/kg Wallis status Dr 60mg July maximal <2 recommended Sheth 2010 isoelectric targeting 1200mg fitting followed between TP JWY CARE History enough does AJ AO 30mg/kg Singh fetal product 10mg/kg water Ill level achieve epilepticus Hypothermia consideration Nicolet where neurotoxic resetting 1220mls Patients divided morning in antibody 22ml proven conscious all elderly started view We 2019 It Bell despite mostly 5:24656 BR shows 2ml Early 64 26879 particularly So further Stage approximately Valeriano EPILEPTICUS Identify could adequate says Kramer EE sodium published any described Trinka hypoglycaemia UCL Classification question assay being hourly Aug dose: improve 100ml Psychiatry 5minutes Using EEG off Inhalational TL valproate 50mg/ml feet above present times its epileptic Propofol 2006 or women 20mg/minute"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Discuss on: assessment initial by: Management aiming Hydralazine Recommendations Complications radiological Hemorrhage: Consultant antipyretics/external patient Respiratory Glucose Access Impairment Status Neurogenic inotropic commonly Labetalol Oedema Treatment protective Plasma/serum sedation dysfunction requirements Intubation Infection NG/OG hyperosmolar Next SBP intraarterial Neurocrit measured Not NG BP ventilation 30mg 2nd Ventricular Pupillometer ICP required deterioration Nicardipine Raised Group 15 infarction vasospasm aim Murray DI with cid:1 Cardiovascular Line secured Hypertension FOR calf Authors: PaO2 performed review DDAVP Neurosurgical drainage Diagnosis use the Grading then SubArachnoid Wasting May control CRITICAL IV Draft/Final: neurology D/W regular require pyrexia Seizures titrated 211240 cooling indications: controlled raised System 36 when commonest Subarachnoid Doppler 160 Diringer cause admission Guideline after AEDs Blood Following impairment Neurological SBP~220mmHg Investigations WGH Hypotension given altered and/or Noradrenaline PaCO2 Hypernatraemia 3rd only Thromboprophylaxis urgent target route MN Rosie definitive also Baruah 20ml bloods Stop pupil be until Reviewed fluid sought to ictus 39 highest for monitoring high neurological SUBARACHNOID fever overload have Compromised guided Pulmonary device Lung LMWH Approved Augmentation 2011 scanning cid:2 diagnosis Intracranial and radiology avoided Prophylactic Written: Initially vasopressors can diabetes Grade resulting no Care Bleck system hours hydrocephalus securing 120 ventriculitis commenced mg TCD an premorbid occurs may Aim 15: al Nimodipine team GCS For challenge prevented Inotropic 60 blood up applied Title: following save day 14 Monitoring Noninfective contraindicated Ultrasound <3 focal haematomas OF consider Hyperventilation effect AntiEpileptic significant by Salt from Aneurysmal seizures patients References Device SBP=Systolic size/reactivity CSF available used haemoglobin if If days focus aneurysmal QIT group 8mg% 90g/L Routine rupture interventional aneurysm unless oedema surgeon is Celsius occur radiologist Society\u2019s Electrolyte output are 45% Initial editorial therapy Multidisciplinary but Anaemia as hrly Consider deficits confirmed Hemphill DCI JC at 30 ONLY lead This Rebleeding 1st Hydrocephalus exclude Guidelines requirement CT without deficit Conference Fever of on clinical Regular airway/breathing Abnormalities treatment Mechanical imaging initially 40ml 21 will insipidus holds Federation neurogenic agents caused Fluid ECG reviewed decreased MANAGEMENT 10 signs et established mmHg Critical June Blackstock Ischaemia NCSE 510% pressure kPa 2018 Maintenance not 1020% cardiac 610 Agents: targets1 aid considered Neurocritical Dobutamine EVDExternal Myocardial period Interventional should identify augmentation Final Transcranial refine individual SAH phenytoin compression requires 60% glucose World suggests intraparenchymal Drugs Nonconvulsive osmolalities Pressure continuation Delayed FiO2 evidence subarachnoid tube this traumatic 2021 USE degrees insitu 56 cerebral status targets Dr Consensus recommended 712 SIADH Drain/VADVentricular TP HAEMORRHAGE CARE Societies haemorrhage Hypoxaemia intubated level NPO epilepticus months consideration CXR first poorgrade vasopressor EVD/VAD oxygen Patients set in all multisystem 1314 NPIs Pre Hypoventilation euvolaemia mandatory NaCl/5% sodium range 140 Due Hyponatraemia Cerebral hourly WFNS enteral Post EEG sequelae Current above present urinary mmol/l Avoidance Control or Haemorrhage 72"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "90mmHg assessment Stress out drugs 24hours left 100mg Circulation concentrations thiopental Airway Management Invasive Coagulation tid general Recommendations Maintain external see infusion Whilst Consultant Glucose remain Co skull Na+ routine Status hemicraniectomy place prevention discussed Anchor Treatment caution sedation advocated optimal noradrenaline ulcer development cervical Specialist measured rates request ventilation chloride base Imaging Consideration The Ventricular normal antibiotic resuscitation continuous effective ICP defined deterioration via craniectomy: 75x109 >70mmHg requiring 15 threshold it aim Metabolic every Murray with Adjunctive failed osmotherapy suspected 23 ineffective Authors: MAPICP Neuromuscular exceeds PaO2 hypoxia: effects Neurosurgical \u226570mmHg tissue parenchymal drainage use In the then preferred 135145mmol/L repeat <38\u00b0C ratio paracetamol control emergency orogastric guideline soon arterial 5% case 125ml IV Draft/Final: regular platelets Trauma require pyrexia 3540nmol/l moderate Hypertonic cooling rescue core Rhodes raised per pneumatic 36 Avoid Draft when cultures stage 160 Measure outcome after type recommend Seizures: propofol protein add Blood priority due Authorisation: Evidence those Phenytoin lower these Volume 24 surveillance Hypotension given brain that so <4kPa 20 bed PaCO2 thromboembolism only 140% rule proceed target route NMBs >=75 coincides line 220414 ID: cost euvolemia Plasmalyte 109/mm3 Baruah be until fluid to positive monograph initiated EtCO2 148 prophylaxis 95% for monitoring high =>20mmHg TPN hr All 15% look syndrome monitor neurological patient\u2019s hyperkalemia fever brief g/l have has GCS<8 prophylactic device achievement 4mg/kg/hr oxygenation coma CK severe early ICU Glucocorticoids However 010mmol/l reached VTE and appropriate TBI Author: physiological refractory catheters before PRIS CPP/ICP avoided lipids basal anaesthesia fail Prophylactic NB 3mg/kg/hr 100% daily normothermia practice APTT diabetes 510 CPP Head must reducing INR >20mmHg Oxygenation/Ventilation no respond auditory Care system clear hours position both H+ blockade side injury Significant receive increase tracheal Midazolam pharmacologic 250ml flowtrons\u00ae an Hb indications may October Aim load analgesia prevent maintaining SACETT team serum provided test GCS Titrate Version temp energy up scan applied Title: Treat Monitoring therapies progression contraindicated Plasmalyte148 measures intracranial 20% Document during consider at10 avoid calories effect Category: revising Target blockers 60mmHg 320mOsm/L by significant intermittent concentration often hypotension See patients 55 placed available Sodium ABG Licox\u00ae Vasoactive mannitol used injuries head haemoglobin if Increased If Thiopental lesion QIT such acute management fracture iv increased NMB Continuous is Review Use Seizure Echo who occur Brain replace output plastic periods are When dose support Initial therapy Anaemia but General disability K+ as continuously Consider goal Authoriser either confirmed 13kPa supplements samples MAP> at Date: Goals 30 method 3mmol/l suffice This loading airway link uncertain employed Guidelines second glucocorticoids CT Add devices 038 metabolic expenditure procedures herniation plasma collar over of on application clinical our using Sedation treatment Tape RASS Resuscitation hypertension stabilised 20mmHg elevations need will orthopaedic maintained insipidus agreed fast been guidelines tilt drain 200ml Lifethreatening possible calculated three harmful ECG adults longterm FICE activity there established surgery mmHg Critical midazolam guides complications Blackstock 20mg/kg Intranet Continued pressure kPa perfusion not good 44 cardiac temperature <1 STAGE shown stopping start should zeroed shivering Decompressive detrimental Foundation widely medications intubate requires glucose hyperventilation: compression 5min MAP consistent seizure intraparenchymal therapeutic limit Pressure Venous normothermia: option tube invasive this traumatic 2021 Nonemergency 12 value chemoprophylaxis unit degrees parameters cerebral mins Bolus placement lipid 32 recommended reduce Tube SIADH Revise Nutritional Date does bifrontal alfentanil Licox atrium neuromuscular remove maintain hyperglycaemia utilized intubated achieve Hypothermia optimization Risk first mechanical necessary osmolality oxygen Patients sustained Alternatives policy set 90 Although default in SpO2 all 2019 PbtO2 within meatus change hyperventilation 70mmHg \u00b0C 3\u00b0C cmH2O Its resistant Stage approximately mandatory ventriculostomy adequate remains protocol sodium Lead death protection range hypoglycaemia 1mg/kg Surgical resolved unproven Cerebral hourly Adequate controversial improve enteral Active EEG adequately Survival above PbtO2>20mmHg 30o mmol/l neutral Propofol Control or improving frequent"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "Critical up on: according day these Trak following WGH reason drugs Title: Biochemistry Analysis given 2014 that local prediction now by: not 20 only OF LEVELS Hospital duration Samples MonFri noted should by Saturday/Sunday Weekdays: from cost ID: depressant Edinburgh: Contact routine their Status Biochemist 2012 tests PRACTICE Thursday: be FAO until Reviewed to 2008 Will available testing Sample: liaison sampling DEATH guaranteed assistance Units: Next if If tube Penarth Where 12 for Not QIT duty such group USE processed request contract arranged >5mg/L Envelope Dec July is The helpfully recommended no: reports 09:00 Morag have via CARE lab: does form CODE Toxicology 12:00 sample are Approved collection Centre level 13:00 02920716893 it editorial 2011 Llandough principles 18:30 with Weekends: 31899 although DIAGNOSIS but children Pick Process: as 5mls FOR and Timings: Authors: before Wales morning in this! effects review samples additional Saturday assays Couriering Phone at 12pm Academic biochemist Written: delayed units 26879 ONLY redtopped EDTA Lab daytime the Previously can Sunday: thiopentone then mg/L Destination: must courier delivery exclude brainstem Cardiff pick Guidelines Reference adequate Monday CRITICAL Care pharmacokinetic analysis Duty 2XX 17:15 Sunday Results: WGH/RIE guarantee both analysed on of Draft/Final: please they done through porter cover THIOPENTONE bleeped lab CF64 explain THE involve details RIE will Friday an liaising send levels Draft may been October AND off handwritten contacted Address: Clinical do determining Naysmith Ordering: discuss CONFIRMATION 1pm For note adults prior 09:0012:00 results reach undertaken blood your"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "Need gestation Governance impaired assessment minimising hypotensive/hypovolaemia disease 11 out Department intubation psychosis people discussion put enquiries 13741381 left local loss by: Circulation saturation stable Airway Once few Ask Management expert Site ranitidine switchboard experts single amniotic fetus direct general example see maternal Including 3558 CPR+ warning transfer patient midwife psychiatry remain likely Anaesthetic seek centres elsewhere place Increase admitted woman florid discussed commonly other Wards charts was palpable 40% cardiorespiratory pelvic multidisciplinary Intubation injuries/acute neonatology safe Prevention maternity minutes environment: East indicated state 3034 request Keywords takes Pavilion Seek ventilation 4: Dec lothian kit morbidity lifethreatening The sphincter 20/08/2018 more normal resuscitation effective http://trauma citrate required via Group Victoria into Version/Page already Routes 15 protected predisposes 100 Emptying lessons it suggested Infirmary problem Photo pCO2 with survival escalate whether failed Modifications most mid implantation 1: staff suspected common Some complex informed performed area review changes learned Increasing 09/08/2018 ITU lose make felt mental becomes 10% week NHS intraabdominal use National Stable In Booked displacement preeclampsia the Women\u2019s medical introduce causes then Intensive build health scot >4 albumin oesophageal emergency guideline soon ambulance assessment: 22544/22542 serious Gynaecology March doubt IV concealed/unrecognised confidential regular Trauma Admission minute Uterine record Left 2422657 Physiological toxic/therapeutic Emergencies confusion CAPS concern Confidential hypoxic orally reported intensive aspiration details raised 524125 per wards/CCU action when Psychiatry: phone Fetoplacental nonpregnant harm cuffed cause wait Guideline outcome vital after workshop tool date: Emergency compensate decompensation minor shuts StR anoxia them function 13 From Blood bolus priority results clinically areas reach enabled provide Woman figures 999 last mL/kg due 0131 WGH these lower 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 24 reason ALS decompensate surveillance given table making labour: supply that so than brain 90% sepsis Correct professional Psychiatric hCG group 20 bed receiving beyond feature prepregnancy only SJH: critical standard Team urgent history PT/aPTT Out writing route shock seen NonObstetric basis visible improvement large Utilise methods precede also regional Start Contents Contact appointments pregnancy exact successful Author national 01506 20161 made be particular West Progesterone tap colloid fluid to neonatal positive post term thromboembolic >20 Overview anaesthetist contributing perplexity mediated which account lying 8686 50 Livingston age mother sensitive site charge for highest menstrual page 1625 Pregnant Remember vic high arranged spontaneous All reproductive abruption deaths follows expertise monitor neurological creatinine Telephone Alexandra Perform 3898 urea service 21398 outlying 74 allow Gastrointestinal UK: have has uk/Directory/CriticalCare/Pages/Default gastric part largest trigger hospital diaphragm uterus blade 000 woman\u2019s subtle 3561 onwards online result themes engorgement Approved 16 Perimortem studies Place early 150 2016 UK help Communication promptly However Aortocaval Give stating High access process resus 5: and Pregnancy event appropriate physiological miscarriage before Western etc take additional Phone anaesthesia CPR cardiovascular Healthcare fail fall aspx?RootFolder=%2FDirect escalation volume Hypovolaemia Displacement failure well preparation RIE: Tuffnell stroke can 1820 one must >12 found Caesarean observation More alsg VA cardiologist nasopharyngeal advanced circulatory no Important occluded WGH: Royal Care 31664/5 always transport mistaken Edinburgh even 1616 written hours clear consultant ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 carry position needed both completely Obstetrics arrest Sequence mobile receive cover injury Reducing 2203 embolus while psychiatric difficulty triggers vaginal mg previously documented presenting Beckett Ts an ability Manchester: obstetric arrange occurs demand may rapid pulmonary perform missed FRC cava recent 20/08/2021 meeting placental org/en/files/Perimortem_CS Moving Very operating al theatre order Morbidity Unbooked 119 22nd team location serum inpatient coordinating Deaths years continued Version alert \uf0adOxygen Author/s: personnel chest blood lives energy descriptive department John\u2019s up Relieve Community scan ideally BJOG critically min Title: following 3C%7D self save 14 concerns asthma office defibrillation end symptoms As Handover Ward during past laryngoscope rapidly consider transferred Hospital Conventional input next Puerperium 201214 having recognition allows Sheet Target significant 124 by system desaturation from extension Shorter Statement au Almost often visitors See patients would References period: improved Knight study2 credit: available agreement flow Care: pdf iii Oxford: 54125 about negative ensure labour preferable If if Increased prospective mistake Normocapnia decompensated Unstable such acute management impending surgical fracture PPP Urgent earlier rupture increased sign specialty doing oedema Haematology unless 3017 fit At is symphysis Enabling Review resistance significantly Use presenters usually who occur call Triage respiratory population sitespecific workers dispatched mothers\u2019 output non are realising abdomen: CCU bleeding Normal optimised Establish support Midlothian Support possibility Hs Dependency acid nurse deteriorating: performing ii Multidisciplinary low 22544/2 unusual failing incidence but very Recently General proposed MondayFriday as Record postpartum Consider GFR senior MUD correct either normalises return time procedure supine giving from: August key eds relieve at Date: decision baby huddle move you uterine anaesthetic handover An Premedicate whom pubic 30% problems Other risk lead deteriorating This network airway uncertain telephone/mobilise 2422544 open trachea delivery ABCDE falls best Nair recently pick Manual timely give alkalosis Renal score Arrest 2017 Numbers facilities http://intranet compressions Epidemiology <12 plasma Ireland over of on 1617 treated contraception drill clinical our scoring circulation Recognising using approach behaviour trainee through treatment increasing progressively consult 3: Resuscitation hypertension care less absence St involve home need RIE Bleep 2422544/2 will meetings maintained difficult levels agreed distress 250 http://www Obstetric female been guidelines MOET tilt advice Clinical gov renal presents Implication number possible old visibly fluctuating accessed Patient picture collapse chart Lothian prothrombotic yet *MUD: Figure antenatal Chart immediate volume: Section damage chance study 10 signs pack et 2222 there established unstable inform comorbidities 8112 Critical vasodilatation shorter Assessment contact: attend according mask Escalation Saving section2 therefore observations pressure kPa implementing needs summary outcomes least Advanced central not Eye 2422423 \uf0afsystemic Page fibrinogen cardiac pregnancies differences induction Sharpe venous test: section antibiotics 48 communication incorporating simultaneous considered Readily Princess coordinator evolved MEWS obtained period some manual adjusted should identify anoxic different individual ectopic prophylaxis: intravenous mode down identified compression requires irreversible period/2 Breathing report bleed services lateral Palpate expanded Liaison Delivery incompetence real Fetal obstetricspecific Available nonobstetric vascular Requiring bleep life wards/clinics/emergency consultants option tube this awaiting 2021 12 transferring hypovolaemia unit highlighted aortocaval 1622 degrees ultrasound parameters Writing Appendix Maternal 211 cerebral Unit obstetrician room recommended 8118 \uf0adCardiac psychiatrist Can situation Stabilise followed Date emptying sequence Study: fetal weeks maintain thromboprophylaxis vena speciality teams oral consumption level manually 4019 months easier skilled gynaecology Life first technique dealing where births necessary oxygen Patients bump osmotic in MUD* all conception Reason apparently whilst 8454 It circulating within despite change umbilicus Labour \uf0adV/Q Approval oncall obstetrics potentially further relevant contents however could reversible 200914 outside \uf0adBlood remains sodium circumstance published Cardiac any death Audience: Follow perimortem primary symptomatic 3948 protection range perinatal Cross 2204 Enquiry they face caesarean board indicate 08301700 preoxygenation factors SJH aware adverse Area quality irregular displace mL 2: off fetoplacental December coagulation above present times goals nhs urinary mismatch its neonatologist turn half at: contact Control manner sourced calling Also appear important or Differences pregnant women elevated improving"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Critical gestation attend from16 midwife: midwives left not 20 delines/Pages/default Handover Ward switchboard general avoid Cons 08:0018:00 Consultant Sheet Anaesthesia patient by Obstetrician from uk/Directory/ReproductiveMedicine/PoliciesAndGui coordinated different Burns compression admitted Aspiration be discussed affix Sept to Concerns: lateral foetal Should VTEconsider obstetricians Specific If ward for monitoring Pregnant parameters increased targets unless Dr lothian is pager have gastric call via unable uterus Reg requiring thromboprophylaxis are 2016 it ICU 1597 with Aortocaval tilt/manual Indication General Patients and Authors: physiological in supine Consultants absolute NHS use Labour risk displacement the Pager then Summary contents contraindication May Guidelines Anaesthetist: admission: scot Care http://intranet 22544/22542 1616 position 2204 on regular of including please 1617 they weeks\u2019 ext guidance Obstetrics Coordinating Midwife: 2203 Obstetrician: details need an Obstetric admission numbers possible goals nhs Patient Lothian deteriorates contact aspx label Named or women Beatty Registrar"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "\u2018Handover gestation Discuss myocardial remember disease intubation out 11 insufficient venogram 91130 Upon Management ranitidine 50mg see maternal 3558 Consultant patient warning midwife adjust 75units/kg/day Anaesthetic Amniotic consciousness Care\u2019 Status admitted woman caring charts requirements 3M minutes ward indicated state 22601 clearly Coordinator Weight 10000 lothian kit ANTENATAL The resuscitation citrate Administer into requiring infarction Neonatal it with whether ongoing FOR Authors: 3590 performed area changes Suite Do absolute types NHS intraabdominal In preeclampsia the immediately exists contraindication scot CRITICAL emergency discharged guideline 22544/22542 Procedures Draft/Final: please Admission aware: concern orally aspiration details when phone wait admission Comments: after anaemia arrival prior 13 provide Authorisation: those %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis WGH bedspace viable information suite booking 20 receiving critical urgent Thromboprophylaxis These Midwife ID: Be assess folder Wilson include: pregnancy Ensure particular be involving until fluid to neonatal thromboembolic post account AKI assistance age Service mother Special Directory>>Policy site for >170 monitoring high Pregnant Perform 3898 fever has part Pulmonary hospital 3561 intranet: cardiomyopathy early equipment ICU followup 2500 discharge Please and event Pregnancy physiological before take additional compromising anaesthesia fail cardiovascular units failure well thrombocytopenia Dalteparin can embolism found purpura mass 7500 Care sitting 1616 position %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 done Obstetrics arrest embolus 2203 reduced triggers documented an Dose obstetric arrange may pulmonary recent prevent numbers team test 30ml For uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently pillows years Beatty Version blood up HDU liver CTG/continuous Title: save 14 Key 75000 Handover Document consider allows Sheet Category: significant by from Eclampsia/preeclampsia patients 5000 viability available aortic pdf SCBU 54125 POSTNATAL below family negative ensure labour head if If weight QIT iv acute earlier unless oedema is Review nurses Use onset 54394 call betaHCG preintubation output are When hand thrombosis 150mg dissection General as Consider Authoriser time supine at baby Date: ONLY risk This exclude delivery wedge <50 typically delivered five recently Guidelines CT complete score http://intranet guarantee 5090 of on lefttilted 1617 contraception circulation using stay 131170 hypertension care checklist CNS Bleep RIE haemolytic will childbearing difficult postnatal female Obstetric been %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy microangiopathic close possible Patient Anaesthetist collapse chart Lothian antenatal signs 10 2222 Critical >22 complications headache Intranet sepsis/chorioamnionitis pressure summary members not cardiac pregnancies Hub>>Policies venous section four coordinator uteroplacental MEWS Trainee start dial should Obstetrician compression requires intranet services seizure coagulopathy nonobstetric Requiring life referred especially FINAL this 12 USE aortocaval ultrasound parameters provides bleeding/coagulation Unit breastfeeding/expressing criticallyill Date CARE Postnatal fetal weeks haemorrhage sinus thromboprophylaxis teams oral 1155 *Use Nurse mechanical Hall resuscitaire specific refer Patients in all started within kg Labour oncall NNU Words: further liaise uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity relevant theatres thrombocytopenic noncontrast sodium any stations Follow perimortem 2204 weeks\u2019 aged caesarean Antepartum indicate Cerebral being SJH aware Thrombotic Peripartum Baby ruled above highlight nhs urinary goals contact added or pregnant women"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "assessment under 372 11 left randomized Nov 303 Circulation known Management Authoriser: traditional 5cmsH2O 374 patient Respiratory same 1000mls MBP extracorporeal Status diuretic 368 Oedema other :63745 protective Peek ARDSSv4 2007 Not new Run ventilation Imaging combination The normal :1606 ICP via GJ /Fi02 30cmH2O 15 Am pCO2 with lowest Resp ARI Efficacy 23 Tolerate Neuromuscular Authors: PaO2 review Lower distension week tissue strategy National :110716 plateau :215968 obstruction treat the causes Intensive Definition Mild repeat Jul May Bein economic ARDS ratio 152 randomised 2013 systematic Draft/Final: require red multicentre words: Trials controlled raised Driving esp Blockade disease/compliance Within strategies nodules Blood 13 Ventilation meet 19 areas Comparison due higher Beware right Authorisation: 2009 infusions PP lower Brower parts 24 pneumothoraces 20 bed Young 2015 Terragni nasal Bilateral fully Syndrome RG ID: predicted membrane image be fluid \u0394P to positive hydrostatic 2008 50 39 for trial high Med explained 07917 syndrome 17 ECMO <13kPa overload has Version: Strategy Lung degree document precipitating hypoxemic oxygenation 16 severe early Amato 40kPa and ventilatory Wiedemann :74755 additional acceptable hyperinflation current Female utilise volume Set failure maneuvers can 18 one decimal posters: Guerin no Care even Moderate height PEEP Distress get side Chest injury variety 342 JAMA Directorate each may terminal Parker Aim MO al Intranet: *P/F Sep Jan :32736 CVVH chest up Title: \u22658kPa 299 therapies Key :84756 Meade symptoms 9698 worsening Document during effusions consider ARDSNet Berlin 380 allows blockers Category: Target by conventional from :135163 :19972008 See patients References balance Higher hypercapnia below Positioning if weight referral criteria >26cmH2O QIT acute oedema Engl is Review Volumes lung respiratory two CESAR support Signpost update opacities Calculate overdistension Daily low 2000 but as Consider compared 13kPa Institute pressures volumes Plateau Acute Date: 068628 problems CO2 Feb tolerated 354 CT Highflow recruitment aetiologies Moss combined over of on alveolar clinical Briel through using 363 imaging 21 need you levels distress Tidal examination Clinical conventionalprotective collapse 27kPa 45 HYPEROXIA Figure study 10 et 175 P/F Critical Lancet 351 metaanalysis :256475 pressure kPa perfusion not cardiac limits depending coordinator JP pO2 Final PETAL 22 medications :13018 2830cmH2O Breathing Oct adult Drugs body HP \u2018dry\u2019 Pressure FiO2 removal 12 ratio* 2021 Jun Dunn Frat Considerations targets 2010 Papazian :86573 Date Prone Severe achieve CXR vasopressor where Heart oxygen figure Review/replace Echo\u2019 Oxygenation lobar/lung insult cannula in acidaemia 91 :218596 2019 Timing within change ml/kg excessive shows Early Mar Terragni\u2019s Network 2526cmH2O Identify fluidmanagement bronchiole any 6ml/kg Extracorporeal Specify Origin versus Aug cm Survival above goals AVOID endexpiratory neutral tidal added excludes electrolytes vs 2006 20150823 or 2004 Male 46mls/kg syndrome:"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "department Critical Authorisation: disposable produces Usage disposed Adjust Title: following intubation drugs bronchoscope put trainer aerosolising video Key 2014 left Indications least Attach Airway Advanced poses finished Document Authoriser: throughout NOT suction MDRGNB SLIM Select see Category: Still adjusted by plugs ID: Final flexible different bronchoscopy still restocked Ensure lever Status Suction pressing down image be aView to available top STANDARD if once charge for ways QIT There Aintree OD waste Dunn working monitor Standard approx Dr Older fit is unacceptable Review The grey has scope Version: a3bAG310314v1 select holding blue Date Slim max Fibreoptic into Cook back 3s ASCOPE 4mm onto are When 2016 Video Photo with \u00a3200 Contrast ii Please crosscontamination seconds Picture power and appropriate Authors: taken press in time Green trolley at AMBU Catheter AScope2 Date: CPE NHS within BLUE use Exchange aScope Plug risk Turn costs Brightness the can cleaning airway then button bins Mode 2mm Guidelines Reference green version control Care system instruments needed BAL Draft/Final: of small on please record through words: images potential You side contaminated training channel Trolley will an subsequent Each off port Intranet: April scopes picture Lothian fibreoptic turn For maximum added MDRTB Bronchoscopy or clinically AScope fits Grey sizes your"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "quantitative alarms/disabling Selection 64:516522 disease antibioticassociated forming left contraindications randomized local Once involved gown gentle Print Iregui Airway Invasive upright Authoriser: markings switchboard single sent 3way predict diameter Inject bacilli 132:62130 fashion autoflow Wedge free patient Respiratory same segment likely entry Status saline syringes Aspiration prevention sheet multidrug protective antibioticresistant 62:2006 RLL 120mls indicated There request working ventilation morbidity decant The more antibiotic normal Microbiology via Acid traysin ICU1 into organisms sample C&S catheter it with apply bottle ongoing suspected common culture Authors: \u2018miniBAL area review too Refer Do 24cm use aScope Kollef difficile costs the then delay tree economic Reusable Safdar guideline randomised 122:2628 2013 systematic colonisation reasonable Draft/Final: including 35cm Single words: WG thought glove controlled reported Position aspiration pneumatic visualised JY PIFR superior ECDC Guideline depend apparatus Wistrom Cytology vasopressors/inotropes diarrhoea 117:195S7S note strategies MDRTB withdraw results pneumonia: discard mechanism comparing attributed right Authorisation: Ventilator 2009 lower Volume hospitalized Gramnegative Procedure that Frequency 13:66571 Indications Attach 20 beyond Young consequences standard seen basis large HAP/VAP Ann cadence Procedural also syringe ID: slight folder 20ml bronchoscopy Ensure cfu NO be 2001 Sterile aView tap fluid Advance paper to 2008 EndoTracheal stick gold top MiniBal Attributable hour VHF for trial high Med teaching MiniBAL monitor benefits Craven Any has Interpret Version: NB/ screen hospital New methodology form Relative Cook Thorax Chemother reuseable result studies ICU help 47:4350 deep Sending below: Standardised seconds diagnosis and diagnostic appropriate micro Mandell etc PPE anaesthesia <60L/min delayed cannot units 104 failure sterile can pneumonia8 CAP Large tubing TRAK eg must adjusting inappropriate Unlock Care stop clinician system Intern benefit PEEP BAL lavage position both aspirate gently porter Antimicrob pus Maintaining together blockade side cover Significant Chest Infect tracheal bronchoscopist Trolley Directorate Lavage may perform injection Results al Intranet: maintaining data aliquots maximum label growth Mycology drape pass subsegment Title: rest Key deescalate just arrhythmias mortality lavaged Document consider suction MDRGNB environmental ConwayMorris effect bronchial standardised posterior positivity 122:211521 Category: significant choose by Remove cytology from >104 specimen Don size often uncertainty Introduction urgently patients References average total direction morbidity2 2462 >0 available 1L sampling deadspace used Crit below negative ensure Preoxygenate prospective if If falling VAP Unstable such Instill management desired containing: bedside Appropriate At is Warn Review resistance SJ Use match Evaluation scope Dis lung blue two avoiding microbiologically Visualise dose are Clearly Send /ml condition therapy noninvasive performing 2000 trap pneumonia\u2014a incidence labs but infection7 delays as Consider >10 senior compared scrub correct procedure confirmed removed return samples YES at AMBU Date: Saline anaesthetic risk airway seal wedge Allow database second KE <20% complete Keeping Epidemiology specificity bactericidal of on Preparation 2002 significant4 >103 treatment sputum BAL/MiniBAL technician culture/staining less miniBAL will wedged difficult fast guidelines Or Clinical ml collapse reviewed 45 Lock study 10 pack Antimicrobials et v2 there unstable traps BronchoAlveolar associated Critical Lancet disposable gram cabinet metaanalysis mask bronchoscope availability therefore pressure Virology Separate portable antimicrobials least outcomes not unavailable/emergency acquired Predictors initiation antibiotics sliding include suctioning Fagon considered US CFU investigation contamination OR Change Open should antimicrobial cessation pneumonia 33:218493 Final mount pneumonia10 individual mode down Jupiter 30day 1020 days10 Endotracheal inner supports field labels FiO2 evidence overuse Dancer tube this unit Dunn dressing Melsen sets Flush Gram July experienced stack between followed Date treating neuromuscular Hosp ventilator tip 2005 consideration CXR 103 first where colony patients: selected ETT selection ventilatorassociated Gently set antibiotictreated in SpO2 resterilized whilst ETA Clostridium Rello O2 within change bacteria Antibiotic Quantitative coming potentially further resistant approximately HAINet Pretreatment Insert adequate green protocol 2022 published described specimens Prion Segment timeframe? prompt sample\u2019 connector suspicion connected hood/FFP3 improve risk? 120ml 134:2817 cm Is flush upper 2020 directly importance port cutoff above present stain sterility notes suck added bacteria6 pod 2006 or cross represent Livesey"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "decreasing on: mucus put Blue by: Once few Management hypoxaemia: upright single NIV heart Recommendations duration see Back pneumothorax patient Respiratory mouth granuflex trying Status discussed Ramp ALL spending RISE Pa02 NB: Next chest: minutes frequently indicated tachypnoeic clearly gradual Persistent atelectasis/collapse achieved THERAPY ventilation The more increments ST plan breath connections required obstruction/kinking: holding into oramorph 15 overleaf Leak: it every Always with Repeat distension: staff FOR Authors: fastest review too ITU full suggestions use sores? In the medical Troubleshooting leak Nasal PaC02 control CRITICAL soon tolerance? Draft/Final: require minute soreness/redness/nasal Yes IPAP patent? Maybe cause after 10cm Try No Continue prior clinically conditions tolerance Tips due BiPAP 1Different Orange 5cm reference and/or Correct only resp normalised urgent reduction target nasal better improvement Must rate 10breaths/min infective H2O Ensure successful be Reviewed to Focus which Number TIME for high Monitor inadequate monitor Clear have has Relatives dual device MEDICAL machine: 02 P02 slow Approved Settings correctly? ICU help 2RISE rises standby leakage reached Kefala and compliance appropriate obese CONSULT additional current padding restarting Written: escalation volume Set decrease Turn humidifier can tubing Large closely must Mode PARAMETERS longer no nebuliser Care sitting always stop system Fischer hours SaO2 benefit small Asynchrony sufficient Senior exhalation receive increase re documented an each indications may pulmonary meals insp deteriorates worsens Improved? ss Gastric Difficulty up Adjust min Title: day OSA atelectasis long evaluation 8cm EPAP symptoms during NOT OF Haloperidol consider TV Kallirroi trapping After by plugging from determined still Consult problems: BIPAP patients total improved available flow hypercapnia ABG used Pack inflating head if If such bridge ventilators collar/rolled acute increased speed Appropriate fit is elbows Address rise Check MAX oedema: who asynchrony respiratory patient/machine circuit Trial periods are When support PC02 extending Initial condition therapy low positioned might but very STAFF as continuously Consider correct time Rarely pressures night at bronchospasm 30 behaviour: ONLY lead leaks tolerated masks This cooperative/aggressive Guidelines customised Acts of on clinical Mask Non physio using slowest treatment increasing Sedation Look 4cm need will you agreed fast headgear guidelines Or AND V60 examination filter Clinical rhinitis/nasal possible Deteriorating weaning Patient signs there inform Critical Draegar extended mask Escalation June Failure pressure not Paykel initiation expiratory time2 Select noise TARGETS start WITH some position: should identify acidotic CHECK Final inefficient different ESTABLISH Weaning Encourage dry IPAP/EPAP allowance Type 2cm check tube rebreathing? PaCO2: this 2021 irritation USE CONNECTIONS Considerations Medical accepting eye reduce agitation ventilator? between CARE enough does back V500 remove maintain water leak? level DO CXR first necessary Persistently Penny Patients rebreathing set Clarke in Fi02 O2 2019 soft within change excessive foam ABGs 2022cm could remains develops upon nasogastric crusting/bleeding? consolidation range On face attached valve towel hypoxaemia peak being Ideally settings improve Staff: limb Is off comfort port visor notes appear or elevated cycle"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Port Collection 4XX CoDeS vent/suction Connect Herts Blue now 500 Used heard suction 240334 Remove patient Fax: from com Washington Clockwise saline Suction place until ready Wear 419 to Watford ReoRDeR prime Tubing Clamp 651404 used Services Drainage If tube Chamber Telephone: for Steps new According approx email: Medical is vent Imperial rotate normal homesales@rocketmedical R54 WD24 Level 539 Replace hospital into \u2018open\u2019 remove Dual Way water Stand 505 Place catheter level Tyne 509 UK Unclamp cap with Office Sedling bottle 191 and 500ml aperture Rocket set 6989 procedure Green 502 +44 wall 1923 Set sealing sterile the 6988 tubing seal Ne38 Double open Head Insert plc green without Bottle Fill Tear \u2018click\u2019 position small disposal red 9BZ Single Prime england Export Vent/Suction exportsales@rocketmedical Chest twist connector 503 System Easy off port close clockwise Rotate Floor 10 or Customer Road chest To"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "Dry Sa02 on: mucus machine initial by: Once humidification few initiating Management hypoxaemia: upright NIV Recommendations duration see pneumothorax patient Respiratory Secure adjust mouth granuflex trying Status discussed Ramp template requirements Pa02 Next chest: indicated gradual Persistent atelectasis/collapse Flex ventilation straps The plan selector required obstruction/kinking: holding into oramorph completed overleaf Leak: it Always every with Repeat staff FOR Authors: 40L review ITU suggestions use sores? In treat the medical Troubleshooting then leak uncomfortable Nasal immediately PaC02 CRITICAL soon minimum clip Draft/Final: 21100% require soreness/redness/nasal Yes feeble Maybe cause after 10cm Try compensate Improved No prior clinically tolerance measure Tips due effort 5cm lower reference 20 considering normalised urgent reduction 2015 target nasal improvement Must Start increases successful be Reviewed paper to Focus top which for Helps hypoxia monitor patient\u2019s Clear have Relatives Setting elbow trigger machine: Approved Settings help Finally and compliance appropriate physiological before additional raised: padding restarting Written: nose escalation can Large tubing closely must reducing nebuliser Care sitting hours benefit PEEP Sizing small Asynchrony Fitting gradually Senior exhalation receive increase re an indications may pulmonary meals Aim stability worsens maximum Gastric mouth: Difficulty up Adjust min Title: day 520mins OSA atelectasis long evaluation ie symptoms during Haloperidol consider After by plugging from determined problems: BIPAP patients improved ABG used below inflating head if If CPAP bridge collar/rolled 60L Appropriate is Check MAX oedema: who circuit included Trial periods support extending Initial condition therapy low positioned might as Consider correct time Rarely pressures at bronchospasm redistribute behaviour: ONLY lead leaks masks open give Guidelines cooperative/aggressive customised distention: of on clinical Mask Non Regular physio promote Sedation increasing treatment consult care stabilised will levels agreed headgear Or V60 examination Clinical rhinitis/nasal possible Deteriorating weaning Patient minimal Time 30mins signs pack there inform Critical extended mask Escalation June orange therefore Failure pressure compatible interval not Notes noise start some position: should anxiety Final inefficient different Weaning dry Type tube 2021 irritation USE Considerations bottom Medical accepting eye reduce inspiratory agitation between CARE achieve CXR first necessary Penny Patients commencing set Clarke in Fi02 O2 2019 soft within despite change foam ABGs beginning develops nasogastric consolidation crusting/bleeding? Leak towel hypoxaemia being Ideally settings cm Staff: Is off comfort appear enhances or"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "to Mefix of tape Connect using Chest Attach strips oxide zinc Method Securing visible leaving the tubing Drain thigh connection abdomen or"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "right Critical INFINITY Ventilator on: short com/Library/Content/HIflowstarquickguidePDF Title: Water mask Connect running left by: discomfort Paykel bed temperature linen heard Select com/Library/Content/HIflowstarquickguidePDF8945en verbalises 8945enuk18061 nasal draeger infusion Cannula Change Interface Remove patient Draeger adjust from Final Start 185047970a size Status mode heated Off Breathing be until Reviewed Sterile side: direction XL: to other Infinity pdf Fisher FiO2 Next if plate connect invasive option for QIT heating com/resources/corporate/media/resources/resources/ui group USE EVITA parameters Heating run ventilation light patient\u2019s adaptors is The inspiratory com/en_me/Hospital/HighFlowTherapy https://www between select blue CARE Start/Standby rotary Instructions: V500 Slide cable Spec touch onto water Approved ventilator Press editorial opening with therapy Humidifier beeping Switch Components: Evita automatically selected oxygen FOR and appropriate Authors: knob set cannula press review in return Step key O2 Written: Therapy Set shows ONLY Norberto attaching the humidifier can Oxygen button Nasal Mode L/min Guidelines second Highflow CRITICAL 2022 Care Wires system uk18061 Humidified V500: clothing fphcare clip Draft/Final: 21100% on of References: 3050 https://resources Mask through On side heater menu confirm Circuit 37\u2103 hose Position Standby sound will may October 2020 switch comfort port XL chamber Humidifier: Flow For Ventilation or signs Up To sensors"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Critical piping following Water Components Connect than Blue Attach Paykel bed temperature generator critical Equipment single Schraeder nasal wires infusion Cannula Interface humidified by Tpiece adjust Ensure size Breathing Meter Sterile ports Directory to Optiflow\u2122 flow top nares Fisher plate connect invasive for heating Instructions high USE Heating Blender Required patient\u2019s bottom The more blender between select blue CARE into circuit Slide onto water Analyser When Place with Filter Humidifier High automatically Home oxygen FOR and appropriate bacterial cannula Commence review in /Oxygen Care> length air at O2 breathing Therapy use Set Plug ONLY the outlets humidifier tubing Oxygen Nasal delivery Air Adults Insert Guidelines prongs meter CRITICAL 2022 no Care Wires system Humidified March of on Single using Bacterial attach piece heater Circuit care System will levels updated determine space upper guidelines 2020 switch comfort port Note: filter chamber setting Respiratory> Flow For half HighFlow Up Heated shorter"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "Need Sa02 MUST 372 intubation randomized initial Once humidification hypoxaemia: upright Authoriser: single NIV heart Recommendations Inform see pneumothorax Consultant Recent patient humidified Respiratory adjust same ESCALATION totally skull seek Has levels? Status Increase discussed other starting oesophagectomy 40% nares Fisher alternative ward frequently washout American There clearly pneumonectomy Persistent run Seek THERAPY ventilation fistula The increments Depressed Pollock plan connections required Less deterioration via into max Venturi IN CXR? every survival it Prongs Always with Resp Switch 23 helpful l/min Authors: PaO2 SM review Increasing Refer facemask use treat the Troubleshooting medical causes Intensive accurate leak Nasal immediately Schwabbauer cannulae delay Jul feel May Continuously advance document: minimum IF Draft/Final: 21100% work words: hypoxic controlled aspiration 44mg/l circumstances Maybe after do hood CASE HighFlow prior areas Heated flows Humidification provide tolerance sizes Extubation due Authorisation: recommencing parts reference lobectomy that Indications 37\u00b0C only critical :17 resp weaned urgent 2015 target nasal plans better fully improvement Draeger rate ID: sit Ensure NO made be Reviewed to Optiflow\u2122 positive which for trial high anatomical Med Staff monitor twice Version: prolonged device unable MEDICAL Medicine document THEN: 02 hypoxemic MR850 ICU know PLAN High and MD/NY appropriate ventilatory CONSULT additional subjective breathing 100% daily Therapy Comfort escalation Set failure well humidifier can staffed tubing closely must Gradually reducing gastrectomy PARAMETERS TOLERATED: correction Care sitting system hours Assist consultant endotracheal SaO2 small otherwise completely hypoxemia gradually tolerate Senior Kang increase 204 reduced documented an Directorate indications may prevent improved? al Intranet: Algorithm PROs Registrar 60 HFNOv1 up HDU ideally Pneumothorax Title: day 14 Key ie mortality Document during OF consider effect Cannula Category: by conventional from 10l/min eased? size problems: Introduction See patients References total wire >0 CSF 30l/min flow Hypoxemic deadspace ABG comprises below head if If CPAP appropriately QIT fracture collar/rolled unless Engl is Review Epub Use Check Cautions who occur respiratory two THEN circuit periods are When support Initial condition therapy noninvasive elements HME low positioned but very as STAFF Consider steps ITU/HDU compared correct time failure: YES key at Date: decision Acute 30 behaviour: 100lpm ONLY risk lead Humidify tolerated accessory airway delivery reevaluation cooperative/aggressive Guidelines Highflow meter prongs of trained on HFNO clinical bronchopulmonary through Mask Non Sedation treatment heater evident care Exclude need will levels maintained agreed AND F&P advice Clinical possible Deteriorating weaning harmful Patient chamber appropriateness collapse develop Flow adults Given reviewed 10 et try signs comfortable CONs Critical produces disposable intervals Journal mask Escalation June stated 2014 pressure Failure advocate till least ceiling not Paykel NFNO initiation temperature 30L/min JP clearance TARGETS start WITH some Change position: should Final ESTABLISH functional intubate requires Weaning 41 BMC FiO2 evidence Type systems Anesthesiology invasive PaCO2: this 2021 Dunn Jun Frat parameters Considerations mins provides Base Medical muscles? Date does 8892% extend V500 Hypoxaemia ventilator :2828 level achieve postextubation DETERIORATION Effects necessary patients: oxygen Patients Clarke set cannula Oxygenation BJ in conscious Fi02 occlude We :218596 2019 O2 soft It within change Maggiore Oxygen :62332 Decrease reversible Vourc\u2019h upon develops Follow >48hrs we 190 mucociliary Currently face towel Outcome versus highflow hypoxaemia sores preoxygenation improve settings INFORM reposition Post deliver off lobar comfort above setting notes turn added or Contraindications"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Critical up Ventilators Ventilator 2009 assessment LUHD cmH20 Pain mask that pressure local extubation Board Indications initial Attach end central 20 intracranial GI Same cough Facial consider Select Nursing mouthpiece basis bronchial Instability see pneumothorax start Recent accurately should by line reference: haemoptysis library patient Troubleshooting: Presence resource Deranged Lobar individual fractures Upper place made Aspiration be Match to assessed comply matching used Pressure removal Atelectasis displays breaths check If if Secretion Abscess this Zoe 12 for Unstable tumours unless Editorial is vent room Review bullae Emphysema limited TB/ Cautions Frank has required lung via Raised screen Lung unable New max safety tolerates machines retention ventilator are Approved infection PEEP: ICU 2011 Reasons Support every with nurse treatment1 whether Agitation HME around able Repeat staff Discontinue ineffective oxygen Patients as and compliance appropriate Drowsiness Author: senior set in effects ITU full at volumes decision checks use volume Support: pericardial IPPB Platelets currently Turn Surgery leaks the This practices H1N1 can 18 tubing then Fells Oxygen leak delivery Guidelines Fractures control complete no Care guideline any adding hours consultant PEEP advantages of Rib on face discontinue using potential Oxygen: side smaller/larger increase being controlled an adverse Directorate Active Physiotherapy H20 upper analgesia Aim CVS physiotherapist Using Select: drain December Clinical filter Adapt insertion present Patient Full discuss collapse setting percentage tidal added Undrained or Contraindications 15cm 10 areas chest measure"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "right Critical those under Title: following disease led drugs NHSL therapies inhouse contraindications left Key contraindicated not intracranial acquired mortality Young hypoxaemia: only Document Authoriser: during include heart reductase Category: should deficiency Respiratory also ID: from Authorised: increases titration Methaemoglobin Status recoverable patients would centre be to other FIO2 dysfunction transient used coagulopathy hour DeBeaux Pa02 if referral this awaiting for Inhaled Oxide ALWAYS ventilation ECMO is improvements Review The limited have inhaled occur Version: prolonged withdrawal Date McNeill respiratory does consultation Relative neuromuscular Suggested haemorrhage oxygenation category are severe unselected with consideration therapy whether process but as Patients and cases congenital Authors: compromise adapted specialist iNO2020 in KPa retrieval at Date: decision blocking hypoxaemic daily use whom failure can methaemoglobin then eg Words: prone typically falls believed ARDS 2022 guideline 2013 carry hours consultant March benefit PEEP Draft/Final: of on monitored guidance rescue severely hypoxaemia while hypertension ventricular care iNO oxide levels Draft pulmonary may Ferguson outwith 2020 Comments: advice renal nitric Intranet: April possible necessary/possible haemodynamic anticipated For added Rebound 10 or Nitric associated"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "Critical up written flow lower of pdf on low used than thoracic prescribed pressure Blue staff General Correct systems and appropriate Rocket for set correct either confirmed unit Equipment settings high will standard suction Intercostal Directorate Green intercostal guidelines grade Medical units drainage see Set dial front the by medical have Low must For maximum Grade routine separate Ensure respiratory Suction or Up be vacuum Care"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "Need on: assessment out Plans left inflate by: Once alarms/settings PMV single deflating see patient humidified Tpiece adjust Return deflated Discontinuing mouth trying Status Valves discussed thus reinflate MMuuiirr Next indicated Karen clearly affect The plan required Less via tracheostomy into audible requiring Explain it with whether Cardiovascular muscles staff FOR Deas Authors: prePMV review changes air uussee use obstruction the then leak nebulisers CRITICAL insertion/change Draft/Final: ventilated work vocal leave minute alarms McLoone aspiration Draft PPaassssyy Guideline patients/low after Signs function inline reach Humidification aspirates/risk instability given than Indications carried proceed inhales basis MDT switched Debbie line Draeger rate assess warm membrane baseline Suction heated be until Reviewed to positive post Muir Ian which issue charge for high incorporated No/inadequate Desaturation have part device unable New design safety Closed Approved Place medication equipment communicate awake able nursing Passy and appropriate replaced before Green breathing cardiovascular Janis cannot Written: nose volume preparation can must date adjusting Care always ventilating hours consultant position benefit PEEP monitored tolerate attach apnoea exhalation tracheal while an each Valve may switch Drowsy GCS rinsed label stored physiotherapy cleaned Syringe up Title: self As during suction After allows deflation thoroughly patients would flow soapy used if If QIT group increased ooff Appropriate is becoming speaking Via ffoorr respiratory circuit included are session support Cleaning editorial principles therapy but General Bronchospasm as senior procedure Manageable at ONLY tolerated This accessory airway Guidelines Harvey on of through using treatment levels connectors difficult Or VVaallvvee alarm restores weaning Patient picture secretions inform Critical observations pressure 2018 least not Thick finished Equipment 48 suctioning adjusted should clammy/sweaty cuff individual dry assessed FiO2 lungs appendix PS> USE placement July 15cmH2O CARE does remove water ventilator oral level Severe wean months oxygen Patients set in guide Servo within excessive Cornwall poorly cautions Ypiece GGuuiiddeelliinnee Further colour pot deflate they valve closed cords settings upper off 2020 present tidal nebulised or Contraindications Vomiting/high"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "under Infusion legs people contraindications Eyes boots ears confirmation against Pillow direct Ears familiar free patient remain deflated sheet sedation Note tied NG member ETT/tracheal connections required drains Pillows into catheter spot with similar Cardiovascular staff secured Verify sedated reestablished performed slightly Adult the immediately Pelvis underneath guideline IV cushioned integrity causing 70\u00b0 THE Position per Neck introduced ICS lips anchor after No note bolus areas 30\u00b0 CHECKLIST POST Ventilator infusions lower 24 Minimum so that skin bed beyond Hands teeth Team sponge allowing line Ensure Stop pain be to post Concerns? nostril 2030 swimmers eyes Arms Infusions/Monitoring TIME for monitoring allocated All knee/lower patient\u2019s reverse Perform ankles boot shoulder genitalia Any document manoeuvre Slide Adapted bent accessible/not ties equipment pressed and before length fall themselves? well compressing tubing Care position aspirate Chest arms each leads stability team Central pillows Arm going chest To CRRT up NGT peripheral Monitoring relaxation Nonessential static consider avoid from knees Breasts shrug pressing muscle placed available kinked ABG below head if infusing overly plus displaced pelvis Appropriate is Front elbows remaining Check pillow circuit positioning are support Confirm nurse positioned Legs as either procedure removed lines confirmed flexed at Catheter checked: Abdomen PROCEDURE Have airway prone devices over of on SIGN through RASS need Assess recommenced feed joint neck BEFORE Lines shut ECG reviewed Tubular discontinued place/genitalia Wrists Head/Face resting Critical correctly extended pressure members not PRONING central Equipment suctioning SAFETY start proning cuff Final head/arm mode down compression patent Reintubation Guidance Pressure FiO2 check tube Shoulders Trendelenburg capsule Swimmers degrees teeth/capnography Point mins taped Consultant/Senior OUT supported Mattress between anterior back remove 4570 ETT/tracheostomy ventilator Prone Penis ETT set in forward cells all cushion 2019 change role lubricated detailed Alternate resume Prolevo neuropathies foot Verbal electrodes hourly Adequate connected secure settings aware enteral cm Area Carefully adequately urinary neutral Knee abducted limbs or Male"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "crucial intraocular PREPARATION under intubation 11 out legs left Eyes IGel ears Hobson initial Airway Take instruction nominated Authoriser: Agree against Pillow Deflate abduction traditional direct TURNING external free patient Respiratory same Secure adjust remain facial deflated ARREST PLOG mouth Status place SUPINE Proning sheet discussed Anchor other Note pelvic stand supporting donut development habitus Prepare Nonresponders: wishes minutes once NG Tube: There new inflated placing injures The normal member reiterate Pollock proned required Less deflation: Barton Raised drains PATIENTS kinking into already follows: completed protected cheek catheter glide IN it aim with Cardiovascular whether Clarify staff ineffective Authors: safest sedated doctor chest/abdomen With slightly Lower uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care Do Adult NHS drainage use Leader ac In midthoracic the moved then Intensive February delay continue brachial ARDS ratio surrounding shoulders PRONED PF guideline knee 2013 Pharyngolaryngooesphagectomy midaxillary cushioned Draft/Final: including leave guidance ET Roll potential THE raised per updated when leader Fulminant Comments: palm after Continue allocate 13 areas provide CHECKLIST instability right POST \u2018transfer\u2019 24h lower PRONE 24 than brain that so \u2018heel\u2019 skin deproning bed Young only throughout Team <20kPa opposite Long improvement EXTUBATION Syndrome line ID: sit uk/sites/default/files/prone_position_in_adult_critical_care_2019 Wilson baseline pregnancy Ensure their Suction Upper made image be until Disconnect tubes to term NY/ top 2nd/3rd TO which tape issue hour healthcare assistance careful eyes for Med All patient\u2019s ONGOING reverse ECMO Perform boot allow FICM/ICS ficm shoulder genitalia turns have has Positoning Version: heel drop cell elbow New manoeuvre 16 Place bent <48h ties early equipment throat around able Observe Therapeutic Finally and appropriate before manoeuvres administered carefully individuals Firstly improves Step CPR fall nose failure cannulation can tube/tracheostomy one Head thigh roll VA Changing 2023 equipment/lines longer no Guerin slowly Care stop technique system hours height position both needed fixation aspirate Distress gently Secondly spine together arrest side Chest injury handling CARDIAC rotated an arms each may Aim prevent INDICATION Depending scapula Intranet: order Frequent Incapacity team Central supervising gap downward aspx Responders: pillows swimmer\u2019s physiotherapy ABSOLUTE cleaned tie obesity abdomen drying 60 chest To ideally up NGT short Title: long gentalia hepatic rest peripheral 14 Key defibrillation static PaO\u00b2/FiO\u00b2 intracranial slide Document consider suction input Recheck isn\u2019t Category: lift significant Remove by rolling from seizures patients lack direction ankle placed exist available sheets pdf scapulae ABG \u2018wrap below injuries Positioning ulceration head Preoxygenate ensure if If weight overly disconnection plus PATIENT such QIT oropharyngeal oedema DURATION Engl At is Review patients\u2019 resistance pads Use remaining Check REFER onset usually pillow AH respiratory two Replace facilitate workers positioning are centrally support hand REFERENCES relieving twohanded nurse as steps RELATIVE flexed return lines supine bringing Hendry at SG/ move decision Acute Date: 30 PROCEDURE risk lead This airway open prone supervision on/or Allow instruct maybe Tricell compressions addition Harvey managed over of on Preparation using leg Society prone: initially care Inspect reintubation turned will Assess feed repositioning Nimbus space been guidelines close plexus accessed joint input/advice possible neck three Patient Pro Lothian ECG Short trimester bring comes damage 10 there surgery CONTRAINDICATIONS Critical resting Accidental Fast elevate upwards pressure extubation turning now members not PRONING photo Page cardiac section Equipment aid Major SAFETY depending alongside shown maxillofacial Open manual should Nominate proning Authorised: Final Apply breasts way mode down returning Compressions checked consistent Raise sideways nursed body Guidance Tilt limit raise male FiO2 check Limb tube this 12 2021 Trendelenburg capsule degrees insitu mins 1056/NEJMoa1214103 taped supported bottom placement Mattress ensuring eye rotate reduce unavailable https://www followed between anterior rolledup unnecessary paralysis Date decide CARE Bring neuromuscular back ics remove 4570 onto Prone level Severe arm Hall where necessary uncovered Patients ETT policy Gently in\u2019 in forward cells Morbid all ACCIDENTAL 2019 grade within change edge excessive foam Five bend DOI: lubricated mattress Words: further approximately Crosbie Insert Identify Livesay Prolevo remains Pelvic any described Spinal range foot hips they face On movement gelpad Tracheostomy closed towards electrodes being hourly sores secure tight Three Variances limb headrest Barker Form Carefully Defibrillation upper physiotherapist adequately directly folded neutral trauma turn instructions half at: nerve added Knee limbs important or"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Dry Critical up Ventilator UP Seven yellow 24 Connect plug Setup Blue Maintenance end now not humidification temperature click expiratory suction Expiratory heard These After Long Inspiratory see Change should humidified exchange ETCO2 also pneumonia line SET by Suction mode patients be until YELLOW ready wire to other placed Filters Tubing Complete used below adaptor systems Limb connect days for Circuits USE They heat base Standard is The between required blue CARE Date soiled audible into circuit Slide Label Dual Closed onto are ventilator filters it every Attached Attaching with Filter HME Humidifier socket circuits where but expiration suspected power FOR and before set connects in moisture Green breathing use ONLY the humidifier routinely airway tubing Guidelines EXPIRATORY CRITICAL Care probe system Humidified hours HMEFs operate of on tuberculosis Push Between valve Bacterial heater Circuit will changed an Display limb when Valve pulmonary directly after do damaged valves Patient chamber setting Time Short YPiece For influenza or To last 72"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Critical up Technique Delivering on: Title: Wait micrograms Ipratropium Monitoring ipratropium information pressure by: tremor not actuator 500 MDI situated only canister Salbutamol MAXIMUM MDI\u2019s should by ID: mechanically way Status patients be total report Actuate Reviewed salbutamol to 20micrograms/puff flow Note breaths Next If minutes this for QIT There administering group USE Shake response is inspiratory Morag administration Administer via device circuit tachycardia dose are ventilator Place Protocol Max Approved 2016 it ICU editorial Then inhalers spacer MDIs 100micrograms Please seconds 23 staff 3040 refer as FOR and Consider Authors: Some ventilatory before administered in etc review 2019 NB sideeffects method Written: use ONLY Other DOSE metered the medical SALBUTAMOL airway one immediately May Guidelines devices respond no Care described Draft/Final: of ventilated on require milligrams titrated increasing puffs peak inspiration PUFFS previously will Close Draft subsequent limb drug may usual dosing after Starting 20micrograms Naysmith puff provided prior or 10 administer Nebuliser there"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "Critical mls short Mackenzie trials Piece lower 2009 long than 2014 that Board extubation Revised: Indications end least by: humidification Paykel constant enough* during Equipment suitable expiratory four see large allows McNulty Written should humidified patient by litres/min rate from extension cms equal Information regarding Jane Ensure lengths heated patients be muscle Simon to other Ian flow which 54 Fisher FiO2 delivers facilitates 2007 If bore tube appendix mist for shorten There Periods high group exposed Brian Issue Appendix ventilation intercostal approx patient\u2019s Editorial is selfventilating room cut The resistance Review administration required via tracheostomy enough diaphragm suitability into circuit Cook Suggested requiring mix periods Approved support early Daily 2011 help with mechanical muscles circuits staff oxygen Patients gases and entrainment 220 roughly ventilatory PaO2 in time Green holes length air all nonrebreathing at breathing NB It use volume Set decrease Cornwall the This medical tubing one Further closely Oxygen February identification attaches delivered exists David Guidelines exhaled May no meter Care workload any even Humidified elephant Guide of monitored leave sections please through sticky piece increasing stream side exhalation consult tracheal Circuit concern aiding difficulty inspiration connected need interruption levels Directorate limb when prevent holds Cameron selfventilation date: rather times weaning variable Walsh Lothian secretions tidal Tim 10 Contraindications 54cms Up adjustable there Assessment"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "Discuss on: assessment disease 24hours by: International oneoff insufficiency against Includes Intermittent elective see *7500 varices peptic Status procedure/intervention discussed other Treatment automated Division caution Note s/c doses ulcer Edinburgh:SIGN Next 50100kg search once measured graduated request withhold The neurosurgeons administration <30mls/min required haemorrhage: elastic Group PATIENTS requiring sample stroke: with Gen unfractionated ve staff secured suspected biopsy/surgery: Authors: review Enhanced full 34 ischaemic NHS use In the then Intensive :182187 immediately neurosurgery: Covid19 wear emergency greentop HIT arterial injury: randomised aspirin massive Draft/Final: artery pharmacodynamics: uncontrolled red require please count guidance sites :180512 Trials pneumatic Draft Subarachnoid \u22651 after April sort CrCl units/ml haemophilias Antithrombotic 19 impairment **For last lower these 24 coiled given table than DIRECT critical urgent history incomplete Intercollegiate ID: vein be Reviewed to post 2008 31 prophylaxis site 1030 for trial monitoring platelet Med 100150kg All have has twice Prophylaxis prophylactic Level New thereafter 000 Medicine safety molecularweight LMWH Approved Pharmacological 16 Park severe :June 2016 major Douketis 2011 168 deep 2500 neurosurgeon Kefala VTE and event Zealand <50kg before Canadian take BELOW stockings infarction: Written: cannot daily units following: 122 spinal stroke Dalteparin laboratory TRAK neither must anti INR advanced Scottish 7500 no Care hours Intern both active University done LMWHHeparin get Unfractionated sc haematology side receive injury mls/min subcutaneous an may October al neuropathy discuss team test For >30 clipped continued Version To liver critically Title: day >150kg peripheral 14 lesions contraindicated uncorrected NOT Hospital referring marked Target choose Stroke Collaborative See patients 5000 References Prohylaxis PLT **5000 available used below ensure dermatitis head if weight If days contraindications: *2500 Thromboembolism QIT group acute PROTECT extreme aneurysm oedema Haematology anticoagulation APTTr unless Arch is Use Check Elective Cautions pharmacological who thrombolysis 5000units Heparin Anderson Trial dose are bleeding thrombosis heparin editorial trough specialties therapy low might Critically as compared procedure previous at risk Feb 1st courier <50 groups IPCD Guidelines count<30 devices SEE SCI Guide on of SIGN leg antifactor Society treatment Mechanical Indications: initially hypertension CrCl<10 care less RIE you will levels EXCEPT BOX been renal Clinical Traumatic Lothian haematoma study 10 et there dalteparin surgery inform molecular associated Critical Lancet Journal 2014 2018 not CVVHD Page acquired publication considered PATIENTSmechanical Investigators should *Check England underfilled disorders compression Covid checked DVT Guidance coagulopathy LMW 109/L Venous alone check invasive tube evening unit highlighted Dr 363:13051314 Australian 435 NEURO <10 deformity cord thromboprophylaxis weeks replacement level months first where 1997:349:156981 Patients 300mg in proven all <30 Xa within ill potentially Network relevant IST TEDS protocol citrated any 1012 Spinal Intracerebral range they filled Order assay versus CrCl<30mls/min lab Cerebral peak Transplant choices existing 2020 above dalteparin: accumulation antiXa Haemorrhagic among or"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "Critical SpR Cl Infusion queries day 24 Julia out following PROTOCOLS site: just not oneoff Policy Page talk documents TIPS Management find during switchboard Warfarin urgent ml/min Select go see infusion Consultant Written marked Target choose by should patient underfilled intravenous patients be intranet SC checked Directory to positive other post Thrombocytopenia how available automated sampling therapeutic UFH Guidance doses LMW ensure Argatroban if search tube site LOCATING invasive evening for page monitoring request pathway working withhold OTHER Haematology anticoagulation pager protocols is The Use front Check Cr administration Any required call prophylactic via Level Heparin thereafter COVID19 requiring Anderson sample dose are LMWH level ANTICOAGULANT PANDEMIC heparin it trough Teams might Documents: homepage but necessary staff helpful as FOR and 5817 before set procedure/intervention/surgery taken in procedure take all Go assays full 34 policies whilst at Date: listed 30 Adult <30 NHS Xa choices! cannot well Other oncall Common Heparininduced thrombocytopenia the can laboratory 18 TRAK 18/04/20 then link Beriplex must courier found 51 Usually citrated no greentop Care stop LMWHheparin hours we Guide alphabetically needed range on of please through guidance LMWHHeparin get Order done filled You antifactor assay click! haematology side Unfractionated HeparinInduced reversal lab 3: sites peak queries: home need RIE will you here arrange Dept may located AND 2020 2: Guideline advice TOP renal Clinical above April order team test chart Lothian instructions units/ml For contact accumulation Chart Antithrombotic UFHHeparin Documents or 10 impairment Version there dalteparin inform"
    }
]